References: Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Data source:
FireBrowse TCGA BRCA Archives.
Samples:
TCGA breast invasive carcinoma (BRCA) tumor samples in file “illuminahiseq_rnaseqv2-RSEM_genes_normalized”.
To avoid possible confounding due to gender and race, we confined our study samples to be only from female Caucasian subjects.
In addition, only samples with somatic mutation annotation were kept, resulted in 700 samples.
Genes:
Only the top 10k variable genes in samples of consideration were kept.
Normalization:
log2(RSEM normalized counts) corrected for subject age and tumor purity. The corrected and scaled expression data were used as input for subsequent factor analysis.
Perturbations:
Somatic mutation status of selected frequently mutated driver genes (TP53, CDH1, GATA3, MAP3K1, PIK3CA).
Mutations were classified into 2 types: missense mutations and loss of function (LOF) mutations.
Mutation | TP53_LOF | TP53_mis | CDH1_LOF | CDH1_mis | GATA3_LOF |
Num_cells | 78 | 113 | 73 | 11 | 63 |
Mutation | GATA3_mis | MAP3K1_LOF | MAP3K1_mis | PIK3CA_LOF | PIK3CA_mis |
Num_cells | 7 | 43 | 11 | 8 | 226 |
Here, our “guide”, \(G\) matrix, consists of the somatic mutation status (missense and LOF separated) of top 5 driver genes across samples.
We specified 20 factors in our model. In each case, Gibbs sampling was conducted for 2000 iterations, and the posterior mean estimates were averaged over the last 500 iterations.
For a given GSFA inference result, we can estimate the effect a certain KO condition \(m\) has on the expression of gene \(j\) by computing the LFSR of \(\beta_{m\cdot} \cdot W_{j\cdot}\).
KO | TP53_LOF | TP53_mis | CDH1_LOF | CDH1_mis | GATA3_LOF |
Num_genes | 7124 | 6995 | 5262 | 0 | 2887 |
KO | GATA3_mis | MAP3K1_LOF | MAP3K1_mis | PIK3CA_LOF | PIK3CA_mis |
Num_genes | 0 | 52 | 0 | 0 | 6823 |
Statistical test: hypergeometric test;
GO category: Biological Process.
Target: Genes w/ PIP > 0.95 in each factor;
Backgroud: all 10000 genes used in factor analysis.
GO terms that passed over-representation test fold change \(\geq\) 1.5 and q value \(<\) 0.05:
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0030198 | GO:0030198 | extracellular matrix organization | 171/3409 | 264/8135 | 1.55 | 2.36e-14 | 1.05e-10 | 264 |
GO:0051216 | GO:0051216 | cartilage development | 95/3409 | 148/8135 | 1.53 | 2.96e-08 | 3.04e-05 | 148 |
GO:0030199 | GO:0030199 | collagen fibril organization | 29/3409 | 37/8135 | 1.87 | 6.54e-06 | 2.42e-03 | 37 |
GO:0002062 | GO:0002062 | chondrocyte differentiation | 56/3409 | 86/8135 | 1.55 | 1.09e-05 | 3.01e-03 | 86 |
GO:0007272 | GO:0007272 | ensheathment of neurons | 46/3409 | 71/8135 | 1.55 | 7.92e-05 | 1.41e-02 | 71 |
GO:0008366 | GO:0008366 | axon ensheathment | 46/3409 | 71/8135 | 1.55 | 7.92e-05 | 1.41e-02 | 71 |
GO:0030728 | GO:0030728 | ovulation | 13/3409 | 14/8135 | 2.22 | 1.04e-04 | 1.71e-02 | 14 |
GO:0042552 | GO:0042552 | myelination | 45/3409 | 70/8135 | 1.53 | 1.24e-04 | 1.84e-02 | 70 |
GO:0035924 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 23/3409 | 31/8135 | 1.77 | 2.66e-04 | 3.19e-02 | 31 |
GO:0051965 | GO:0051965 | positive regulation of synapse assembly | 35/3409 | 53/8135 | 1.58 | 3.24e-04 | 3.51e-02 | 53 |
GO:0032835 | GO:0032835 | glomerulus development | 30/3409 | 44/8135 | 1.63 | 3.75e-04 | 3.78e-02 | 44 |
GO:0061035 | GO:0061035 | regulation of cartilage development | 31/3409 | 46/8135 | 1.61 | 4.14e-04 | 3.99e-02 | 46 |
GO:0010595 | GO:0010595 | positive regulation of endothelial cell migration | 34/3409 | 52/8135 | 1.56 | 5.20e-04 | 4.44e-02 | 52 |
GO:0090322 | GO:0090322 | regulation of superoxide metabolic process | 16/3409 | 20/8135 | 1.91 | 5.87e-04 | 4.56e-02 | 20 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:1905517 | GO:1905517 | macrophage migration | 32/5002 | 34/8135 | 1.53 | 1.55e-05 | 0.00832 | 34 |
GO:0021532 | GO:0021532 | neural tube patterning | 18/5002 | 18/8135 | 1.63 | 1.56e-04 | 0.02237 | 18 |
GO:1905521 | GO:1905521 | regulation of macrophage migration | 22/5002 | 23/8135 | 1.56 | 2.10e-04 | 0.02776 | 23 |
GO:0048246 | GO:0048246 | macrophage chemotaxis | 25/5002 | 27/8135 | 1.51 | 3.03e-04 | 0.03457 | 27 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0030198 | GO:0030198 | extracellular matrix organization | 177/2974 | 264/8135 | 1.83 | 1.65e-24 | 6.62e-21 | 264 |
GO:0043062 | GO:0043062 | extracellular structure organization | 191/2974 | 300/8135 | 1.74 | 2.67e-22 | 5.36e-19 | 300 |
GO:0001501 | GO:0001501 | skeletal system development | 201/2974 | 334/8135 | 1.65 | 3.14e-19 | 4.20e-16 | 334 |
GO:0001944 | GO:0001944 | vasculature development | 236/2974 | 417/8135 | 1.55 | 1.09e-17 | 1.09e-14 | 417 |
GO:0072358 | GO:0072358 | cardiovascular system development | 238/2974 | 422/8135 | 1.54 | 1.40e-17 | 1.12e-14 | 422 |
GO:0001568 | GO:0001568 | blood vessel development | 228/2974 | 401/8135 | 1.56 | 1.93e-17 | 1.29e-14 | 401 |
GO:0048514 | GO:0048514 | blood vessel morphogenesis | 198/2974 | 360/8135 | 1.50 | 2.55e-13 | 1.46e-10 | 360 |
GO:0001503 | GO:0001503 | ossification | 141/2974 | 238/8135 | 1.62 | 4.66e-13 | 2.33e-10 | 238 |
GO:0001525 | GO:0001525 | angiogenesis | 172/2974 | 306/8135 | 1.54 | 8.32e-13 | 3.33e-10 | 306 |
GO:0001649 | GO:0001649 | osteoblast differentiation | 80/2974 | 121/8135 | 1.81 | 2.91e-11 | 8.97e-09 | 121 |
GO:0051216 | GO:0051216 | cartilage development | 92/2974 | 148/8135 | 1.70 | 1.59e-10 | 3.99e-08 | 148 |
GO:0060485 | GO:0060485 | mesenchyme development | 103/2974 | 171/8135 | 1.65 | 1.83e-10 | 4.30e-08 | 171 |
GO:0061448 | GO:0061448 | connective tissue development | 106/2974 | 179/8135 | 1.62 | 4.05e-10 | 8.11e-08 | 179 |
GO:0030199 | GO:0030199 | collagen fibril organization | 32/2974 | 37/8135 | 2.37 | 4.65e-10 | 8.87e-08 | 37 |
GO:0048762 | GO:0048762 | mesenchymal cell differentiation | 81/2974 | 129/8135 | 1.72 | 9.93e-10 | 1.81e-07 | 129 |
GO:0030111 | GO:0030111 | regulation of Wnt signaling pathway | 96/2974 | 163/8135 | 1.61 | 4.07e-09 | 6.27e-07 | 163 |
GO:0090287 | GO:0090287 | regulation of cellular response to growth factor stimulus | 94/2974 | 159/8135 | 1.62 | 4.50e-09 | 6.69e-07 | 159 |
GO:0002062 | GO:0002062 | chondrocyte differentiation | 58/2974 | 86/8135 | 1.84 | 5.05e-09 | 7.22e-07 | 86 |
GO:0090130 | GO:0090130 | tissue migration | 89/2974 | 149/8135 | 1.63 | 5.72e-09 | 7.91e-07 | 149 |
GO:0048705 | GO:0048705 | skeletal system morphogenesis | 95/2974 | 162/8135 | 1.60 | 6.68e-09 | 8.92e-07 | 162 |
GO:0060070 | GO:0060070 | canonical Wnt signaling pathway | 92/2974 | 157/8135 | 1.60 | 1.22e-08 | 1.52e-06 | 157 |
GO:0030178 | GO:0030178 | negative regulation of Wnt signaling pathway | 63/2974 | 98/8135 | 1.76 | 1.95e-08 | 2.36e-06 | 98 |
GO:0010631 | GO:0010631 | epithelial cell migration | 84/2974 | 142/8135 | 1.62 | 2.88e-08 | 3.31e-06 | 142 |
GO:0060828 | GO:0060828 | regulation of canonical Wnt signaling pathway | 74/2974 | 122/8135 | 1.66 | 4.47e-08 | 4.62e-06 | 122 |
GO:0090132 | GO:0090132 | epithelium migration | 84/2974 | 143/8135 | 1.61 | 4.50e-08 | 4.62e-06 | 143 |
GO:0045667 | GO:0045667 | regulation of osteoblast differentiation | 48/2974 | 70/8135 | 1.88 | 4.77e-08 | 4.78e-06 | 70 |
GO:0010634 | GO:0010634 | positive regulation of epithelial cell migration | 51/2974 | 76/8135 | 1.84 | 5.51e-08 | 5.26e-06 | 76 |
GO:0010632 | GO:0010632 | regulation of epithelial cell migration | 67/2974 | 109/8135 | 1.68 | 9.34e-08 | 8.10e-06 | 109 |
GO:0060348 | GO:0060348 | bone development | 79/2974 | 135/8135 | 1.60 | 1.42e-07 | 1.16e-05 | 135 |
GO:0048706 | GO:0048706 | embryonic skeletal system development | 58/2974 | 92/8135 | 1.72 | 1.95e-07 | 1.56e-05 | 92 |
GO:0071559 | GO:0071559 | response to transforming growth factor beta | 75/2974 | 128/8135 | 1.60 | 2.72e-07 | 2.10e-05 | 128 |
GO:0043542 | GO:0043542 | endothelial cell migration | 61/2974 | 99/8135 | 1.69 | 3.10e-07 | 2.34e-05 | 99 |
GO:0090288 | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 55/2974 | 87/8135 | 1.73 | 3.52e-07 | 2.57e-05 | 87 |
GO:0010595 | GO:0010595 | positive regulation of endothelial cell migration | 37/2974 | 52/8135 | 1.95 | 3.89e-07 | 2.78e-05 | 52 |
GO:0001837 | GO:0001837 | epithelial to mesenchymal transition | 49/2974 | 76/8135 | 1.76 | 6.46e-07 | 4.39e-05 | 76 |
GO:0090090 | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 50/2974 | 79/8135 | 1.73 | 1.14e-06 | 7.48e-05 | 79 |
GO:0071560 | GO:0071560 | cellular response to transforming growth factor beta stimulus | 71/2974 | 123/8135 | 1.58 | 1.23e-06 | 7.98e-05 | 123 |
GO:0072132 | GO:0072132 | mesenchyme morphogenesis | 28/2974 | 37/8135 | 2.07 | 1.38e-06 | 8.50e-05 | 37 |
GO:0042476 | GO:0042476 | odontogenesis | 57/2974 | 94/8135 | 1.66 | 1.59e-06 | 9.66e-05 | 94 |
GO:0090101 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 45/2974 | 70/8135 | 1.76 | 2.08e-06 | 1.23e-04 | 70 |
GO:0003170 | GO:0003170 | heart valve development | 27/2974 | 36/8135 | 2.05 | 2.89e-06 | 1.65e-04 | 36 |
GO:1904018 | GO:1904018 | positive regulation of vasculature development | 68/2974 | 119/8135 | 1.56 | 3.38e-06 | 1.88e-04 | 119 |
GO:0010594 | GO:0010594 | regulation of endothelial cell migration | 47/2974 | 75/8135 | 1.71 | 3.57e-06 | 1.96e-04 | 75 |
GO:0060021 | GO:0060021 | roof of mouth development | 39/2974 | 59/8135 | 1.81 | 3.62e-06 | 1.96e-04 | 59 |
GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 62/2974 | 107/8135 | 1.58 | 4.86e-06 | 2.56e-04 | 107 |
GO:0061035 | GO:0061035 | regulation of cartilage development | 32/2974 | 46/8135 | 1.90 | 5.25e-06 | 2.73e-04 | 46 |
GO:0090092 | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 77/2974 | 140/8135 | 1.50 | 5.68e-06 | 2.85e-04 | 140 |
GO:0030323 | GO:0030323 | respiratory tube development | 64/2974 | 112/8135 | 1.56 | 6.52e-06 | 3.06e-04 | 112 |
GO:0022617 | GO:0022617 | extracellular matrix disassembly | 37/2974 | 56/8135 | 1.81 | 6.53e-06 | 3.06e-04 | 56 |
GO:0032963 | GO:0032963 | collagen metabolic process | 43/2974 | 68/8135 | 1.73 | 6.59e-06 | 3.06e-04 | 68 |
GO:0002063 | GO:0002063 | chondrocyte development | 27/2974 | 37/8135 | 2.00 | 6.96e-06 | 3.17e-04 | 37 |
GO:0030278 | GO:0030278 | regulation of ossification | 68/2974 | 121/8135 | 1.54 | 7.43e-06 | 3.35e-04 | 121 |
GO:0060541 | GO:0060541 | respiratory system development | 71/2974 | 128/8135 | 1.52 | 8.77e-06 | 3.91e-04 | 128 |
GO:0030324 | GO:0030324 | lung development | 63/2974 | 111/8135 | 1.55 | 1.04e-05 | 4.42e-04 | 111 |
GO:0003281 | GO:0003281 | ventricular septum development | 32/2974 | 47/8135 | 1.86 | 1.07e-05 | 4.51e-04 | 47 |
GO:0048704 | GO:0048704 | embryonic skeletal system morphogenesis | 43/2974 | 69/8135 | 1.70 | 1.13e-05 | 4.58e-04 | 69 |
GO:0003279 | GO:0003279 | cardiac septum development | 42/2974 | 67/8135 | 1.71 | 1.16e-05 | 4.60e-04 | 67 |
GO:0002040 | GO:0002040 | sprouting angiogenesis | 41/2974 | 65/8135 | 1.73 | 1.18e-05 | 4.64e-04 | 65 |
GO:0017015 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 37/2974 | 57/8135 | 1.78 | 1.21e-05 | 4.70e-04 | 57 |
GO:0060349 | GO:0060349 | bone morphogenesis | 48/2974 | 80/8135 | 1.64 | 1.57e-05 | 6.01e-04 | 80 |
GO:0060412 | GO:0060412 | ventricular septum morphogenesis | 22/2974 | 29/8135 | 2.08 | 1.83e-05 | 6.84e-04 | 29 |
GO:0061437 | GO:0061437 | renal system vasculature development | 13/2974 | 14/8135 | 2.54 | 1.90e-05 | 6.85e-04 | 14 |
GO:0061440 | GO:0061440 | kidney vasculature development | 13/2974 | 14/8135 | 2.54 | 1.90e-05 | 6.85e-04 | 14 |
GO:0072012 | GO:0072012 | glomerulus vasculature development | 13/2974 | 14/8135 | 2.54 | 1.90e-05 | 6.85e-04 | 14 |
GO:1903844 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 37/2974 | 58/8135 | 1.74 | 2.17e-05 | 7.56e-04 | 58 |
GO:0003179 | GO:0003179 | heart valve morphogenesis | 24/2974 | 33/8135 | 1.99 | 2.51e-05 | 8.61e-04 | 33 |
GO:0030512 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 26/2974 | 37/8135 | 1.92 | 3.09e-05 | 1.03e-03 | 37 |
GO:0006024 | GO:0006024 | glycosaminoglycan biosynthetic process | 40/2974 | 65/8135 | 1.68 | 3.49e-05 | 1.14e-03 | 65 |
GO:0022612 | GO:0022612 | gland morphogenesis | 50/2974 | 86/8135 | 1.59 | 3.50e-05 | 1.14e-03 | 86 |
GO:0003158 | GO:0003158 | endothelium development | 37/2974 | 59/8135 | 1.72 | 3.78e-05 | 1.22e-03 | 59 |
GO:0060840 | GO:0060840 | artery development | 32/2974 | 49/8135 | 1.79 | 3.92e-05 | 1.26e-03 | 49 |
GO:0003205 | GO:0003205 | cardiac chamber development | 60/2974 | 108/8135 | 1.52 | 4.02e-05 | 1.27e-03 | 108 |
GO:0060317 | GO:0060317 | cardiac epithelial to mesenchymal transition | 17/2974 | 21/8135 | 2.21 | 4.03e-05 | 1.27e-03 | 21 |
GO:0030574 | GO:0030574 | collagen catabolic process | 23/2974 | 32/8135 | 1.97 | 5.07e-05 | 1.59e-03 | 32 |
GO:1905314 | GO:1905314 | semi-lunar valve development | 18/2974 | 23/8135 | 2.14 | 5.38e-05 | 1.66e-03 | 23 |
GO:0006023 | GO:0006023 | aminoglycan biosynthetic process | 41/2974 | 68/8135 | 1.65 | 5.53e-05 | 1.68e-03 | 68 |
GO:0045669 | GO:0045669 | positive regulation of osteoblast differentiation | 25/2974 | 36/8135 | 1.90 | 6.03e-05 | 1.79e-03 | 36 |
GO:0035107 | GO:0035107 | appendage morphogenesis | 54/2974 | 96/8135 | 1.54 | 6.12e-05 | 1.79e-03 | 96 |
GO:0035108 | GO:0035108 | limb morphogenesis | 54/2974 | 96/8135 | 1.54 | 6.12e-05 | 1.79e-03 | 96 |
GO:1903845 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus | 26/2974 | 38/8135 | 1.87 | 6.39e-05 | 1.84e-03 | 38 |
GO:0010717 | GO:0010717 | regulation of epithelial to mesenchymal transition | 30/2974 | 46/8135 | 1.78 | 7.10e-05 | 1.98e-03 | 46 |
GO:0007179 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 51/2974 | 90/8135 | 1.55 | 7.49e-05 | 2.03e-03 | 90 |
GO:0003231 | GO:0003231 | cardiac ventricle development | 48/2974 | 84/8135 | 1.56 | 9.11e-05 | 2.30e-03 | 84 |
GO:0042733 | GO:0042733 | embryonic digit morphogenesis | 21/2974 | 29/8135 | 1.98 | 9.12e-05 | 2.30e-03 | 29 |
GO:0032330 | GO:0032330 | regulation of chondrocyte differentiation | 24/2974 | 35/8135 | 1.88 | 1.16e-04 | 2.84e-03 | 35 |
GO:0035329 | GO:0035329 | hippo signaling | 11/2974 | 12/8135 | 2.51 | 1.23e-04 | 2.97e-03 | 12 |
GO:0060411 | GO:0060411 | cardiac septum morphogenesis | 32/2974 | 51/8135 | 1.72 | 1.24e-04 | 2.97e-03 | 51 |
GO:0003203 | GO:0003203 | endocardial cushion morphogenesis | 18/2974 | 24/8135 | 2.05 | 1.42e-04 | 3.36e-03 | 24 |
GO:0071526 | GO:0071526 | semaphorin-plexin signaling pathway | 18/2974 | 24/8135 | 2.05 | 1.42e-04 | 3.36e-03 | 24 |
GO:0043392 | GO:0043392 | negative regulation of DNA binding | 19/2974 | 26/8135 | 2.00 | 1.64e-04 | 3.84e-03 | 26 |
GO:0010977 | GO:0010977 | negative regulation of neuron projection development | 50/2974 | 90/8135 | 1.52 | 1.73e-04 | 3.98e-03 | 90 |
GO:0042310 | GO:0042310 | vasoconstriction | 36/2974 | 60/8135 | 1.64 | 1.79e-04 | 4.10e-03 | 60 |
GO:0003197 | GO:0003197 | endocardial cushion development | 21/2974 | 30/8135 | 1.91 | 1.99e-04 | 4.46e-03 | 30 |
GO:0010906 | GO:0010906 | regulation of glucose metabolic process | 32/2974 | 52/8135 | 1.68 | 2.10e-04 | 4.65e-03 | 52 |
GO:0045446 | GO:0045446 | endothelial cell differentiation | 32/2974 | 52/8135 | 1.68 | 2.10e-04 | 4.65e-03 | 52 |
GO:0003177 | GO:0003177 | pulmonary valve development | 12/2974 | 14/8135 | 2.34 | 2.25e-04 | 4.91e-03 | 14 |
GO:0003181 | GO:0003181 | atrioventricular valve morphogenesis | 12/2974 | 14/8135 | 2.34 | 2.25e-04 | 4.91e-03 | 14 |
GO:0030326 | GO:0030326 | embryonic limb morphogenesis | 45/2974 | 80/8135 | 1.54 | 2.46e-04 | 5.27e-03 | 80 |
GO:0035113 | GO:0035113 | embryonic appendage morphogenesis | 45/2974 | 80/8135 | 1.54 | 2.46e-04 | 5.27e-03 | 80 |
GO:0097756 | GO:0097756 | negative regulation of blood vessel diameter | 37/2974 | 63/8135 | 1.61 | 2.69e-04 | 5.74e-03 | 63 |
GO:0051100 | GO:0051100 | negative regulation of binding | 43/2974 | 76/8135 | 1.55 | 2.82e-04 | 5.86e-03 | 76 |
GO:0014033 | GO:0014033 | neural crest cell differentiation | 34/2974 | 57/8135 | 1.63 | 3.15e-04 | 6.51e-03 | 57 |
GO:0014031 | GO:0014031 | mesenchymal cell development | 33/2974 | 55/8135 | 1.64 | 3.30e-04 | 6.76e-03 | 55 |
GO:0003171 | GO:0003171 | atrioventricular valve development | 13/2974 | 16/8135 | 2.22 | 3.33e-04 | 6.76e-03 | 16 |
GO:0006939 | GO:0006939 | smooth muscle contraction | 46/2974 | 83/8135 | 1.52 | 3.34e-04 | 6.76e-03 | 83 |
GO:0045778 | GO:0045778 | positive regulation of ossification | 32/2974 | 53/8135 | 1.65 | 3.45e-04 | 6.89e-03 | 53 |
GO:0043536 | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 19/2974 | 27/8135 | 1.92 | 3.64e-04 | 7.15e-03 | 27 |
GO:0014812 | GO:0014812 | muscle cell migration | 29/2974 | 47/8135 | 1.69 | 3.88e-04 | 7.48e-03 | 47 |
GO:0001885 | GO:0001885 | endothelial cell development | 20/2974 | 29/8135 | 1.89 | 3.88e-04 | 7.48e-03 | 29 |
GO:0035904 | GO:0035904 | aorta development | 20/2974 | 29/8135 | 1.89 | 3.88e-04 | 7.48e-03 | 29 |
GO:0035924 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 21/2974 | 31/8135 | 1.85 | 4.06e-04 | 7.71e-03 | 31 |
GO:0048566 | GO:0048566 | embryonic digestive tract development | 21/2974 | 31/8135 | 1.85 | 4.06e-04 | 7.71e-03 | 31 |
GO:0043255 | GO:0043255 | regulation of carbohydrate biosynthetic process | 27/2974 | 43/8135 | 1.72 | 4.10e-04 | 7.75e-03 | 43 |
GO:0048146 | GO:0048146 | positive regulation of fibroblast proliferation | 22/2974 | 33/8135 | 1.82 | 4.17e-04 | 7.81e-03 | 33 |
GO:0014909 | GO:0014909 | smooth muscle cell migration | 25/2974 | 39/8135 | 1.75 | 4.23e-04 | 7.82e-03 | 39 |
GO:0032092 | GO:0032092 | positive regulation of protein binding | 23/2974 | 35/8135 | 1.80 | 4.24e-04 | 7.82e-03 | 35 |
GO:0060325 | GO:0060325 | face morphogenesis | 14/2974 | 18/8135 | 2.13 | 4.36e-04 | 7.98e-03 | 18 |
GO:0061028 | GO:0061028 | establishment of endothelial barrier | 14/2974 | 18/8135 | 2.13 | 4.36e-04 | 7.98e-03 | 18 |
GO:0003151 | GO:0003151 | outflow tract morphogenesis | 33/2974 | 56/8135 | 1.61 | 5.24e-04 | 9.51e-03 | 56 |
GO:0002089 | GO:0002089 | lens morphogenesis in camera-type eye | 11/2974 | 13/8135 | 2.31 | 5.33e-04 | 9.59e-03 | 13 |
GO:0003184 | GO:0003184 | pulmonary valve morphogenesis | 11/2974 | 13/8135 | 2.31 | 5.33e-04 | 9.59e-03 | 13 |
GO:0014032 | GO:0014032 | neural crest cell development | 31/2974 | 52/8135 | 1.63 | 5.82e-04 | 1.03e-02 | 52 |
GO:0043534 | GO:0043534 | blood vessel endothelial cell migration | 31/2974 | 52/8135 | 1.63 | 5.82e-04 | 1.03e-02 | 52 |
GO:0060350 | GO:0060350 | endochondral bone morphogenesis | 31/2974 | 52/8135 | 1.63 | 5.82e-04 | 1.03e-02 | 52 |
GO:0038084 | GO:0038084 | vascular endothelial growth factor signaling pathway | 16/2974 | 22/8135 | 1.99 | 6.05e-04 | 1.06e-02 | 22 |
GO:0061037 | GO:0061037 | negative regulation of cartilage development | 16/2974 | 22/8135 | 1.99 | 6.05e-04 | 1.06e-02 | 22 |
GO:0042475 | GO:0042475 | odontogenesis of dentin-containing tooth | 36/2974 | 63/8135 | 1.56 | 6.71e-04 | 1.15e-02 | 63 |
GO:0030705 | GO:0030705 | cytoskeleton-dependent intracellular transport | 27/2974 | 44/8135 | 1.68 | 6.94e-04 | 1.17e-02 | 44 |
GO:0045668 | GO:0045668 | negative regulation of osteoblast differentiation | 19/2974 | 28/8135 | 1.86 | 7.45e-04 | 1.25e-02 | 28 |
GO:0051099 | GO:0051099 | positive regulation of binding | 40/2974 | 72/8135 | 1.52 | 7.50e-04 | 1.25e-02 | 72 |
GO:0060973 | GO:0060973 | cell migration involved in heart development | 12/2974 | 15/8135 | 2.19 | 7.50e-04 | 1.25e-02 | 15 |
GO:0010463 | GO:0010463 | mesenchymal cell proliferation | 24/2974 | 38/8135 | 1.73 | 7.57e-04 | 1.25e-02 | 38 |
GO:0050919 | GO:0050919 | negative chemotaxis | 20/2974 | 30/8135 | 1.82 | 7.65e-04 | 1.26e-02 | 30 |
GO:0003198 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 9/2974 | 10/8135 | 2.46 | 7.77e-04 | 1.27e-02 | 10 |
GO:0051101 | GO:0051101 | regulation of DNA binding | 33/2974 | 57/8135 | 1.58 | 8.12e-04 | 1.32e-02 | 57 |
GO:0030279 | GO:0030279 | negative regulation of ossification | 27/2974 | 45/8135 | 1.64 | 1.13e-03 | 1.78e-02 | 45 |
GO:0005978 | GO:0005978 | glycogen biosynthetic process | 15/2974 | 21/8135 | 1.95 | 1.22e-03 | 1.89e-02 | 21 |
GO:0009250 | GO:0009250 | glucan biosynthetic process | 15/2974 | 21/8135 | 1.95 | 1.22e-03 | 1.89e-02 | 21 |
GO:0010675 | GO:0010675 | regulation of cellular carbohydrate metabolic process | 38/2974 | 69/8135 | 1.51 | 1.26e-03 | 1.92e-02 | 69 |
GO:0015980 | GO:0015980 | energy derivation by oxidation of organic compounds | 38/2974 | 69/8135 | 1.51 | 1.26e-03 | 1.92e-02 | 69 |
GO:0060324 | GO:0060324 | face development | 17/2974 | 25/8135 | 1.86 | 1.37e-03 | 2.05e-02 | 25 |
GO:0033692 | GO:0033692 | cellular polysaccharide biosynthetic process | 21/2974 | 33/8135 | 1.74 | 1.40e-03 | 2.07e-02 | 33 |
GO:1905207 | GO:1905207 | regulation of cardiocyte differentiation | 21/2974 | 33/8135 | 1.74 | 1.40e-03 | 2.07e-02 | 33 |
GO:0009954 | GO:0009954 | proximal/distal pattern formation | 19/2974 | 29/8135 | 1.79 | 1.42e-03 | 2.09e-02 | 29 |
GO:0010718 | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 19/2974 | 29/8135 | 1.79 | 1.42e-03 | 2.09e-02 | 29 |
GO:0003272 | GO:0003272 | endocardial cushion formation | 12/2974 | 16/8135 | 2.05 | 2.00e-03 | 2.75e-02 | 16 |
GO:0006929 | GO:0006929 | substrate-dependent cell migration | 12/2974 | 16/8135 | 2.05 | 2.00e-03 | 2.75e-02 | 16 |
GO:0032331 | GO:0032331 | negative regulation of chondrocyte differentiation | 12/2974 | 16/8135 | 2.05 | 2.00e-03 | 2.75e-02 | 16 |
GO:1903010 | GO:1903010 | regulation of bone development | 12/2974 | 16/8135 | 2.05 | 2.00e-03 | 2.75e-02 | 16 |
GO:0002088 | GO:0002088 | lens development in camera-type eye | 25/2974 | 42/8135 | 1.63 | 2.01e-03 | 2.76e-02 | 42 |
GO:0048864 | GO:0048864 | stem cell development | 31/2974 | 55/8135 | 1.54 | 2.10e-03 | 2.86e-02 | 55 |
GO:0016339 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 24/2974 | 40/8135 | 1.64 | 2.12e-03 | 2.87e-02 | 40 |
GO:0043535 | GO:0043535 | regulation of blood vessel endothelial cell migration | 23/2974 | 38/8135 | 1.66 | 2.22e-03 | 2.99e-02 | 38 |
GO:0048844 | GO:0048844 | artery morphogenesis | 23/2974 | 38/8135 | 1.66 | 2.22e-03 | 2.99e-02 | 38 |
GO:0001938 | GO:0001938 | positive regulation of endothelial cell proliferation | 30/2974 | 53/8135 | 1.55 | 2.26e-03 | 3.03e-02 | 53 |
GO:0014910 | GO:0014910 | regulation of smooth muscle cell migration | 22/2974 | 36/8135 | 1.67 | 2.32e-03 | 3.08e-02 | 36 |
GO:0060351 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 22/2974 | 36/8135 | 1.67 | 2.32e-03 | 3.08e-02 | 36 |
GO:0000271 | GO:0000271 | polysaccharide biosynthetic process | 21/2974 | 34/8135 | 1.69 | 2.41e-03 | 3.18e-02 | 34 |
GO:0003209 | GO:0003209 | cardiac atrium morphogenesis | 14/2974 | 20/8135 | 1.91 | 2.43e-03 | 3.19e-02 | 20 |
GO:0060323 | GO:0060323 | head morphogenesis | 14/2974 | 20/8135 | 1.91 | 2.43e-03 | 3.19e-02 | 20 |
GO:0007224 | GO:0007224 | smoothened signaling pathway | 34/2974 | 62/8135 | 1.50 | 2.45e-03 | 3.19e-02 | 62 |
GO:0003156 | GO:0003156 | regulation of animal organ formation | 20/2974 | 32/8135 | 1.71 | 2.49e-03 | 3.22e-02 | 32 |
GO:0003230 | GO:0003230 | cardiac atrium development | 15/2974 | 22/8135 | 1.87 | 2.55e-03 | 3.22e-02 | 22 |
GO:0040036 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 15/2974 | 22/8135 | 1.87 | 2.55e-03 | 3.22e-02 | 22 |
GO:0099068 | GO:0099068 | postsynapse assembly | 18/2974 | 28/8135 | 1.76 | 2.61e-03 | 3.28e-02 | 28 |
GO:0005979 | GO:0005979 | regulation of glycogen biosynthetic process | 9/2974 | 11/8135 | 2.24 | 2.88e-03 | 3.52e-02 | 11 |
GO:0010934 | GO:0010934 | macrophage cytokine production | 9/2974 | 11/8135 | 2.24 | 2.88e-03 | 3.52e-02 | 11 |
GO:0010962 | GO:0010962 | regulation of glucan biosynthetic process | 9/2974 | 11/8135 | 2.24 | 2.88e-03 | 3.52e-02 | 11 |
GO:0036035 | GO:0036035 | osteoclast development | 9/2974 | 11/8135 | 2.24 | 2.88e-03 | 3.52e-02 | 11 |
GO:0061162 | GO:0061162 | establishment of monopolar cell polarity | 9/2974 | 11/8135 | 2.24 | 2.88e-03 | 3.52e-02 | 11 |
GO:0044264 | GO:0044264 | cellular polysaccharide metabolic process | 26/2974 | 45/8135 | 1.58 | 2.96e-03 | 3.55e-02 | 45 |
GO:1903524 | GO:1903524 | positive regulation of blood circulation | 31/2974 | 56/8135 | 1.51 | 3.08e-03 | 3.67e-02 | 56 |
GO:0001755 | GO:0001755 | neural crest cell migration | 24/2974 | 41/8135 | 1.60 | 3.35e-03 | 3.93e-02 | 41 |
GO:0006112 | GO:0006112 | energy reserve metabolic process | 24/2974 | 41/8135 | 1.60 | 3.35e-03 | 3.93e-02 | 41 |
GO:0008589 | GO:0008589 | regulation of smoothened signaling pathway | 23/2974 | 39/8135 | 1.61 | 3.56e-03 | 4.10e-02 | 39 |
GO:1901888 | GO:1901888 | regulation of cell junction assembly | 23/2974 | 39/8135 | 1.61 | 3.56e-03 | 4.10e-02 | 39 |
GO:0030516 | GO:0030516 | regulation of axon extension | 29/2974 | 52/8135 | 1.53 | 3.58e-03 | 4.11e-02 | 52 |
GO:0032885 | GO:0032885 | regulation of polysaccharide biosynthetic process | 10/2974 | 13/8135 | 2.10 | 3.63e-03 | 4.13e-02 | 13 |
GO:0040037 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 10/2974 | 13/8135 | 2.10 | 3.63e-03 | 4.13e-02 | 13 |
GO:1902547 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 10/2974 | 13/8135 | 2.10 | 3.63e-03 | 4.13e-02 | 13 |
GO:0010827 | GO:0010827 | regulation of glucose transmembrane transport | 22/2974 | 37/8135 | 1.63 | 3.77e-03 | 4.25e-02 | 37 |
GO:2001022 | GO:2001022 | positive regulation of response to DNA damage stimulus | 21/2974 | 35/8135 | 1.64 | 3.97e-03 | 4.41e-02 | 35 |
GO:0046847 | GO:0046847 | filopodium assembly | 20/2974 | 33/8135 | 1.66 | 4.17e-03 | 4.58e-02 | 33 |
GO:0060425 | GO:0060425 | lung morphogenesis | 20/2974 | 33/8135 | 1.66 | 4.17e-03 | 4.58e-02 | 33 |
GO:0006073 | GO:0006073 | cellular glucan metabolic process | 19/2974 | 31/8135 | 1.68 | 4.36e-03 | 4.70e-02 | 31 |
GO:0044042 | GO:0044042 | glucan metabolic process | 19/2974 | 31/8135 | 1.68 | 4.36e-03 | 4.70e-02 | 31 |
GO:0099072 | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 19/2974 | 31/8135 | 1.68 | 4.36e-03 | 4.70e-02 | 31 |
GO:0007044 | GO:0007044 | cell-substrate junction assembly | 26/2974 | 46/8135 | 1.55 | 4.46e-03 | 4.75e-02 | 46 |
GO:0003176 | GO:0003176 | aortic valve development | 12/2974 | 17/8135 | 1.93 | 4.54e-03 | 4.80e-02 | 17 |
GO:0055025 | GO:0055025 | positive regulation of cardiac muscle tissue development | 18/2974 | 29/8135 | 1.70 | 4.54e-03 | 4.80e-02 | 29 |
GO:0010171 | GO:0010171 | body morphogenesis | 17/2974 | 27/8135 | 1.72 | 4.69e-03 | 4.88e-02 | 27 |
GO:0010464 | GO:0010464 | regulation of mesenchymal cell proliferation | 17/2974 | 27/8135 | 1.72 | 4.69e-03 | 4.88e-02 | 27 |
GO:0048048 | GO:0048048 | embryonic eye morphogenesis | 17/2974 | 27/8135 | 1.72 | 4.69e-03 | 4.88e-02 | 27 |
GO:0010907 | GO:0010907 | positive regulation of glucose metabolic process | 13/2974 | 19/8135 | 1.87 | 4.76e-03 | 4.93e-02 | 19 |
GO:0032835 | GO:0032835 | glomerulus development | 25/2974 | 44/8135 | 1.55 | 4.79e-03 | 4.93e-02 | 44 |
GO:0090263 | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 25/2974 | 44/8135 | 1.55 | 4.79e-03 | 4.93e-02 | 44 |
GO:0048008 | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 14/2974 | 21/8135 | 1.82 | 4.85e-03 | 4.96e-02 | 21 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0002263 | GO:0002263 | cell activation involved in immune response | 171/1028 | 356/8135 | 3.80 | 1.33e-63 | 2.47e-60 | 356 |
GO:0002443 | GO:0002443 | leukocyte mediated immunity | 185/1028 | 410/8135 | 3.57 | 1.50e-63 | 2.47e-60 | 410 |
GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 170/1028 | 354/8135 | 3.80 | 3.39e-63 | 3.73e-60 | 354 |
GO:0046649 | GO:0046649 | lymphocyte activation | 180/1028 | 397/8135 | 3.59 | 3.75e-62 | 3.09e-59 | 397 |
GO:0042110 | GO:0042110 | T cell activation | 143/1028 | 285/8135 | 3.97 | 6.24e-56 | 4.12e-53 | 285 |
GO:0002274 | GO:0002274 | myeloid leukocyte activation | 153/1028 | 328/8135 | 3.69 | 1.59e-54 | 8.73e-52 | 328 |
GO:0050865 | GO:0050865 | regulation of cell activation | 156/1028 | 344/8135 | 3.59 | 1.45e-53 | 6.85e-51 | 344 |
GO:0045087 | GO:0045087 | innate immune response | 190/1028 | 485/8135 | 3.10 | 1.97e-53 | 8.12e-51 | 485 |
GO:0002694 | GO:0002694 | regulation of leukocyte activation | 148/1028 | 316/8135 | 3.71 | 5.63e-53 | 2.06e-50 | 316 |
GO:0002250 | GO:0002250 | adaptive immune response | 133/1028 | 269/8135 | 3.91 | 5.72e-51 | 1.89e-48 | 269 |
GO:0050778 | GO:0050778 | positive regulation of immune response | 171/1028 | 423/8135 | 3.20 | 4.05e-50 | 1.22e-47 | 423 |
GO:0051249 | GO:0051249 | regulation of lymphocyte activation | 125/1028 | 260/8135 | 3.80 | 3.74e-46 | 1.03e-43 | 260 |
GO:0043299 | GO:0043299 | leukocyte degranulation | 123/1028 | 254/8135 | 3.83 | 7.79e-46 | 1.98e-43 | 254 |
GO:0050863 | GO:0050863 | regulation of T cell activation | 108/1028 | 203/8135 | 4.21 | 2.70e-45 | 6.36e-43 | 203 |
GO:0001816 | GO:0001816 | cytokine production | 169/1028 | 444/8135 | 3.01 | 3.17e-45 | 6.97e-43 | 444 |
GO:0002275 | GO:0002275 | myeloid cell activation involved in immune response | 124/1028 | 261/8135 | 3.76 | 4.49e-45 | 9.26e-43 | 261 |
GO:0002444 | GO:0002444 | myeloid leukocyte mediated immunity | 123/1028 | 262/8135 | 3.72 | 5.20e-44 | 1.01e-41 | 262 |
GO:0002764 | GO:0002764 | immune response-regulating signaling pathway | 125/1028 | 270/8135 | 3.66 | 6.51e-44 | 1.19e-41 | 270 |
GO:0050867 | GO:0050867 | positive regulation of cell activation | 107/1028 | 210/8135 | 4.03 | 1.61e-42 | 2.79e-40 | 210 |
GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 109/1028 | 218/8135 | 3.96 | 2.72e-42 | 4.48e-40 | 218 |
GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 104/1028 | 202/8135 | 4.07 | 7.14e-42 | 1.12e-39 | 202 |
GO:0002757 | GO:0002757 | immune response-activating signal transduction | 116/1028 | 249/8135 | 3.69 | 4.58e-41 | 6.87e-39 | 249 |
GO:0002521 | GO:0002521 | leukocyte differentiation | 133/1028 | 318/8135 | 3.31 | 1.19e-40 | 1.71e-38 | 318 |
GO:0036230 | GO:0036230 | granulocyte activation | 111/1028 | 233/8135 | 3.77 | 1.83e-40 | 2.52e-38 | 233 |
GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 100/1028 | 196/8135 | 4.04 | 8.23e-40 | 1.09e-37 | 196 |
GO:0042119 | GO:0042119 | neutrophil activation | 109/1028 | 230/8135 | 3.75 | 1.83e-39 | 2.33e-37 | 230 |
GO:0002253 | GO:0002253 | activation of immune response | 127/1028 | 302/8135 | 3.33 | 4.27e-39 | 5.22e-37 | 302 |
GO:0002768 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 97/1028 | 189/8135 | 4.06 | 6.53e-39 | 7.70e-37 | 189 |
GO:0001817 | GO:0001817 | regulation of cytokine production | 151/1028 | 406/8135 | 2.94 | 7.85e-39 | 8.94e-37 | 406 |
GO:0002283 | GO:0002283 | neutrophil activation involved in immune response | 105/1028 | 222/8135 | 3.74 | 6.42e-38 | 7.06e-36 | 222 |
GO:0043312 | GO:0043312 | neutrophil degranulation | 104/1028 | 219/8135 | 3.76 | 9.30e-38 | 9.90e-36 | 219 |
GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 90/1028 | 170/8135 | 4.19 | 1.50e-37 | 1.55e-35 | 170 |
GO:0050870 | GO:0050870 | positive regulation of T cell activation | 80/1028 | 139/8135 | 4.55 | 5.49e-37 | 5.49e-35 | 139 |
GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 83/1028 | 149/8135 | 4.41 | 6.97e-37 | 6.77e-35 | 149 |
GO:0002446 | GO:0002446 | neutrophil mediated immunity | 104/1028 | 227/8135 | 3.63 | 5.22e-36 | 4.92e-34 | 227 |
GO:0002429 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 87/1028 | 167/8135 | 4.12 | 1.34e-35 | 1.23e-33 | 167 |
GO:0031347 | GO:0031347 | regulation of defense response | 148/1028 | 425/8135 | 2.76 | 3.26e-34 | 2.91e-32 | 425 |
GO:0001819 | GO:0001819 | positive regulation of cytokine production | 112/1028 | 271/8135 | 3.27 | 1.29e-33 | 1.12e-31 | 271 |
GO:0050900 | GO:0050900 | leukocyte migration | 119/1028 | 306/8135 | 3.08 | 1.15e-32 | 9.76e-31 | 306 |
GO:0030097 | GO:0030097 | hemopoiesis | 151/1028 | 459/8135 | 2.60 | 1.07e-31 | 8.83e-30 | 459 |
GO:0006887 | GO:0006887 | exocytosis | 152/1028 | 466/8135 | 2.58 | 1.95e-31 | 1.56e-29 | 466 |
GO:0045055 | GO:0045055 | regulated exocytosis | 143/1028 | 423/8135 | 2.68 | 1.98e-31 | 1.56e-29 | 423 |
GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 85/1028 | 177/8135 | 3.80 | 2.18e-31 | 1.67e-29 | 177 |
GO:0032943 | GO:0032943 | mononuclear cell proliferation | 85/1028 | 179/8135 | 3.76 | 6.19e-31 | 4.64e-29 | 179 |
GO:0030098 | GO:0030098 | lymphocyte differentiation | 94/1028 | 214/8135 | 3.48 | 8.89e-31 | 6.52e-29 | 214 |
GO:0046651 | GO:0046651 | lymphocyte proliferation | 84/1028 | 177/8135 | 3.76 | 1.48e-30 | 1.06e-28 | 177 |
GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 105/1028 | 260/8135 | 3.20 | 1.71e-30 | 1.20e-28 | 260 |
GO:0070661 | GO:0070661 | leukocyte proliferation | 88/1028 | 193/8135 | 3.61 | 2.44e-30 | 1.68e-28 | 193 |
GO:0048534 | GO:0048534 | hematopoietic or lymphoid organ development | 154/1028 | 487/8135 | 2.50 | 3.88e-30 | 2.61e-28 | 487 |
GO:0019221 | GO:0019221 | cytokine-mediated signaling pathway | 147/1028 | 459/8135 | 2.53 | 2.09e-29 | 1.38e-27 | 459 |
GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 77/1028 | 158/8135 | 3.86 | 4.80e-29 | 3.11e-27 | 158 |
GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 75/1028 | 151/8135 | 3.93 | 5.30e-29 | 3.36e-27 | 151 |
GO:0030155 | GO:0030155 | regulation of cell adhesion | 137/1028 | 419/8135 | 2.59 | 2.08e-28 | 1.30e-26 | 419 |
GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 74/1028 | 150/8135 | 3.90 | 2.21e-28 | 1.35e-26 | 150 |
GO:0030217 | GO:0030217 | T cell differentiation | 73/1028 | 151/8135 | 3.83 | 2.68e-27 | 1.61e-25 | 151 |
GO:0042098 | GO:0042098 | T cell proliferation | 64/1028 | 120/8135 | 4.22 | 3.65e-27 | 2.15e-25 | 120 |
GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 100/1028 | 262/8135 | 3.02 | 1.00e-26 | 5.81e-25 | 262 |
GO:0050851 | GO:0050851 | antigen receptor-mediated signaling pathway | 59/1028 | 108/8135 | 4.32 | 7.41e-26 | 4.22e-24 | 108 |
GO:1902105 | GO:1902105 | regulation of leukocyte differentiation | 77/1028 | 175/8135 | 3.48 | 2.14e-25 | 1.20e-23 | 175 |
GO:0006909 | GO:0006909 | phagocytosis | 63/1028 | 126/8135 | 3.96 | 1.02e-24 | 5.64e-23 | 126 |
GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 57/1028 | 106/8135 | 4.26 | 1.51e-24 | 8.16e-23 | 106 |
GO:0002697 | GO:0002697 | regulation of immune effector process | 94/1028 | 251/8135 | 2.96 | 1.94e-24 | 1.03e-22 | 251 |
GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 47/1028 | 76/8135 | 4.89 | 4.94e-24 | 2.59e-22 | 76 |
GO:0042129 | GO:0042129 | regulation of T cell proliferation | 57/1028 | 108/8135 | 4.18 | 5.31e-24 | 2.74e-22 | 108 |
GO:0002460 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 73/1028 | 168/8135 | 3.44 | 1.02e-23 | 5.19e-22 | 168 |
GO:0031349 | GO:0031349 | positive regulation of defense response | 94/1028 | 257/8135 | 2.89 | 1.46e-23 | 7.31e-22 | 257 |
GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 55/1028 | 103/8135 | 4.23 | 1.58e-23 | 7.81e-22 | 103 |
GO:0002683 | GO:0002683 | negative regulation of immune system process | 97/1028 | 273/8135 | 2.81 | 3.34e-23 | 1.62e-21 | 273 |
GO:0002703 | GO:0002703 | regulation of leukocyte mediated immunity | 63/1028 | 133/8135 | 3.75 | 4.40e-23 | 2.11e-21 | 133 |
GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 54/1028 | 102/8135 | 4.19 | 7.00e-23 | 3.30e-21 | 102 |
GO:0002449 | GO:0002449 | lymphocyte mediated immunity | 70/1028 | 161/8135 | 3.44 | 8.44e-23 | 3.92e-21 | 161 |
GO:0046631 | GO:0046631 | alpha-beta T cell activation | 51/1028 | 93/8135 | 4.34 | 1.33e-22 | 6.09e-21 | 93 |
GO:0030595 | GO:0030595 | leukocyte chemotaxis | 72/1028 | 170/8135 | 3.35 | 1.35e-22 | 6.09e-21 | 170 |
GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 54/1028 | 104/8135 | 4.11 | 2.38e-22 | 1.06e-20 | 104 |
GO:0045088 | GO:0045088 | regulation of innate immune response | 78/1028 | 198/8135 | 3.12 | 5.17e-22 | 2.28e-20 | 198 |
GO:0097529 | GO:0097529 | myeloid leukocyte migration | 67/1028 | 154/8135 | 3.44 | 6.93e-22 | 3.01e-20 | 154 |
GO:0050852 | GO:0050852 | T cell receptor signaling pathway | 46/1028 | 80/8135 | 4.55 | 1.15e-21 | 4.93e-20 | 80 |
GO:0060326 | GO:0060326 | cell chemotaxis | 82/1028 | 221/8135 | 2.94 | 4.09e-21 | 1.73e-19 | 221 |
GO:0002699 | GO:0002699 | positive regulation of immune effector process | 61/1028 | 140/8135 | 3.45 | 4.62e-20 | 1.93e-18 | 140 |
GO:0032103 | GO:0032103 | positive regulation of response to external stimulus | 77/1028 | 208/8135 | 2.93 | 8.17e-20 | 3.37e-18 | 208 |
GO:0034341 | GO:0034341 | response to interferon-gamma | 57/1028 | 126/8135 | 3.58 | 8.87e-20 | 3.62e-18 | 126 |
GO:0050663 | GO:0050663 | cytokine secretion | 61/1028 | 145/8135 | 3.33 | 3.97e-19 | 1.60e-17 | 145 |
GO:0045580 | GO:0045580 | regulation of T cell differentiation | 46/1028 | 89/8135 | 4.09 | 4.15e-19 | 1.65e-17 | 89 |
GO:1903706 | GO:1903706 | regulation of hemopoiesis | 83/1028 | 241/8135 | 2.73 | 5.48e-19 | 2.15e-17 | 241 |
GO:0045619 | GO:0045619 | regulation of lymphocyte differentiation | 51/1028 | 108/8135 | 3.74 | 7.91e-19 | 3.07e-17 | 108 |
GO:0046634 | GO:0046634 | regulation of alpha-beta T cell activation | 38/1028 | 64/8135 | 4.70 | 8.82e-19 | 3.38e-17 | 64 |
GO:0038093 | GO:0038093 | Fc receptor signaling pathway | 34/1028 | 54/8135 | 4.98 | 4.47e-18 | 1.69e-16 | 54 |
GO:0050866 | GO:0050866 | negative regulation of cell activation | 54/1028 | 123/8135 | 3.47 | 4.50e-18 | 1.69e-16 | 123 |
GO:0002695 | GO:0002695 | negative regulation of leukocyte activation | 50/1028 | 108/8135 | 3.66 | 5.05e-18 | 1.87e-16 | 108 |
GO:0045089 | GO:0045089 | positive regulation of innate immune response | 65/1028 | 169/8135 | 3.04 | 7.04e-18 | 2.58e-16 | 169 |
GO:0002685 | GO:0002685 | regulation of leukocyte migration | 56/1028 | 132/8135 | 3.36 | 7.38e-18 | 2.68e-16 | 132 |
GO:0002286 | GO:0002286 | T cell activation involved in immune response | 37/1028 | 64/8135 | 4.57 | 8.93e-18 | 3.20e-16 | 64 |
GO:0050727 | GO:0050727 | regulation of inflammatory response | 83/1028 | 251/8135 | 2.62 | 9.49e-18 | 3.37e-16 | 251 |
GO:0009617 | GO:0009617 | response to bacterium | 112/1028 | 398/8135 | 2.23 | 1.54e-17 | 5.40e-16 | 398 |
GO:0006897 | GO:0006897 | endocytosis | 104/1028 | 357/8135 | 2.31 | 1.71e-17 | 5.94e-16 | 357 |
GO:0071346 | GO:0071346 | cellular response to interferon-gamma | 50/1028 | 112/8135 | 3.53 | 3.39e-17 | 1.16e-15 | 112 |
GO:0098657 | GO:0098657 | import into cell | 120/1028 | 445/8135 | 2.13 | 3.72e-17 | 1.26e-15 | 445 |
GO:0002819 | GO:0002819 | regulation of adaptive immune response | 48/1028 | 105/8135 | 3.62 | 4.50e-17 | 1.52e-15 | 105 |
GO:0042089 | GO:0042089 | cytokine biosynthetic process | 40/1028 | 77/8135 | 4.11 | 7.02e-17 | 2.34e-15 | 77 |
GO:0042113 | GO:0042113 | B cell activation | 55/1028 | 134/8135 | 3.25 | 8.78e-17 | 2.90e-15 | 134 |
GO:0042107 | GO:0042107 | cytokine metabolic process | 40/1028 | 78/8135 | 4.06 | 1.27e-16 | 4.15e-15 | 78 |
GO:0051250 | GO:0051250 | negative regulation of lymphocyte activation | 43/1028 | 89/8135 | 3.82 | 1.57e-16 | 5.07e-15 | 89 |
GO:0098542 | GO:0098542 | defense response to other organism | 84/1028 | 268/8135 | 2.48 | 2.32e-16 | 7.44e-15 | 268 |
GO:0050707 | GO:0050707 | regulation of cytokine secretion | 53/1028 | 129/8135 | 3.25 | 3.07e-16 | 9.75e-15 | 129 |
GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 74/1028 | 222/8135 | 2.64 | 3.79e-16 | 1.19e-14 | 222 |
GO:0042035 | GO:0042035 | regulation of cytokine biosynthetic process | 37/1028 | 70/8135 | 4.18 | 4.94e-16 | 1.52e-14 | 70 |
GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 37/1028 | 70/8135 | 4.18 | 4.94e-16 | 1.52e-14 | 70 |
GO:0002822 | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 44/1028 | 95/8135 | 3.67 | 5.11e-16 | 1.56e-14 | 95 |
GO:0071674 | GO:0071674 | mononuclear cell migration | 36/1028 | 67/8135 | 4.25 | 6.18e-16 | 1.86e-14 | 67 |
GO:0032609 | GO:0032609 | interferon-gamma production | 42/1028 | 88/8135 | 3.78 | 6.20e-16 | 1.86e-14 | 88 |
GO:0001818 | GO:0001818 | negative regulation of cytokine production | 61/1028 | 165/8135 | 2.93 | 6.87e-16 | 2.04e-14 | 165 |
GO:1902107 | GO:1902107 | positive regulation of leukocyte differentiation | 44/1028 | 96/8135 | 3.63 | 8.31e-16 | 2.45e-14 | 96 |
GO:0097530 | GO:0097530 | granulocyte migration | 48/1028 | 112/8135 | 3.39 | 1.08e-15 | 3.16e-14 | 112 |
GO:0002706 | GO:0002706 | regulation of lymphocyte mediated immunity | 44/1028 | 98/8135 | 3.55 | 2.14e-15 | 6.20e-14 | 98 |
GO:0002218 | GO:0002218 | activation of innate immune response | 52/1028 | 130/8135 | 3.17 | 2.26e-15 | 6.47e-14 | 130 |
GO:0046635 | GO:0046635 | positive regulation of alpha-beta T cell activation | 28/1028 | 44/8135 | 5.04 | 2.78e-15 | 7.91e-14 | 44 |
GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 53/1028 | 135/8135 | 3.11 | 3.08e-15 | 8.69e-14 | 135 |
GO:0032496 | GO:0032496 | response to lipopolysaccharide | 70/1028 | 213/8135 | 2.60 | 5.63e-15 | 1.57e-13 | 213 |
GO:0045621 | GO:0045621 | positive regulation of lymphocyte differentiation | 34/1028 | 64/8135 | 4.20 | 6.34e-15 | 1.76e-13 | 64 |
GO:0071706 | GO:0071706 | tumor necrosis factor superfamily cytokine production | 41/1028 | 90/8135 | 3.61 | 1.06e-14 | 2.88e-13 | 90 |
GO:1903555 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 41/1028 | 90/8135 | 3.61 | 1.06e-14 | 2.88e-13 | 90 |
GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 51/1028 | 130/8135 | 3.10 | 1.08e-14 | 2.91e-13 | 130 |
GO:0042108 | GO:0042108 | positive regulation of cytokine biosynthetic process | 27/1028 | 43/8135 | 4.97 | 1.43e-14 | 3.85e-13 | 43 |
GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 32/1028 | 59/8135 | 4.29 | 1.84e-14 | 4.89e-13 | 59 |
GO:0032649 | GO:0032649 | regulation of interferon-gamma production | 38/1028 | 80/8135 | 3.76 | 1.87e-14 | 4.95e-13 | 80 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 44/1028 | 103/8135 | 3.38 | 1.99e-14 | 5.20e-13 | 103 |
GO:0002824 | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 34/1028 | 66/8135 | 4.08 | 2.13e-14 | 5.53e-13 | 66 |
GO:0032729 | GO:0032729 | positive regulation of interferon-gamma production | 30/1028 | 53/8135 | 4.48 | 2.60e-14 | 6.70e-13 | 53 |
GO:0032623 | GO:0032623 | interleukin-2 production | 26/1028 | 41/8135 | 5.02 | 3.15e-14 | 8.07e-13 | 41 |
GO:0002292 | GO:0002292 | T cell differentiation involved in immune response | 27/1028 | 44/8135 | 4.86 | 3.27e-14 | 8.30e-13 | 44 |
GO:0002705 | GO:0002705 | positive regulation of leukocyte mediated immunity | 39/1028 | 85/8135 | 3.63 | 3.56e-14 | 8.96e-13 | 85 |
GO:0002758 | GO:0002758 | innate immune response-activating signal transduction | 49/1028 | 125/8135 | 3.10 | 3.76e-14 | 9.39e-13 | 125 |
GO:0050868 | GO:0050868 | negative regulation of T cell activation | 34/1028 | 67/8135 | 4.02 | 3.80e-14 | 9.44e-13 | 67 |
GO:0045582 | GO:0045582 | positive regulation of T cell differentiation | 31/1028 | 57/8135 | 4.30 | 4.28e-14 | 1.05e-12 | 57 |
GO:0001909 | GO:0001909 | leukocyte mediated cytotoxicity | 36/1028 | 75/8135 | 3.80 | 6.14e-14 | 1.50e-12 | 75 |
GO:0071887 | GO:0071887 | leukocyte apoptotic process | 34/1028 | 68/8135 | 3.96 | 6.70e-14 | 1.63e-12 | 68 |
GO:0002821 | GO:0002821 | positive regulation of adaptive immune response | 34/1028 | 69/8135 | 3.90 | 1.16e-13 | 2.80e-12 | 69 |
GO:2000106 | GO:2000106 | regulation of leukocyte apoptotic process | 32/1028 | 62/8135 | 4.08 | 1.17e-13 | 2.80e-12 | 62 |
GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 49/1028 | 129/8135 | 3.01 | 1.57e-13 | 3.72e-12 | 129 |
GO:1990266 | GO:1990266 | neutrophil migration | 41/1028 | 96/8135 | 3.38 | 1.58e-13 | 3.72e-12 | 96 |
GO:0050729 | GO:0050729 | positive regulation of inflammatory response | 42/1028 | 100/8135 | 3.32 | 1.59e-13 | 3.73e-12 | 100 |
GO:2000514 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 25/1028 | 40/8135 | 4.95 | 1.62e-13 | 3.75e-12 | 40 |
GO:0046637 | GO:0046637 | regulation of alpha-beta T cell differentiation | 26/1028 | 43/8135 | 4.78 | 1.63e-13 | 3.75e-12 | 43 |
GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 37/1028 | 81/8135 | 3.61 | 1.93e-13 | 4.41e-12 | 81 |
GO:0051345 | GO:0051345 | positive regulation of hydrolase activity | 95/1028 | 356/8135 | 2.11 | 1.94e-13 | 4.41e-12 | 356 |
GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 45/1028 | 113/8135 | 3.15 | 2.16e-13 | 4.89e-12 | 113 |
GO:0043367 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 28/1028 | 50/8135 | 4.43 | 2.77e-13 | 6.21e-12 | 50 |
GO:0032640 | GO:0032640 | tumor necrosis factor production | 38/1028 | 86/8135 | 3.50 | 3.35e-13 | 7.42e-12 | 86 |
GO:0032680 | GO:0032680 | regulation of tumor necrosis factor production | 38/1028 | 86/8135 | 3.50 | 3.35e-13 | 7.42e-12 | 86 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 39/1028 | 90/8135 | 3.43 | 3.53e-13 | 7.76e-12 | 90 |
GO:1903038 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 35/1028 | 75/8135 | 3.69 | 3.97e-13 | 8.67e-12 | 75 |
GO:0002548 | GO:0002548 | monocyte chemotaxis | 29/1028 | 54/8135 | 4.25 | 4.42e-13 | 9.60e-12 | 54 |
GO:0019882 | GO:0019882 | antigen processing and presentation | 37/1028 | 83/8135 | 3.53 | 4.93e-13 | 1.06e-11 | 83 |
GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 38/1028 | 87/8135 | 3.46 | 5.24e-13 | 1.12e-11 | 87 |
GO:0072676 | GO:0072676 | lymphocyte migration | 36/1028 | 80/8135 | 3.56 | 7.20e-13 | 1.53e-11 | 80 |
GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 47/1028 | 125/8135 | 2.98 | 7.71e-13 | 1.63e-11 | 125 |
GO:0050715 | GO:0050715 | positive regulation of cytokine secretion | 38/1028 | 89/8135 | 3.38 | 1.25e-12 | 2.63e-11 | 89 |
GO:0006935 | GO:0006935 | chemotaxis | 108/1028 | 441/8135 | 1.94 | 1.74e-12 | 3.63e-11 | 441 |
GO:0042330 | GO:0042330 | taxis | 108/1028 | 442/8135 | 1.93 | 2.03e-12 | 4.22e-11 | 442 |
GO:0038094 | GO:0038094 | Fc-gamma receptor signaling pathway | 20/1028 | 29/8135 | 5.46 | 2.96e-12 | 6.10e-11 | 29 |
GO:0050864 | GO:0050864 | regulation of B cell activation | 33/1028 | 72/8135 | 3.63 | 3.52e-12 | 7.21e-11 | 72 |
GO:0032663 | GO:0032663 | regulation of interleukin-2 production | 22/1028 | 35/8135 | 4.97 | 4.05e-12 | 8.24e-11 | 35 |
GO:0002708 | GO:0002708 | positive regulation of lymphocyte mediated immunity | 32/1028 | 69/8135 | 3.67 | 5.04e-12 | 1.02e-10 | 69 |
GO:0019884 | GO:0019884 | antigen processing and presentation of exogenous antigen | 29/1028 | 59/8135 | 3.89 | 8.25e-12 | 1.66e-10 | 59 |
GO:0043370 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 21/1028 | 33/8135 | 5.04 | 8.91e-12 | 1.78e-10 | 33 |
GO:0032653 | GO:0032653 | regulation of interleukin-10 production | 22/1028 | 36/8135 | 4.84 | 9.17e-12 | 1.81e-10 | 36 |
GO:0045058 | GO:0045058 | T cell selection | 22/1028 | 36/8135 | 4.84 | 9.17e-12 | 1.81e-10 | 36 |
GO:0032635 | GO:0032635 | interleukin-6 production | 37/1028 | 91/8135 | 3.22 | 1.46e-11 | 2.86e-10 | 91 |
GO:0032743 | GO:0032743 | positive regulation of interleukin-2 production | 15/1028 | 18/8135 | 6.59 | 1.72e-11 | 3.34e-10 | 18 |
GO:0042094 | GO:0042094 | interleukin-2 biosynthetic process | 15/1028 | 18/8135 | 6.59 | 1.72e-11 | 3.34e-10 | 18 |
GO:0002287 | GO:0002287 | alpha-beta T cell activation involved in immune response | 23/1028 | 40/8135 | 4.55 | 1.82e-11 | 3.49e-10 | 40 |
GO:0002293 | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 23/1028 | 40/8135 | 4.55 | 1.82e-11 | 3.49e-10 | 40 |
GO:0031295 | GO:0031295 | T cell costimulation | 22/1028 | 37/8135 | 4.71 | 2.00e-11 | 3.78e-10 | 37 |
GO:0032613 | GO:0032613 | interleukin-10 production | 22/1028 | 37/8135 | 4.71 | 2.00e-11 | 3.78e-10 | 37 |
GO:0070098 | GO:0070098 | chemokine-mediated signaling pathway | 34/1028 | 80/8135 | 3.36 | 2.26e-11 | 4.27e-10 | 80 |
GO:0045076 | GO:0045076 | regulation of interleukin-2 biosynthetic process | 14/1028 | 16/8135 | 6.92 | 2.29e-11 | 4.30e-10 | 16 |
GO:0071356 | GO:0071356 | cellular response to tumor necrosis factor | 48/1028 | 141/8135 | 2.69 | 2.88e-11 | 5.36e-10 | 141 |
GO:0048247 | GO:0048247 | lymphocyte chemotaxis | 26/1028 | 51/8135 | 4.03 | 3.48e-11 | 6.45e-10 | 51 |
GO:0001906 | GO:0001906 | cell killing | 40/1028 | 106/8135 | 2.99 | 3.53e-11 | 6.51e-10 | 106 |
GO:0031294 | GO:0031294 | lymphocyte costimulation | 22/1028 | 38/8135 | 4.58 | 4.18e-11 | 7.66e-10 | 38 |
GO:0002431 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 19/1028 | 29/8135 | 5.18 | 4.21e-11 | 7.67e-10 | 29 |
GO:0051092 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 31/1028 | 70/8135 | 3.50 | 4.82e-11 | 8.73e-10 | 70 |
GO:1990868 | GO:1990868 | response to chemokine | 35/1028 | 86/8135 | 3.22 | 5.05e-11 | 9.06e-10 | 86 |
GO:1990869 | GO:1990869 | cellular response to chemokine | 35/1028 | 86/8135 | 3.22 | 5.05e-11 | 9.06e-10 | 86 |
GO:0019724 | GO:0019724 | B cell mediated immunity | 31/1028 | 71/8135 | 3.46 | 7.53e-11 | 1.34e-09 | 71 |
GO:0002294 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 22/1028 | 39/8135 | 4.46 | 8.45e-11 | 1.50e-09 | 39 |
GO:2000516 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 18/1028 | 27/8135 | 5.28 | 8.99e-11 | 1.59e-09 | 27 |
GO:0034612 | GO:0034612 | response to tumor necrosis factor | 49/1028 | 150/8135 | 2.59 | 9.56e-11 | 1.66e-09 | 150 |
GO:0002886 | GO:0002886 | regulation of myeloid leukocyte mediated immunity | 21/1028 | 36/8135 | 4.62 | 9.59e-11 | 1.66e-09 | 36 |
GO:0050853 | GO:0050853 | B cell receptor signaling pathway | 21/1028 | 36/8135 | 4.62 | 9.59e-11 | 1.66e-09 | 36 |
GO:0045086 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 11/1028 | 11/8135 | 7.91 | 1.25e-10 | 2.16e-09 | 11 |
GO:0051090 | GO:0051090 | regulation of DNA-binding transcription factor activity | 58/1028 | 195/8135 | 2.35 | 1.26e-10 | 2.16e-09 | 195 |
GO:0044419 | GO:0044419 | interspecies interaction between organisms | 73/1028 | 273/8135 | 2.12 | 1.27e-10 | 2.18e-09 | 273 |
GO:0072678 | GO:0072678 | T cell migration | 23/1028 | 43/8135 | 4.23 | 1.35e-10 | 2.29e-09 | 43 |
GO:0032675 | GO:0032675 | regulation of interleukin-6 production | 34/1028 | 85/8135 | 3.17 | 1.68e-10 | 2.84e-09 | 85 |
GO:0032945 | GO:0032945 | negative regulation of mononuclear cell proliferation | 24/1028 | 47/8135 | 4.04 | 1.91e-10 | 3.21e-09 | 47 |
GO:0050672 | GO:0050672 | negative regulation of lymphocyte proliferation | 24/1028 | 47/8135 | 4.04 | 1.91e-10 | 3.21e-09 | 47 |
GO:0016064 | GO:0016064 | immunoglobulin mediated immune response | 30/1028 | 70/8135 | 3.39 | 2.68e-10 | 4.46e-09 | 70 |
GO:0030099 | GO:0030099 | myeloid cell differentiation | 61/1028 | 214/8135 | 2.26 | 2.83e-10 | 4.70e-09 | 214 |
GO:1903557 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 26/1028 | 55/8135 | 3.74 | 3.02e-10 | 4.98e-09 | 55 |
GO:0072507 | GO:0072507 | divalent inorganic cation homeostasis | 86/1028 | 350/8135 | 1.94 | 3.18e-10 | 5.22e-09 | 350 |
GO:0002221 | GO:0002221 | pattern recognition receptor signaling pathway | 35/1028 | 91/8135 | 3.04 | 3.26e-10 | 5.33e-09 | 91 |
GO:0072503 | GO:0072503 | cellular divalent inorganic cation homeostasis | 83/1028 | 334/8135 | 1.97 | 3.64e-10 | 5.92e-09 | 334 |
GO:0048002 | GO:0048002 | antigen processing and presentation of peptide antigen | 28/1028 | 63/8135 | 3.52 | 3.79e-10 | 6.13e-09 | 63 |
GO:0070664 | GO:0070664 | negative regulation of leukocyte proliferation | 25/1028 | 52/8135 | 3.80 | 4.22e-10 | 6.80e-09 | 52 |
GO:0002433 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 17/1028 | 26/8135 | 5.17 | 4.83e-10 | 7.66e-09 | 26 |
GO:0038096 | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 17/1028 | 26/8135 | 5.17 | 4.83e-10 | 7.66e-09 | 26 |
GO:0043368 | GO:0043368 | positive T cell selection | 17/1028 | 26/8135 | 5.17 | 4.83e-10 | 7.66e-09 | 26 |
GO:0046638 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 19/1028 | 32/8135 | 4.70 | 5.01e-10 | 7.91e-09 | 32 |
GO:0001776 | GO:0001776 | leukocyte homeostasis | 27/1028 | 60/8135 | 3.56 | 5.54e-10 | 8.66e-09 | 60 |
GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 27/1028 | 60/8135 | 3.56 | 5.54e-10 | 8.66e-09 | 60 |
GO:0007204 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 64/1028 | 233/8135 | 2.17 | 5.57e-10 | 8.68e-09 | 233 |
GO:0006968 | GO:0006968 | cellular defense response | 24/1028 | 49/8135 | 3.88 | 5.83e-10 | 9.03e-09 | 49 |
GO:0009615 | GO:0009615 | response to virus | 50/1028 | 162/8135 | 2.44 | 5.91e-10 | 9.12e-09 | 162 |
GO:0031341 | GO:0031341 | regulation of cell killing | 29/1028 | 68/8135 | 3.37 | 6.14e-10 | 9.42e-09 | 68 |
GO:0042116 | GO:0042116 | macrophage activation | 25/1028 | 53/8135 | 3.73 | 7.05e-10 | 1.08e-08 | 53 |
GO:0022408 | GO:0022408 | negative regulation of cell-cell adhesion | 37/1028 | 102/8135 | 2.87 | 7.19e-10 | 1.09e-08 | 102 |
GO:0044403 | GO:0044403 | symbiont process | 66/1028 | 245/8135 | 2.13 | 7.28e-10 | 1.10e-08 | 245 |
GO:0070227 | GO:0070227 | lymphocyte apoptotic process | 23/1028 | 46/8135 | 3.96 | 7.92e-10 | 1.19e-08 | 46 |
GO:0001910 | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 27/1028 | 61/8135 | 3.50 | 8.76e-10 | 1.31e-08 | 61 |
GO:0002448 | GO:0002448 | mast cell mediated immunity | 20/1028 | 36/8135 | 4.40 | 8.96e-10 | 1.34e-08 | 36 |
GO:0055074 | GO:0055074 | calcium ion homeostasis | 80/1028 | 323/8135 | 1.96 | 9.15e-10 | 1.36e-08 | 323 |
GO:0002224 | GO:0002224 | toll-like receptor signaling pathway | 29/1028 | 69/8135 | 3.33 | 9.33e-10 | 1.38e-08 | 69 |
GO:0006874 | GO:0006874 | cellular calcium ion homeostasis | 78/1028 | 312/8135 | 1.98 | 9.43e-10 | 1.39e-08 | 312 |
GO:2000403 | GO:2000403 | positive regulation of lymphocyte migration | 16/1028 | 24/8135 | 5.28 | 1.04e-09 | 1.52e-08 | 24 |
GO:0002495 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 22/1028 | 43/8135 | 4.05 | 1.05e-09 | 1.54e-08 | 43 |
GO:0042088 | GO:0042088 | T-helper 1 type immune response | 18/1028 | 30/8135 | 4.75 | 1.14e-09 | 1.65e-08 | 30 |
GO:0043300 | GO:0043300 | regulation of leukocyte degranulation | 18/1028 | 30/8135 | 4.75 | 1.14e-09 | 1.65e-08 | 30 |
GO:0016032 | GO:0016032 | viral process | 59/1028 | 211/8135 | 2.21 | 1.27e-09 | 1.83e-08 | 211 |
GO:0030316 | GO:0030316 | osteoclast differentiation | 27/1028 | 62/8135 | 3.45 | 1.37e-09 | 1.96e-08 | 62 |
GO:0042093 | GO:0042093 | T-helper cell differentiation | 20/1028 | 37/8135 | 4.28 | 1.72e-09 | 2.46e-08 | 37 |
GO:0002504 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 22/1028 | 44/8135 | 3.96 | 1.86e-09 | 2.64e-08 | 44 |
GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 49/1028 | 162/8135 | 2.39 | 1.89e-09 | 2.68e-08 | 162 |
GO:0006875 | GO:0006875 | cellular metal ion homeostasis | 88/1028 | 374/8135 | 1.86 | 2.05e-09 | 2.89e-08 | 374 |
GO:0031663 | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 19/1028 | 34/8135 | 4.42 | 2.08e-09 | 2.91e-08 | 34 |
GO:0043303 | GO:0043303 | mast cell degranulation | 19/1028 | 34/8135 | 4.42 | 2.08e-09 | 2.91e-08 | 34 |
GO:0002440 | GO:0002440 | production of molecular mediator of immune response | 39/1028 | 115/8135 | 2.68 | 2.39e-09 | 3.33e-08 | 115 |
GO:0002704 | GO:0002704 | negative regulation of leukocyte mediated immunity | 18/1028 | 31/8135 | 4.59 | 2.40e-09 | 3.33e-08 | 31 |
GO:0070228 | GO:0070228 | regulation of lymphocyte apoptotic process | 21/1028 | 41/8135 | 4.05 | 2.47e-09 | 3.41e-08 | 41 |
GO:0032633 | GO:0032633 | interleukin-4 production | 17/1028 | 28/8135 | 4.80 | 2.58e-09 | 3.55e-08 | 28 |
GO:0046641 | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 13/1028 | 17/8135 | 6.05 | 2.85e-09 | 3.90e-08 | 17 |
GO:2000401 | GO:2000401 | regulation of lymphocyte migration | 20/1028 | 38/8135 | 4.16 | 3.20e-09 | 4.33e-08 | 38 |
GO:0032637 | GO:0032637 | interleukin-8 production | 22/1028 | 45/8135 | 3.87 | 3.21e-09 | 4.33e-08 | 45 |
GO:0045576 | GO:0045576 | mast cell activation | 22/1028 | 45/8135 | 3.87 | 3.21e-09 | 4.33e-08 | 45 |
GO:0002279 | GO:0002279 | mast cell activation involved in immune response | 19/1028 | 35/8135 | 4.30 | 4.02e-09 | 5.39e-08 | 35 |
GO:0032655 | GO:0032655 | regulation of interleukin-12 production | 19/1028 | 35/8135 | 4.30 | 4.02e-09 | 5.39e-08 | 35 |
GO:0050920 | GO:0050920 | regulation of chemotaxis | 45/1028 | 146/8135 | 2.44 | 4.54e-09 | 6.07e-08 | 146 |
GO:0051091 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 40/1028 | 122/8135 | 2.59 | 4.57e-09 | 6.08e-08 | 122 |
GO:0042100 | GO:0042100 | B cell proliferation | 26/1028 | 61/8135 | 3.37 | 4.84e-09 | 6.41e-08 | 61 |
GO:0009306 | GO:0009306 | protein secretion | 81/1028 | 340/8135 | 1.89 | 5.07e-09 | 6.70e-08 | 340 |
GO:0043372 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 15/1028 | 23/8135 | 5.16 | 5.55e-09 | 7.27e-08 | 23 |
GO:0046633 | GO:0046633 | alpha-beta T cell proliferation | 15/1028 | 23/8135 | 5.16 | 5.55e-09 | 7.27e-08 | 23 |
GO:0048872 | GO:0048872 | homeostasis of number of cells | 41/1028 | 128/8135 | 2.53 | 6.36e-09 | 8.29e-08 | 128 |
GO:0030003 | GO:0030003 | cellular cation homeostasis | 92/1028 | 406/8135 | 1.79 | 6.59e-09 | 8.56e-08 | 406 |
GO:0002478 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 24/1028 | 54/8135 | 3.52 | 6.89e-09 | 8.92e-08 | 54 |
GO:0002456 | GO:0002456 | T cell mediated immunity | 28/1028 | 70/8135 | 3.17 | 6.94e-09 | 8.95e-08 | 70 |
GO:0032418 | GO:0032418 | lysosome localization | 19/1028 | 36/8135 | 4.18 | 7.51e-09 | 9.58e-08 | 36 |
GO:0032615 | GO:0032615 | interleukin-12 production | 19/1028 | 36/8135 | 4.18 | 7.51e-09 | 9.58e-08 | 36 |
GO:0002228 | GO:0002228 | natural killer cell mediated immunity | 21/1028 | 43/8135 | 3.86 | 7.52e-09 | 9.58e-08 | 43 |
GO:0070374 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 50/1028 | 174/8135 | 2.27 | 8.83e-09 | 1.12e-07 | 174 |
GO:0050764 | GO:0050764 | regulation of phagocytosis | 23/1028 | 51/8135 | 3.57 | 1.01e-08 | 1.28e-07 | 51 |
GO:0019886 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 20/1028 | 40/8135 | 3.96 | 1.02e-08 | 1.28e-07 | 40 |
GO:0032677 | GO:0032677 | regulation of interleukin-8 production | 20/1028 | 40/8135 | 3.96 | 1.02e-08 | 1.28e-07 | 40 |
GO:0055065 | GO:0055065 | metal ion homeostasis | 94/1028 | 422/8135 | 1.76 | 1.12e-08 | 1.39e-07 | 422 |
GO:0032753 | GO:0032753 | positive regulation of interleukin-4 production | 14/1028 | 21/8135 | 5.28 | 1.20e-08 | 1.49e-07 | 21 |
GO:0046640 | GO:0046640 | regulation of alpha-beta T cell proliferation | 14/1028 | 21/8135 | 5.28 | 1.20e-08 | 1.49e-07 | 21 |
GO:0043410 | GO:0043410 | positive regulation of MAPK cascade | 84/1028 | 364/8135 | 1.83 | 1.28e-08 | 1.59e-07 | 364 |
GO:0032673 | GO:0032673 | regulation of interleukin-4 production | 15/1028 | 24/8135 | 4.95 | 1.31e-08 | 1.60e-07 | 24 |
GO:0050777 | GO:0050777 | negative regulation of immune response | 32/1028 | 89/8135 | 2.85 | 1.31e-08 | 1.60e-07 | 89 |
GO:0070555 | GO:0070555 | response to interleukin-1 | 32/1028 | 89/8135 | 2.85 | 1.31e-08 | 1.60e-07 | 89 |
GO:0030334 | GO:0030334 | regulation of cell migration | 105/1028 | 490/8135 | 1.70 | 1.34e-08 | 1.63e-07 | 490 |
GO:0032760 | GO:0032760 | positive regulation of tumor necrosis factor production | 23/1028 | 52/8135 | 3.50 | 1.59e-08 | 1.93e-07 | 52 |
GO:0019722 | GO:0019722 | calcium-mediated signaling | 44/1028 | 147/8135 | 2.37 | 1.82e-08 | 2.20e-07 | 147 |
GO:0043900 | GO:0043900 | regulation of multi-organism process | 52/1028 | 188/8135 | 2.19 | 1.85e-08 | 2.23e-07 | 188 |
GO:0002790 | GO:0002790 | peptide secretion | 84/1028 | 367/8135 | 1.81 | 1.92e-08 | 2.31e-07 | 367 |
GO:0050871 | GO:0050871 | positive regulation of B cell activation | 21/1028 | 45/8135 | 3.69 | 2.10e-08 | 2.51e-07 | 45 |
GO:0030335 | GO:0030335 | positive regulation of cell migration | 70/1028 | 287/8135 | 1.93 | 2.12e-08 | 2.53e-07 | 287 |
GO:0002698 | GO:0002698 | negative regulation of immune effector process | 27/1028 | 69/8135 | 3.10 | 2.26e-08 | 2.68e-07 | 69 |
GO:0030168 | GO:0030168 | platelet activation | 34/1028 | 100/8135 | 2.69 | 2.36e-08 | 2.80e-07 | 100 |
GO:0032612 | GO:0032612 | interleukin-1 production | 26/1028 | 65/8135 | 3.17 | 2.40e-08 | 2.82e-07 | 65 |
GO:0150076 | GO:0150076 | neuroinflammatory response | 19/1028 | 38/8135 | 3.96 | 2.41e-08 | 2.82e-07 | 38 |
GO:0002755 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 13/1028 | 19/8135 | 5.41 | 2.54e-08 | 2.96e-07 | 19 |
GO:2000406 | GO:2000406 | positive regulation of T cell migration | 13/1028 | 19/8135 | 5.41 | 2.54e-08 | 2.96e-07 | 19 |
GO:0006873 | GO:0006873 | cellular ion homeostasis | 92/1028 | 417/8135 | 1.75 | 2.65e-08 | 3.07e-07 | 417 |
GO:0045622 | GO:0045622 | regulation of T-helper cell differentiation | 15/1028 | 25/8135 | 4.75 | 2.89e-08 | 3.35e-07 | 25 |
GO:0032660 | GO:0032660 | regulation of interleukin-17 production | 14/1028 | 22/8135 | 5.04 | 2.91e-08 | 3.35e-07 | 22 |
GO:0032733 | GO:0032733 | positive regulation of interleukin-10 production | 14/1028 | 22/8135 | 5.04 | 2.91e-08 | 3.35e-07 | 22 |
GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 32/1028 | 92/8135 | 2.75 | 3.29e-08 | 3.77e-07 | 92 |
GO:0030888 | GO:0030888 | regulation of B cell proliferation | 21/1028 | 46/8135 | 3.61 | 3.40e-08 | 3.89e-07 | 46 |
GO:0040017 | GO:0040017 | positive regulation of locomotion | 75/1028 | 319/8135 | 1.86 | 3.51e-08 | 4.00e-07 | 319 |
GO:0055080 | GO:0055080 | cation homeostasis | 98/1028 | 457/8135 | 1.70 | 4.10e-08 | 4.65e-07 | 457 |
GO:0042267 | GO:0042267 | natural killer cell mediated cytotoxicity | 19/1028 | 39/8135 | 3.86 | 4.14e-08 | 4.68e-07 | 39 |
GO:0002761 | GO:0002761 | regulation of myeloid leukocyte differentiation | 28/1028 | 75/8135 | 2.95 | 4.15e-08 | 4.68e-07 | 75 |
GO:0042742 | GO:0042742 | defense response to bacterium | 45/1028 | 156/8135 | 2.28 | 4.34e-08 | 4.87e-07 | 156 |
GO:0051480 | GO:0051480 | regulation of cytosolic calcium ion concentration | 65/1028 | 264/8135 | 1.95 | 4.69e-08 | 5.25e-07 | 264 |
GO:0050710 | GO:0050710 | negative regulation of cytokine secretion | 20/1028 | 43/8135 | 3.68 | 4.90e-08 | 5.46e-07 | 43 |
GO:0030183 | GO:0030183 | B cell differentiation | 26/1028 | 67/8135 | 3.07 | 5.04e-08 | 5.60e-07 | 67 |
GO:0031348 | GO:0031348 | negative regulation of defense response | 37/1028 | 117/8135 | 2.50 | 5.10e-08 | 5.63e-07 | 117 |
GO:0002712 | GO:0002712 | regulation of B cell mediated immunity | 16/1028 | 29/8135 | 4.37 | 5.13e-08 | 5.63e-07 | 29 |
GO:0002889 | GO:0002889 | regulation of immunoglobulin mediated immune response | 16/1028 | 29/8135 | 4.37 | 5.13e-08 | 5.63e-07 | 29 |
GO:0038095 | GO:0038095 | Fc-epsilon receptor signaling pathway | 16/1028 | 29/8135 | 4.37 | 5.13e-08 | 5.63e-07 | 29 |
GO:0002709 | GO:0002709 | regulation of T cell mediated immunity | 21/1028 | 47/8135 | 3.54 | 5.43e-08 | 5.93e-07 | 47 |
GO:0098771 | GO:0098771 | inorganic ion homeostasis | 99/1028 | 467/8135 | 1.68 | 6.36e-08 | 6.93e-07 | 467 |
GO:0051607 | GO:0051607 | defense response to virus | 37/1028 | 118/8135 | 2.48 | 6.55e-08 | 7.10e-07 | 118 |
GO:0032620 | GO:0032620 | interleukin-17 production | 14/1028 | 23/8135 | 4.82 | 6.58e-08 | 7.10e-07 | 23 |
GO:0045730 | GO:0045730 | respiratory burst | 14/1028 | 23/8135 | 4.82 | 6.58e-08 | 7.10e-07 | 23 |
GO:2000107 | GO:2000107 | negative regulation of leukocyte apoptotic process | 19/1028 | 40/8135 | 3.76 | 6.96e-08 | 7.48e-07 | 40 |
GO:0035747 | GO:0035747 | natural killer cell chemotaxis | 9/1028 | 10/8135 | 7.12 | 7.07e-08 | 7.57e-07 | 10 |
GO:0002260 | GO:0002260 | lymphocyte homeostasis | 20/1028 | 44/8135 | 3.60 | 7.93e-08 | 8.46e-07 | 44 |
GO:0051209 | GO:0051209 | release of sequestered calcium ion into cytosol | 28/1028 | 77/8135 | 2.88 | 8.03e-08 | 8.52e-07 | 77 |
GO:0051283 | GO:0051283 | negative regulation of sequestering of calcium ion | 28/1028 | 77/8135 | 2.88 | 8.03e-08 | 8.52e-07 | 77 |
GO:2000147 | GO:2000147 | positive regulation of cell motility | 71/1028 | 302/8135 | 1.86 | 8.27e-08 | 8.74e-07 | 302 |
GO:0070371 | GO:0070371 | ERK1 and ERK2 cascade | 58/1028 | 229/8135 | 2.00 | 8.84e-08 | 9.32e-07 | 229 |
GO:0010942 | GO:0010942 | positive regulation of cell death | 74/1028 | 320/8135 | 1.83 | 8.99e-08 | 9.45e-07 | 320 |
GO:0043547 | GO:0043547 | positive regulation of GTPase activity | 49/1028 | 181/8135 | 2.14 | 1.00e-07 | 1.05e-06 | 181 |
GO:0070372 | GO:0070372 | regulation of ERK1 and ERK2 cascade | 56/1028 | 219/8135 | 2.02 | 1.04e-07 | 1.09e-06 | 219 |
GO:0051282 | GO:0051282 | regulation of sequestering of calcium ion | 28/1028 | 78/8135 | 2.84 | 1.10e-07 | 1.15e-06 | 78 |
GO:0002367 | GO:0002367 | cytokine production involved in immune response | 25/1028 | 65/8135 | 3.04 | 1.12e-07 | 1.15e-06 | 65 |
GO:0007229 | GO:0007229 | integrin-mediated signaling pathway | 25/1028 | 65/8135 | 3.04 | 1.12e-07 | 1.15e-06 | 65 |
GO:1902106 | GO:1902106 | negative regulation of leukocyte differentiation | 25/1028 | 65/8135 | 3.04 | 1.12e-07 | 1.15e-06 | 65 |
GO:0007249 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 35/1028 | 111/8135 | 2.50 | 1.27e-07 | 1.31e-06 | 111 |
GO:0031343 | GO:0031343 | positive regulation of cell killing | 21/1028 | 49/8135 | 3.39 | 1.31e-07 | 1.35e-06 | 49 |
GO:1901623 | GO:1901623 | regulation of lymphocyte chemotaxis | 12/1028 | 18/8135 | 5.28 | 1.40e-07 | 1.42e-06 | 18 |
GO:0002825 | GO:0002825 | regulation of T-helper 1 type immune response | 14/1028 | 24/8135 | 4.62 | 1.40e-07 | 1.42e-06 | 24 |
GO:0001773 | GO:0001773 | myeloid dendritic cell activation | 13/1028 | 21/8135 | 4.90 | 1.49e-07 | 1.51e-06 | 21 |
GO:0045066 | GO:0045066 | regulatory T cell differentiation | 13/1028 | 21/8135 | 4.90 | 1.49e-07 | 1.51e-06 | 21 |
GO:0051208 | GO:0051208 | sequestering of calcium ion | 28/1028 | 79/8135 | 2.80 | 1.51e-07 | 1.52e-06 | 79 |
GO:0043087 | GO:0043087 | regulation of GTPase activity | 55/1028 | 216/8135 | 2.01 | 1.58e-07 | 1.59e-06 | 216 |
GO:0045453 | GO:0045453 | bone resorption | 19/1028 | 42/8135 | 3.58 | 1.84e-07 | 1.85e-06 | 42 |
GO:0032611 | GO:0032611 | interleukin-1 beta production | 22/1028 | 54/8135 | 3.22 | 1.96e-07 | 1.96e-06 | 54 |
GO:0002831 | GO:0002831 | regulation of response to biotic stimulus | 25/1028 | 67/8135 | 2.95 | 2.23e-07 | 2.23e-06 | 67 |
GO:0032479 | GO:0032479 | regulation of type I interferon production | 18/1028 | 39/8135 | 3.65 | 2.67e-07 | 2.64e-06 | 39 |
GO:0032606 | GO:0032606 | type I interferon production | 18/1028 | 39/8135 | 3.65 | 2.67e-07 | 2.64e-06 | 39 |
GO:0050766 | GO:0050766 | positive regulation of phagocytosis | 18/1028 | 39/8135 | 3.65 | 2.67e-07 | 2.64e-06 | 39 |
GO:0051272 | GO:0051272 | positive regulation of cellular component movement | 71/1028 | 311/8135 | 1.81 | 2.82e-07 | 2.77e-06 | 311 |
GO:0001912 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 19/1028 | 43/8135 | 3.50 | 2.92e-07 | 2.86e-06 | 43 |
GO:0002377 | GO:0002377 | immunoglobulin production | 21/1028 | 51/8135 | 3.26 | 3.00e-07 | 2.94e-06 | 51 |
GO:0002711 | GO:0002711 | positive regulation of T cell mediated immunity | 16/1028 | 32/8135 | 3.96 | 3.13e-07 | 3.04e-06 | 32 |
GO:0070231 | GO:0070231 | T cell apoptotic process | 16/1028 | 32/8135 | 3.96 | 3.13e-07 | 3.04e-06 | 32 |
GO:0071675 | GO:0071675 | regulation of mononuclear cell migration | 16/1028 | 32/8135 | 3.96 | 3.13e-07 | 3.04e-06 | 32 |
GO:0097553 | GO:0097553 | calcium ion transmembrane import into cytosol | 30/1028 | 91/8135 | 2.61 | 3.41e-07 | 3.30e-06 | 91 |
GO:0032695 | GO:0032695 | negative regulation of interleukin-12 production | 9/1028 | 11/8135 | 6.47 | 3.45e-07 | 3.33e-06 | 11 |
GO:0032720 | GO:0032720 | negative regulation of tumor necrosis factor production | 17/1028 | 36/8135 | 3.74 | 3.82e-07 | 3.68e-06 | 36 |
GO:0051222 | GO:0051222 | positive regulation of protein transport | 54/1028 | 216/8135 | 1.98 | 3.89e-07 | 3.73e-06 | 216 |
GO:0030100 | GO:0030100 | regulation of endocytosis | 38/1028 | 131/8135 | 2.30 | 4.17e-07 | 3.99e-06 | 131 |
GO:0006911 | GO:0006911 | phagocytosis, engulfment | 15/1028 | 29/8135 | 4.09 | 4.18e-07 | 3.99e-06 | 29 |
GO:0032755 | GO:0032755 | positive regulation of interleukin-6 production | 22/1028 | 56/8135 | 3.11 | 4.19e-07 | 3.99e-06 | 56 |
GO:0002312 | GO:0002312 | B cell activation involved in immune response | 18/1028 | 40/8135 | 3.56 | 4.29e-07 | 4.07e-06 | 40 |
GO:0045670 | GO:0045670 | regulation of osteoclast differentiation | 19/1028 | 44/8135 | 3.42 | 4.53e-07 | 4.28e-06 | 44 |
GO:0051235 | GO:0051235 | maintenance of location | 45/1028 | 168/8135 | 2.12 | 4.64e-07 | 4.37e-06 | 168 |
GO:1904951 | GO:1904951 | positive regulation of establishment of protein localization | 55/1028 | 223/8135 | 1.95 | 4.87e-07 | 4.58e-06 | 223 |
GO:0002700 | GO:0002700 | regulation of production of molecular mediator of immune response | 28/1028 | 83/8135 | 2.67 | 4.90e-07 | 4.60e-06 | 83 |
GO:0001774 | GO:0001774 | microglial cell activation | 14/1028 | 26/8135 | 4.26 | 5.37e-07 | 5.01e-06 | 26 |
GO:0002269 | GO:0002269 | leukocyte activation involved in inflammatory response | 14/1028 | 26/8135 | 4.26 | 5.37e-07 | 5.01e-06 | 26 |
GO:0043068 | GO:0043068 | positive regulation of programmed cell death | 66/1028 | 287/8135 | 1.82 | 5.66e-07 | 5.26e-06 | 287 |
GO:0050714 | GO:0050714 | positive regulation of protein secretion | 44/1028 | 164/8135 | 2.12 | 5.92e-07 | 5.49e-06 | 164 |
GO:0060333 | GO:0060333 | interferon-gamma-mediated signaling pathway | 22/1028 | 57/8135 | 3.05 | 6.02e-07 | 5.57e-06 | 57 |
GO:0002718 | GO:0002718 | regulation of cytokine production involved in immune response | 21/1028 | 53/8135 | 3.14 | 6.49e-07 | 5.98e-06 | 53 |
GO:0002707 | GO:0002707 | negative regulation of lymphocyte mediated immunity | 13/1028 | 23/8135 | 4.47 | 6.56e-07 | 5.99e-06 | 23 |
GO:0032481 | GO:0032481 | positive regulation of type I interferon production | 13/1028 | 23/8135 | 4.47 | 6.56e-07 | 5.99e-06 | 23 |
GO:1905521 | GO:1905521 | regulation of macrophage migration | 13/1028 | 23/8135 | 4.47 | 6.56e-07 | 5.99e-06 | 23 |
GO:1903530 | GO:1903530 | regulation of secretion by cell | 95/1028 | 465/8135 | 1.62 | 7.23e-07 | 6.58e-06 | 465 |
GO:0050708 | GO:0050708 | regulation of protein secretion | 65/1028 | 283/8135 | 1.82 | 7.23e-07 | 6.58e-06 | 283 |
GO:0033003 | GO:0033003 | regulation of mast cell activation | 15/1028 | 30/8135 | 3.96 | 7.39e-07 | 6.66e-06 | 30 |
GO:0002714 | GO:0002714 | positive regulation of B cell mediated immunity | 12/1028 | 20/8135 | 4.75 | 7.42e-07 | 6.66e-06 | 20 |
GO:0002891 | GO:0002891 | positive regulation of immunoglobulin mediated immune response | 12/1028 | 20/8135 | 4.75 | 7.42e-07 | 6.66e-06 | 20 |
GO:0050869 | GO:0050869 | negative regulation of B cell activation | 12/1028 | 20/8135 | 4.75 | 7.42e-07 | 6.66e-06 | 20 |
GO:0002544 | GO:0002544 | chronic inflammatory response | 11/1028 | 17/8135 | 5.12 | 7.47e-07 | 6.66e-06 | 17 |
GO:0042533 | GO:0042533 | tumor necrosis factor biosynthetic process | 11/1028 | 17/8135 | 5.12 | 7.47e-07 | 6.66e-06 | 17 |
GO:0042534 | GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 11/1028 | 17/8135 | 5.12 | 7.47e-07 | 6.66e-06 | 17 |
GO:1905517 | GO:1905517 | macrophage migration | 16/1028 | 34/8135 | 3.72 | 8.97e-07 | 7.98e-06 | 34 |
GO:0071347 | GO:0071347 | cellular response to interleukin-1 | 26/1028 | 76/8135 | 2.71 | 9.21e-07 | 8.17e-06 | 76 |
GO:0043065 | GO:0043065 | positive regulation of apoptotic process | 65/1028 | 285/8135 | 1.80 | 9.43e-07 | 8.34e-06 | 285 |
GO:2000404 | GO:2000404 | regulation of T cell migration | 14/1028 | 27/8135 | 4.10 | 9.87e-07 | 8.71e-06 | 27 |
GO:1903556 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production | 17/1028 | 38/8135 | 3.54 | 9.98e-07 | 8.78e-06 | 38 |
GO:0045807 | GO:0045807 | positive regulation of endocytosis | 27/1028 | 81/8135 | 2.64 | 1.03e-06 | 9.00e-06 | 81 |
GO:0002791 | GO:0002791 | regulation of peptide secretion | 68/1028 | 305/8135 | 1.76 | 1.26e-06 | 1.10e-05 | 305 |
GO:0010324 | GO:0010324 | membrane invagination | 15/1028 | 31/8135 | 3.83 | 1.27e-06 | 1.10e-05 | 31 |
GO:0050854 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 15/1028 | 31/8135 | 3.83 | 1.27e-06 | 1.10e-05 | 31 |
GO:0099024 | GO:0099024 | plasma membrane invagination | 15/1028 | 31/8135 | 3.83 | 1.27e-06 | 1.10e-05 | 31 |
GO:0033674 | GO:0033674 | positive regulation of kinase activity | 68/1028 | 306/8135 | 1.76 | 1.43e-06 | 1.24e-05 | 306 |
GO:0042130 | GO:0042130 | negative regulation of T cell proliferation | 16/1028 | 35/8135 | 3.62 | 1.46e-06 | 1.26e-05 | 35 |
GO:0050702 | GO:0050702 | interleukin-1 beta secretion | 16/1028 | 35/8135 | 3.62 | 1.46e-06 | 1.26e-05 | 35 |
GO:0043304 | GO:0043304 | regulation of mast cell degranulation | 12/1028 | 21/8135 | 4.52 | 1.53e-06 | 1.32e-05 | 21 |
GO:0045123 | GO:0045123 | cellular extravasation | 18/1028 | 43/8135 | 3.31 | 1.59e-06 | 1.36e-05 | 43 |
GO:2000515 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 10/1028 | 15/8135 | 5.28 | 1.64e-06 | 1.40e-05 | 15 |
GO:0009595 | GO:0009595 | detection of biotic stimulus | 11/1028 | 18/8135 | 4.84 | 1.70e-06 | 1.45e-05 | 18 |
GO:0070232 | GO:0070232 | regulation of T cell apoptotic process | 14/1028 | 28/8135 | 3.96 | 1.74e-06 | 1.48e-05 | 28 |
GO:0019932 | GO:0019932 | second-messenger-mediated signaling | 69/1028 | 314/8135 | 1.74 | 1.83e-06 | 1.56e-05 | 314 |
GO:0045862 | GO:0045862 | positive regulation of proteolysis | 39/1028 | 144/8135 | 2.14 | 2.00e-06 | 1.69e-05 | 144 |
GO:0060402 | GO:0060402 | calcium ion transport into cytosol | 31/1028 | 103/8135 | 2.38 | 2.04e-06 | 1.72e-05 | 103 |
GO:0061900 | GO:0061900 | glial cell activation | 15/1028 | 32/8135 | 3.71 | 2.11e-06 | 1.77e-05 | 32 |
GO:0001911 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 8/1028 | 10/8135 | 6.33 | 2.26e-06 | 1.88e-05 | 10 |
GO:0002430 | GO:0002430 | complement receptor mediated signaling pathway | 8/1028 | 10/8135 | 6.33 | 2.26e-06 | 1.88e-05 | 10 |
GO:0030889 | GO:0030889 | negative regulation of B cell proliferation | 8/1028 | 10/8135 | 6.33 | 2.26e-06 | 1.88e-05 | 10 |
GO:0033209 | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 22/1028 | 61/8135 | 2.85 | 2.31e-06 | 1.93e-05 | 61 |
GO:0001913 | GO:0001913 | T cell mediated cytotoxicity | 16/1028 | 36/8135 | 3.52 | 2.32e-06 | 1.93e-05 | 36 |
GO:0001914 | GO:0001914 | regulation of T cell mediated cytotoxicity | 13/1028 | 25/8135 | 4.11 | 2.33e-06 | 1.93e-05 | 25 |
GO:0072677 | GO:0072677 | eosinophil migration | 13/1028 | 25/8135 | 4.11 | 2.33e-06 | 1.93e-05 | 25 |
GO:0060401 | GO:0060401 | cytosolic calcium ion transport | 31/1028 | 104/8135 | 2.36 | 2.56e-06 | 2.11e-05 | 104 |
GO:0032652 | GO:0032652 | regulation of interleukin-1 production | 21/1028 | 57/8135 | 2.92 | 2.64e-06 | 2.17e-05 | 57 |
GO:0032757 | GO:0032757 | positive regulation of interleukin-8 production | 14/1028 | 29/8135 | 3.82 | 2.98e-06 | 2.43e-05 | 29 |
GO:0097028 | GO:0097028 | dendritic cell differentiation | 14/1028 | 29/8135 | 3.82 | 2.98e-06 | 2.43e-05 | 29 |
GO:0033006 | GO:0033006 | regulation of mast cell activation involved in immune response | 12/1028 | 22/8135 | 4.32 | 2.98e-06 | 2.43e-05 | 22 |
GO:0072606 | GO:0072606 | interleukin-8 secretion | 12/1028 | 22/8135 | 4.32 | 2.98e-06 | 2.43e-05 | 22 |
GO:0002793 | GO:0002793 | positive regulation of peptide secretion | 45/1028 | 179/8135 | 1.99 | 3.09e-06 | 2.51e-05 | 179 |
GO:0050857 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 9/1028 | 13/8135 | 5.48 | 3.53e-06 | 2.86e-05 | 13 |
GO:0002507 | GO:0002507 | tolerance induction | 11/1028 | 19/8135 | 4.58 | 3.58e-06 | 2.87e-05 | 19 |
GO:0045589 | GO:0045589 | regulation of regulatory T cell differentiation | 11/1028 | 19/8135 | 4.58 | 3.58e-06 | 2.87e-05 | 19 |
GO:0150077 | GO:0150077 | regulation of neuroinflammatory response | 11/1028 | 19/8135 | 4.58 | 3.58e-06 | 2.87e-05 | 19 |
GO:2000482 | GO:2000482 | regulation of interleukin-8 secretion | 11/1028 | 19/8135 | 4.58 | 3.58e-06 | 2.87e-05 | 19 |
GO:0002220 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 16/1028 | 37/8135 | 3.42 | 3.61e-06 | 2.88e-05 | 37 |
GO:0002532 | GO:0002532 | production of molecular mediator involved in inflammatory response | 16/1028 | 37/8135 | 3.42 | 3.61e-06 | 2.88e-05 | 37 |
GO:0060759 | GO:0060759 | regulation of response to cytokine stimulus | 26/1028 | 81/8135 | 2.54 | 3.62e-06 | 2.88e-05 | 81 |
GO:0050701 | GO:0050701 | interleukin-1 secretion | 17/1028 | 41/8135 | 3.28 | 3.62e-06 | 2.88e-05 | 41 |
GO:0051047 | GO:0051047 | positive regulation of secretion | 61/1028 | 272/8135 | 1.77 | 3.67e-06 | 2.91e-05 | 272 |
GO:1903532 | GO:1903532 | positive regulation of secretion by cell | 57/1028 | 250/8135 | 1.80 | 4.48e-06 | 3.55e-05 | 250 |
GO:0051223 | GO:0051223 | regulation of protein transport | 74/1028 | 353/8135 | 1.66 | 4.92e-06 | 3.88e-05 | 353 |
GO:0032715 | GO:0032715 | negative regulation of interleukin-6 production | 14/1028 | 30/8135 | 3.69 | 4.95e-06 | 3.90e-05 | 30 |
GO:0043281 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 29/1028 | 97/8135 | 2.37 | 5.02e-06 | 3.95e-05 | 97 |
GO:0060627 | GO:0060627 | regulation of vesicle-mediated transport | 58/1028 | 257/8135 | 1.79 | 5.19e-06 | 4.07e-05 | 257 |
GO:0002715 | GO:0002715 | regulation of natural killer cell mediated immunity | 15/1028 | 34/8135 | 3.49 | 5.40e-06 | 4.22e-05 | 34 |
GO:0043408 | GO:0043408 | regulation of MAPK cascade | 92/1028 | 467/8135 | 1.56 | 5.51e-06 | 4.30e-05 | 467 |
GO:0046636 | GO:0046636 | negative regulation of alpha-beta T cell activation | 12/1028 | 23/8135 | 4.13 | 5.52e-06 | 4.30e-05 | 23 |
GO:0038061 | GO:0038061 | NIK/NF-kappaB signaling | 20/1028 | 55/8135 | 2.88 | 5.75e-06 | 4.47e-05 | 55 |
GO:2000116 | GO:2000116 | regulation of cysteine-type endopeptidase activity | 32/1028 | 113/8135 | 2.24 | 5.96e-06 | 4.61e-05 | 113 |
GO:0055082 | GO:0055082 | cellular chemical homeostasis | 95/1028 | 488/8135 | 1.54 | 6.49e-06 | 5.02e-05 | 488 |
GO:1901222 | GO:1901222 | regulation of NIK/NF-kappaB signaling | 19/1028 | 51/8135 | 2.95 | 6.51e-06 | 5.02e-05 | 51 |
GO:0070201 | GO:0070201 | regulation of establishment of protein localization | 75/1028 | 362/8135 | 1.64 | 6.64e-06 | 5.11e-05 | 362 |
GO:0002526 | GO:0002526 | acute inflammatory response | 33/1028 | 119/8135 | 2.19 | 7.02e-06 | 5.37e-05 | 119 |
GO:0002381 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 13/1028 | 27/8135 | 3.81 | 7.04e-06 | 5.37e-05 | 27 |
GO:0010818 | GO:0010818 | T cell chemotaxis | 11/1028 | 20/8135 | 4.35 | 7.05e-06 | 5.37e-05 | 20 |
GO:0036336 | GO:0036336 | dendritic cell migration | 11/1028 | 20/8135 | 4.35 | 7.05e-06 | 5.37e-05 | 20 |
GO:0031342 | GO:0031342 | negative regulation of cell killing | 8/1028 | 11/8135 | 5.76 | 7.35e-06 | 5.56e-05 | 11 |
GO:0036005 | GO:0036005 | response to macrophage colony-stimulating factor | 8/1028 | 11/8135 | 5.76 | 7.35e-06 | 5.56e-05 | 11 |
GO:0036006 | GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 8/1028 | 11/8135 | 5.76 | 7.35e-06 | 5.56e-05 | 11 |
GO:0090087 | GO:0090087 | regulation of peptide transport | 77/1028 | 376/8135 | 1.62 | 7.82e-06 | 5.90e-05 | 376 |
GO:0043030 | GO:0043030 | regulation of macrophage activation | 15/1028 | 35/8135 | 3.39 | 8.35e-06 | 6.27e-05 | 35 |
GO:0048010 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 15/1028 | 35/8135 | 3.39 | 8.35e-06 | 6.27e-05 | 35 |
GO:2000108 | GO:2000108 | positive regulation of leukocyte apoptotic process | 10/1028 | 17/8135 | 4.65 | 8.36e-06 | 6.27e-05 | 17 |
GO:0043373 | GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 9/1028 | 14/8135 | 5.09 | 8.78e-06 | 6.57e-05 | 14 |
GO:0046849 | GO:0046849 | bone remodeling | 21/1028 | 61/8135 | 2.72 | 9.14e-06 | 6.82e-05 | 61 |
GO:0010950 | GO:0010950 | positive regulation of endopeptidase activity | 25/1028 | 80/8135 | 2.47 | 9.47e-06 | 7.05e-05 | 80 |
GO:0034113 | GO:0034113 | heterotypic cell-cell adhesion | 17/1028 | 44/8135 | 3.06 | 1.13e-05 | 8.40e-05 | 44 |
GO:0051347 | GO:0051347 | positive regulation of transferase activity | 69/1028 | 330/8135 | 1.65 | 1.13e-05 | 8.40e-05 | 330 |
GO:0002820 | GO:0002820 | negative regulation of adaptive immune response | 13/1028 | 28/8135 | 3.67 | 1.16e-05 | 8.61e-05 | 28 |
GO:0043062 | GO:0043062 | extracellular structure organization | 64/1028 | 300/8135 | 1.69 | 1.21e-05 | 8.93e-05 | 300 |
GO:1901224 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 16/1028 | 40/8135 | 3.17 | 1.22e-05 | 8.97e-05 | 40 |
GO:0042269 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 14/1028 | 32/8135 | 3.46 | 1.25e-05 | 9.20e-05 | 32 |
GO:0071622 | GO:0071622 | regulation of granulocyte chemotaxis | 14/1028 | 32/8135 | 3.46 | 1.25e-05 | 9.20e-05 | 32 |
GO:0072538 | GO:0072538 | T-helper 17 type immune response | 11/1028 | 21/8135 | 4.15 | 1.31e-05 | 9.60e-05 | 21 |
GO:0043029 | GO:0043029 | T cell homeostasis | 12/1028 | 25/8135 | 3.80 | 1.67e-05 | 1.21e-04 | 25 |
GO:0002827 | GO:0002827 | positive regulation of T-helper 1 type immune response | 10/1028 | 18/8135 | 4.40 | 1.67e-05 | 1.21e-04 | 18 |
GO:0045577 | GO:0045577 | regulation of B cell differentiation | 10/1028 | 18/8135 | 4.40 | 1.67e-05 | 1.21e-04 | 18 |
GO:0045860 | GO:0045860 | positive regulation of protein kinase activity | 61/1028 | 285/8135 | 1.69 | 1.74e-05 | 1.26e-04 | 285 |
GO:0034121 | GO:0034121 | regulation of toll-like receptor signaling pathway | 16/1028 | 41/8135 | 3.09 | 1.77e-05 | 1.28e-04 | 41 |
GO:0045637 | GO:0045637 | regulation of myeloid cell differentiation | 35/1028 | 135/8135 | 2.05 | 1.88e-05 | 1.36e-04 | 135 |
GO:0008360 | GO:0008360 | regulation of cell shape | 24/1028 | 78/8135 | 2.43 | 1.90e-05 | 1.37e-04 | 78 |
GO:0010952 | GO:0010952 | positive regulation of peptidase activity | 26/1028 | 88/8135 | 2.34 | 1.94e-05 | 1.39e-04 | 88 |
GO:0002363 | GO:0002363 | alpha-beta T cell lineage commitment | 9/1028 | 15/8135 | 4.75 | 1.95e-05 | 1.39e-04 | 15 |
GO:0032607 | GO:0032607 | interferon-alpha production | 9/1028 | 15/8135 | 4.75 | 1.95e-05 | 1.39e-04 | 15 |
GO:0032647 | GO:0032647 | regulation of interferon-alpha production | 9/1028 | 15/8135 | 4.75 | 1.95e-05 | 1.39e-04 | 15 |
GO:0045061 | GO:0045061 | thymic T cell selection | 9/1028 | 15/8135 | 4.75 | 1.95e-05 | 1.39e-04 | 15 |
GO:0098581 | GO:0098581 | detection of external biotic stimulus | 9/1028 | 15/8135 | 4.75 | 1.95e-05 | 1.39e-04 | 15 |
GO:1905523 | GO:1905523 | positive regulation of macrophage migration | 8/1028 | 12/8135 | 5.28 | 1.96e-05 | 1.39e-04 | 12 |
GO:0030101 | GO:0030101 | natural killer cell activation | 18/1028 | 50/8135 | 2.85 | 1.97e-05 | 1.40e-04 | 50 |
GO:0032651 | GO:0032651 | regulation of interleukin-1 beta production | 17/1028 | 46/8135 | 2.92 | 2.25e-05 | 1.59e-04 | 46 |
GO:0002828 | GO:0002828 | regulation of type 2 immune response | 11/1028 | 22/8135 | 3.96 | 2.32e-05 | 1.64e-04 | 22 |
GO:0050718 | GO:0050718 | positive regulation of interleukin-1 beta secretion | 11/1028 | 22/8135 | 3.96 | 2.32e-05 | 1.64e-04 | 22 |
GO:0043123 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 24/1028 | 79/8135 | 2.40 | 2.41e-05 | 1.69e-04 | 79 |
GO:0006959 | GO:0006959 | humoral immune response | 44/1028 | 187/8135 | 1.86 | 2.42e-05 | 1.70e-04 | 187 |
GO:0050848 | GO:0050848 | regulation of calcium-mediated signaling | 20/1028 | 60/8135 | 2.64 | 2.56e-05 | 1.79e-04 | 60 |
GO:0002823 | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 12/1028 | 26/8135 | 3.65 | 2.74e-05 | 1.91e-04 | 26 |
GO:0042092 | GO:0042092 | type 2 immune response | 12/1028 | 26/8135 | 3.65 | 2.74e-05 | 1.91e-04 | 26 |
GO:0043122 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 28/1028 | 100/8135 | 2.22 | 2.83e-05 | 1.96e-04 | 100 |
GO:0002223 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway | 14/1028 | 34/8135 | 3.26 | 2.90e-05 | 2.01e-04 | 34 |
GO:0002686 | GO:0002686 | negative regulation of leukocyte migration | 14/1028 | 34/8135 | 3.26 | 2.90e-05 | 2.01e-04 | 34 |
GO:0032880 | GO:0032880 | regulation of protein localization | 89/1028 | 467/8135 | 1.51 | 3.02e-05 | 2.09e-04 | 467 |
GO:0022617 | GO:0022617 | extracellular matrix disassembly | 19/1028 | 56/8135 | 2.68 | 3.07e-05 | 2.11e-04 | 56 |
GO:0001916 | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 10/1028 | 19/8135 | 4.16 | 3.12e-05 | 2.14e-04 | 19 |
GO:0072539 | GO:0072539 | T-helper 17 cell differentiation | 10/1028 | 19/8135 | 4.16 | 3.12e-05 | 2.14e-04 | 19 |
GO:0090025 | GO:0090025 | regulation of monocyte chemotaxis | 10/1028 | 19/8135 | 4.16 | 3.12e-05 | 2.14e-04 | 19 |
GO:0048771 | GO:0048771 | tissue remodeling | 29/1028 | 106/8135 | 2.16 | 3.29e-05 | 2.25e-04 | 106 |
GO:1903707 | GO:1903707 | negative regulation of hemopoiesis | 26/1028 | 91/8135 | 2.26 | 3.70e-05 | 2.52e-04 | 91 |
GO:0001959 | GO:0001959 | regulation of cytokine-mediated signaling pathway | 23/1028 | 76/8135 | 2.39 | 3.80e-05 | 2.59e-04 | 76 |
GO:1903531 | GO:1903531 | negative regulation of secretion by cell | 32/1028 | 123/8135 | 2.06 | 3.94e-05 | 2.67e-04 | 123 |
GO:0043369 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 9/1028 | 16/8135 | 4.45 | 3.96e-05 | 2.67e-04 | 16 |
GO:0045624 | GO:0045624 | positive regulation of T-helper cell differentiation | 9/1028 | 16/8135 | 4.45 | 3.96e-05 | 2.67e-04 | 16 |
GO:0071677 | GO:0071677 | positive regulation of mononuclear cell migration | 9/1028 | 16/8135 | 4.45 | 3.96e-05 | 2.67e-04 | 16 |
GO:0031532 | GO:0031532 | actin cytoskeleton reorganization | 17/1028 | 48/8135 | 2.80 | 4.27e-05 | 2.87e-04 | 48 |
GO:0032700 | GO:0032700 | negative regulation of interleukin-17 production | 7/1028 | 10/8135 | 5.54 | 4.28e-05 | 2.88e-04 | 10 |
GO:0045428 | GO:0045428 | regulation of nitric oxide biosynthetic process | 13/1028 | 31/8135 | 3.32 | 4.45e-05 | 2.98e-04 | 31 |
GO:0002295 | GO:0002295 | T-helper cell lineage commitment | 8/1028 | 13/8135 | 4.87 | 4.53e-05 | 3.01e-04 | 13 |
GO:0006925 | GO:0006925 | inflammatory cell apoptotic process | 8/1028 | 13/8135 | 4.87 | 4.53e-05 | 3.01e-04 | 13 |
GO:0090026 | GO:0090026 | positive regulation of monocyte chemotaxis | 8/1028 | 13/8135 | 4.87 | 4.53e-05 | 3.01e-04 | 13 |
GO:0150078 | GO:0150078 | positive regulation of neuroinflammatory response | 8/1028 | 13/8135 | 4.87 | 4.53e-05 | 3.01e-04 | 13 |
GO:0051924 | GO:0051924 | regulation of calcium ion transport | 39/1028 | 163/8135 | 1.89 | 4.68e-05 | 3.11e-04 | 163 |
GO:0002702 | GO:0002702 | positive regulation of production of molecular mediator of immune response | 18/1028 | 53/8135 | 2.69 | 4.87e-05 | 3.22e-04 | 53 |
GO:1903725 | GO:1903725 | regulation of phospholipid metabolic process | 16/1028 | 44/8135 | 2.88 | 4.93e-05 | 3.26e-04 | 44 |
GO:0019058 | GO:0019058 | viral life cycle | 31/1028 | 119/8135 | 2.06 | 5.04e-05 | 3.32e-04 | 119 |
GO:0035590 | GO:0035590 | purinergic nucleotide receptor signaling pathway | 10/1028 | 20/8135 | 3.96 | 5.54e-05 | 3.64e-04 | 20 |
GO:0043032 | GO:0043032 | positive regulation of macrophage activation | 10/1028 | 20/8135 | 3.96 | 5.54e-05 | 3.64e-04 | 20 |
GO:0006919 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 15/1028 | 40/8135 | 2.97 | 5.59e-05 | 3.66e-04 | 40 |
GO:0046209 | GO:0046209 | nitric oxide metabolic process | 15/1028 | 40/8135 | 2.97 | 5.59e-05 | 3.66e-04 | 40 |
GO:1903426 | GO:1903426 | regulation of reactive oxygen species biosynthetic process | 15/1028 | 40/8135 | 2.97 | 5.59e-05 | 3.66e-04 | 40 |
GO:0002792 | GO:0002792 | negative regulation of peptide secretion | 24/1028 | 83/8135 | 2.29 | 5.91e-05 | 3.85e-04 | 83 |
GO:0070838 | GO:0070838 | divalent metal ion transport | 61/1028 | 297/8135 | 1.63 | 6.35e-05 | 4.14e-04 | 297 |
GO:0007596 | GO:0007596 | blood coagulation | 46/1028 | 206/8135 | 1.77 | 6.42e-05 | 4.17e-04 | 206 |
GO:0010517 | GO:0010517 | regulation of phospholipase activity | 18/1028 | 54/8135 | 2.64 | 6.45e-05 | 4.17e-04 | 54 |
GO:1905954 | GO:1905954 | positive regulation of lipid localization | 18/1028 | 54/8135 | 2.64 | 6.45e-05 | 4.17e-04 | 54 |
GO:1902622 | GO:1902622 | regulation of neutrophil migration | 11/1028 | 24/8135 | 3.63 | 6.46e-05 | 4.17e-04 | 24 |
GO:0030574 | GO:0030574 | collagen catabolic process | 13/1028 | 32/8135 | 3.21 | 6.63e-05 | 4.27e-04 | 32 |
GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 41/1028 | 177/8135 | 1.83 | 6.67e-05 | 4.29e-04 | 177 |
GO:0014068 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 16/1028 | 45/8135 | 2.81 | 6.76e-05 | 4.33e-04 | 45 |
GO:0032689 | GO:0032689 | negative regulation of interferon-gamma production | 12/1028 | 28/8135 | 3.39 | 6.77e-05 | 4.33e-04 | 28 |
GO:0032731 | GO:0032731 | positive regulation of interleukin-1 beta production | 12/1028 | 28/8135 | 3.39 | 6.77e-05 | 4.33e-04 | 28 |
GO:0046718 | GO:0046718 | viral entry into host cell | 20/1028 | 64/8135 | 2.47 | 7.29e-05 | 4.65e-04 | 64 |
GO:0018108 | GO:0018108 | peptidyl-tyrosine phosphorylation | 51/1028 | 237/8135 | 1.70 | 7.31e-05 | 4.65e-04 | 237 |
GO:0018212 | GO:0018212 | peptidyl-tyrosine modification | 51/1028 | 237/8135 | 1.70 | 7.31e-05 | 4.65e-04 | 237 |
GO:2000249 | GO:2000249 | regulation of actin cytoskeleton reorganization | 9/1028 | 17/8135 | 4.19 | 7.46e-05 | 4.73e-04 | 17 |
GO:2001056 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 21/1028 | 69/8135 | 2.41 | 7.47e-05 | 4.73e-04 | 69 |
GO:0006816 | GO:0006816 | calcium ion transport | 57/1028 | 274/8135 | 1.65 | 7.62e-05 | 4.82e-04 | 274 |
GO:0072511 | GO:0072511 | divalent inorganic cation transport | 61/1028 | 299/8135 | 1.61 | 7.78e-05 | 4.91e-04 | 299 |
GO:0070588 | GO:0070588 | calcium ion transmembrane transport | 44/1028 | 196/8135 | 1.78 | 8.07e-05 | 5.08e-04 | 196 |
GO:0007599 | GO:0007599 | hemostasis | 46/1028 | 208/8135 | 1.75 | 8.23e-05 | 5.17e-04 | 208 |
GO:0032602 | GO:0032602 | chemokine production | 19/1028 | 60/8135 | 2.51 | 8.99e-05 | 5.64e-04 | 60 |
GO:0050817 | GO:0050817 | coagulation | 46/1028 | 209/8135 | 1.74 | 9.29e-05 | 5.81e-04 | 209 |
GO:0051048 | GO:0051048 | negative regulation of secretion | 35/1028 | 145/8135 | 1.91 | 9.35e-05 | 5.81e-04 | 145 |
GO:0048245 | GO:0048245 | eosinophil chemotaxis | 10/1028 | 21/8135 | 3.77 | 9.39e-05 | 5.81e-04 | 21 |
GO:0035589 | GO:0035589 | G protein-coupled purinergic nucleotide receptor signaling pathway | 8/1028 | 14/8135 | 4.52 | 9.40e-05 | 5.81e-04 | 14 |
GO:0050855 | GO:0050855 | regulation of B cell receptor signaling pathway | 8/1028 | 14/8135 | 4.52 | 9.40e-05 | 5.81e-04 | 14 |
GO:0055094 | GO:0055094 | response to lipoprotein particle | 8/1028 | 14/8135 | 4.52 | 9.40e-05 | 5.81e-04 | 14 |
GO:0097242 | GO:0097242 | amyloid-beta clearance | 8/1028 | 14/8135 | 4.52 | 9.40e-05 | 5.81e-04 | 14 |
GO:0140131 | GO:0140131 | positive regulation of lymphocyte chemotaxis | 8/1028 | 14/8135 | 4.52 | 9.40e-05 | 5.81e-04 | 14 |
GO:0002637 | GO:0002637 | regulation of immunoglobulin production | 13/1028 | 33/8135 | 3.12 | 9.68e-05 | 5.95e-04 | 33 |
GO:0032732 | GO:0032732 | positive regulation of interleukin-1 production | 13/1028 | 33/8135 | 3.12 | 9.68e-05 | 5.95e-04 | 33 |
GO:0050688 | GO:0050688 | regulation of defense response to virus | 13/1028 | 33/8135 | 3.12 | 9.68e-05 | 5.95e-04 | 33 |
GO:0030198 | GO:0030198 | extracellular matrix organization | 55/1028 | 264/8135 | 1.65 | 9.74e-05 | 5.97e-04 | 264 |
GO:0030225 | GO:0030225 | macrophage differentiation | 11/1028 | 25/8135 | 3.48 | 1.02e-04 | 6.23e-04 | 25 |
GO:0045581 | GO:0045581 | negative regulation of T cell differentiation | 11/1028 | 25/8135 | 3.48 | 1.02e-04 | 6.23e-04 | 25 |
GO:0050706 | GO:0050706 | regulation of interleukin-1 beta secretion | 12/1028 | 29/8135 | 3.27 | 1.02e-04 | 6.23e-04 | 29 |
GO:1903727 | GO:1903727 | positive regulation of phospholipid metabolic process | 12/1028 | 29/8135 | 3.27 | 1.02e-04 | 6.23e-04 | 29 |
GO:0002756 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0043371 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0043383 | GO:0043383 | negative T cell selection | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0045408 | GO:0045408 | regulation of interleukin-6 biosynthetic process | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0046629 | GO:0046629 | gamma-delta T cell activation | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0070230 | GO:0070230 | positive regulation of lymphocyte apoptotic process | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0072540 | GO:0072540 | T-helper 17 cell lineage commitment | 7/1028 | 11/8135 | 5.04 | 1.05e-04 | 6.30e-04 | 11 |
GO:0043901 | GO:0043901 | negative regulation of multi-organism process | 25/1028 | 91/8135 | 2.17 | 1.05e-04 | 6.31e-04 | 91 |
GO:0051051 | GO:0051051 | negative regulation of transport | 56/1028 | 271/8135 | 1.64 | 1.06e-04 | 6.36e-04 | 271 |
GO:0006801 | GO:0006801 | superoxide metabolic process | 15/1028 | 42/8135 | 2.83 | 1.07e-04 | 6.40e-04 | 42 |
GO:0033077 | GO:0033077 | T cell differentiation in thymus | 15/1028 | 42/8135 | 2.83 | 1.07e-04 | 6.40e-04 | 42 |
GO:2001057 | GO:2001057 | reactive nitrogen species metabolic process | 15/1028 | 42/8135 | 2.83 | 1.07e-04 | 6.40e-04 | 42 |
GO:1903409 | GO:1903409 | reactive oxygen species biosynthetic process | 18/1028 | 56/8135 | 2.54 | 1.10e-04 | 6.56e-04 | 56 |
GO:0050709 | GO:0050709 | negative regulation of protein secretion | 22/1028 | 76/8135 | 2.29 | 1.17e-04 | 6.92e-04 | 76 |
GO:0006809 | GO:0006809 | nitric oxide biosynthetic process | 14/1028 | 38/8135 | 2.92 | 1.24e-04 | 7.32e-04 | 38 |
GO:0030162 | GO:0030162 | regulation of proteolysis | 72/1028 | 374/8135 | 1.52 | 1.27e-04 | 7.53e-04 | 374 |
GO:0002360 | GO:0002360 | T cell lineage commitment | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0002407 | GO:0002407 | dendritic cell chemotaxis | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0002888 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0030866 | GO:0030866 | cortical actin cytoskeleton organization | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0036037 | GO:0036037 | CD8-positive, alpha-beta T cell activation | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0045671 | GO:0045671 | negative regulation of osteoclast differentiation | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0070233 | GO:0070233 | negative regulation of T cell apoptotic process | 9/1028 | 18/8135 | 3.96 | 1.33e-04 | 7.75e-04 | 18 |
GO:0050728 | GO:0050728 | negative regulation of inflammatory response | 24/1028 | 87/8135 | 2.18 | 1.34e-04 | 7.79e-04 | 87 |
GO:1905952 | GO:1905952 | regulation of lipid localization | 24/1028 | 87/8135 | 2.18 | 1.34e-04 | 7.79e-04 | 87 |
GO:0043280 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 18/1028 | 57/8135 | 2.50 | 1.43e-04 | 8.28e-04 | 57 |
GO:0030260 | GO:0030260 | entry into host cell | 20/1028 | 67/8135 | 2.36 | 1.48e-04 | 8.56e-04 | 67 |
GO:0044409 | GO:0044409 | entry into host | 20/1028 | 67/8135 | 2.36 | 1.48e-04 | 8.56e-04 | 67 |
GO:0051806 | GO:0051806 | entry into cell of other organism involved in symbiotic interaction | 20/1028 | 67/8135 | 2.36 | 1.48e-04 | 8.56e-04 | 67 |
GO:0051828 | GO:0051828 | entry into other organism involved in symbiotic interaction | 20/1028 | 67/8135 | 2.36 | 1.48e-04 | 8.56e-04 | 67 |
GO:0032102 | GO:0032102 | negative regulation of response to external stimulus | 45/1028 | 207/8135 | 1.72 | 1.50e-04 | 8.62e-04 | 207 |
GO:0002720 | GO:0002720 | positive regulation of cytokine production involved in immune response | 12/1028 | 30/8135 | 3.17 | 1.51e-04 | 8.66e-04 | 30 |
GO:0009620 | GO:0009620 | response to fungus | 12/1028 | 30/8135 | 3.17 | 1.51e-04 | 8.66e-04 | 30 |
GO:0034142 | GO:0034142 | toll-like receptor 4 signaling pathway | 10/1028 | 22/8135 | 3.60 | 1.53e-04 | 8.70e-04 | 22 |
GO:0050901 | GO:0050901 | leukocyte tethering or rolling | 10/1028 | 22/8135 | 3.60 | 1.53e-04 | 8.70e-04 | 22 |
GO:0090022 | GO:0090022 | regulation of neutrophil chemotaxis | 10/1028 | 22/8135 | 3.60 | 1.53e-04 | 8.70e-04 | 22 |
GO:0010543 | GO:0010543 | regulation of platelet activation | 11/1028 | 26/8135 | 3.35 | 1.57e-04 | 8.93e-04 | 26 |
GO:0050716 | GO:0050716 | positive regulation of interleukin-1 secretion | 11/1028 | 26/8135 | 3.35 | 1.57e-04 | 8.93e-04 | 26 |
GO:0072593 | GO:0072593 | reactive oxygen species metabolic process | 34/1028 | 143/8135 | 1.88 | 1.60e-04 | 9.10e-04 | 143 |
GO:0002577 | GO:0002577 | regulation of antigen processing and presentation | 8/1028 | 15/8135 | 4.22 | 1.79e-04 | 1.01e-03 | 15 |
GO:0002689 | GO:0002689 | negative regulation of leukocyte chemotaxis | 8/1028 | 15/8135 | 4.22 | 1.79e-04 | 1.01e-03 | 15 |
GO:0032604 | GO:0032604 | granulocyte macrophage colony-stimulating factor production | 8/1028 | 15/8135 | 4.22 | 1.79e-04 | 1.01e-03 | 15 |
GO:0042832 | GO:0042832 | defense response to protozoan | 8/1028 | 15/8135 | 4.22 | 1.79e-04 | 1.01e-03 | 15 |
GO:0071402 | GO:0071402 | cellular response to lipoprotein particle stimulus | 8/1028 | 15/8135 | 4.22 | 1.79e-04 | 1.01e-03 | 15 |
GO:2000316 | GO:2000316 | regulation of T-helper 17 type immune response | 8/1028 | 15/8135 | 4.22 | 1.79e-04 | 1.01e-03 | 15 |
GO:0010863 | GO:0010863 | positive regulation of phospholipase C activity | 13/1028 | 35/8135 | 2.94 | 1.96e-04 | 1.09e-03 | 35 |
GO:0050704 | GO:0050704 | regulation of interleukin-1 secretion | 13/1028 | 35/8135 | 2.94 | 1.96e-04 | 1.09e-03 | 35 |
GO:0051928 | GO:0051928 | positive regulation of calcium ion transport | 22/1028 | 79/8135 | 2.20 | 2.17e-04 | 1.21e-03 | 79 |
GO:0045124 | GO:0045124 | regulation of bone resorption | 12/1028 | 31/8135 | 3.06 | 2.19e-04 | 1.22e-03 | 31 |
GO:0002719 | GO:0002719 | negative regulation of cytokine production involved in immune response | 9/1028 | 19/8135 | 3.75 | 2.24e-04 | 1.24e-03 | 19 |
GO:0033032 | GO:0033032 | regulation of myeloid cell apoptotic process | 9/1028 | 19/8135 | 3.75 | 2.24e-04 | 1.24e-03 | 19 |
GO:0050856 | GO:0050856 | regulation of T cell receptor signaling pathway | 9/1028 | 19/8135 | 3.75 | 2.24e-04 | 1.24e-03 | 19 |
GO:0042226 | GO:0042226 | interleukin-6 biosynthetic process | 7/1028 | 12/8135 | 4.62 | 2.24e-04 | 1.24e-03 | 12 |
GO:0098543 | GO:0098543 | detection of other organism | 7/1028 | 12/8135 | 4.62 | 2.24e-04 | 1.24e-03 | 12 |
GO:1903978 | GO:1903978 | regulation of microglial cell activation | 7/1028 | 12/8135 | 4.62 | 2.24e-04 | 1.24e-03 | 12 |
GO:0002673 | GO:0002673 | regulation of acute inflammatory response | 21/1028 | 74/8135 | 2.25 | 2.25e-04 | 1.24e-03 | 74 |
GO:0010522 | GO:0010522 | regulation of calcium ion transport into cytosol | 20/1028 | 69/8135 | 2.29 | 2.31e-04 | 1.27e-03 | 69 |
GO:0060191 | GO:0060191 | regulation of lipase activity | 20/1028 | 69/8135 | 2.29 | 2.31e-04 | 1.27e-03 | 69 |
GO:0045824 | GO:0045824 | negative regulation of innate immune response | 11/1028 | 27/8135 | 3.22 | 2.35e-04 | 1.29e-03 | 27 |
GO:0050850 | GO:0050850 | positive regulation of calcium-mediated signaling | 11/1028 | 27/8135 | 3.22 | 2.35e-04 | 1.29e-03 | 27 |
GO:1903053 | GO:1903053 | regulation of extracellular matrix organization | 10/1028 | 23/8135 | 3.44 | 2.40e-04 | 1.31e-03 | 23 |
GO:0010518 | GO:0010518 | positive regulation of phospholipase activity | 15/1028 | 45/8135 | 2.64 | 2.60e-04 | 1.42e-03 | 45 |
GO:0002763 | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 13/1028 | 36/8135 | 2.86 | 2.71e-04 | 1.47e-03 | 36 |
GO:0046456 | GO:0046456 | icosanoid biosynthetic process | 13/1028 | 36/8135 | 2.86 | 2.71e-04 | 1.47e-03 | 36 |
GO:1900274 | GO:1900274 | regulation of phospholipase C activity | 13/1028 | 36/8135 | 2.86 | 2.71e-04 | 1.47e-03 | 36 |
GO:0097190 | GO:0097190 | apoptotic signaling pathway | 50/1028 | 243/8135 | 1.63 | 2.74e-04 | 1.48e-03 | 243 |
GO:0001525 | GO:0001525 | angiogenesis | 60/1028 | 306/8135 | 1.55 | 2.78e-04 | 1.50e-03 | 306 |
GO:0043491 | GO:0043491 | protein kinase B signaling | 34/1028 | 147/8135 | 1.83 | 2.81e-04 | 1.52e-03 | 147 |
GO:0030890 | GO:0030890 | positive regulation of B cell proliferation | 12/1028 | 32/8135 | 2.97 | 3.10e-04 | 1.66e-03 | 32 |
GO:0043551 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 12/1028 | 32/8135 | 2.97 | 3.10e-04 | 1.66e-03 | 32 |
GO:0060760 | GO:0060760 | positive regulation of response to cytokine stimulus | 12/1028 | 32/8135 | 2.97 | 3.10e-04 | 1.66e-03 | 32 |
GO:0001562 | GO:0001562 | response to protozoan | 8/1028 | 16/8135 | 3.96 | 3.19e-04 | 1.71e-03 | 16 |
GO:0032147 | GO:0032147 | activation of protein kinase activity | 38/1028 | 172/8135 | 1.75 | 3.41e-04 | 1.82e-03 | 172 |
GO:0001894 | GO:0001894 | tissue homeostasis | 33/1028 | 143/8135 | 1.83 | 3.59e-04 | 1.92e-03 | 143 |
GO:0006509 | GO:0006509 | membrane protein ectodomain proteolysis | 9/1028 | 20/8135 | 3.56 | 3.62e-04 | 1.92e-03 | 20 |
GO:0030865 | GO:0030865 | cortical cytoskeleton organization | 9/1028 | 20/8135 | 3.56 | 3.62e-04 | 1.92e-03 | 20 |
GO:0033028 | GO:0033028 | myeloid cell apoptotic process | 9/1028 | 20/8135 | 3.56 | 3.62e-04 | 1.92e-03 | 20 |
GO:0030224 | GO:0030224 | monocyte differentiation | 10/1028 | 24/8135 | 3.30 | 3.65e-04 | 1.93e-03 | 24 |
GO:0032735 | GO:0032735 | positive regulation of interleukin-12 production | 10/1028 | 24/8135 | 3.30 | 3.65e-04 | 1.93e-03 | 24 |
GO:1903131 | GO:1903131 | mononuclear cell differentiation | 10/1028 | 24/8135 | 3.30 | 3.65e-04 | 1.93e-03 | 24 |
GO:0070527 | GO:0070527 | platelet aggregation | 13/1028 | 37/8135 | 2.78 | 3.70e-04 | 1.96e-03 | 37 |
GO:0014065 | GO:0014065 | phosphatidylinositol 3-kinase signaling | 22/1028 | 82/8135 | 2.12 | 3.87e-04 | 2.04e-03 | 82 |
GO:0050730 | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 34/1028 | 150/8135 | 1.79 | 4.19e-04 | 2.21e-03 | 150 |
GO:0002643 | GO:0002643 | regulation of tolerance induction | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:0002710 | GO:0002710 | negative regulation of T cell mediated immunity | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:0002830 | GO:0002830 | positive regulation of type 2 immune response | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:0010919 | GO:0010919 | regulation of inositol phosphate biosynthetic process | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:0032740 | GO:0032740 | positive regulation of interleukin-17 production | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:0033033 | GO:0033033 | negative regulation of myeloid cell apoptotic process | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:2000319 | GO:2000319 | regulation of T-helper 17 cell differentiation | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:2000484 | GO:2000484 | positive regulation of interleukin-8 secretion | 7/1028 | 13/8135 | 4.26 | 4.33e-04 | 2.25e-03 | 13 |
GO:0071902 | GO:0071902 | positive regulation of protein serine/threonine kinase activity | 39/1028 | 180/8135 | 1.71 | 4.34e-04 | 2.25e-03 | 180 |
GO:0035587 | GO:0035587 | purinergic receptor signaling pathway | 11/1028 | 29/8135 | 3.00 | 4.91e-04 | 2.54e-03 | 29 |
GO:0050731 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 30/1028 | 128/8135 | 1.85 | 4.96e-04 | 2.56e-03 | 128 |
GO:0048017 | GO:0048017 | inositol lipid-mediated signaling | 25/1028 | 100/8135 | 1.98 | 5.17e-04 | 2.67e-03 | 100 |
GO:0002861 | GO:0002861 | regulation of inflammatory response to antigenic stimulus | 8/1028 | 17/8135 | 3.72 | 5.36e-04 | 2.71e-03 | 17 |
GO:0032693 | GO:0032693 | negative regulation of interleukin-10 production | 8/1028 | 17/8135 | 3.72 | 5.36e-04 | 2.71e-03 | 17 |
GO:0002517 | GO:0002517 | T cell tolerance induction | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0010759 | GO:0010759 | positive regulation of macrophage chemotaxis | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0032727 | GO:0032727 | positive regulation of interferon-alpha production | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0042535 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0045060 | GO:0045060 | negative thymic T cell selection | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0045063 | GO:0045063 | T-helper 1 cell differentiation | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0045591 | GO:0045591 | positive regulation of regulatory T cell differentiation | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0045623 | GO:0045623 | negative regulation of T-helper cell differentiation | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0051044 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 6/1028 | 10/8135 | 4.75 | 5.36e-04 | 2.71e-03 | 10 |
GO:0002534 | GO:0002534 | cytokine production involved in inflammatory response | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0002675 | GO:0002675 | positive regulation of acute inflammatory response | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0002701 | GO:0002701 | negative regulation of production of molecular mediator of immune response | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0034122 | GO:0034122 | negative regulation of toll-like receptor signaling pathway | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0043277 | GO:0043277 | apoptotic cell clearance | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0061756 | GO:0061756 | leukocyte adhesion to vascular endothelial cell | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0070229 | GO:0070229 | negative regulation of lymphocyte apoptotic process | 10/1028 | 25/8135 | 3.17 | 5.40e-04 | 2.71e-03 | 25 |
GO:0043552 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 9/1028 | 21/8135 | 3.39 | 5.63e-04 | 2.81e-03 | 21 |
GO:1902932 | GO:1902932 | positive regulation of alcohol biosynthetic process | 9/1028 | 21/8135 | 3.39 | 5.63e-04 | 2.81e-03 | 21 |
GO:0033627 | GO:0033627 | cell adhesion mediated by integrin | 15/1028 | 48/8135 | 2.47 | 5.71e-04 | 2.85e-03 | 48 |
GO:0001659 | GO:0001659 | temperature homeostasis | 25/1028 | 101/8135 | 1.96 | 6.07e-04 | 3.02e-03 | 101 |
GO:1903169 | GO:1903169 | regulation of calcium ion transmembrane transport | 24/1028 | 96/8135 | 1.98 | 6.64e-04 | 3.29e-03 | 96 |
GO:0051897 | GO:0051897 | positive regulation of protein kinase B signaling | 27/1028 | 113/8135 | 1.89 | 6.77e-04 | 3.36e-03 | 113 |
GO:0002437 | GO:0002437 | inflammatory response to antigenic stimulus | 11/1028 | 30/8135 | 2.90 | 6.88e-04 | 3.40e-03 | 30 |
GO:0016485 | GO:0016485 | protein processing | 33/1028 | 148/8135 | 1.76 | 6.90e-04 | 3.40e-03 | 148 |
GO:0007264 | GO:0007264 | small GTPase mediated signal transduction | 51/1028 | 259/8135 | 1.56 | 7.07e-04 | 3.48e-03 | 259 |
GO:0050830 | GO:0050830 | defense response to Gram-positive bacterium | 17/1028 | 59/8135 | 2.28 | 7.20e-04 | 3.54e-03 | 59 |
GO:0045639 | GO:0045639 | positive regulation of myeloid cell differentiation | 16/1028 | 54/8135 | 2.34 | 7.31e-04 | 3.59e-03 | 54 |
GO:0051279 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 16/1028 | 54/8135 | 2.34 | 7.31e-04 | 3.59e-03 | 54 |
GO:0032645 | GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 7/1028 | 14/8135 | 3.96 | 7.72e-04 | 3.77e-03 | 14 |
GO:0045191 | GO:0045191 | regulation of isotype switching | 7/1028 | 14/8135 | 3.96 | 7.72e-04 | 3.77e-03 | 14 |
GO:0048305 | GO:0048305 | immunoglobulin secretion | 7/1028 | 14/8135 | 3.96 | 7.72e-04 | 3.77e-03 | 14 |
GO:0002369 | GO:0002369 | T cell cytokine production | 10/1028 | 26/8135 | 3.04 | 7.79e-04 | 3.79e-03 | 26 |
GO:0007202 | GO:0007202 | activation of phospholipase C activity | 10/1028 | 26/8135 | 3.04 | 7.79e-04 | 3.79e-03 | 26 |
GO:1903428 | GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | 10/1028 | 26/8135 | 3.04 | 7.79e-04 | 3.79e-03 | 26 |
GO:0034599 | GO:0034599 | cellular response to oxidative stress | 27/1028 | 114/8135 | 1.87 | 7.83e-04 | 3.80e-03 | 114 |
GO:0043550 | GO:0043550 | regulation of lipid kinase activity | 12/1028 | 35/8135 | 2.71 | 7.98e-04 | 3.86e-03 | 35 |
GO:0006644 | GO:0006644 | phospholipid metabolic process | 46/1028 | 229/8135 | 1.59 | 8.19e-04 | 3.96e-03 | 229 |
GO:0016445 | GO:0016445 | somatic diversification of immunoglobulins | 9/1028 | 22/8135 | 3.24 | 8.46e-04 | 4.06e-03 | 22 |
GO:0032692 | GO:0032692 | negative regulation of interleukin-1 production | 9/1028 | 22/8135 | 3.24 | 8.46e-04 | 4.06e-03 | 22 |
GO:0038083 | GO:0038083 | peptidyl-tyrosine autophosphorylation | 9/1028 | 22/8135 | 3.24 | 8.46e-04 | 4.06e-03 | 22 |
GO:0050691 | GO:0050691 | regulation of defense response to virus by host | 9/1028 | 22/8135 | 3.24 | 8.46e-04 | 4.06e-03 | 22 |
GO:0052548 | GO:0052548 | regulation of endopeptidase activity | 48/1028 | 242/8135 | 1.57 | 8.51e-04 | 4.08e-03 | 242 |
GO:0009612 | GO:0009612 | response to mechanical stimulus | 30/1028 | 132/8135 | 1.80 | 8.54e-04 | 4.09e-03 | 132 |
GO:0002335 | GO:0002335 | mature B cell differentiation | 8/1028 | 18/8135 | 3.52 | 8.59e-04 | 4.09e-03 | 18 |
GO:0010758 | GO:0010758 | regulation of macrophage chemotaxis | 8/1028 | 18/8135 | 3.52 | 8.59e-04 | 4.09e-03 | 18 |
GO:0032958 | GO:0032958 | inositol phosphate biosynthetic process | 8/1028 | 18/8135 | 3.52 | 8.59e-04 | 4.09e-03 | 18 |
GO:1904646 | GO:1904646 | cellular response to amyloid-beta | 8/1028 | 18/8135 | 3.52 | 8.59e-04 | 4.09e-03 | 18 |
GO:0032722 | GO:0032722 | positive regulation of chemokine production | 13/1028 | 40/8135 | 2.57 | 8.70e-04 | 4.14e-03 | 40 |
GO:0042136 | GO:0042136 | neurotransmitter biosynthetic process | 17/1028 | 60/8135 | 2.24 | 8.88e-04 | 4.22e-03 | 60 |
GO:0048015 | GO:0048015 | phosphatidylinositol-mediated signaling | 24/1028 | 98/8135 | 1.94 | 9.11e-04 | 4.32e-03 | 98 |
GO:0060193 | GO:0060193 | positive regulation of lipase activity | 15/1028 | 50/8135 | 2.37 | 9.21e-04 | 4.36e-03 | 50 |
GO:0032088 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 11/1028 | 31/8135 | 2.81 | 9.47e-04 | 4.48e-03 | 31 |
GO:0031589 | GO:0031589 | cell-substrate adhesion | 42/1028 | 206/8135 | 1.61 | 9.98e-04 | 4.71e-03 | 206 |
GO:0010715 | GO:0010715 | regulation of extracellular matrix disassembly | 6/1028 | 11/8135 | 4.32 | 1.05e-03 | 4.93e-03 | 11 |
GO:0010819 | GO:0010819 | regulation of T cell chemotaxis | 6/1028 | 11/8135 | 4.32 | 1.05e-03 | 4.93e-03 | 11 |
GO:0016045 | GO:0016045 | detection of bacterium | 6/1028 | 11/8135 | 4.32 | 1.05e-03 | 4.93e-03 | 11 |
GO:0044126 | GO:0044126 | regulation of growth of symbiont in host | 6/1028 | 11/8135 | 4.32 | 1.05e-03 | 4.93e-03 | 11 |
GO:0044130 | GO:0044130 | negative regulation of growth of symbiont in host | 6/1028 | 11/8135 | 4.32 | 1.05e-03 | 4.93e-03 | 11 |
GO:0071361 | GO:0071361 | cellular response to ethanol | 6/1028 | 11/8135 | 4.32 | 1.05e-03 | 4.93e-03 | 11 |
GO:0046850 | GO:0046850 | regulation of bone remodeling | 12/1028 | 36/8135 | 2.64 | 1.06e-03 | 4.96e-03 | 36 |
GO:0002262 | GO:0002262 | myeloid cell homeostasis | 17/1028 | 61/8135 | 2.21 | 1.09e-03 | 5.09e-03 | 61 |
GO:0000187 | GO:0000187 | activation of MAPK activity | 22/1028 | 88/8135 | 1.98 | 1.10e-03 | 5.10e-03 | 88 |
GO:0097696 | GO:0097696 | STAT cascade | 22/1028 | 88/8135 | 1.98 | 1.10e-03 | 5.10e-03 | 88 |
GO:0002833 | GO:0002833 | positive regulation of response to biotic stimulus | 10/1028 | 27/8135 | 2.93 | 1.10e-03 | 5.10e-03 | 27 |
GO:0048246 | GO:0048246 | macrophage chemotaxis | 10/1028 | 27/8135 | 2.93 | 1.10e-03 | 5.10e-03 | 27 |
GO:0032370 | GO:0032370 | positive regulation of lipid transport | 13/1028 | 41/8135 | 2.51 | 1.13e-03 | 5.23e-03 | 41 |
GO:0034103 | GO:0034103 | regulation of tissue remodeling | 15/1028 | 51/8135 | 2.33 | 1.16e-03 | 5.35e-03 | 51 |
GO:0051224 | GO:0051224 | negative regulation of protein transport | 23/1028 | 94/8135 | 1.94 | 1.17e-03 | 5.41e-03 | 94 |
GO:0043902 | GO:0043902 | positive regulation of multi-organism process | 19/1028 | 72/8135 | 2.09 | 1.17e-03 | 5.42e-03 | 72 |
GO:0035588 | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:0042036 | GO:0042036 | negative regulation of cytokine biosynthetic process | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:0042554 | GO:0042554 | superoxide anion generation | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:0045429 | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:0090218 | GO:0090218 | positive regulation of lipid kinase activity | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:1900015 | GO:1900015 | regulation of cytokine production involved in inflammatory response | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:1904407 | GO:1904407 | positive regulation of nitric oxide metabolic process | 9/1028 | 23/8135 | 3.10 | 1.24e-03 | 5.65e-03 | 23 |
GO:0002762 | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 11/1028 | 32/8135 | 2.72 | 1.28e-03 | 5.83e-03 | 32 |
GO:0045620 | GO:0045620 | negative regulation of lymphocyte differentiation | 11/1028 | 32/8135 | 2.72 | 1.28e-03 | 5.83e-03 | 32 |
GO:0002230 | GO:0002230 | positive regulation of defense response to virus by host | 7/1028 | 15/8135 | 3.69 | 1.29e-03 | 5.84e-03 | 15 |
GO:0042095 | GO:0042095 | interferon-gamma biosynthetic process | 7/1028 | 15/8135 | 3.69 | 1.29e-03 | 5.84e-03 | 15 |
GO:0046639 | GO:0046639 | negative regulation of alpha-beta T cell differentiation | 7/1028 | 15/8135 | 3.69 | 1.29e-03 | 5.84e-03 | 15 |
GO:0051043 | GO:0051043 | regulation of membrane protein ectodomain proteolysis | 7/1028 | 15/8135 | 3.69 | 1.29e-03 | 5.84e-03 | 15 |
GO:0001782 | GO:0001782 | B cell homeostasis | 8/1028 | 19/8135 | 3.33 | 1.32e-03 | 5.95e-03 | 19 |
GO:0002724 | GO:0002724 | regulation of T cell cytokine production | 8/1028 | 19/8135 | 3.33 | 1.32e-03 | 5.95e-03 | 19 |
GO:0045920 | GO:0045920 | negative regulation of exocytosis | 8/1028 | 19/8135 | 3.33 | 1.32e-03 | 5.95e-03 | 19 |
GO:1904950 | GO:1904950 | negative regulation of establishment of protein localization | 23/1028 | 95/8135 | 1.92 | 1.36e-03 | 6.13e-03 | 95 |
GO:0051056 | GO:0051056 | regulation of small GTPase mediated signal transduction | 35/1028 | 166/8135 | 1.67 | 1.39e-03 | 6.25e-03 | 166 |
GO:0007259 | GO:0007259 | JAK-STAT cascade | 21/1028 | 84/8135 | 1.98 | 1.41e-03 | 6.31e-03 | 84 |
GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 25/1028 | 107/8135 | 1.85 | 1.48e-03 | 6.64e-03 | 107 |
GO:0046006 | GO:0046006 | regulation of activated T cell proliferation | 10/1028 | 28/8135 | 2.83 | 1.52e-03 | 6.79e-03 | 28 |
GO:0010959 | GO:0010959 | regulation of metal ion transport | 49/1028 | 255/8135 | 1.52 | 1.55e-03 | 6.91e-03 | 255 |
GO:0046488 | GO:0046488 | phosphatidylinositol metabolic process | 27/1028 | 119/8135 | 1.80 | 1.56e-03 | 6.95e-03 | 119 |
GO:0051701 | GO:0051701 | interaction with host | 21/1028 | 85/8135 | 1.96 | 1.65e-03 | 7.34e-03 | 85 |
GO:0043406 | GO:0043406 | positive regulation of MAP kinase activity | 33/1028 | 156/8135 | 1.67 | 1.78e-03 | 7.89e-03 | 156 |
GO:0002455 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 12/1028 | 38/8135 | 2.50 | 1.81e-03 | 8.00e-03 | 38 |
GO:0001935 | GO:0001935 | endothelial cell proliferation | 20/1028 | 80/8135 | 1.98 | 1.81e-03 | 8.02e-03 | 80 |
GO:0002374 | GO:0002374 | cytokine secretion involved in immune response | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0002726 | GO:0002726 | positive regulation of T cell cytokine production | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0032728 | GO:0032728 | positive regulation of interferon-beta production | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0033004 | GO:0033004 | negative regulation of mast cell activation | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0044144 | GO:0044144 | modulation of growth of symbiont involved in interaction with host | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0044146 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0045655 | GO:0045655 | regulation of monocyte differentiation | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0060732 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process | 6/1028 | 12/8135 | 3.96 | 1.88e-03 | 8.24e-03 | 12 |
GO:0043903 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 21/1028 | 86/8135 | 1.93 | 1.93e-03 | 8.43e-03 | 86 |
GO:2000377 | GO:2000377 | regulation of reactive oxygen species metabolic process | 21/1028 | 86/8135 | 1.93 | 1.93e-03 | 8.43e-03 | 86 |
GO:0043405 | GO:0043405 | regulation of MAP kinase activity | 39/1028 | 194/8135 | 1.59 | 1.95e-03 | 8.44e-03 | 194 |
GO:0051604 | GO:0051604 | protein maturation | 34/1028 | 163/8135 | 1.65 | 1.96e-03 | 8.44e-03 | 163 |
GO:0002204 | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:0002208 | GO:0002208 | somatic diversification of immunoglobulins involved in immune response | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:0016447 | GO:0016447 | somatic recombination of immunoglobulin gene segments | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:0045190 | GO:0045190 | isotype switching | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:0090322 | GO:0090322 | regulation of superoxide metabolic process | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:1902624 | GO:1902624 | positive regulation of neutrophil migration | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:1904645 | GO:1904645 | response to amyloid-beta | 8/1028 | 20/8135 | 3.17 | 1.96e-03 | 8.44e-03 | 20 |
GO:0070613 | GO:0070613 | regulation of protein processing | 19/1028 | 75/8135 | 2.00 | 1.98e-03 | 8.51e-03 | 75 |
GO:0052547 | GO:0052547 | regulation of peptidase activity | 49/1028 | 258/8135 | 1.50 | 2.00e-03 | 8.58e-03 | 258 |
GO:0006929 | GO:0006929 | substrate-dependent cell migration | 7/1028 | 16/8135 | 3.46 | 2.05e-03 | 8.77e-03 | 16 |
GO:0019883 | GO:0019883 | antigen processing and presentation of endogenous antigen | 7/1028 | 16/8135 | 3.46 | 2.05e-03 | 8.77e-03 | 16 |
GO:0050798 | GO:0050798 | activated T cell proliferation | 10/1028 | 29/8135 | 2.73 | 2.06e-03 | 8.80e-03 | 29 |
GO:0051482 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway | 10/1028 | 29/8135 | 2.73 | 2.06e-03 | 8.80e-03 | 29 |
GO:0032368 | GO:0032368 | regulation of lipid transport | 18/1028 | 70/8135 | 2.03 | 2.15e-03 | 9.18e-03 | 70 |
GO:0007260 | GO:0007260 | tyrosine phosphorylation of STAT protein | 15/1028 | 54/8135 | 2.20 | 2.18e-03 | 9.28e-03 | 54 |
GO:0007200 | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 21/1028 | 87/8135 | 1.91 | 2.25e-03 | 9.59e-03 | 87 |
GO:0042531 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 14/1028 | 49/8135 | 2.26 | 2.27e-03 | 9.64e-03 | 49 |
GO:0014015 | GO:0014015 | positive regulation of gliogenesis | 12/1028 | 39/8135 | 2.43 | 2.31e-03 | 9.80e-03 | 39 |
GO:1903317 | GO:1903317 | regulation of protein maturation | 19/1028 | 76/8135 | 1.98 | 2.33e-03 | 9.87e-03 | 76 |
GO:1904062 | GO:1904062 | regulation of cation transmembrane transport | 41/1028 | 209/8135 | 1.55 | 2.44e-03 | 1.03e-02 | 209 |
GO:0001936 | GO:0001936 | regulation of endothelial cell proliferation | 18/1028 | 71/8135 | 2.01 | 2.55e-03 | 1.08e-02 | 71 |
GO:0045765 | GO:0045765 | regulation of angiogenesis | 36/1028 | 178/8135 | 1.60 | 2.57e-03 | 1.08e-02 | 178 |
GO:0032642 | GO:0032642 | regulation of chemokine production | 15/1028 | 55/8135 | 2.16 | 2.65e-03 | 1.11e-02 | 55 |
GO:0070670 | GO:0070670 | response to interleukin-4 | 8/1028 | 21/8135 | 3.01 | 2.82e-03 | 1.18e-02 | 21 |
GO:1904427 | GO:1904427 | positive regulation of calcium ion transmembrane transport | 13/1028 | 45/8135 | 2.29 | 2.89e-03 | 1.21e-02 | 45 |
GO:0010524 | GO:0010524 | positive regulation of calcium ion transport into cytosol | 12/1028 | 40/8135 | 2.37 | 2.93e-03 | 1.23e-02 | 40 |
GO:0120162 | GO:0120162 | positive regulation of cold-induced thermogenesis | 16/1028 | 61/8135 | 2.08 | 2.99e-03 | 1.25e-02 | 61 |
GO:0043433 | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 18/1028 | 72/8135 | 1.98 | 3.01e-03 | 1.25e-02 | 72 |
GO:0042133 | GO:0042133 | neurotransmitter metabolic process | 21/1028 | 89/8135 | 1.87 | 3.03e-03 | 1.26e-02 | 89 |
GO:0001516 | GO:0001516 | prostaglandin biosynthetic process | 7/1028 | 17/8135 | 3.26 | 3.10e-03 | 1.28e-02 | 17 |
GO:0032608 | GO:0032608 | interferon-beta production | 7/1028 | 17/8135 | 3.26 | 3.10e-03 | 1.28e-02 | 17 |
GO:0032648 | GO:0032648 | regulation of interferon-beta production | 7/1028 | 17/8135 | 3.26 | 3.10e-03 | 1.28e-02 | 17 |
GO:0032703 | GO:0032703 | negative regulation of interleukin-2 production | 7/1028 | 17/8135 | 3.26 | 3.10e-03 | 1.28e-02 | 17 |
GO:0046457 | GO:0046457 | prostanoid biosynthetic process | 7/1028 | 17/8135 | 3.26 | 3.10e-03 | 1.28e-02 | 17 |
GO:0007040 | GO:0007040 | lysosome organization | 6/1028 | 13/8135 | 3.65 | 3.13e-03 | 1.28e-02 | 13 |
GO:0032725 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 6/1028 | 13/8135 | 3.65 | 3.13e-03 | 1.28e-02 | 13 |
GO:0045780 | GO:0045780 | positive regulation of bone resorption | 6/1028 | 13/8135 | 3.65 | 3.13e-03 | 1.28e-02 | 13 |
GO:0046852 | GO:0046852 | positive regulation of bone remodeling | 6/1028 | 13/8135 | 3.65 | 3.13e-03 | 1.28e-02 | 13 |
GO:0050858 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 6/1028 | 13/8135 | 3.65 | 3.13e-03 | 1.28e-02 | 13 |
GO:0080171 | GO:0080171 | lytic vacuole organization | 6/1028 | 13/8135 | 3.65 | 3.13e-03 | 1.28e-02 | 13 |
GO:0046777 | GO:0046777 | protein autophosphorylation | 24/1028 | 107/8135 | 1.77 | 3.25e-03 | 1.33e-02 | 107 |
GO:1904018 | GO:1904018 | positive regulation of vasculature development | 26/1028 | 119/8135 | 1.73 | 3.29e-03 | 1.35e-02 | 119 |
GO:0002200 | GO:0002200 | somatic diversification of immune receptors | 9/1028 | 26/8135 | 2.74 | 3.33e-03 | 1.36e-02 | 26 |
GO:0033619 | GO:0033619 | membrane protein proteolysis | 9/1028 | 26/8135 | 2.74 | 3.33e-03 | 1.36e-02 | 26 |
GO:0046330 | GO:0046330 | positive regulation of JNK cascade | 20/1028 | 84/8135 | 1.88 | 3.36e-03 | 1.37e-02 | 84 |
GO:2000117 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 13/1028 | 46/8135 | 2.24 | 3.57e-03 | 1.45e-02 | 46 |
GO:1904894 | GO:1904894 | positive regulation of STAT cascade | 16/1028 | 62/8135 | 2.04 | 3.57e-03 | 1.45e-02 | 62 |
GO:0071260 | GO:0071260 | cellular response to mechanical stimulus | 12/1028 | 41/8135 | 2.32 | 3.68e-03 | 1.49e-02 | 41 |
GO:1902930 | GO:1902930 | regulation of alcohol biosynthetic process | 12/1028 | 41/8135 | 2.32 | 3.68e-03 | 1.49e-02 | 41 |
GO:0032963 | GO:0032963 | collagen metabolic process | 17/1028 | 68/8135 | 1.98 | 3.88e-03 | 1.57e-02 | 68 |
GO:0045954 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 8/1028 | 22/8135 | 2.88 | 3.95e-03 | 1.60e-02 | 22 |
GO:0042509 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 14/1028 | 52/8135 | 2.13 | 4.13e-03 | 1.67e-02 | 52 |
GO:2000379 | GO:2000379 | positive regulation of reactive oxygen species metabolic process | 14/1028 | 52/8135 | 2.13 | 4.13e-03 | 1.67e-02 | 52 |
GO:0014066 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | 16/1028 | 63/8135 | 2.01 | 4.24e-03 | 1.71e-02 | 63 |
GO:0008347 | GO:0008347 | glial cell migration | 9/1028 | 27/8135 | 2.64 | 4.44e-03 | 1.78e-02 | 27 |
GO:0002691 | GO:0002691 | regulation of cellular extravasation | 7/1028 | 18/8135 | 3.08 | 4.53e-03 | 1.82e-02 | 18 |
GO:0090023 | GO:0090023 | positive regulation of neutrophil chemotaxis | 7/1028 | 18/8135 | 3.08 | 4.53e-03 | 1.82e-02 | 18 |
GO:0043154 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 12/1028 | 42/8135 | 2.26 | 4.57e-03 | 1.83e-02 | 42 |
GO:0001771 | GO:0001771 | immunological synapse formation | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0001780 | GO:0001780 | neutrophil homeostasis | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0002418 | GO:0002418 | immune response to tumor cell | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0002923 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0010820 | GO:0010820 | positive regulation of T cell chemotaxis | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0042362 | GO:0042362 | fat-soluble vitamin biosynthetic process | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0045830 | GO:0045830 | positive regulation of isotype switching | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0060252 | GO:0060252 | positive regulation of glial cell proliferation | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0071404 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:2001185 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation | 5/1028 | 10/8135 | 3.96 | 4.65e-03 | 1.84e-02 | 10 |
GO:0033628 | GO:0033628 | regulation of cell adhesion mediated by integrin | 10/1028 | 32/8135 | 2.47 | 4.66e-03 | 1.84e-02 | 32 |
GO:0031331 | GO:0031331 | positive regulation of cellular catabolic process | 24/1028 | 110/8135 | 1.73 | 4.73e-03 | 1.86e-02 | 110 |
GO:0032928 | GO:0032928 | regulation of superoxide anion generation | 6/1028 | 14/8135 | 3.39 | 4.89e-03 | 1.91e-02 | 14 |
GO:0043302 | GO:0043302 | positive regulation of leukocyte degranulation | 6/1028 | 14/8135 | 3.39 | 4.89e-03 | 1.91e-02 | 14 |
GO:0044117 | GO:0044117 | growth of symbiont in host | 6/1028 | 14/8135 | 3.39 | 4.89e-03 | 1.91e-02 | 14 |
GO:0045072 | GO:0045072 | regulation of interferon-gamma biosynthetic process | 6/1028 | 14/8135 | 3.39 | 4.89e-03 | 1.91e-02 | 14 |
GO:0045911 | GO:0045911 | positive regulation of DNA recombination | 6/1028 | 14/8135 | 3.39 | 4.89e-03 | 1.91e-02 | 14 |
GO:1903306 | GO:1903306 | negative regulation of regulated secretory pathway | 6/1028 | 14/8135 | 3.39 | 4.89e-03 | 1.91e-02 | 14 |
GO:0001938 | GO:0001938 | positive regulation of endothelial cell proliferation | 14/1028 | 53/8135 | 2.09 | 4.98e-03 | 1.94e-02 | 53 |
GO:0034109 | GO:0034109 | homotypic cell-cell adhesion | 14/1028 | 53/8135 | 2.09 | 4.98e-03 | 1.94e-02 | 53 |
GO:0030193 | GO:0030193 | regulation of blood coagulation | 16/1028 | 64/8135 | 1.98 | 5.01e-03 | 1.95e-02 | 64 |
GO:1900046 | GO:1900046 | regulation of hemostasis | 16/1028 | 64/8135 | 1.98 | 5.01e-03 | 1.95e-02 | 64 |
GO:0070304 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 22/1028 | 99/8135 | 1.76 | 5.31e-03 | 2.07e-02 | 99 |
GO:0046854 | GO:0046854 | phosphatidylinositol phosphorylation | 17/1028 | 70/8135 | 1.92 | 5.33e-03 | 2.07e-02 | 70 |
GO:0002639 | GO:0002639 | positive regulation of immunoglobulin production | 8/1028 | 23/8135 | 2.75 | 5.39e-03 | 2.09e-02 | 23 |
GO:0002717 | GO:0002717 | positive regulation of natural killer cell mediated immunity | 8/1028 | 23/8135 | 2.75 | 5.39e-03 | 2.09e-02 | 23 |
GO:0050832 | GO:0050832 | defense response to fungus | 8/1028 | 23/8135 | 2.75 | 5.39e-03 | 2.09e-02 | 23 |
GO:0046427 | GO:0046427 | positive regulation of JAK-STAT cascade | 15/1028 | 59/8135 | 2.01 | 5.48e-03 | 2.12e-02 | 59 |
GO:0006650 | GO:0006650 | glycerophospholipid metabolic process | 35/1028 | 180/8135 | 1.54 | 5.65e-03 | 2.18e-02 | 180 |
GO:0035690 | GO:0035690 | cellular response to drug | 35/1028 | 180/8135 | 1.54 | 5.65e-03 | 2.18e-02 | 180 |
GO:0106106 | GO:0106106 | cold-induced thermogenesis | 19/1028 | 82/8135 | 1.83 | 5.76e-03 | 2.22e-02 | 82 |
GO:0120161 | GO:0120161 | regulation of cold-induced thermogenesis | 19/1028 | 82/8135 | 1.83 | 5.76e-03 | 2.22e-02 | 82 |
GO:0001961 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 9/1028 | 28/8135 | 2.54 | 5.82e-03 | 2.24e-02 | 28 |
GO:0051281 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 9/1028 | 28/8135 | 2.54 | 5.82e-03 | 2.24e-02 | 28 |
GO:0019915 | GO:0019915 | lipid storage | 11/1028 | 38/8135 | 2.29 | 5.85e-03 | 2.24e-02 | 38 |
GO:0043647 | GO:0043647 | inositol phosphate metabolic process | 11/1028 | 38/8135 | 2.29 | 5.85e-03 | 2.24e-02 | 38 |
GO:0050818 | GO:0050818 | regulation of coagulation | 16/1028 | 65/8135 | 1.95 | 5.88e-03 | 2.25e-02 | 65 |
GO:1903305 | GO:1903305 | regulation of regulated secretory pathway | 22/1028 | 100/8135 | 1.74 | 6.01e-03 | 2.30e-02 | 100 |
GO:0045672 | GO:0045672 | positive regulation of osteoclast differentiation | 7/1028 | 19/8135 | 2.92 | 6.40e-03 | 2.44e-02 | 19 |
GO:0071353 | GO:0071353 | cellular response to interleukin-4 | 7/1028 | 19/8135 | 2.92 | 6.40e-03 | 2.44e-02 | 19 |
GO:0046834 | GO:0046834 | lipid phosphorylation | 18/1028 | 77/8135 | 1.85 | 6.44e-03 | 2.45e-02 | 77 |
GO:0043270 | GO:0043270 | positive regulation of ion transport | 36/1028 | 188/8135 | 1.52 | 6.51e-03 | 2.48e-02 | 188 |
GO:0017157 | GO:0017157 | regulation of exocytosis | 26/1028 | 125/8135 | 1.65 | 6.55e-03 | 2.49e-02 | 125 |
GO:0048661 | GO:0048661 | positive regulation of smooth muscle cell proliferation | 14/1028 | 55/8135 | 2.01 | 7.09e-03 | 2.69e-02 | 55 |
GO:0002562 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 8/1028 | 24/8135 | 2.64 | 7.21e-03 | 2.72e-02 | 24 |
GO:0009164 | GO:0009164 | nucleoside catabolic process | 8/1028 | 24/8135 | 2.64 | 7.21e-03 | 2.72e-02 | 24 |
GO:0010955 | GO:0010955 | negative regulation of protein processing | 8/1028 | 24/8135 | 2.64 | 7.21e-03 | 2.72e-02 | 24 |
GO:0016444 | GO:0016444 | somatic cell DNA recombination | 8/1028 | 24/8135 | 2.64 | 7.21e-03 | 2.72e-02 | 24 |
GO:0045806 | GO:0045806 | negative regulation of endocytosis | 8/1028 | 24/8135 | 2.64 | 7.21e-03 | 2.72e-02 | 24 |
GO:1903318 | GO:1903318 | negative regulation of protein maturation | 8/1028 | 24/8135 | 2.64 | 7.21e-03 | 2.72e-02 | 24 |
GO:0002313 | GO:0002313 | mature B cell differentiation involved in immune response | 6/1028 | 15/8135 | 3.17 | 7.29e-03 | 2.73e-02 | 15 |
GO:0006837 | GO:0006837 | serotonin transport | 6/1028 | 15/8135 | 3.17 | 7.29e-03 | 2.73e-02 | 15 |
GO:0030947 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 6/1028 | 15/8135 | 3.17 | 7.29e-03 | 2.73e-02 | 15 |
GO:0044110 | GO:0044110 | growth involved in symbiotic interaction | 6/1028 | 15/8135 | 3.17 | 7.29e-03 | 2.73e-02 | 15 |
GO:0044116 | GO:0044116 | growth of symbiont involved in interaction with host | 6/1028 | 15/8135 | 3.17 | 7.29e-03 | 2.73e-02 | 15 |
GO:1904037 | GO:1904037 | positive regulation of epithelial cell apoptotic process | 6/1028 | 15/8135 | 3.17 | 7.29e-03 | 2.73e-02 | 15 |
GO:0033089 | GO:0033089 | positive regulation of T cell differentiation in thymus | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:0034162 | GO:0034162 | toll-like receptor 9 signaling pathway | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:0043011 | GO:0043011 | myeloid dendritic cell differentiation | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:0043374 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:0051767 | GO:0051767 | nitric-oxide synthase biosynthetic process | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:0051769 | GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:1904469 | GO:1904469 | positive regulation of tumor necrosis factor secretion | 5/1028 | 11/8135 | 3.60 | 7.64e-03 | 2.84e-02 | 11 |
GO:1901136 | GO:1901136 | carbohydrate derivative catabolic process | 22/1028 | 102/8135 | 1.71 | 7.67e-03 | 2.84e-02 | 102 |
GO:0051896 | GO:0051896 | regulation of protein kinase B signaling | 27/1028 | 133/8135 | 1.61 | 7.91e-03 | 2.93e-02 | 133 |
GO:0002920 | GO:0002920 | regulation of humoral immune response | 14/1028 | 56/8135 | 1.98 | 8.38e-03 | 3.10e-02 | 56 |
GO:0032814 | GO:0032814 | regulation of natural killer cell activation | 7/1028 | 20/8135 | 2.77 | 8.79e-03 | 3.24e-02 | 20 |
GO:0046135 | GO:0046135 | pyrimidine nucleoside catabolic process | 7/1028 | 20/8135 | 2.77 | 8.79e-03 | 3.24e-02 | 20 |
GO:0071624 | GO:0071624 | positive regulation of granulocyte chemotaxis | 7/1028 | 20/8135 | 2.77 | 8.79e-03 | 3.24e-02 | 20 |
GO:0001960 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 10/1028 | 35/8135 | 2.26 | 9.32e-03 | 3.43e-02 | 35 |
GO:0010573 | GO:0010573 | vascular endothelial growth factor production | 8/1028 | 25/8135 | 2.53 | 9.45e-03 | 3.47e-02 | 25 |
GO:0010883 | GO:0010883 | regulation of lipid storage | 8/1028 | 25/8135 | 2.53 | 9.45e-03 | 3.47e-02 | 25 |
GO:0070741 | GO:0070741 | response to interleukin-6 | 8/1028 | 25/8135 | 2.53 | 9.45e-03 | 3.47e-02 | 25 |
GO:0034767 | GO:0034767 | positive regulation of ion transmembrane transport | 22/1028 | 104/8135 | 1.67 | 9.67e-03 | 3.54e-02 | 104 |
GO:0032874 | GO:0032874 | positive regulation of stress-activated MAPK cascade | 21/1028 | 98/8135 | 1.70 | 9.76e-03 | 3.57e-02 | 98 |
GO:0032616 | GO:0032616 | interleukin-13 production | 6/1028 | 16/8135 | 2.97 | 1.04e-02 | 3.79e-02 | 16 |
GO:0032691 | GO:0032691 | negative regulation of interleukin-1 beta production | 6/1028 | 16/8135 | 2.97 | 1.04e-02 | 3.79e-02 | 16 |
GO:0042454 | GO:0042454 | ribonucleoside catabolic process | 6/1028 | 16/8135 | 2.97 | 1.04e-02 | 3.79e-02 | 16 |
GO:0042590 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6/1028 | 16/8135 | 2.97 | 1.04e-02 | 3.79e-02 | 16 |
GO:1904467 | GO:1904467 | regulation of tumor necrosis factor secretion | 6/1028 | 16/8135 | 2.97 | 1.04e-02 | 3.79e-02 | 16 |
GO:1990774 | GO:1990774 | tumor necrosis factor secretion | 6/1028 | 16/8135 | 2.97 | 1.04e-02 | 3.79e-02 | 16 |
GO:0097006 | GO:0097006 | regulation of plasma lipoprotein particle levels | 13/1028 | 52/8135 | 1.98 | 1.09e-02 | 3.94e-02 | 52 |
GO:1990845 | GO:1990845 | adaptive thermogenesis | 19/1028 | 87/8135 | 1.73 | 1.11e-02 | 4.01e-02 | 87 |
GO:0060761 | GO:0060761 | negative regulation of response to cytokine stimulus | 10/1028 | 36/8135 | 2.20 | 1.15e-02 | 4.14e-02 | 36 |
GO:0071825 | GO:0071825 | protein-lipid complex subunit organization | 10/1028 | 36/8135 | 2.20 | 1.15e-02 | 4.14e-02 | 36 |
GO:0002475 | GO:0002475 | antigen processing and presentation via MHC class Ib | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0009110 | GO:0009110 | vitamin biosynthetic process | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0032373 | GO:0032373 | positive regulation of sterol transport | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0032376 | GO:0032376 | positive regulation of cholesterol transport | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0046133 | GO:0046133 | pyrimidine ribonucleoside catabolic process | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0051023 | GO:0051023 | regulation of immunoglobulin secretion | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0060099 | GO:0060099 | regulation of phagocytosis, engulfment | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:1904994 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:1905153 | GO:1905153 | regulation of membrane invagination | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:2000353 | GO:2000353 | positive regulation of endothelial cell apoptotic process | 5/1028 | 12/8135 | 3.30 | 1.18e-02 | 4.19e-02 | 12 |
GO:0006692 | GO:0006692 | prostanoid metabolic process | 7/1028 | 21/8135 | 2.64 | 1.18e-02 | 4.19e-02 | 21 |
GO:0006693 | GO:0006693 | prostaglandin metabolic process | 7/1028 | 21/8135 | 2.64 | 1.18e-02 | 4.19e-02 | 21 |
GO:0034105 | GO:0034105 | positive regulation of tissue remodeling | 7/1028 | 21/8135 | 2.64 | 1.18e-02 | 4.19e-02 | 21 |
GO:0071354 | GO:0071354 | cellular response to interleukin-6 | 7/1028 | 21/8135 | 2.64 | 1.18e-02 | 4.19e-02 | 21 |
GO:0035924 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 9/1028 | 31/8135 | 2.30 | 1.20e-02 | 4.26e-02 | 31 |
GO:0050792 | GO:0050792 | regulation of viral process | 16/1028 | 70/8135 | 1.81 | 1.23e-02 | 4.36e-02 | 70 |
GO:1904064 | GO:1904064 | positive regulation of cation transmembrane transport | 20/1028 | 94/8135 | 1.68 | 1.24e-02 | 4.40e-02 | 94 |
GO:0034764 | GO:0034764 | positive regulation of transmembrane transport | 25/1028 | 125/8135 | 1.58 | 1.25e-02 | 4.41e-02 | 125 |
GO:1904892 | GO:1904892 | regulation of STAT cascade | 18/1028 | 82/8135 | 1.74 | 1.25e-02 | 4.43e-02 | 82 |
GO:0050922 | GO:0050922 | negative regulation of chemotaxis | 11/1028 | 42/8135 | 2.07 | 1.30e-02 | 4.59e-02 | 42 |
GO:1903034 | GO:1903034 | regulation of response to wounding | 22/1028 | 107/8135 | 1.63 | 1.34e-02 | 4.74e-02 | 107 |
GO:0046579 | GO:0046579 | positive regulation of Ras protein signal transduction | 10/1028 | 37/8135 | 2.14 | 1.40e-02 | 4.94e-02 | 37 |
GO:0030282 | GO:0030282 | bone mineralization | 17/1028 | 77/8135 | 1.75 | 1.42e-02 | 4.99e-02 | 77 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0060271 | GO:0060271 | cilium assembly | 83/3587 | 123/8135 | 1.53 | 1.17e-07 | 0.000266 | 123 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0007156 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 81/2982 | 144/8135 | 1.53 | 1.10e-06 | 0.00517 | 144 |
GO:0003341 | GO:0003341 | cilium movement | 31/2982 | 46/8135 | 1.84 | 2.15e-05 | 0.04666 | 46 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0044782 | GO:0044782 | cilium organization | 89/2640 | 132/8135 | 2.08 | 1.18e-16 | 5.14e-13 | 132 |
GO:0060271 | GO:0060271 | cilium assembly | 84/2640 | 123/8135 | 2.10 | 2.64e-16 | 5.73e-13 | 123 |
GO:0003341 | GO:0003341 | cilium movement | 41/2640 | 46/8135 | 2.75 | 1.55e-15 | 1.40e-12 | 46 |
GO:0035082 | GO:0035082 | axoneme assembly | 41/2640 | 46/8135 | 2.75 | 1.55e-15 | 1.40e-12 | 46 |
GO:0007017 | GO:0007017 | microtubule-based process | 162/2640 | 298/8135 | 1.68 | 1.61e-15 | 1.40e-12 | 298 |
GO:0007018 | GO:0007018 | microtubule-based movement | 79/2640 | 119/8135 | 2.05 | 2.36e-14 | 1.71e-11 | 119 |
GO:0120031 | GO:0120031 | plasma membrane bounded cell projection assembly | 124/2640 | 222/8135 | 1.72 | 2.87e-13 | 1.78e-10 | 222 |
GO:0001578 | GO:0001578 | microtubule bundle formation | 48/2640 | 62/8135 | 2.39 | 3.87e-13 | 2.10e-10 | 62 |
GO:0030031 | GO:0030031 | cell projection assembly | 127/2640 | 231/8135 | 1.69 | 6.94e-13 | 3.34e-10 | 231 |
GO:0099504 | GO:0099504 | synaptic vesicle cycle | 77/2640 | 122/8135 | 1.94 | 2.63e-12 | 1.14e-09 | 122 |
GO:0099003 | GO:0099003 | vesicle-mediated transport in synapse | 73/2640 | 115/8135 | 1.96 | 6.50e-12 | 2.56e-09 | 115 |
GO:0007269 | GO:0007269 | neurotransmitter secretion | 72/2640 | 114/8135 | 1.95 | 1.29e-11 | 4.32e-09 | 114 |
GO:0099643 | GO:0099643 | signal release from synapse | 72/2640 | 114/8135 | 1.95 | 1.29e-11 | 4.32e-09 | 114 |
GO:0097479 | GO:0097479 | synaptic vesicle localization | 66/2640 | 102/8135 | 1.99 | 1.91e-11 | 5.81e-09 | 102 |
GO:0017156 | GO:0017156 | calcium ion regulated exocytosis | 65/2640 | 100/8135 | 2.00 | 2.01e-11 | 5.81e-09 | 100 |
GO:0070286 | GO:0070286 | axonemal dynein complex assembly | 24/2640 | 25/8135 | 2.96 | 2.99e-11 | 8.11e-09 | 25 |
GO:0017158 | GO:0017158 | regulation of calcium ion-dependent exocytosis | 50/2640 | 72/8135 | 2.14 | 1.20e-10 | 3.07e-08 | 72 |
GO:0006836 | GO:0006836 | neurotransmitter transport | 103/2640 | 188/8135 | 1.69 | 1.42e-10 | 3.43e-08 | 188 |
GO:0048489 | GO:0048489 | synaptic vesicle transport | 60/2640 | 93/8135 | 1.99 | 1.89e-10 | 4.10e-08 | 93 |
GO:0097480 | GO:0097480 | establishment of synaptic vesicle localization | 60/2640 | 93/8135 | 1.99 | 1.89e-10 | 4.10e-08 | 93 |
GO:0016079 | GO:0016079 | synaptic vesicle exocytosis | 53/2640 | 81/8135 | 2.02 | 1.02e-09 | 1.77e-07 | 81 |
GO:0000226 | GO:0000226 | microtubule cytoskeleton organization | 114/2640 | 224/8135 | 1.57 | 5.35e-09 | 8.59e-07 | 224 |
GO:0098693 | GO:0098693 | regulation of synaptic vesicle cycle | 47/2640 | 72/8135 | 2.01 | 1.02e-08 | 1.48e-06 | 72 |
GO:0051648 | GO:0051648 | vesicle localization | 75/2640 | 134/8135 | 1.72 | 1.35e-08 | 1.88e-06 | 134 |
GO:0051650 | GO:0051650 | establishment of vesicle localization | 69/2640 | 122/8135 | 1.74 | 2.89e-08 | 3.80e-06 | 122 |
GO:0001505 | GO:0001505 | regulation of neurotransmitter levels | 111/2640 | 225/8135 | 1.52 | 7.51e-08 | 9.30e-06 | 225 |
GO:1902803 | GO:1902803 | regulation of synaptic vesicle transport | 38/2640 | 57/8135 | 2.05 | 1.15e-07 | 1.25e-05 | 57 |
GO:2000300 | GO:2000300 | regulation of synaptic vesicle exocytosis | 36/2640 | 53/8135 | 2.09 | 1.20e-07 | 1.27e-05 | 53 |
GO:0045956 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 18/2640 | 20/8135 | 2.77 | 1.40e-07 | 1.41e-05 | 20 |
GO:0046928 | GO:0046928 | regulation of neurotransmitter secretion | 45/2640 | 72/8135 | 1.93 | 1.45e-07 | 1.43e-05 | 72 |
GO:0036158 | GO:0036158 | outer dynein arm assembly | 13/2640 | 13/8135 | 3.08 | 4.34e-07 | 3.84e-05 | 13 |
GO:0001539 | GO:0001539 | cilium or flagellum-dependent cell motility | 19/2640 | 23/8135 | 2.55 | 1.01e-06 | 8.15e-05 | 23 |
GO:0060285 | GO:0060285 | cilium-dependent cell motility | 19/2640 | 23/8135 | 2.55 | 1.01e-06 | 8.15e-05 | 23 |
GO:0031338 | GO:0031338 | regulation of vesicle fusion | 16/2640 | 18/8135 | 2.74 | 1.09e-06 | 8.57e-05 | 18 |
GO:0017157 | GO:0017157 | regulation of exocytosis | 66/2640 | 125/8135 | 1.63 | 1.73e-06 | 1.32e-04 | 125 |
GO:0030073 | GO:0030073 | insulin secretion | 68/2640 | 133/8135 | 1.58 | 5.35e-06 | 3.78e-04 | 133 |
GO:0030072 | GO:0030072 | peptide hormone secretion | 81/2640 | 165/8135 | 1.51 | 5.50e-06 | 3.78e-04 | 165 |
GO:1903305 | GO:1903305 | regulation of regulated secretory pathway | 54/2640 | 100/8135 | 1.66 | 6.23e-06 | 4.17e-04 | 100 |
GO:0008306 | GO:0008306 | associative learning | 30/2640 | 47/8135 | 1.97 | 9.57e-06 | 6.10e-04 | 47 |
GO:0051588 | GO:0051588 | regulation of neurotransmitter transport | 52/2640 | 97/8135 | 1.65 | 1.21e-05 | 7.47e-04 | 97 |
GO:0036159 | GO:0036159 | inner dynein arm assembly | 12/2640 | 13/8135 | 2.84 | 1.22e-05 | 7.47e-04 | 13 |
GO:0007368 | GO:0007368 | determination of left/right symmetry | 39/2640 | 69/8135 | 1.74 | 3.02e-05 | 1.77e-03 | 69 |
GO:0003351 | GO:0003351 | epithelial cilium movement | 14/2640 | 17/8135 | 2.54 | 3.26e-05 | 1.88e-03 | 17 |
GO:0044458 | GO:0044458 | motile cilium assembly | 11/2640 | 12/8135 | 2.82 | 3.50e-05 | 2.00e-03 | 12 |
GO:0009855 | GO:0009855 | determination of bilateral symmetry | 41/2640 | 75/8135 | 1.68 | 5.49e-05 | 3.09e-03 | 75 |
GO:0007632 | GO:0007632 | visual behavior | 20/2640 | 29/8135 | 2.13 | 5.96e-05 | 3.31e-03 | 29 |
GO:1990138 | GO:1990138 | neuron projection extension | 48/2640 | 92/8135 | 1.61 | 6.52e-05 | 3.58e-03 | 92 |
GO:0048167 | GO:0048167 | regulation of synaptic plasticity | 57/2640 | 114/8135 | 1.54 | 6.86e-05 | 3.72e-03 | 114 |
GO:0009799 | GO:0009799 | specification of symmetry | 41/2640 | 76/8135 | 1.66 | 8.22e-05 | 4.35e-03 | 76 |
GO:0035418 | GO:0035418 | protein localization to synapse | 25/2640 | 40/8135 | 1.93 | 8.87e-05 | 4.63e-03 | 40 |
GO:0007612 | GO:0007612 | learning | 48/2640 | 93/8135 | 1.59 | 9.28e-05 | 4.79e-03 | 93 |
GO:0045921 | GO:0045921 | positive regulation of exocytosis | 28/2640 | 47/8135 | 1.84 | 1.15e-04 | 5.77e-03 | 47 |
GO:0008542 | GO:0008542 | visual learning | 18/2640 | 26/8135 | 2.13 | 1.31e-04 | 6.52e-03 | 26 |
GO:0140029 | GO:0140029 | exocytic process | 25/2640 | 41/8135 | 1.88 | 1.58e-04 | 7.76e-03 | 41 |
GO:0035249 | GO:0035249 | synaptic transmission, glutamatergic | 38/2640 | 71/8135 | 1.65 | 1.85e-04 | 8.71e-03 | 71 |
GO:0060632 | GO:0060632 | regulation of microtubule-based movement | 12/2640 | 15/8135 | 2.47 | 2.11e-04 | 9.85e-03 | 15 |
GO:1902475 | GO:1902475 | L-alpha-amino acid transmembrane transport | 20/2640 | 31/8135 | 1.99 | 2.44e-04 | 1.10e-02 | 31 |
GO:0090313 | GO:0090313 | regulation of protein targeting to membrane | 14/2640 | 19/8135 | 2.27 | 2.73e-04 | 1.22e-02 | 19 |
GO:0031630 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 9/2640 | 10/8135 | 2.77 | 2.80e-04 | 1.24e-02 | 10 |
GO:1905475 | GO:1905475 | regulation of protein localization to membrane | 41/2640 | 81/8135 | 1.56 | 5.00e-04 | 2.13e-02 | 81 |
GO:0031629 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane | 12/2640 | 16/8135 | 2.31 | 5.95e-04 | 2.48e-02 | 16 |
GO:0090314 | GO:0090314 | positive regulation of protein targeting to membrane | 12/2640 | 16/8135 | 2.31 | 5.95e-04 | 2.48e-02 | 16 |
GO:0006865 | GO:0006865 | amino acid transport | 43/2640 | 87/8135 | 1.52 | 7.05e-04 | 2.78e-02 | 87 |
GO:0006906 | GO:0006906 | vesicle fusion | 21/2640 | 35/8135 | 1.85 | 7.17e-04 | 2.78e-02 | 35 |
GO:0090174 | GO:0090174 | organelle membrane fusion | 21/2640 | 35/8135 | 1.85 | 7.17e-04 | 2.78e-02 | 35 |
GO:1903307 | GO:1903307 | positive regulation of regulated secretory pathway | 21/2640 | 35/8135 | 1.85 | 7.17e-04 | 2.78e-02 | 35 |
GO:0007215 | GO:0007215 | glutamate receptor signaling pathway | 36/2640 | 70/8135 | 1.58 | 7.38e-04 | 2.81e-02 | 70 |
GO:0099565 | GO:0099565 | chemical synaptic transmission, postsynaptic | 39/2640 | 78/8135 | 1.54 | 9.24e-04 | 3.34e-02 | 78 |
GO:0051966 | GO:0051966 | regulation of synaptic transmission, glutamatergic | 29/2640 | 54/8135 | 1.65 | 9.71e-04 | 3.48e-02 | 54 |
GO:0048675 | GO:0048675 | axon extension | 33/2640 | 64/8135 | 1.59 | 1.14e-03 | 3.99e-02 | 64 |
GO:0008038 | GO:0008038 | neuron recognition | 21/2640 | 36/8135 | 1.80 | 1.20e-03 | 4.15e-02 | 36 |
GO:0021591 | GO:0021591 | ventricular system development | 10/2640 | 13/8135 | 2.37 | 1.29e-03 | 4.33e-02 | 13 |
GO:0021587 | GO:0021587 | cerebellum morphogenesis | 14/2640 | 21/8135 | 2.05 | 1.34e-03 | 4.45e-02 | 21 |
GO:0048640 | GO:0048640 | negative regulation of developmental growth | 34/2640 | 67/8135 | 1.56 | 1.39e-03 | 4.49e-02 | 67 |
GO:0021696 | GO:0021696 | cerebellar cortex morphogenesis | 13/2640 | 19/8135 | 2.11 | 1.40e-03 | 4.50e-02 | 19 |
GO:0099500 | GO:0099500 | vesicle fusion to plasma membrane | 12/2640 | 17/8135 | 2.18 | 1.42e-03 | 4.54e-02 | 17 |
GO:0015807 | GO:0015807 | L-amino acid transport | 23/2640 | 41/8135 | 1.73 | 1.48e-03 | 4.64e-02 | 41 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0006281 | GO:0006281 | DNA repair | 79/3246 | 130/8135 | 1.52 | 1.04e-06 | 0.00153 | 130 |
GO:0030833 | GO:0030833 | regulation of actin filament polymerization | 47/3246 | 74/8135 | 1.59 | 3.21e-05 | 0.01244 | 74 |
GO:0030041 | GO:0030041 | actin filament polymerization | 52/3246 | 85/8135 | 1.53 | 5.55e-05 | 0.01746 | 85 |
GO:0035747 | GO:0035747 | natural killer cell chemotaxis | 10/3246 | 10/8135 | 2.51 | 1.01e-04 | 0.02352 | 10 |
GO:0008064 | GO:0008064 | regulation of actin polymerization or depolymerization | 49/3246 | 81/8135 | 1.52 | 1.35e-04 | 0.02481 | 81 |
GO:0006302 | GO:0006302 | double-strand break repair | 48/3246 | 79/8135 | 1.52 | 1.35e-04 | 0.02481 | 79 |
GO:0072678 | GO:0072678 | T cell migration | 29/3246 | 43/8135 | 1.69 | 2.32e-04 | 0.03093 | 43 |
GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 24/3246 | 34/8135 | 1.77 | 2.79e-04 | 0.03322 | 34 |
GO:0048002 | GO:0048002 | antigen processing and presentation of peptide antigen | 39/3246 | 63/8135 | 1.55 | 3.27e-04 | 0.03793 | 63 |
GO:0010972 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 14/3246 | 17/8135 | 2.06 | 4.33e-04 | 0.04886 | 17 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0070268 | GO:0070268 | cornification | 74/3339 | 95/8135 | 1.90 | 2.02e-13 | 9.49e-10 | 95 |
GO:0031424 | GO:0031424 | keratinization | 88/3339 | 123/8135 | 1.74 | 5.21e-12 | 1.22e-08 | 123 |
GO:0030216 | GO:0030216 | keratinocyte differentiation | 109/3339 | 162/8135 | 1.64 | 8.99e-12 | 1.41e-08 | 162 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:1903047 | GO:1903047 | mitotic cell cycle process | 124/752 | 267/8135 | 5.02 | 1.61e-59 | 6.09e-56 | 267 |
GO:0000278 | GO:0000278 | mitotic cell cycle | 135/752 | 326/8135 | 4.48 | 2.05e-57 | 3.88e-54 | 326 |
GO:0022402 | GO:0022402 | cell cycle process | 158/752 | 470/8135 | 3.64 | 6.85e-53 | 8.63e-50 | 470 |
GO:0051301 | GO:0051301 | cell division | 95/752 | 219/8135 | 4.69 | 3.57e-42 | 3.37e-39 | 219 |
GO:0051276 | GO:0051276 | chromosome organization | 128/752 | 385/8135 | 3.60 | 8.24e-42 | 6.23e-39 | 385 |
GO:0007059 | GO:0007059 | chromosome segregation | 68/752 | 118/8135 | 6.23 | 2.17e-40 | 1.37e-37 | 118 |
GO:0044772 | GO:0044772 | mitotic cell cycle phase transition | 79/752 | 164/8135 | 5.21 | 3.51e-39 | 1.89e-36 | 164 |
GO:0044770 | GO:0044770 | cell cycle phase transition | 81/752 | 177/8135 | 4.95 | 4.48e-38 | 2.12e-35 | 177 |
GO:0140014 | GO:0140014 | mitotic nuclear division | 62/752 | 107/8135 | 6.27 | 4.50e-37 | 1.89e-34 | 107 |
GO:0000819 | GO:0000819 | sister chromatid segregation | 49/752 | 68/8135 | 7.80 | 3.06e-36 | 1.16e-33 | 68 |
GO:0000070 | GO:0000070 | mitotic sister chromatid segregation | 44/752 | 56/8135 | 8.50 | 1.87e-35 | 6.42e-33 | 56 |
GO:0000280 | GO:0000280 | nuclear division | 80/752 | 192/8135 | 4.51 | 5.45e-34 | 1.70e-31 | 192 |
GO:0048285 | GO:0048285 | organelle fission | 83/752 | 206/8135 | 4.36 | 5.85e-34 | 1.70e-31 | 206 |
GO:0098813 | GO:0098813 | nuclear chromosome segregation | 58/752 | 106/8135 | 5.92 | 7.56e-33 | 2.04e-30 | 106 |
GO:0006259 | GO:0006259 | DNA metabolic process | 98/752 | 301/8135 | 3.52 | 5.26e-31 | 1.32e-28 | 301 |
GO:0006260 | GO:0006260 | DNA replication | 48/752 | 77/8135 | 6.74 | 5.67e-31 | 1.34e-28 | 77 |
GO:0010564 | GO:0010564 | regulation of cell cycle process | 86/752 | 243/8135 | 3.83 | 3.17e-30 | 7.04e-28 | 243 |
GO:0051726 | GO:0051726 | regulation of cell cycle | 115/752 | 412/8135 | 3.02 | 1.78e-29 | 3.73e-27 | 412 |
GO:0007346 | GO:0007346 | regulation of mitotic cell cycle | 76/752 | 207/8135 | 3.97 | 5.79e-28 | 1.15e-25 | 207 |
GO:0006974 | GO:0006974 | cellular response to DNA damage stimulus | 77/752 | 230/8135 | 3.62 | 2.63e-25 | 4.96e-23 | 230 |
GO:1901990 | GO:1901990 | regulation of mitotic cell cycle phase transition | 52/752 | 113/8135 | 4.98 | 7.75e-25 | 1.40e-22 | 113 |
GO:1901987 | GO:1901987 | regulation of cell cycle phase transition | 54/752 | 125/8135 | 4.67 | 4.23e-24 | 7.27e-22 | 125 |
GO:0006281 | GO:0006281 | DNA repair | 55/752 | 130/8135 | 4.58 | 5.51e-24 | 9.06e-22 | 130 |
GO:0051983 | GO:0051983 | regulation of chromosome segregation | 28/752 | 35/8135 | 8.65 | 2.49e-23 | 3.93e-21 | 35 |
GO:0000075 | GO:0000075 | cell cycle checkpoint | 38/752 | 67/8135 | 6.14 | 1.24e-22 | 1.87e-20 | 67 |
GO:0006261 | GO:0006261 | DNA-dependent DNA replication | 30/752 | 42/8135 | 7.73 | 2.08e-22 | 3.02e-20 | 42 |
GO:0010948 | GO:0010948 | negative regulation of cell cycle process | 45/752 | 95/8135 | 5.12 | 2.77e-22 | 3.87e-20 | 95 |
GO:0071103 | GO:0071103 | DNA conformation change | 50/752 | 121/8135 | 4.47 | 2.39e-21 | 3.23e-19 | 121 |
GO:0044839 | GO:0044839 | cell cycle G2/M phase transition | 38/752 | 74/8135 | 5.56 | 1.42e-20 | 1.85e-18 | 74 |
GO:0045786 | GO:0045786 | negative regulation of cell cycle | 67/752 | 212/8135 | 3.42 | 1.51e-20 | 1.90e-18 | 212 |
GO:1902850 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 30/752 | 47/8135 | 6.90 | 3.29e-20 | 4.01e-18 | 47 |
GO:0033045 | GO:0033045 | regulation of sister chromatid segregation | 23/752 | 28/8135 | 8.89 | 7.54e-20 | 8.91e-18 | 28 |
GO:0007093 | GO:0007093 | mitotic cell cycle checkpoint | 32/752 | 55/8135 | 6.29 | 1.03e-19 | 1.18e-17 | 55 |
GO:0010965 | GO:0010965 | regulation of mitotic sister chromatid separation | 21/752 | 24/8135 | 9.47 | 2.30e-19 | 2.41e-17 | 24 |
GO:0033047 | GO:0033047 | regulation of mitotic sister chromatid segregation | 21/752 | 24/8135 | 9.47 | 2.30e-19 | 2.41e-17 | 24 |
GO:0051306 | GO:0051306 | mitotic sister chromatid separation | 21/752 | 24/8135 | 9.47 | 2.30e-19 | 2.41e-17 | 24 |
GO:0007088 | GO:0007088 | regulation of mitotic nuclear division | 38/752 | 79/8135 | 5.20 | 2.72e-19 | 2.78e-17 | 79 |
GO:0000086 | GO:0000086 | G2/M transition of mitotic cell cycle | 35/752 | 68/8135 | 5.57 | 4.35e-19 | 4.33e-17 | 68 |
GO:0007051 | GO:0007051 | spindle organization | 30/752 | 51/8135 | 6.36 | 9.57e-19 | 9.27e-17 | 51 |
GO:1905818 | GO:1905818 | regulation of chromosome separation | 21/752 | 25/8135 | 9.09 | 1.31e-18 | 1.24e-16 | 25 |
GO:0051304 | GO:0051304 | chromosome separation | 25/752 | 36/8135 | 7.51 | 2.17e-18 | 1.97e-16 | 36 |
GO:0007052 | GO:0007052 | mitotic spindle organization | 26/752 | 39/8135 | 7.21 | 2.19e-18 | 1.97e-16 | 39 |
GO:0006302 | GO:0006302 | double-strand break repair | 37/752 | 79/8135 | 5.07 | 2.54e-18 | 2.23e-16 | 79 |
GO:0045930 | GO:0045930 | negative regulation of mitotic cell cycle | 42/752 | 101/8135 | 4.50 | 3.09e-18 | 2.65e-16 | 101 |
GO:0006310 | GO:0006310 | DNA recombination | 42/752 | 104/8135 | 4.37 | 1.14e-17 | 9.54e-16 | 104 |
GO:0051321 | GO:0051321 | meiotic cell cycle | 50/752 | 143/8135 | 3.78 | 1.17e-17 | 9.59e-16 | 143 |
GO:1901988 | GO:1901988 | negative regulation of cell cycle phase transition | 33/752 | 66/8135 | 5.41 | 1.44e-17 | 1.16e-15 | 66 |
GO:0051783 | GO:0051783 | regulation of nuclear division | 40/752 | 96/8135 | 4.51 | 1.84e-17 | 1.45e-15 | 96 |
GO:0031570 | GO:0031570 | DNA integrity checkpoint | 27/752 | 45/8135 | 6.49 | 2.64e-17 | 2.04e-15 | 45 |
GO:1901991 | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 31/752 | 60/8135 | 5.59 | 4.14e-17 | 3.13e-15 | 60 |
GO:0044843 | GO:0044843 | cell cycle G1/S phase transition | 38/752 | 91/8135 | 4.52 | 1.09e-16 | 8.09e-15 | 91 |
GO:0007091 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 18/752 | 21/8135 | 9.27 | 2.05e-16 | 1.49e-14 | 21 |
GO:0000082 | GO:0000082 | G1/S transition of mitotic cell cycle | 36/752 | 84/8135 | 4.64 | 2.59e-16 | 1.85e-14 | 84 |
GO:0033046 | GO:0033046 | negative regulation of sister chromatid segregation | 17/752 | 19/8135 | 9.68 | 3.19e-16 | 2.15e-14 | 19 |
GO:0034502 | GO:0034502 | protein localization to chromosome | 17/752 | 19/8135 | 9.68 | 3.19e-16 | 2.15e-14 | 19 |
GO:0051985 | GO:0051985 | negative regulation of chromosome segregation | 17/752 | 19/8135 | 9.68 | 3.19e-16 | 2.15e-14 | 19 |
GO:2001251 | GO:2001251 | negative regulation of chromosome organization | 26/752 | 45/8135 | 6.25 | 3.83e-16 | 2.54e-14 | 45 |
GO:1902749 | GO:1902749 | regulation of cell cycle G2/M phase transition | 28/752 | 53/8135 | 5.72 | 6.61e-16 | 4.31e-14 | 53 |
GO:0044784 | GO:0044784 | metaphase/anaphase transition of cell cycle | 18/752 | 22/8135 | 8.85 | 1.03e-15 | 6.60e-14 | 22 |
GO:0030071 | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 17/752 | 20/8135 | 9.20 | 1.94e-15 | 1.22e-13 | 20 |
GO:0000724 | GO:0000724 | double-strand break repair via homologous recombination | 25/752 | 44/8135 | 6.15 | 2.47e-15 | 1.51e-13 | 44 |
GO:0000725 | GO:0000725 | recombinational repair | 25/752 | 44/8135 | 6.15 | 2.47e-15 | 1.51e-13 | 44 |
GO:0033048 | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 16/752 | 18/8135 | 9.62 | 3.15e-15 | 1.83e-13 | 18 |
GO:1905819 | GO:1905819 | negative regulation of chromosome separation | 16/752 | 18/8135 | 9.62 | 3.15e-15 | 1.83e-13 | 18 |
GO:2000816 | GO:2000816 | negative regulation of mitotic sister chromatid separation | 16/752 | 18/8135 | 9.62 | 3.15e-15 | 1.83e-13 | 18 |
GO:0032392 | GO:0032392 | DNA geometric change | 18/752 | 23/8135 | 8.47 | 4.34e-15 | 2.48e-13 | 23 |
GO:0090068 | GO:0090068 | positive regulation of cell cycle process | 41/752 | 116/8135 | 3.82 | 7.02e-15 | 3.96e-13 | 116 |
GO:0033044 | GO:0033044 | regulation of chromosome organization | 37/752 | 97/8135 | 4.13 | 9.12e-15 | 5.07e-13 | 97 |
GO:1902099 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 17/752 | 21/8135 | 8.76 | 9.32e-15 | 5.11e-13 | 21 |
GO:0045787 | GO:0045787 | positive regulation of cell cycle | 50/752 | 166/8135 | 3.26 | 1.18e-14 | 6.38e-13 | 166 |
GO:0045839 | GO:0045839 | negative regulation of mitotic nuclear division | 18/752 | 24/8135 | 8.11 | 1.59e-14 | 8.44e-13 | 24 |
GO:0010389 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 25/752 | 47/8135 | 5.75 | 1.98e-14 | 1.04e-12 | 47 |
GO:1903046 | GO:1903046 | meiotic cell cycle process | 39/752 | 112/8135 | 3.77 | 5.70e-14 | 2.95e-12 | 112 |
GO:0032508 | GO:0032508 | DNA duplex unwinding | 16/752 | 20/8135 | 8.65 | 8.33e-14 | 4.26e-12 | 20 |
GO:0051784 | GO:0051784 | negative regulation of nuclear division | 19/752 | 29/8135 | 7.09 | 1.49e-13 | 7.51e-12 | 29 |
GO:0006325 | GO:0006325 | chromatin organization | 63/752 | 261/8135 | 2.61 | 3.79e-13 | 1.88e-11 | 261 |
GO:0008608 | GO:0008608 | attachment of spindle microtubules to kinetochore | 13/752 | 14/8135 | 10.00 | 4.20e-13 | 2.06e-11 | 14 |
GO:0033043 | GO:0033043 | regulation of organelle organization | 92/752 | 467/8135 | 2.13 | 6.01e-13 | 2.91e-11 | 467 |
GO:0051310 | GO:0051310 | metaphase plate congression | 15/752 | 19/8135 | 8.54 | 7.35e-13 | 3.52e-11 | 19 |
GO:0140013 | GO:0140013 | meiotic nuclear division | 36/752 | 107/8135 | 3.64 | 1.76e-12 | 8.32e-11 | 107 |
GO:0000910 | GO:0000910 | cytokinesis | 25/752 | 55/8135 | 4.92 | 2.01e-12 | 9.37e-11 | 55 |
GO:0007094 | GO:0007094 | mitotic spindle assembly checkpoint | 13/752 | 15/8135 | 9.38 | 2.88e-12 | 1.25e-10 | 15 |
GO:0031577 | GO:0031577 | spindle checkpoint | 13/752 | 15/8135 | 9.38 | 2.88e-12 | 1.25e-10 | 15 |
GO:0045841 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 13/752 | 15/8135 | 9.38 | 2.88e-12 | 1.25e-10 | 15 |
GO:0071173 | GO:0071173 | spindle assembly checkpoint | 13/752 | 15/8135 | 9.38 | 2.88e-12 | 1.25e-10 | 15 |
GO:0071174 | GO:0071174 | mitotic spindle checkpoint | 13/752 | 15/8135 | 9.38 | 2.88e-12 | 1.25e-10 | 15 |
GO:1902100 | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 13/752 | 15/8135 | 9.38 | 2.88e-12 | 1.25e-10 | 15 |
GO:0006323 | GO:0006323 | DNA packaging | 34/752 | 100/8135 | 3.68 | 5.26e-12 | 2.26e-10 | 100 |
GO:0000226 | GO:0000226 | microtubule cytoskeleton organization | 55/752 | 224/8135 | 2.66 | 6.17e-12 | 2.62e-10 | 224 |
GO:0007017 | GO:0007017 | microtubule-based process | 66/752 | 298/8135 | 2.40 | 7.04e-12 | 2.96e-10 | 298 |
GO:0000077 | GO:0000077 | DNA damage checkpoint | 20/752 | 38/8135 | 5.69 | 1.10e-11 | 4.57e-10 | 38 |
GO:0007080 | GO:0007080 | mitotic metaphase plate congression | 12/752 | 14/8135 | 9.27 | 2.74e-11 | 1.13e-09 | 14 |
GO:0071459 | GO:0071459 | protein localization to chromosome, centromeric region | 10/752 | 10/8135 | 10.80 | 4.31e-11 | 1.74e-09 | 10 |
GO:0031145 | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 11/752 | 12/8135 | 9.92 | 4.33e-11 | 1.74e-09 | 12 |
GO:0044774 | GO:0044774 | mitotic DNA integrity checkpoint | 18/752 | 33/8135 | 5.90 | 5.47e-11 | 2.17e-09 | 33 |
GO:0010639 | GO:0010639 | negative regulation of organelle organization | 40/752 | 143/8135 | 3.03 | 7.43e-11 | 2.93e-09 | 143 |
GO:0065004 | GO:0065004 | protein-DNA complex assembly | 32/752 | 98/8135 | 3.53 | 7.54e-11 | 2.94e-09 | 98 |
GO:0071824 | GO:0071824 | protein-DNA complex subunit organization | 34/752 | 109/8135 | 3.37 | 7.92e-11 | 3.06e-09 | 109 |
GO:1901989 | GO:1901989 | positive regulation of cell cycle phase transition | 20/752 | 42/8135 | 5.15 | 1.18e-10 | 4.45e-09 | 42 |
GO:0034508 | GO:0034508 | centromere complex assembly | 16/752 | 27/8135 | 6.41 | 1.20e-10 | 4.45e-09 | 27 |
GO:0050000 | GO:0050000 | chromosome localization | 16/752 | 27/8135 | 6.41 | 1.20e-10 | 4.45e-09 | 27 |
GO:0051303 | GO:0051303 | establishment of chromosome localization | 16/752 | 27/8135 | 6.41 | 1.20e-10 | 4.45e-09 | 27 |
GO:0006270 | GO:0006270 | DNA replication initiation | 12/752 | 15/8135 | 8.65 | 1.26e-10 | 4.61e-09 | 15 |
GO:0000281 | GO:0000281 | mitotic cytokinesis | 16/752 | 28/8135 | 6.18 | 2.57e-10 | 9.33e-09 | 28 |
GO:0051052 | GO:0051052 | regulation of DNA metabolic process | 37/752 | 131/8135 | 3.06 | 2.86e-10 | 1.03e-08 | 131 |
GO:0072401 | GO:0072401 | signal transduction involved in DNA integrity checkpoint | 14/752 | 22/8135 | 6.88 | 4.69e-10 | 1.66e-08 | 22 |
GO:0072422 | GO:0072422 | signal transduction involved in DNA damage checkpoint | 14/752 | 22/8135 | 6.88 | 4.69e-10 | 1.66e-08 | 22 |
GO:0051225 | GO:0051225 | spindle assembly | 16/752 | 29/8135 | 5.97 | 5.24e-10 | 1.83e-08 | 29 |
GO:0072395 | GO:0072395 | signal transduction involved in cell cycle checkpoint | 14/752 | 23/8135 | 6.58 | 1.10e-09 | 3.79e-08 | 23 |
GO:0044786 | GO:0044786 | cell cycle DNA replication | 11/752 | 14/8135 | 8.50 | 1.10e-09 | 3.79e-08 | 14 |
GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 17/752 | 34/8135 | 5.41 | 1.14e-09 | 3.88e-08 | 34 |
GO:0090307 | GO:0090307 | mitotic spindle assembly | 13/752 | 20/8135 | 7.03 | 1.37e-09 | 4.62e-08 | 20 |
GO:0007062 | GO:0007062 | sister chromatid cohesion | 12/752 | 17/8135 | 7.64 | 1.43e-09 | 4.80e-08 | 17 |
GO:0042770 | GO:0042770 | signal transduction in response to DNA damage | 19/752 | 43/8135 | 4.78 | 1.70e-09 | 5.64e-08 | 43 |
GO:1901992 | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 17/752 | 35/8135 | 5.25 | 2.03e-09 | 6.66e-08 | 35 |
GO:0006336 | GO:0006336 | DNA replication-independent nucleosome assembly | 14/752 | 24/8135 | 6.31 | 2.41e-09 | 7.79e-08 | 24 |
GO:0034724 | GO:0034724 | DNA replication-independent nucleosome organization | 14/752 | 24/8135 | 6.31 | 2.41e-09 | 7.79e-08 | 24 |
GO:1902750 | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 13/752 | 21/8135 | 6.70 | 3.29e-09 | 1.05e-07 | 21 |
GO:0007098 | GO:0007098 | centrosome cycle | 16/752 | 32/8135 | 5.41 | 3.55e-09 | 1.13e-07 | 32 |
GO:0031497 | GO:0031497 | chromatin assembly | 27/752 | 85/8135 | 3.44 | 4.61e-09 | 1.45e-07 | 85 |
GO:0031055 | GO:0031055 | chromatin remodeling at centromere | 14/752 | 25/8135 | 6.06 | 5.02e-09 | 1.57e-07 | 25 |
GO:0061982 | GO:0061982 | meiosis I cell cycle process | 25/752 | 75/8135 | 3.61 | 5.66e-09 | 1.75e-07 | 75 |
GO:0006275 | GO:0006275 | regulation of DNA replication | 16/752 | 33/8135 | 5.25 | 6.31e-09 | 1.94e-07 | 33 |
GO:0034728 | GO:0034728 | nucleosome organization | 27/752 | 87/8135 | 3.36 | 8.13e-09 | 2.48e-07 | 87 |
GO:0072331 | GO:0072331 | signal transduction by p53 class mediator | 24/752 | 71/8135 | 3.66 | 8.35e-09 | 2.52e-07 | 71 |
GO:0045931 | GO:0045931 | positive regulation of mitotic cell cycle | 23/752 | 66/8135 | 3.77 | 8.78e-09 | 2.63e-07 | 66 |
GO:0006334 | GO:0006334 | nucleosome assembly | 25/752 | 77/8135 | 3.51 | 1.04e-08 | 3.11e-07 | 77 |
GO:0034080 | GO:0034080 | CENP-A containing nucleosome assembly | 13/752 | 23/8135 | 6.11 | 1.55e-08 | 4.55e-07 | 23 |
GO:0061641 | GO:0061641 | CENP-A containing chromatin organization | 13/752 | 23/8135 | 6.11 | 1.55e-08 | 4.55e-07 | 23 |
GO:0045132 | GO:0045132 | meiotic chromosome segregation | 20/752 | 53/8135 | 4.08 | 1.73e-08 | 5.03e-07 | 53 |
GO:0006333 | GO:0006333 | chromatin assembly or disassembly | 27/752 | 90/8135 | 3.25 | 1.84e-08 | 5.30e-07 | 90 |
GO:0043486 | GO:0043486 | histone exchange | 14/752 | 27/8135 | 5.61 | 1.89e-08 | 5.42e-07 | 27 |
GO:0043161 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 25/752 | 81/8135 | 3.34 | 3.30e-08 | 9.38e-07 | 81 |
GO:0006511 | GO:0006511 | ubiquitin-dependent protein catabolic process | 32/752 | 123/8135 | 2.81 | 4.10e-08 | 1.16e-06 | 123 |
GO:0032200 | GO:0032200 | telomere organization | 18/752 | 46/8135 | 4.23 | 4.66e-08 | 1.30e-06 | 46 |
GO:0031023 | GO:0031023 | microtubule organizing center organization | 16/752 | 37/8135 | 4.68 | 4.88e-08 | 1.36e-06 | 37 |
GO:0019941 | GO:0019941 | modification-dependent protein catabolic process | 32/752 | 124/8135 | 2.79 | 5.06e-08 | 1.39e-06 | 124 |
GO:0007127 | GO:0007127 | meiosis I | 23/752 | 72/8135 | 3.46 | 5.73e-08 | 1.57e-06 | 72 |
GO:0043044 | GO:0043044 | ATP-dependent chromatin remodeling | 14/752 | 29/8135 | 5.22 | 6.13e-08 | 1.66e-06 | 29 |
GO:0044773 | GO:0044773 | mitotic DNA damage checkpoint | 14/752 | 29/8135 | 5.22 | 6.13e-08 | 1.66e-06 | 29 |
GO:0043632 | GO:0043632 | modification-dependent macromolecule catabolic process | 32/752 | 125/8135 | 2.77 | 6.21e-08 | 1.66e-06 | 125 |
GO:0000083 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 9/752 | 12/8135 | 8.11 | 8.02e-08 | 2.12e-06 | 12 |
GO:0033260 | GO:0033260 | nuclear DNA replication | 9/752 | 12/8135 | 8.11 | 8.02e-08 | 2.12e-06 | 12 |
GO:0033365 | GO:0033365 | protein localization to organelle | 45/752 | 216/8135 | 2.25 | 1.23e-07 | 3.22e-06 | 216 |
GO:0006338 | GO:0006338 | chromatin remodeling | 20/752 | 59/8135 | 3.67 | 1.40e-07 | 3.64e-06 | 59 |
GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 18/752 | 49/8135 | 3.97 | 1.46e-07 | 3.78e-06 | 49 |
GO:0032465 | GO:0032465 | regulation of cytokinesis | 14/752 | 31/8135 | 4.89 | 1.76e-07 | 4.52e-06 | 31 |
GO:2000779 | GO:2000779 | regulation of double-strand break repair | 12/752 | 23/8135 | 5.64 | 1.85e-07 | 4.73e-06 | 23 |
GO:0051054 | GO:0051054 | positive regulation of DNA metabolic process | 22/752 | 71/8135 | 3.35 | 2.04e-07 | 5.18e-06 | 71 |
GO:0010498 | GO:0010498 | proteasomal protein catabolic process | 26/752 | 94/8135 | 2.99 | 2.07e-07 | 5.22e-06 | 94 |
GO:0030330 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 15/752 | 36/8135 | 4.51 | 2.34e-07 | 5.86e-06 | 36 |
GO:0006282 | GO:0006282 | regulation of DNA repair | 15/752 | 37/8135 | 4.39 | 3.60e-07 | 8.96e-06 | 37 |
GO:0000079 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 16/752 | 42/8135 | 4.12 | 4.05e-07 | 1.00e-05 | 42 |
GO:0006890 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:0006977 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:0010569 | GO:0010569 | regulation of double-strand break repair via homologous recombination | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:0010972 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:0072413 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:0072431 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:1902400 | GO:1902400 | intracellular signal transduction involved in G1 DNA damage checkpoint | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:1902402 | GO:1902402 | signal transduction involved in mitotic DNA damage checkpoint | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:1902403 | GO:1902403 | signal transduction involved in mitotic DNA integrity checkpoint | 10/752 | 17/8135 | 6.36 | 4.58e-07 | 1.07e-05 | 17 |
GO:2000045 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 17/752 | 48/8135 | 3.83 | 5.97e-07 | 1.38e-05 | 48 |
GO:0090329 | GO:0090329 | regulation of DNA-dependent DNA replication | 9/752 | 14/8135 | 6.95 | 6.15e-07 | 1.42e-05 | 14 |
GO:0045738 | GO:0045738 | negative regulation of DNA repair | 8/752 | 11/8135 | 7.87 | 6.59e-07 | 1.49e-05 | 11 |
GO:0070316 | GO:0070316 | regulation of G0 to G1 transition | 8/752 | 11/8135 | 7.87 | 6.59e-07 | 1.49e-05 | 11 |
GO:2000780 | GO:2000780 | negative regulation of double-strand break repair | 8/752 | 11/8135 | 7.87 | 6.59e-07 | 1.49e-05 | 11 |
GO:1902806 | GO:1902806 | regulation of cell cycle G1/S phase transition | 18/752 | 54/8135 | 3.61 | 7.86e-07 | 1.76e-05 | 54 |
GO:0051603 | GO:0051603 | proteolysis involved in cellular protein catabolic process | 34/752 | 152/8135 | 2.42 | 7.89e-07 | 1.76e-05 | 152 |
GO:0044257 | GO:0044257 | cellular protein catabolic process | 36/752 | 166/8135 | 2.35 | 8.30e-07 | 1.85e-05 | 166 |
GO:0031571 | GO:0031571 | mitotic G1 DNA damage checkpoint | 10/752 | 18/8135 | 6.01 | 9.45e-07 | 2.06e-05 | 18 |
GO:0044783 | GO:0044783 | G1 DNA damage checkpoint | 10/752 | 18/8135 | 6.01 | 9.45e-07 | 2.06e-05 | 18 |
GO:0044819 | GO:0044819 | mitotic G1/S transition checkpoint | 10/752 | 18/8135 | 6.01 | 9.45e-07 | 2.06e-05 | 18 |
GO:1904029 | GO:1904029 | regulation of cyclin-dependent protein kinase activity | 16/752 | 45/8135 | 3.85 | 1.21e-06 | 2.62e-05 | 45 |
GO:0000723 | GO:0000723 | telomere maintenance | 14/752 | 36/8135 | 4.21 | 1.62e-06 | 3.50e-05 | 36 |
GO:0071158 | GO:0071158 | positive regulation of cell cycle arrest | 12/752 | 27/8135 | 4.81 | 1.68e-06 | 3.61e-05 | 27 |
GO:0071156 | GO:0071156 | regulation of cell cycle arrest | 15/752 | 41/8135 | 3.96 | 1.72e-06 | 3.66e-05 | 41 |
GO:0031572 | GO:0031572 | G2 DNA damage checkpoint | 8/752 | 12/8135 | 7.21 | 1.82e-06 | 3.82e-05 | 12 |
GO:0044818 | GO:0044818 | mitotic G2/M transition checkpoint | 8/752 | 12/8135 | 7.21 | 1.82e-06 | 3.82e-05 | 12 |
GO:0045023 | GO:0045023 | G0 to G1 transition | 8/752 | 12/8135 | 7.21 | 1.82e-06 | 3.82e-05 | 12 |
GO:0007050 | GO:0007050 | cell cycle arrest | 25/752 | 99/8135 | 2.73 | 2.27e-06 | 4.74e-05 | 99 |
GO:2001020 | GO:2001020 | regulation of response to DNA damage stimulus | 20/752 | 69/8135 | 3.14 | 2.37e-06 | 4.92e-05 | 69 |
GO:0051302 | GO:0051302 | regulation of cell division | 23/752 | 87/8135 | 2.86 | 2.46e-06 | 5.09e-05 | 87 |
GO:0006342 | GO:0006342 | chromatin silencing | 15/752 | 44/8135 | 3.69 | 4.77e-06 | 9.80e-05 | 44 |
GO:0034622 | GO:0034622 | cellular protein-containing complex assembly | 61/752 | 372/8135 | 1.77 | 5.19e-06 | 1.06e-04 | 372 |
GO:0000726 | GO:0000726 | non-recombinational repair | 11/752 | 25/8135 | 4.76 | 5.20e-06 | 1.06e-04 | 25 |
GO:0000729 | GO:0000729 | DNA double-strand break processing | 7/752 | 10/8135 | 7.57 | 5.25e-06 | 1.06e-04 | 10 |
GO:0045740 | GO:0045740 | positive regulation of DNA replication | 9/752 | 17/8135 | 5.73 | 5.78e-06 | 1.16e-04 | 17 |
GO:2001021 | GO:2001021 | negative regulation of response to DNA damage stimulus | 11/752 | 26/8135 | 4.58 | 8.26e-06 | 1.65e-04 | 26 |
GO:0070647 | GO:0070647 | protein modification by small protein conjugation or removal | 45/752 | 251/8135 | 1.94 | 9.34e-06 | 1.86e-04 | 251 |
GO:0000018 | GO:0000018 | regulation of DNA recombination | 14/752 | 41/8135 | 3.69 | 9.70e-06 | 1.92e-04 | 41 |
GO:1902751 | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 9/752 | 18/8135 | 5.41 | 1.06e-05 | 2.09e-04 | 18 |
GO:0036297 | GO:0036297 | interstrand cross-link repair | 7/752 | 11/8135 | 6.88 | 1.33e-05 | 2.60e-04 | 11 |
GO:2000134 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 12/752 | 32/8135 | 4.06 | 1.41e-05 | 2.75e-04 | 32 |
GO:0070507 | GO:0070507 | regulation of microtubule cytoskeleton organization | 18/752 | 65/8135 | 3.00 | 1.52e-05 | 2.95e-04 | 65 |
GO:0006303 | GO:0006303 | double-strand break repair via nonhomologous end joining | 10/752 | 23/8135 | 4.70 | 1.61e-05 | 3.10e-04 | 23 |
GO:0046605 | GO:0046605 | regulation of centrosome cycle | 8/752 | 15/8135 | 5.77 | 1.83e-05 | 3.52e-04 | 15 |
GO:0007131 | GO:0007131 | reciprocal meiotic recombination | 11/752 | 28/8135 | 4.25 | 1.93e-05 | 3.67e-04 | 28 |
GO:0035825 | GO:0035825 | homologous recombination | 11/752 | 28/8135 | 4.25 | 1.93e-05 | 3.67e-04 | 28 |
GO:0040029 | GO:0040029 | regulation of gene expression, epigenetic | 22/752 | 92/8135 | 2.59 | 2.32e-05 | 4.39e-04 | 92 |
GO:0051640 | GO:0051640 | organelle localization | 44/752 | 254/8135 | 1.87 | 2.85e-05 | 5.35e-04 | 254 |
GO:1902807 | GO:1902807 | negative regulation of cell cycle G1/S phase transition | 12/752 | 34/8135 | 3.82 | 2.88e-05 | 5.39e-04 | 34 |
GO:0016579 | GO:0016579 | protein deubiquitination | 16/752 | 56/8135 | 3.09 | 2.94e-05 | 5.45e-04 | 56 |
GO:0070646 | GO:0070646 | protein modification by small protein removal | 16/752 | 56/8135 | 3.09 | 2.94e-05 | 5.45e-04 | 56 |
GO:0070925 | GO:0070925 | organelle assembly | 47/752 | 279/8135 | 1.82 | 3.20e-05 | 5.90e-04 | 279 |
GO:0010971 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 8/752 | 16/8135 | 5.41 | 3.37e-05 | 6.19e-04 | 16 |
GO:0000209 | GO:0000209 | protein polyubiquitination | 18/752 | 69/8135 | 2.82 | 3.69e-05 | 6.74e-04 | 69 |
GO:0051129 | GO:0051129 | negative regulation of cellular component organization | 51/752 | 318/8135 | 1.73 | 5.73e-05 | 1.04e-03 | 318 |
GO:0051782 | GO:0051782 | negative regulation of cell division | 7/752 | 13/8135 | 5.82 | 5.85e-05 | 1.05e-03 | 13 |
GO:0045910 | GO:0045910 | negative regulation of DNA recombination | 8/752 | 17/8135 | 5.09 | 5.86e-05 | 1.05e-03 | 17 |
GO:0010638 | GO:0010638 | positive regulation of organelle organization | 38/752 | 216/8135 | 1.90 | 7.06e-05 | 1.26e-03 | 216 |
GO:0030163 | GO:0030163 | protein catabolic process | 41/752 | 242/8135 | 1.83 | 8.92e-05 | 1.59e-03 | 242 |
GO:0006284 | GO:0006284 | base-excision repair | 6/752 | 10/8135 | 6.49 | 9.28e-05 | 1.64e-03 | 10 |
GO:0045005 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity | 6/752 | 10/8135 | 6.49 | 9.28e-05 | 1.64e-03 | 10 |
GO:0030261 | GO:0030261 | chromosome condensation | 8/752 | 18/8135 | 4.81 | 9.69e-05 | 1.70e-03 | 18 |
GO:0048193 | GO:0048193 | Golgi vesicle transport | 20/752 | 87/8135 | 2.49 | 9.81e-05 | 1.72e-03 | 87 |
GO:0044380 | GO:0044380 | protein localization to cytoskeleton | 7/752 | 14/8135 | 5.41 | 1.08e-04 | 1.88e-03 | 14 |
GO:0016567 | GO:0016567 | protein ubiquitination | 35/752 | 197/8135 | 1.92 | 1.10e-04 | 1.91e-03 | 197 |
GO:0071897 | GO:0071897 | DNA biosynthetic process | 14/752 | 50/8135 | 3.03 | 1.17e-04 | 2.02e-03 | 50 |
GO:0032886 | GO:0032886 | regulation of microtubule-based process | 19/752 | 82/8135 | 2.51 | 1.30e-04 | 2.24e-03 | 82 |
GO:0080135 | GO:0080135 | regulation of cellular response to stress | 43/752 | 263/8135 | 1.77 | 1.40e-04 | 2.39e-03 | 263 |
GO:0044265 | GO:0044265 | cellular macromolecule catabolic process | 40/752 | 240/8135 | 1.80 | 1.56e-04 | 2.66e-03 | 240 |
GO:0000022 | GO:0000022 | mitotic spindle elongation | 6/752 | 11/8135 | 5.90 | 1.88e-04 | 3.18e-03 | 11 |
GO:0051231 | GO:0051231 | spindle elongation | 6/752 | 11/8135 | 5.90 | 1.88e-04 | 3.18e-03 | 11 |
GO:1903320 | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 14/752 | 54/8135 | 2.80 | 2.86e-04 | 4.81e-03 | 54 |
GO:0032446 | GO:0032446 | protein modification by small protein conjugation | 35/752 | 207/8135 | 1.83 | 3.00e-04 | 5.01e-03 | 207 |
GO:0007143 | GO:0007143 | female meiotic nuclear division | 7/752 | 16/8135 | 4.73 | 3.04e-04 | 5.07e-03 | 16 |
GO:0010822 | GO:0010822 | positive regulation of mitochondrion organization | 10/752 | 31/8135 | 3.49 | 3.14e-04 | 5.21e-03 | 31 |
GO:0072698 | GO:0072698 | protein localization to microtubule cytoskeleton | 6/752 | 12/8135 | 5.41 | 3.47e-04 | 5.73e-03 | 12 |
GO:0007569 | GO:0007569 | cell aging | 11/752 | 37/8135 | 3.22 | 3.54e-04 | 5.82e-03 | 37 |
GO:0031396 | GO:0031396 | regulation of protein ubiquitination | 13/752 | 49/8135 | 2.87 | 3.67e-04 | 6.01e-03 | 49 |
GO:0051053 | GO:0051053 | negative regulation of DNA metabolic process | 12/752 | 43/8135 | 3.02 | 3.70e-04 | 6.02e-03 | 43 |
GO:0051338 | GO:0051338 | regulation of transferase activity | 64/752 | 457/8135 | 1.51 | 4.12e-04 | 6.68e-03 | 457 |
GO:0045143 | GO:0045143 | homologous chromosome segregation | 11/752 | 38/8135 | 3.13 | 4.57e-04 | 7.39e-03 | 38 |
GO:0007018 | GO:0007018 | microtubule-based movement | 23/752 | 119/8135 | 2.09 | 4.80e-04 | 7.72e-03 | 119 |
GO:0009057 | GO:0009057 | macromolecule catabolic process | 52/752 | 356/8135 | 1.58 | 5.34e-04 | 8.55e-03 | 356 |
GO:0016569 | GO:0016569 | covalent chromatin modification | 23/752 | 120/8135 | 2.07 | 5.43e-04 | 8.66e-03 | 120 |
GO:0051445 | GO:0051445 | regulation of meiotic cell cycle | 10/752 | 33/8135 | 3.28 | 5.53e-04 | 8.78e-03 | 33 |
GO:1901796 | GO:1901796 | regulation of signal transduction by p53 class mediator | 11/752 | 39/8135 | 3.05 | 5.85e-04 | 9.25e-03 | 39 |
GO:0051298 | GO:0051298 | centrosome duplication | 6/752 | 13/8135 | 4.99 | 5.94e-04 | 9.32e-03 | 13 |
GO:0051438 | GO:0051438 | regulation of ubiquitin-protein transferase activity | 6/752 | 13/8135 | 4.99 | 5.94e-04 | 9.32e-03 | 13 |
GO:0045840 | GO:0045840 | positive regulation of mitotic nuclear division | 8/752 | 23/8135 | 3.76 | 7.15e-04 | 1.11e-02 | 23 |
GO:0016572 | GO:0016572 | histone phosphorylation | 7/752 | 18/8135 | 4.21 | 7.18e-04 | 1.11e-02 | 18 |
GO:0032467 | GO:0032467 | positive regulation of cytokinesis | 7/752 | 18/8135 | 4.21 | 7.18e-04 | 1.11e-02 | 18 |
GO:0097193 | GO:0097193 | intrinsic apoptotic signaling pathway | 21/752 | 108/8135 | 2.10 | 7.67e-04 | 1.18e-02 | 108 |
GO:0060968 | GO:0060968 | regulation of gene silencing | 13/752 | 53/8135 | 2.65 | 8.32e-04 | 1.28e-02 | 53 |
GO:0016458 | GO:0016458 | gene silencing | 18/752 | 87/8135 | 2.24 | 8.41e-04 | 1.29e-02 | 87 |
GO:0006479 | GO:0006479 | protein methylation | 11/752 | 41/8135 | 2.90 | 9.29e-04 | 1.41e-02 | 41 |
GO:0008213 | GO:0008213 | protein alkylation | 11/752 | 41/8135 | 2.90 | 9.29e-04 | 1.41e-02 | 41 |
GO:0016570 | GO:0016570 | histone modification | 22/752 | 117/8135 | 2.03 | 9.30e-04 | 1.41e-02 | 117 |
GO:0051307 | GO:0051307 | meiotic chromosome separation | 6/752 | 14/8135 | 4.64 | 9.59e-04 | 1.43e-02 | 14 |
GO:0051653 | GO:0051653 | spindle localization | 6/752 | 14/8135 | 4.64 | 9.59e-04 | 1.43e-02 | 14 |
GO:0061647 | GO:0061647 | histone H3-K9 modification | 6/752 | 14/8135 | 4.64 | 9.59e-04 | 1.43e-02 | 14 |
GO:0051256 | GO:0051256 | mitotic spindle midzone assembly | 5/752 | 10/8135 | 5.41 | 1.13e-03 | 1.68e-02 | 10 |
GO:0051567 | GO:0051567 | histone H3-K9 methylation | 5/752 | 10/8135 | 5.41 | 1.13e-03 | 1.68e-02 | 10 |
GO:0051656 | GO:0051656 | establishment of organelle localization | 33/752 | 206/8135 | 1.73 | 1.17e-03 | 1.72e-02 | 206 |
GO:0002495 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 11/752 | 43/8135 | 2.77 | 1.43e-03 | 2.09e-02 | 43 |
GO:2001252 | GO:2001252 | positive regulation of chromosome organization | 11/752 | 43/8135 | 2.77 | 1.43e-03 | 2.09e-02 | 43 |
GO:0070192 | GO:0070192 | chromosome organization involved in meiotic cell cycle | 10/752 | 37/8135 | 2.92 | 1.48e-03 | 2.16e-02 | 37 |
GO:0045739 | GO:0045739 | positive regulation of DNA repair | 7/752 | 20/8135 | 3.79 | 1.48e-03 | 2.16e-02 | 20 |
GO:0002504 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 11/752 | 44/8135 | 2.70 | 1.74e-03 | 2.52e-02 | 44 |
GO:0001824 | GO:0001824 | blastocyst development | 8/752 | 26/8135 | 3.33 | 1.77e-03 | 2.55e-02 | 26 |
GO:0045185 | GO:0045185 | maintenance of protein location | 10/752 | 38/8135 | 2.85 | 1.85e-03 | 2.64e-02 | 38 |
GO:0051651 | GO:0051651 | maintenance of location in cell | 9/752 | 32/8135 | 3.04 | 1.87e-03 | 2.67e-02 | 32 |
GO:0031062 | GO:0031062 | positive regulation of histone methylation | 5/752 | 11/8135 | 4.92 | 1.92e-03 | 2.69e-02 | 11 |
GO:0051255 | GO:0051255 | spindle midzone assembly | 5/752 | 11/8135 | 4.92 | 1.92e-03 | 2.69e-02 | 11 |
GO:0090224 | GO:0090224 | regulation of spindle organization | 5/752 | 11/8135 | 4.92 | 1.92e-03 | 2.69e-02 | 11 |
GO:0097711 | GO:0097711 | ciliary basal body-plasma membrane docking | 5/752 | 11/8135 | 4.92 | 1.92e-03 | 2.69e-02 | 11 |
GO:0090398 | GO:0090398 | cellular senescence | 7/752 | 21/8135 | 3.61 | 2.05e-03 | 2.87e-02 | 21 |
GO:0010821 | GO:0010821 | regulation of mitochondrion organization | 11/752 | 45/8135 | 2.64 | 2.12e-03 | 2.96e-02 | 45 |
GO:0090342 | GO:0090342 | regulation of cell aging | 6/752 | 16/8135 | 4.06 | 2.18e-03 | 3.02e-02 | 16 |
GO:0006027 | GO:0006027 | glycosaminoglycan catabolic process | 10/752 | 40/8135 | 2.70 | 2.80e-03 | 3.86e-02 | 40 |
GO:0019886 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 10/752 | 40/8135 | 2.70 | 2.80e-03 | 3.86e-02 | 40 |
GO:0008637 | GO:0008637 | apoptotic mitochondrial changes | 9/752 | 34/8135 | 2.86 | 2.96e-03 | 4.04e-02 | 34 |
GO:0016571 | GO:0016571 | histone methylation | 9/752 | 34/8135 | 2.86 | 2.96e-03 | 4.04e-02 | 34 |
GO:1903322 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 9/752 | 34/8135 | 2.86 | 2.96e-03 | 4.04e-02 | 34 |
GO:0051293 | GO:0051293 | establishment of spindle localization | 5/752 | 12/8135 | 4.51 | 3.04e-03 | 4.13e-02 | 12 |
GO:0007005 | GO:0007005 | mitochondrion organization | 18/752 | 98/8135 | 1.99 | 3.43e-03 | 4.64e-02 | 98 |
GO:2001022 | GO:2001022 | positive regulation of response to DNA damage stimulus | 9/752 | 35/8135 | 2.78 | 3.67e-03 | 4.92e-02 | 35 |
GO:0006335 | GO:0006335 | DNA replication-dependent nucleosome assembly | 7/752 | 23/8135 | 3.29 | 3.67e-03 | 4.92e-02 | 23 |
GO:0034723 | GO:0034723 | DNA replication-dependent nucleosome organization | 7/752 | 23/8135 | 3.29 | 3.67e-03 | 4.92e-02 | 23 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0001944 | GO:0001944 | vasculature development | 194/2060 | 417/8135 | 1.84 | 5.31e-22 | 1.76e-18 | 417 |
GO:0072358 | GO:0072358 | cardiovascular system development | 194/2060 | 422/8135 | 1.82 | 2.99e-21 | 4.94e-18 | 422 |
GO:0001568 | GO:0001568 | blood vessel development | 186/2060 | 401/8135 | 1.83 | 6.20e-21 | 6.84e-18 | 401 |
GO:0001525 | GO:0001525 | angiogenesis | 150/2060 | 306/8135 | 1.94 | 8.00e-20 | 6.34e-17 | 306 |
GO:0048514 | GO:0048514 | blood vessel morphogenesis | 169/2060 | 360/8135 | 1.85 | 9.57e-20 | 6.34e-17 | 360 |
GO:0035239 | GO:0035239 | tube morphogenesis | 213/2060 | 499/8135 | 1.69 | 1.75e-18 | 9.65e-16 | 499 |
GO:0045765 | GO:0045765 | regulation of angiogenesis | 92/2060 | 178/8135 | 2.04 | 2.38e-14 | 1.13e-11 | 178 |
GO:1901342 | GO:1901342 | regulation of vasculature development | 100/2060 | 200/8135 | 1.97 | 2.82e-14 | 1.17e-11 | 200 |
GO:0030334 | GO:0030334 | regulation of cell migration | 195/2060 | 490/8135 | 1.57 | 2.66e-13 | 9.79e-11 | 490 |
GO:0040017 | GO:0040017 | positive regulation of locomotion | 138/2060 | 319/8135 | 1.71 | 8.26e-13 | 2.73e-10 | 319 |
GO:2000147 | GO:2000147 | positive regulation of cell motility | 131/2060 | 302/8135 | 1.71 | 2.55e-12 | 7.68e-10 | 302 |
GO:0002040 | GO:0002040 | sprouting angiogenesis | 43/2060 | 65/8135 | 2.61 | 4.23e-12 | 1.17e-09 | 65 |
GO:0030335 | GO:0030335 | positive regulation of cell migration | 124/2060 | 287/8135 | 1.71 | 1.40e-11 | 3.56e-09 | 287 |
GO:0030155 | GO:0030155 | regulation of cell adhesion | 166/2060 | 419/8135 | 1.56 | 2.81e-11 | 6.64e-09 | 419 |
GO:0051272 | GO:0051272 | positive regulation of cellular component movement | 131/2060 | 311/8135 | 1.66 | 3.12e-11 | 6.87e-09 | 311 |
GO:0001935 | GO:0001935 | endothelial cell proliferation | 48/2060 | 80/8135 | 2.37 | 4.47e-11 | 9.24e-09 | 80 |
GO:0010631 | GO:0010631 | epithelial cell migration | 72/2060 | 142/8135 | 2.00 | 5.29e-11 | 1.03e-08 | 142 |
GO:0001936 | GO:0001936 | regulation of endothelial cell proliferation | 44/2060 | 71/8135 | 2.45 | 6.32e-11 | 1.16e-08 | 71 |
GO:0090132 | GO:0090132 | epithelium migration | 72/2060 | 143/8135 | 1.99 | 8.06e-11 | 1.40e-08 | 143 |
GO:0043062 | GO:0043062 | extracellular structure organization | 126/2060 | 300/8135 | 1.66 | 9.50e-11 | 1.51e-08 | 300 |
GO:0001667 | GO:0001667 | ameboidal-type cell migration | 95/2060 | 208/8135 | 1.80 | 9.58e-11 | 1.51e-08 | 208 |
GO:0043542 | GO:0043542 | endothelial cell migration | 55/2060 | 99/8135 | 2.19 | 1.15e-10 | 1.73e-08 | 99 |
GO:0032496 | GO:0032496 | response to lipopolysaccharide | 96/2060 | 213/8135 | 1.78 | 1.89e-10 | 2.72e-08 | 213 |
GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 99/2060 | 222/8135 | 1.76 | 2.04e-10 | 2.81e-08 | 222 |
GO:0030198 | GO:0030198 | extracellular matrix organization | 113/2060 | 264/8135 | 1.69 | 2.32e-10 | 3.07e-08 | 264 |
GO:1904018 | GO:1904018 | positive regulation of vasculature development | 62/2060 | 119/8135 | 2.06 | 2.77e-10 | 3.52e-08 | 119 |
GO:0090130 | GO:0090130 | tissue migration | 73/2060 | 149/8135 | 1.93 | 3.01e-10 | 3.69e-08 | 149 |
GO:0050727 | GO:0050727 | regulation of inflammatory response | 108/2060 | 251/8135 | 1.70 | 4.06e-10 | 4.80e-08 | 251 |
GO:0043534 | GO:0043534 | blood vessel endothelial cell migration | 34/2060 | 52/8135 | 2.58 | 1.23e-09 | 1.35e-07 | 52 |
GO:0051051 | GO:0051051 | negative regulation of transport | 113/2060 | 271/8135 | 1.65 | 1.52e-09 | 1.54e-07 | 271 |
GO:0031347 | GO:0031347 | regulation of defense response | 162/2060 | 425/8135 | 1.51 | 1.53e-09 | 1.54e-07 | 425 |
GO:0019216 | GO:0019216 | regulation of lipid metabolic process | 89/2060 | 200/8135 | 1.76 | 1.94e-09 | 1.88e-07 | 200 |
GO:0060326 | GO:0060326 | cell chemotaxis | 96/2060 | 221/8135 | 1.72 | 2.13e-09 | 1.94e-07 | 221 |
GO:0050673 | GO:0050673 | epithelial cell proliferation | 99/2060 | 230/8135 | 1.70 | 2.16e-09 | 1.94e-07 | 230 |
GO:0019932 | GO:0019932 | second-messenger-mediated signaling | 126/2060 | 314/8135 | 1.58 | 3.08e-09 | 2.68e-07 | 314 |
GO:0009617 | GO:0009617 | response to bacterium | 152/2060 | 398/8135 | 1.51 | 4.34e-09 | 3.68e-07 | 398 |
GO:0050678 | GO:0050678 | regulation of epithelial cell proliferation | 87/2060 | 197/8135 | 1.74 | 4.65e-09 | 3.84e-07 | 197 |
GO:0006897 | GO:0006897 | endocytosis | 139/2060 | 357/8135 | 1.54 | 4.86e-09 | 3.92e-07 | 357 |
GO:0008285 | GO:0008285 | negative regulation of cell proliferation | 150/2060 | 394/8135 | 1.50 | 7.07e-09 | 5.44e-07 | 394 |
GO:0019935 | GO:0019935 | cyclic-nucleotide-mediated signaling | 73/2060 | 158/8135 | 1.82 | 7.92e-09 | 5.86e-07 | 158 |
GO:0001501 | GO:0001501 | skeletal system development | 131/2060 | 334/8135 | 1.55 | 8.09e-09 | 5.86e-07 | 334 |
GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 86/2060 | 196/8135 | 1.73 | 8.32e-09 | 5.86e-07 | 196 |
GO:0000302 | GO:0000302 | response to reactive oxygen species | 52/2060 | 100/8135 | 2.05 | 8.33e-09 | 5.86e-07 | 100 |
GO:0071674 | GO:0071674 | mononuclear cell migration | 39/2060 | 67/8135 | 2.30 | 1.00e-08 | 6.93e-07 | 67 |
GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 93/2060 | 218/8135 | 1.68 | 1.15e-08 | 7.60e-07 | 218 |
GO:0010594 | GO:0010594 | regulation of endothelial cell migration | 42/2060 | 75/8135 | 2.21 | 1.33e-08 | 8.55e-07 | 75 |
GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 79/2060 | 177/8135 | 1.76 | 1.34e-08 | 8.55e-07 | 177 |
GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 107/2060 | 262/8135 | 1.61 | 1.62e-08 | 1.01e-06 | 262 |
GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 54/2060 | 107/8135 | 1.99 | 1.69e-08 | 1.04e-06 | 107 |
GO:0033002 | GO:0033002 | muscle cell proliferation | 60/2060 | 124/8135 | 1.91 | 2.09e-08 | 1.23e-06 | 124 |
GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 106/2060 | 260/8135 | 1.61 | 2.11e-08 | 1.23e-06 | 260 |
GO:0048659 | GO:0048659 | smooth muscle cell proliferation | 47/2060 | 89/8135 | 2.09 | 2.30e-08 | 1.31e-06 | 89 |
GO:0050679 | GO:0050679 | positive regulation of epithelial cell proliferation | 59/2060 | 122/8135 | 1.91 | 2.80e-08 | 1.52e-06 | 122 |
GO:0050867 | GO:0050867 | positive regulation of cell activation | 89/2060 | 210/8135 | 1.67 | 3.46e-08 | 1.82e-06 | 210 |
GO:0050900 | GO:0050900 | leukocyte migration | 120/2060 | 306/8135 | 1.55 | 3.54e-08 | 1.83e-06 | 306 |
GO:0019933 | GO:0019933 | cAMP-mediated signaling | 64/2060 | 137/8135 | 1.84 | 3.93e-08 | 2.00e-06 | 137 |
GO:0002042 | GO:0002042 | cell migration involved in sprouting angiogenesis | 22/2060 | 30/8135 | 2.90 | 4.52e-08 | 2.27e-06 | 30 |
GO:0048660 | GO:0048660 | regulation of smooth muscle cell proliferation | 46/2060 | 88/8135 | 2.06 | 4.89e-08 | 2.42e-06 | 88 |
GO:1901652 | GO:1901652 | response to peptide | 100/2060 | 245/8135 | 1.61 | 4.98e-08 | 2.43e-06 | 245 |
GO:0001819 | GO:0001819 | positive regulation of cytokine production | 108/2060 | 271/8135 | 1.57 | 6.51e-08 | 3.08e-06 | 271 |
GO:0097529 | GO:0097529 | myeloid leukocyte migration | 69/2060 | 154/8135 | 1.77 | 9.25e-08 | 4.31e-06 | 154 |
GO:0010632 | GO:0010632 | regulation of epithelial cell migration | 53/2060 | 109/8135 | 1.92 | 1.13e-07 | 5.20e-06 | 109 |
GO:0007204 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 95/2060 | 233/8135 | 1.61 | 1.15e-07 | 5.20e-06 | 233 |
GO:0002548 | GO:0002548 | monocyte chemotaxis | 32/2060 | 54/8135 | 2.34 | 1.19e-07 | 5.29e-06 | 54 |
GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 67/2060 | 149/8135 | 1.78 | 1.20e-07 | 5.29e-06 | 149 |
GO:0006874 | GO:0006874 | cellular calcium ion homeostasis | 120/2060 | 312/8135 | 1.52 | 1.26e-07 | 5.40e-06 | 312 |
GO:0030595 | GO:0030595 | leukocyte chemotaxis | 74/2060 | 170/8135 | 1.72 | 1.36e-07 | 5.78e-06 | 170 |
GO:0051216 | GO:0051216 | cartilage development | 66/2060 | 148/8135 | 1.76 | 2.18e-07 | 9.02e-06 | 148 |
GO:0032103 | GO:0032103 | positive regulation of response to external stimulus | 86/2060 | 208/8135 | 1.63 | 2.22e-07 | 9.07e-06 | 208 |
GO:0051480 | GO:0051480 | regulation of cytosolic calcium ion concentration | 104/2060 | 264/8135 | 1.56 | 2.26e-07 | 9.12e-06 | 264 |
GO:0062012 | GO:0062012 | regulation of small molecule metabolic process | 76/2060 | 178/8135 | 1.69 | 2.42e-07 | 9.63e-06 | 178 |
GO:0016525 | GO:0016525 | negative regulation of angiogenesis | 35/2060 | 63/8135 | 2.19 | 2.82e-07 | 1.09e-05 | 63 |
GO:0006979 | GO:0006979 | response to oxidative stress | 80/2060 | 191/8135 | 1.65 | 3.09e-07 | 1.18e-05 | 191 |
GO:0061448 | GO:0061448 | connective tissue development | 76/2060 | 179/8135 | 1.68 | 3.18e-07 | 1.18e-05 | 179 |
GO:0010565 | GO:0010565 | regulation of cellular ketone metabolic process | 38/2060 | 71/8135 | 2.11 | 3.22e-07 | 1.19e-05 | 71 |
GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 70/2060 | 162/8135 | 1.71 | 4.17e-07 | 1.50e-05 | 162 |
GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 75/2060 | 177/8135 | 1.67 | 4.18e-07 | 1.50e-05 | 177 |
GO:1903670 | GO:1903670 | regulation of sprouting angiogenesis | 24/2060 | 37/8135 | 2.56 | 4.37e-07 | 1.55e-05 | 37 |
GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 83/2060 | 202/8135 | 1.62 | 4.94e-07 | 1.74e-05 | 202 |
GO:0043434 | GO:0043434 | response to peptide hormone | 86/2060 | 212/8135 | 1.60 | 5.93e-07 | 2.07e-05 | 212 |
GO:0002250 | GO:0002250 | adaptive immune response | 104/2060 | 269/8135 | 1.53 | 6.59e-07 | 2.22e-05 | 269 |
GO:0002062 | GO:0002062 | chondrocyte differentiation | 43/2060 | 86/8135 | 1.97 | 6.71e-07 | 2.24e-05 | 86 |
GO:0050729 | GO:0050729 | positive regulation of inflammatory response | 48/2060 | 100/8135 | 1.90 | 7.24e-07 | 2.40e-05 | 100 |
GO:2000181 | GO:2000181 | negative regulation of blood vessel morphogenesis | 35/2060 | 65/8135 | 2.13 | 7.75e-07 | 2.54e-05 | 65 |
GO:0045444 | GO:0045444 | fat cell differentiation | 57/2060 | 126/8135 | 1.79 | 8.18e-07 | 2.65e-05 | 126 |
GO:0070371 | GO:0070371 | ERK1 and ERK2 cascade | 91/2060 | 229/8135 | 1.57 | 8.28e-07 | 2.66e-05 | 229 |
GO:0002685 | GO:0002685 | regulation of leukocyte migration | 59/2060 | 132/8135 | 1.77 | 8.66e-07 | 2.76e-05 | 132 |
GO:0043535 | GO:0043535 | regulation of blood vessel endothelial cell migration | 24/2060 | 38/8135 | 2.49 | 9.02e-07 | 2.84e-05 | 38 |
GO:0071346 | GO:0071346 | cellular response to interferon-gamma | 52/2060 | 112/8135 | 1.83 | 9.29e-07 | 2.90e-05 | 112 |
GO:0042180 | GO:0042180 | cellular ketone metabolic process | 48/2060 | 101/8135 | 1.88 | 1.04e-06 | 3.23e-05 | 101 |
GO:0001938 | GO:0001938 | positive regulation of endothelial cell proliferation | 30/2060 | 53/8135 | 2.24 | 1.17e-06 | 3.58e-05 | 53 |
GO:0050870 | GO:0050870 | positive regulation of T cell activation | 61/2060 | 139/8135 | 1.73 | 1.22e-06 | 3.70e-05 | 139 |
GO:0046677 | GO:0046677 | response to antibiotic | 69/2060 | 163/8135 | 1.67 | 1.26e-06 | 3.76e-05 | 163 |
GO:0072001 | GO:0072001 | renal system development | 79/2060 | 194/8135 | 1.61 | 1.42e-06 | 4.08e-05 | 194 |
GO:0001937 | GO:0001937 | negative regulation of endothelial cell proliferation | 15/2060 | 19/8135 | 3.12 | 1.44e-06 | 4.08e-05 | 19 |
GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 71/2060 | 170/8135 | 1.65 | 1.62e-06 | 4.53e-05 | 170 |
GO:0070098 | GO:0070098 | chemokine-mediated signaling pathway | 40/2060 | 80/8135 | 1.97 | 1.64e-06 | 4.56e-05 | 80 |
GO:0007517 | GO:0007517 | muscle organ development | 97/2060 | 252/8135 | 1.52 | 1.97e-06 | 5.44e-05 | 252 |
GO:0007189 | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 48/2060 | 103/8135 | 1.84 | 2.12e-06 | 5.80e-05 | 103 |
GO:0070555 | GO:0070555 | response to interleukin-1 | 43/2060 | 89/8135 | 1.91 | 2.18e-06 | 5.93e-05 | 89 |
GO:0030323 | GO:0030323 | respiratory tube development | 51/2060 | 112/8135 | 1.80 | 2.42e-06 | 6.41e-05 | 112 |
GO:0051249 | GO:0051249 | regulation of lymphocyte activation | 99/2060 | 260/8135 | 1.50 | 2.72e-06 | 7.02e-05 | 260 |
GO:0050863 | GO:0050863 | regulation of T cell activation | 81/2060 | 203/8135 | 1.58 | 2.74e-06 | 7.02e-05 | 203 |
GO:0007187 | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 80/2060 | 200/8135 | 1.58 | 2.81e-06 | 7.16e-05 | 200 |
GO:1990845 | GO:1990845 | adaptive thermogenesis | 42/2060 | 87/8135 | 1.91 | 2.94e-06 | 7.42e-05 | 87 |
GO:0010634 | GO:0010634 | positive regulation of epithelial cell migration | 38/2060 | 76/8135 | 1.97 | 2.97e-06 | 7.45e-05 | 76 |
GO:0001822 | GO:0001822 | kidney development | 74/2060 | 182/8135 | 1.61 | 3.26e-06 | 8.11e-05 | 182 |
GO:0014068 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 26/2060 | 45/8135 | 2.28 | 3.59e-06 | 8.86e-05 | 45 |
GO:0022408 | GO:0022408 | negative regulation of cell-cell adhesion | 47/2060 | 102/8135 | 1.82 | 3.99e-06 | 9.78e-05 | 102 |
GO:0031294 | GO:0031294 | lymphocyte costimulation | 23/2060 | 38/8135 | 2.39 | 4.41e-06 | 1.07e-04 | 38 |
GO:0070374 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 71/2060 | 174/8135 | 1.61 | 4.42e-06 | 1.07e-04 | 174 |
GO:0030324 | GO:0030324 | lung development | 50/2060 | 111/8135 | 1.78 | 4.45e-06 | 1.07e-04 | 111 |
GO:0046320 | GO:0046320 | regulation of fatty acid oxidation | 14/2060 | 18/8135 | 3.07 | 4.53e-06 | 1.08e-04 | 18 |
GO:0009612 | GO:0009612 | response to mechanical stimulus | 57/2060 | 132/8135 | 1.71 | 5.00e-06 | 1.17e-04 | 132 |
GO:0007188 | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 71/2060 | 175/8135 | 1.60 | 5.62e-06 | 1.29e-04 | 175 |
GO:1990868 | GO:1990868 | response to chemokine | 41/2060 | 86/8135 | 1.88 | 5.72e-06 | 1.29e-04 | 86 |
GO:1990869 | GO:1990869 | cellular response to chemokine | 41/2060 | 86/8135 | 1.88 | 5.72e-06 | 1.29e-04 | 86 |
GO:0001655 | GO:0001655 | urogenital system development | 85/2060 | 219/8135 | 1.53 | 5.78e-06 | 1.29e-04 | 219 |
GO:0070372 | GO:0070372 | regulation of ERK1 and ERK2 cascade | 85/2060 | 219/8135 | 1.53 | 5.78e-06 | 1.29e-04 | 219 |
GO:0019217 | GO:0019217 | regulation of fatty acid metabolic process | 26/2060 | 46/8135 | 2.23 | 6.27e-06 | 1.39e-04 | 46 |
GO:0046890 | GO:0046890 | regulation of lipid biosynthetic process | 43/2060 | 92/8135 | 1.85 | 6.48e-06 | 1.43e-04 | 92 |
GO:0050663 | GO:0050663 | cytokine secretion | 61/2060 | 145/8135 | 1.66 | 6.55e-06 | 1.43e-04 | 145 |
GO:0002822 | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 44/2060 | 95/8135 | 1.83 | 6.82e-06 | 1.48e-04 | 95 |
GO:0001659 | GO:0001659 | temperature homeostasis | 46/2060 | 101/8135 | 1.80 | 7.42e-06 | 1.59e-04 | 101 |
GO:0034614 | GO:0034614 | cellular response to reactive oxygen species | 32/2060 | 62/8135 | 2.04 | 7.59e-06 | 1.61e-04 | 62 |
GO:0050920 | GO:0050920 | regulation of chemotaxis | 61/2060 | 146/8135 | 1.65 | 8.51e-06 | 1.77e-04 | 146 |
GO:1903672 | GO:1903672 | positive regulation of sprouting angiogenesis | 17/2060 | 25/8135 | 2.69 | 8.57e-06 | 1.77e-04 | 25 |
GO:0002699 | GO:0002699 | positive regulation of immune effector process | 59/2060 | 140/8135 | 1.66 | 8.66e-06 | 1.77e-04 | 140 |
GO:0060541 | GO:0060541 | respiratory system development | 55/2060 | 128/8135 | 1.70 | 8.72e-06 | 1.77e-04 | 128 |
GO:0071347 | GO:0071347 | cellular response to interleukin-1 | 37/2060 | 76/8135 | 1.92 | 8.85e-06 | 1.79e-04 | 76 |
GO:0036293 | GO:0036293 | response to decreased oxygen levels | 69/2060 | 171/8135 | 1.59 | 9.47e-06 | 1.89e-04 | 171 |
GO:0010595 | GO:0010595 | positive regulation of endothelial cell migration | 28/2060 | 52/8135 | 2.13 | 9.84e-06 | 1.95e-04 | 52 |
GO:0046460 | GO:0046460 | neutral lipid biosynthetic process | 16/2060 | 23/8135 | 2.75 | 1.02e-05 | 1.99e-04 | 23 |
GO:0046463 | GO:0046463 | acylglycerol biosynthetic process | 16/2060 | 23/8135 | 2.75 | 1.02e-05 | 1.99e-04 | 23 |
GO:0014065 | GO:0014065 | phosphatidylinositol 3-kinase signaling | 39/2060 | 82/8135 | 1.88 | 1.03e-05 | 2.01e-04 | 82 |
GO:0002819 | GO:0002819 | regulation of adaptive immune response | 47/2060 | 105/8135 | 1.77 | 1.05e-05 | 2.04e-04 | 105 |
GO:0031295 | GO:0031295 | T cell costimulation | 22/2060 | 37/8135 | 2.35 | 1.07e-05 | 2.06e-04 | 37 |
GO:0034612 | GO:0034612 | response to tumor necrosis factor | 62/2060 | 150/8135 | 1.63 | 1.09e-05 | 2.07e-04 | 150 |
GO:2001057 | GO:2001057 | reactive nitrogen species metabolic process | 24/2060 | 42/8135 | 2.26 | 1.11e-05 | 2.09e-04 | 42 |
GO:0071356 | GO:0071356 | cellular response to tumor necrosis factor | 59/2060 | 141/8135 | 1.65 | 1.13e-05 | 2.12e-04 | 141 |
GO:0034341 | GO:0034341 | response to interferon-gamma | 54/2060 | 126/8135 | 1.69 | 1.15e-05 | 2.15e-04 | 126 |
GO:0019432 | GO:0019432 | triglyceride biosynthetic process | 15/2060 | 21/8135 | 2.82 | 1.18e-05 | 2.19e-04 | 21 |
GO:0002824 | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 33/2060 | 66/8135 | 1.97 | 1.32e-05 | 2.44e-04 | 66 |
GO:0042542 | GO:0042542 | response to hydrogen peroxide | 30/2060 | 58/8135 | 2.04 | 1.38e-05 | 2.50e-04 | 58 |
GO:0048662 | GO:0048662 | negative regulation of smooth muscle cell proliferation | 21/2060 | 35/8135 | 2.37 | 1.40e-05 | 2.52e-04 | 35 |
GO:0051048 | GO:0051048 | negative regulation of secretion | 60/2060 | 145/8135 | 1.63 | 1.44e-05 | 2.58e-04 | 145 |
GO:0002708 | GO:0002708 | positive regulation of lymphocyte mediated immunity | 34/2060 | 69/8135 | 1.95 | 1.46e-05 | 2.61e-04 | 69 |
GO:0062013 | GO:0062013 | positive regulation of small molecule metabolic process | 40/2060 | 86/8135 | 1.84 | 1.56e-05 | 2.76e-04 | 86 |
GO:0001101 | GO:0001101 | response to acid chemical | 78/2060 | 202/8135 | 1.52 | 1.73e-05 | 2.99e-04 | 202 |
GO:0070482 | GO:0070482 | response to oxygen levels | 71/2060 | 180/8135 | 1.56 | 1.78e-05 | 3.06e-04 | 180 |
GO:0072593 | GO:0072593 | reactive oxygen species metabolic process | 59/2060 | 143/8135 | 1.63 | 1.88e-05 | 3.21e-04 | 143 |
GO:0001666 | GO:0001666 | response to hypoxia | 67/2060 | 168/8135 | 1.57 | 2.00e-05 | 3.36e-04 | 168 |
GO:0001818 | GO:0001818 | negative regulation of cytokine production | 66/2060 | 165/8135 | 1.58 | 2.06e-05 | 3.44e-04 | 165 |
GO:0003158 | GO:0003158 | endothelium development | 30/2060 | 59/8135 | 2.01 | 2.13e-05 | 3.52e-04 | 59 |
GO:0045834 | GO:0045834 | positive regulation of lipid metabolic process | 40/2060 | 87/8135 | 1.82 | 2.19e-05 | 3.61e-04 | 87 |
GO:1901343 | GO:1901343 | negative regulation of vasculature development | 35/2060 | 73/8135 | 1.89 | 2.34e-05 | 3.82e-04 | 73 |
GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 36/2060 | 76/8135 | 1.87 | 2.51e-05 | 4.05e-04 | 76 |
GO:0071229 | GO:0071229 | cellular response to acid chemical | 55/2060 | 132/8135 | 1.65 | 2.56e-05 | 4.11e-04 | 132 |
GO:0042129 | GO:0042129 | regulation of T cell proliferation | 47/2060 | 108/8135 | 1.72 | 2.60e-05 | 4.12e-04 | 108 |
GO:1903531 | GO:1903531 | negative regulation of secretion by cell | 52/2060 | 123/8135 | 1.67 | 2.62e-05 | 4.12e-04 | 123 |
GO:0034599 | GO:0034599 | cellular response to oxidative stress | 49/2060 | 114/8135 | 1.70 | 2.63e-05 | 4.12e-04 | 114 |
GO:0003018 | GO:0003018 | vascular process in circulatory system | 50/2060 | 117/8135 | 1.69 | 2.64e-05 | 4.12e-04 | 117 |
GO:0106106 | GO:0106106 | cold-induced thermogenesis | 38/2060 | 82/8135 | 1.83 | 2.81e-05 | 4.32e-04 | 82 |
GO:0120161 | GO:0120161 | regulation of cold-induced thermogenesis | 38/2060 | 82/8135 | 1.83 | 2.81e-05 | 4.32e-04 | 82 |
GO:0051224 | GO:0051224 | negative regulation of protein transport | 42/2060 | 94/8135 | 1.76 | 3.23e-05 | 4.95e-04 | 94 |
GO:0016051 | GO:0016051 | carbohydrate biosynthetic process | 44/2060 | 100/8135 | 1.74 | 3.36e-05 | 5.11e-04 | 100 |
GO:0090049 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 14/2060 | 20/8135 | 2.76 | 3.37e-05 | 5.11e-04 | 20 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 45/2060 | 103/8135 | 1.73 | 3.41e-05 | 5.15e-04 | 103 |
GO:0097530 | GO:0097530 | granulocyte migration | 48/2060 | 112/8135 | 1.69 | 3.48e-05 | 5.23e-04 | 112 |
GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 63/2060 | 158/8135 | 1.57 | 3.53e-05 | 5.29e-04 | 158 |
GO:0014066 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | 31/2060 | 63/8135 | 1.94 | 3.59e-05 | 5.33e-04 | 63 |
GO:0030258 | GO:0030258 | lipid modification | 61/2060 | 152/8135 | 1.58 | 3.72e-05 | 5.50e-04 | 152 |
GO:0032642 | GO:0032642 | regulation of chemokine production | 28/2060 | 55/8135 | 2.01 | 3.88e-05 | 5.69e-04 | 55 |
GO:0002021 | GO:0002021 | response to dietary excess | 13/2060 | 18/8135 | 2.85 | 3.88e-05 | 5.69e-04 | 18 |
GO:0032768 | GO:0032768 | regulation of monooxygenase activity | 17/2060 | 27/8135 | 2.49 | 3.90e-05 | 5.69e-04 | 27 |
GO:0002821 | GO:0002821 | positive regulation of adaptive immune response | 33/2060 | 69/8135 | 1.89 | 4.24e-05 | 6.07e-04 | 69 |
GO:0060191 | GO:0060191 | regulation of lipase activity | 33/2060 | 69/8135 | 1.89 | 4.24e-05 | 6.07e-04 | 69 |
GO:1904950 | GO:1904950 | negative regulation of establishment of protein localization | 42/2060 | 95/8135 | 1.75 | 4.40e-05 | 6.27e-04 | 95 |
GO:0002711 | GO:0002711 | positive regulation of T cell mediated immunity | 19/2060 | 32/8135 | 2.34 | 4.44e-05 | 6.30e-04 | 32 |
GO:0002706 | GO:0002706 | regulation of lymphocyte mediated immunity | 43/2060 | 98/8135 | 1.73 | 4.47e-05 | 6.32e-04 | 98 |
GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 60/2060 | 150/8135 | 1.58 | 4.82e-05 | 6.76e-04 | 150 |
GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 37/2060 | 81/8135 | 1.80 | 5.25e-05 | 7.25e-04 | 81 |
GO:0060759 | GO:0060759 | regulation of response to cytokine stimulus | 37/2060 | 81/8135 | 1.80 | 5.25e-05 | 7.25e-04 | 81 |
GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 39/2060 | 87/8135 | 1.77 | 5.60e-05 | 7.69e-04 | 87 |
GO:0051591 | GO:0051591 | response to cAMP | 32/2060 | 67/8135 | 1.89 | 5.71e-05 | 7.75e-04 | 67 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 40/2060 | 90/8135 | 1.76 | 5.73e-05 | 7.75e-04 | 90 |
GO:0034440 | GO:0034440 | lipid oxidation | 22/2060 | 40/8135 | 2.17 | 5.74e-05 | 7.75e-04 | 40 |
GO:0046209 | GO:0046209 | nitric oxide metabolic process | 22/2060 | 40/8135 | 2.17 | 5.74e-05 | 7.75e-04 | 40 |
GO:0010863 | GO:0010863 | positive regulation of phospholipase C activity | 20/2060 | 35/8135 | 2.26 | 6.01e-05 | 8.07e-04 | 35 |
GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 44/2060 | 102/8135 | 1.70 | 6.03e-05 | 8.07e-04 | 102 |
GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 60/2060 | 151/8135 | 1.57 | 6.06e-05 | 8.08e-04 | 151 |
GO:0060419 | GO:0060419 | heart growth | 29/2060 | 59/8135 | 1.94 | 6.53e-05 | 8.61e-04 | 59 |
GO:0070542 | GO:0070542 | response to fatty acid | 29/2060 | 59/8135 | 1.94 | 6.53e-05 | 8.61e-04 | 59 |
GO:0001570 | GO:0001570 | vasculogenesis | 23/2060 | 43/8135 | 2.11 | 7.01e-05 | 9.17e-04 | 43 |
GO:0002705 | GO:0002705 | positive regulation of leukocyte mediated immunity | 38/2060 | 85/8135 | 1.77 | 7.47e-05 | 9.73e-04 | 85 |
GO:0002367 | GO:0002367 | cytokine production involved in immune response | 31/2060 | 65/8135 | 1.88 | 7.68e-05 | 9.90e-04 | 65 |
GO:0006809 | GO:0006809 | nitric oxide biosynthetic process | 21/2060 | 38/8135 | 2.18 | 7.70e-05 | 9.90e-04 | 38 |
GO:0019915 | GO:0019915 | lipid storage | 21/2060 | 38/8135 | 2.18 | 7.70e-05 | 9.90e-04 | 38 |
GO:0010596 | GO:0010596 | negative regulation of endothelial cell migration | 14/2060 | 21/8135 | 2.63 | 7.75e-05 | 9.90e-04 | 21 |
GO:0048008 | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 14/2060 | 21/8135 | 2.63 | 7.75e-05 | 9.90e-04 | 21 |
GO:0097237 | GO:0097237 | cellular response to toxic substance | 48/2060 | 115/8135 | 1.65 | 7.80e-05 | 9.93e-04 | 115 |
GO:0010517 | GO:0010517 | regulation of phospholipase activity | 27/2060 | 54/8135 | 1.97 | 7.96e-05 | 1.00e-03 | 54 |
GO:1904659 | GO:1904659 | glucose transmembrane transport | 27/2060 | 54/8135 | 1.97 | 7.96e-05 | 1.00e-03 | 54 |
GO:1901215 | GO:1901215 | negative regulation of neuron death | 45/2060 | 106/8135 | 1.68 | 7.96e-05 | 1.00e-03 | 106 |
GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 44/2060 | 103/8135 | 1.69 | 7.98e-05 | 1.00e-03 | 103 |
GO:0006091 | GO:0006091 | generation of precursor metabolites and energy | 64/2060 | 165/8135 | 1.53 | 8.22e-05 | 1.03e-03 | 165 |
GO:0001701 | GO:0001701 | in utero embryonic development | 56/2060 | 140/8135 | 1.58 | 8.51e-05 | 1.05e-03 | 140 |
GO:0097305 | GO:0097305 | response to alcohol | 56/2060 | 140/8135 | 1.58 | 8.51e-05 | 1.05e-03 | 140 |
GO:0008217 | GO:0008217 | regulation of blood pressure | 53/2060 | 131/8135 | 1.60 | 9.17e-05 | 1.13e-03 | 131 |
GO:0003014 | GO:0003014 | renal system process | 35/2060 | 77/8135 | 1.80 | 9.40e-05 | 1.15e-03 | 77 |
GO:0006112 | GO:0006112 | energy reserve metabolic process | 22/2060 | 41/8135 | 2.12 | 9.45e-05 | 1.15e-03 | 41 |
GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 51/2060 | 125/8135 | 1.61 | 9.58e-05 | 1.17e-03 | 125 |
GO:0032602 | GO:0032602 | chemokine production | 29/2060 | 60/8135 | 1.91 | 9.61e-05 | 1.17e-03 | 60 |
GO:0007202 | GO:0007202 | activation of phospholipase C activity | 16/2060 | 26/8135 | 2.43 | 9.87e-05 | 1.19e-03 | 26 |
GO:0002792 | GO:0002792 | negative regulation of peptide secretion | 37/2060 | 83/8135 | 1.76 | 9.96e-05 | 1.20e-03 | 83 |
GO:0043491 | GO:0043491 | protein kinase B signaling | 58/2060 | 147/8135 | 1.56 | 1.01e-04 | 1.21e-03 | 147 |
GO:0043112 | GO:0043112 | receptor metabolic process | 38/2060 | 86/8135 | 1.74 | 1.02e-04 | 1.21e-03 | 86 |
GO:1900274 | GO:1900274 | regulation of phospholipase C activity | 20/2060 | 36/8135 | 2.19 | 1.03e-04 | 1.23e-03 | 36 |
GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 40/2060 | 92/8135 | 1.72 | 1.04e-04 | 1.24e-03 | 92 |
GO:0048015 | GO:0048015 | phosphatidylinositol-mediated signaling | 42/2060 | 98/8135 | 1.69 | 1.05e-04 | 1.24e-03 | 98 |
GO:0045428 | GO:0045428 | regulation of nitric oxide biosynthetic process | 18/2060 | 31/8135 | 2.29 | 1.06e-04 | 1.24e-03 | 31 |
GO:0045446 | GO:0045446 | endothelial cell differentiation | 26/2060 | 52/8135 | 1.97 | 1.08e-04 | 1.26e-03 | 52 |
GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 52/2060 | 129/8135 | 1.59 | 1.19e-04 | 1.38e-03 | 129 |
GO:0050707 | GO:0050707 | regulation of cytokine secretion | 52/2060 | 129/8135 | 1.59 | 1.19e-04 | 1.38e-03 | 129 |
GO:1903038 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 34/2060 | 75/8135 | 1.79 | 1.26e-04 | 1.45e-03 | 75 |
GO:0042098 | GO:0042098 | T cell proliferation | 49/2060 | 120/8135 | 1.61 | 1.27e-04 | 1.46e-03 | 120 |
GO:0007190 | GO:0007190 | activation of adenylate cyclase activity | 15/2060 | 24/8135 | 2.47 | 1.28e-04 | 1.46e-03 | 24 |
GO:0034694 | GO:0034694 | response to prostaglandin | 15/2060 | 24/8135 | 2.47 | 1.28e-04 | 1.46e-03 | 24 |
GO:0031348 | GO:0031348 | negative regulation of defense response | 48/2060 | 117/8135 | 1.62 | 1.30e-04 | 1.47e-03 | 117 |
GO:0008645 | GO:0008645 | hexose transmembrane transport | 28/2060 | 58/8135 | 1.91 | 1.30e-04 | 1.47e-03 | 58 |
GO:1905476 | GO:1905476 | negative regulation of protein localization to membrane | 9/2060 | 11/8135 | 3.23 | 1.39e-04 | 1.55e-03 | 11 |
GO:1990266 | GO:1990266 | neutrophil migration | 41/2060 | 96/8135 | 1.69 | 1.39e-04 | 1.55e-03 | 96 |
GO:0120162 | GO:0120162 | positive regulation of cold-induced thermogenesis | 29/2060 | 61/8135 | 1.88 | 1.39e-04 | 1.55e-03 | 61 |
GO:0051580 | GO:0051580 | regulation of neurotransmitter uptake | 10/2060 | 13/8135 | 3.04 | 1.40e-04 | 1.55e-03 | 13 |
GO:0030336 | GO:0030336 | negative regulation of cell migration | 59/2060 | 152/8135 | 1.53 | 1.50e-04 | 1.65e-03 | 152 |
GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 52/2060 | 130/8135 | 1.58 | 1.50e-04 | 1.65e-03 | 130 |
GO:0002440 | GO:0002440 | production of molecular mediator of immune response | 47/2060 | 115/8135 | 1.61 | 1.69e-04 | 1.83e-03 | 115 |
GO:0045598 | GO:0045598 | regulation of fat cell differentiation | 34/2060 | 76/8135 | 1.77 | 1.73e-04 | 1.86e-03 | 76 |
GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 44/2060 | 106/8135 | 1.64 | 1.78e-04 | 1.91e-03 | 106 |
GO:0048017 | GO:0048017 | inositol lipid-mediated signaling | 42/2060 | 100/8135 | 1.66 | 1.81e-04 | 1.94e-03 | 100 |
GO:0009896 | GO:0009896 | positive regulation of catabolic process | 53/2060 | 134/8135 | 1.56 | 1.83e-04 | 1.96e-03 | 134 |
GO:0071675 | GO:0071675 | regulation of mononuclear cell migration | 18/2060 | 32/8135 | 2.22 | 1.85e-04 | 1.97e-03 | 32 |
GO:0043536 | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 16/2060 | 27/8135 | 2.34 | 1.86e-04 | 1.97e-03 | 27 |
GO:0015749 | GO:0015749 | monosaccharide transmembrane transport | 28/2060 | 59/8135 | 1.87 | 1.88e-04 | 1.98e-03 | 59 |
GO:0031623 | GO:0031623 | receptor internalization | 29/2060 | 62/8135 | 1.85 | 1.99e-04 | 2.09e-03 | 62 |
GO:0050886 | GO:0050886 | endocrine process | 30/2060 | 65/8135 | 1.82 | 2.09e-04 | 2.17e-03 | 65 |
GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 53/2060 | 135/8135 | 1.55 | 2.29e-04 | 2.35e-03 | 135 |
GO:0019882 | GO:0019882 | antigen processing and presentation | 36/2060 | 83/8135 | 1.71 | 2.41e-04 | 2.45e-03 | 83 |
GO:2000377 | GO:2000377 | regulation of reactive oxygen species metabolic process | 37/2060 | 86/8135 | 1.70 | 2.42e-04 | 2.46e-03 | 86 |
GO:0061756 | GO:0061756 | leukocyte adhesion to vascular endothelial cell | 15/2060 | 25/8135 | 2.37 | 2.44e-04 | 2.47e-03 | 25 |
GO:0072677 | GO:0072677 | eosinophil migration | 15/2060 | 25/8135 | 2.37 | 2.44e-04 | 2.47e-03 | 25 |
GO:0061035 | GO:0061035 | regulation of cartilage development | 23/2060 | 46/8135 | 1.97 | 2.66e-04 | 2.67e-03 | 46 |
GO:0034219 | GO:0034219 | carbohydrate transmembrane transport | 28/2060 | 60/8135 | 1.84 | 2.68e-04 | 2.68e-03 | 60 |
GO:0019395 | GO:0019395 | fatty acid oxidation | 20/2060 | 38/8135 | 2.08 | 2.77e-04 | 2.76e-03 | 38 |
GO:0008016 | GO:0008016 | regulation of heart contraction | 59/2060 | 155/8135 | 1.50 | 2.78e-04 | 2.76e-03 | 155 |
GO:0031343 | GO:0031343 | positive regulation of cell killing | 24/2060 | 49/8135 | 1.93 | 2.94e-04 | 2.85e-03 | 49 |
GO:0002703 | GO:0002703 | regulation of leukocyte mediated immunity | 52/2060 | 133/8135 | 1.54 | 2.94e-04 | 2.85e-03 | 133 |
GO:0051896 | GO:0051896 | regulation of protein kinase B signaling | 52/2060 | 133/8135 | 1.54 | 2.94e-04 | 2.85e-03 | 133 |
GO:0035150 | GO:0035150 | regulation of tube size | 43/2060 | 105/8135 | 1.62 | 2.99e-04 | 2.87e-03 | 105 |
GO:0072006 | GO:0072006 | nephron development | 43/2060 | 105/8135 | 1.62 | 2.99e-04 | 2.87e-03 | 105 |
GO:0008643 | GO:0008643 | carbohydrate transport | 32/2060 | 72/8135 | 1.76 | 3.08e-04 | 2.95e-03 | 72 |
GO:0001909 | GO:0001909 | leukocyte mediated cytotoxicity | 33/2060 | 75/8135 | 1.74 | 3.13e-04 | 2.95e-03 | 75 |
GO:0046631 | GO:0046631 | alpha-beta T cell activation | 39/2060 | 93/8135 | 1.66 | 3.16e-04 | 2.95e-03 | 93 |
GO:0046683 | GO:0046683 | response to organophosphorus | 39/2060 | 93/8135 | 1.66 | 3.16e-04 | 2.95e-03 | 93 |
GO:0001945 | GO:0001945 | lymph vessel development | 11/2060 | 16/8135 | 2.71 | 3.18e-04 | 2.95e-03 | 16 |
GO:0019883 | GO:0019883 | antigen processing and presentation of endogenous antigen | 11/2060 | 16/8135 | 2.71 | 3.18e-04 | 2.95e-03 | 16 |
GO:0071470 | GO:0071470 | cellular response to osmotic stress | 11/2060 | 16/8135 | 2.71 | 3.18e-04 | 2.95e-03 | 16 |
GO:0055017 | GO:0055017 | cardiac muscle tissue growth | 25/2060 | 52/8135 | 1.90 | 3.19e-04 | 2.95e-03 | 52 |
GO:0050728 | GO:0050728 | negative regulation of inflammatory response | 37/2060 | 87/8135 | 1.68 | 3.20e-04 | 2.95e-03 | 87 |
GO:1902930 | GO:1902930 | regulation of alcohol biosynthetic process | 21/2060 | 41/8135 | 2.02 | 3.20e-04 | 2.95e-03 | 41 |
GO:0015837 | GO:0015837 | amine transport | 36/2060 | 84/8135 | 1.69 | 3.20e-04 | 2.95e-03 | 84 |
GO:0045429 | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 14/2060 | 23/8135 | 2.40 | 3.21e-04 | 2.95e-03 | 23 |
GO:0045923 | GO:0045923 | positive regulation of fatty acid metabolic process | 14/2060 | 23/8135 | 2.40 | 3.21e-04 | 2.95e-03 | 23 |
GO:1904407 | GO:1904407 | positive regulation of nitric oxide metabolic process | 14/2060 | 23/8135 | 2.40 | 3.21e-04 | 2.95e-03 | 23 |
GO:0008206 | GO:0008206 | bile acid metabolic process | 16/2060 | 28/8135 | 2.26 | 3.32e-04 | 3.02e-03 | 28 |
GO:0048661 | GO:0048661 | positive regulation of smooth muscle cell proliferation | 26/2060 | 55/8135 | 1.87 | 3.41e-04 | 3.09e-03 | 55 |
GO:0032835 | GO:0032835 | glomerulus development | 22/2060 | 44/8135 | 1.97 | 3.61e-04 | 3.26e-03 | 44 |
GO:0050730 | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 57/2060 | 150/8135 | 1.50 | 3.68e-04 | 3.32e-03 | 150 |
GO:0090050 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 10/2060 | 14/8135 | 2.82 | 3.78e-04 | 3.40e-03 | 14 |
GO:0006694 | GO:0006694 | steroid biosynthetic process | 43/2060 | 106/8135 | 1.60 | 3.81e-04 | 3.42e-03 | 106 |
GO:0045926 | GO:0045926 | negative regulation of growth | 56/2060 | 147/8135 | 1.50 | 3.84e-04 | 3.43e-03 | 147 |
GO:0046634 | GO:0046634 | regulation of alpha-beta T cell activation | 29/2060 | 64/8135 | 1.79 | 3.91e-04 | 3.49e-03 | 64 |
GO:0002709 | GO:0002709 | regulation of T cell mediated immunity | 23/2060 | 47/8135 | 1.93 | 3.98e-04 | 3.53e-03 | 47 |
GO:0048245 | GO:0048245 | eosinophil chemotaxis | 13/2060 | 21/8135 | 2.44 | 4.18e-04 | 3.66e-03 | 21 |
GO:0032609 | GO:0032609 | interferon-gamma production | 37/2060 | 88/8135 | 1.66 | 4.19e-04 | 3.66e-03 | 88 |
GO:0001504 | GO:0001504 | neurotransmitter uptake | 17/2060 | 31/8135 | 2.17 | 4.20e-04 | 3.66e-03 | 31 |
GO:0035924 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 17/2060 | 31/8135 | 2.17 | 4.20e-04 | 3.66e-03 | 31 |
GO:0001959 | GO:0001959 | regulation of cytokine-mediated signaling pathway | 33/2060 | 76/8135 | 1.71 | 4.21e-04 | 3.66e-03 | 76 |
GO:0002475 | GO:0002475 | antigen processing and presentation via MHC class Ib | 9/2060 | 12/8135 | 2.96 | 4.30e-04 | 3.69e-03 | 12 |
GO:0043537 | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 9/2060 | 12/8135 | 2.96 | 4.30e-04 | 3.69e-03 | 12 |
GO:0046321 | GO:0046321 | positive regulation of fatty acid oxidation | 9/2060 | 12/8135 | 2.96 | 4.30e-04 | 3.69e-03 | 12 |
GO:0060193 | GO:0060193 | positive regulation of lipase activity | 24/2060 | 50/8135 | 1.90 | 4.31e-04 | 3.69e-03 | 50 |
GO:0035265 | GO:0035265 | organ growth | 47/2060 | 119/8135 | 1.56 | 4.32e-04 | 3.69e-03 | 119 |
GO:0010611 | GO:0010611 | regulation of cardiac muscle hypertrophy | 15/2060 | 26/8135 | 2.28 | 4.43e-04 | 3.77e-03 | 26 |
GO:0034329 | GO:0034329 | cell junction assembly | 46/2060 | 116/8135 | 1.57 | 4.45e-04 | 3.78e-03 | 116 |
GO:0031998 | GO:0031998 | regulation of fatty acid beta-oxidation | 8/2060 | 10/8135 | 3.16 | 4.53e-04 | 3.82e-03 | 10 |
GO:0051897 | GO:0051897 | positive regulation of protein kinase B signaling | 45/2060 | 113/8135 | 1.57 | 4.58e-04 | 3.85e-03 | 113 |
GO:0031331 | GO:0031331 | positive regulation of cellular catabolic process | 44/2060 | 110/8135 | 1.58 | 4.71e-04 | 3.95e-03 | 110 |
GO:1903409 | GO:1903409 | reactive oxygen species biosynthetic process | 26/2060 | 56/8135 | 1.83 | 4.85e-04 | 4.04e-03 | 56 |
GO:0097755 | GO:0097755 | positive regulation of blood vessel diameter | 21/2060 | 42/8135 | 1.97 | 4.89e-04 | 4.04e-03 | 42 |
GO:0050880 | GO:0050880 | regulation of blood vessel size | 42/2060 | 104/8135 | 1.59 | 4.96e-04 | 4.08e-03 | 104 |
GO:0060401 | GO:0060401 | cytosolic calcium ion transport | 42/2060 | 104/8135 | 1.59 | 4.96e-04 | 4.08e-03 | 104 |
GO:0019884 | GO:0019884 | antigen processing and presentation of exogenous antigen | 27/2060 | 59/8135 | 1.81 | 5.07e-04 | 4.16e-03 | 59 |
GO:0050866 | GO:0050866 | negative regulation of cell activation | 48/2060 | 123/8135 | 1.54 | 5.20e-04 | 4.26e-03 | 123 |
GO:2001023 | GO:2001023 | regulation of response to drug | 28/2060 | 62/8135 | 1.78 | 5.24e-04 | 4.28e-03 | 62 |
GO:0010518 | GO:0010518 | positive regulation of phospholipase activity | 22/2060 | 45/8135 | 1.93 | 5.39e-04 | 4.37e-03 | 45 |
GO:0001916 | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 12/2060 | 19/8135 | 2.49 | 5.42e-04 | 4.37e-03 | 19 |
GO:0051147 | GO:0051147 | regulation of muscle cell differentiation | 37/2060 | 89/8135 | 1.64 | 5.45e-04 | 4.39e-03 | 89 |
GO:0043524 | GO:0043524 | negative regulation of neuron apoptotic process | 36/2060 | 86/8135 | 1.65 | 5.52e-04 | 4.42e-03 | 86 |
GO:0051952 | GO:0051952 | regulation of amine transport | 33/2060 | 77/8135 | 1.69 | 5.60e-04 | 4.48e-03 | 77 |
GO:0050873 | GO:0050873 | brown fat cell differentiation | 16/2060 | 29/8135 | 2.18 | 5.67e-04 | 4.52e-03 | 29 |
GO:0010827 | GO:0010827 | regulation of glucose transmembrane transport | 19/2060 | 37/8135 | 2.03 | 5.88e-04 | 4.66e-03 | 37 |
GO:0048247 | GO:0048247 | lymphocyte chemotaxis | 24/2060 | 51/8135 | 1.86 | 6.21e-04 | 4.89e-03 | 51 |
GO:0003044 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 20/2060 | 40/8135 | 1.97 | 6.63e-04 | 5.17e-03 | 40 |
GO:1903426 | GO:1903426 | regulation of reactive oxygen species biosynthetic process | 20/2060 | 40/8135 | 1.97 | 6.63e-04 | 5.17e-03 | 40 |
GO:1901654 | GO:1901654 | response to ketone | 46/2060 | 118/8135 | 1.54 | 6.92e-04 | 5.36e-03 | 118 |
GO:0002861 | GO:0002861 | regulation of inflammatory response to antigenic stimulus | 11/2060 | 17/8135 | 2.56 | 6.94e-04 | 5.37e-03 | 17 |
GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 27/2060 | 60/8135 | 1.78 | 7.02e-04 | 5.41e-03 | 60 |
GO:0001912 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 21/2060 | 43/8135 | 1.93 | 7.30e-04 | 5.58e-03 | 43 |
GO:0050710 | GO:0050710 | negative regulation of cytokine secretion | 21/2060 | 43/8135 | 1.93 | 7.30e-04 | 5.58e-03 | 43 |
GO:0060420 | GO:0060420 | regulation of heart growth | 21/2060 | 43/8135 | 1.93 | 7.30e-04 | 5.58e-03 | 43 |
GO:0050731 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 49/2060 | 128/8135 | 1.51 | 7.62e-04 | 5.79e-03 | 128 |
GO:0038084 | GO:0038084 | vascular endothelial growth factor signaling pathway | 13/2060 | 22/8135 | 2.33 | 7.86e-04 | 5.89e-03 | 22 |
GO:0050901 | GO:0050901 | leukocyte tethering or rolling | 13/2060 | 22/8135 | 2.33 | 7.86e-04 | 5.89e-03 | 22 |
GO:0014897 | GO:0014897 | striated muscle hypertrophy | 22/2060 | 46/8135 | 1.89 | 7.88e-04 | 5.89e-03 | 46 |
GO:0046889 | GO:0046889 | positive regulation of lipid biosynthetic process | 22/2060 | 46/8135 | 1.89 | 7.88e-04 | 5.89e-03 | 46 |
GO:0051341 | GO:0051341 | regulation of oxidoreductase activity | 22/2060 | 46/8135 | 1.89 | 7.88e-04 | 5.89e-03 | 46 |
GO:0060395 | GO:0060395 | SMAD protein signal transduction | 22/2060 | 46/8135 | 1.89 | 7.88e-04 | 5.89e-03 | 46 |
GO:1903828 | GO:1903828 | negative regulation of cellular protein localization | 22/2060 | 46/8135 | 1.89 | 7.88e-04 | 5.89e-03 | 46 |
GO:0032330 | GO:0032330 | regulation of chondrocyte differentiation | 18/2060 | 35/8135 | 2.03 | 7.99e-04 | 5.95e-03 | 35 |
GO:0060402 | GO:0060402 | calcium ion transport into cytosol | 41/2060 | 103/8135 | 1.57 | 8.13e-04 | 6.02e-03 | 103 |
GO:0060828 | GO:0060828 | regulation of canonical Wnt signaling pathway | 47/2060 | 122/8135 | 1.52 | 8.24e-04 | 6.09e-03 | 122 |
GO:0042698 | GO:0042698 | ovulation cycle | 23/2060 | 49/8135 | 1.85 | 8.38e-04 | 6.18e-03 | 49 |
GO:0032332 | GO:0032332 | positive regulation of chondrocyte differentiation | 10/2060 | 15/8135 | 2.63 | 8.77e-04 | 6.34e-03 | 15 |
GO:0060669 | GO:0060669 | embryonic placenta morphogenesis | 10/2060 | 15/8135 | 2.63 | 8.77e-04 | 6.34e-03 | 15 |
GO:2000515 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 10/2060 | 15/8135 | 2.63 | 8.77e-04 | 6.34e-03 | 15 |
GO:0034308 | GO:0034308 | primary alcohol metabolic process | 24/2060 | 52/8135 | 1.82 | 8.80e-04 | 6.34e-03 | 52 |
GO:0060291 | GO:0060291 | long-term synaptic potentiation | 24/2060 | 52/8135 | 1.82 | 8.80e-04 | 6.34e-03 | 52 |
GO:2000379 | GO:2000379 | positive regulation of reactive oxygen species metabolic process | 24/2060 | 52/8135 | 1.82 | 8.80e-04 | 6.34e-03 | 52 |
GO:0062014 | GO:0062014 | negative regulation of small molecule metabolic process | 25/2060 | 55/8135 | 1.80 | 9.14e-04 | 6.53e-03 | 55 |
GO:0042088 | GO:0042088 | T-helper 1 type immune response | 16/2060 | 30/8135 | 2.11 | 9.32e-04 | 6.63e-03 | 30 |
GO:0019233 | GO:0019233 | sensory perception of pain | 34/2060 | 82/8135 | 1.64 | 9.52e-04 | 6.75e-03 | 82 |
GO:0090090 | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 33/2060 | 79/8135 | 1.65 | 9.65e-04 | 6.82e-03 | 79 |
GO:0050709 | GO:0050709 | negative regulation of protein secretion | 32/2060 | 76/8135 | 1.66 | 9.74e-04 | 6.86e-03 | 76 |
GO:0034332 | GO:0034332 | adherens junction organization | 29/2060 | 67/8135 | 1.71 | 9.80e-04 | 6.86e-03 | 67 |
GO:0002456 | GO:0002456 | T cell mediated immunity | 30/2060 | 70/8135 | 1.69 | 9.82e-04 | 6.86e-03 | 70 |
GO:0042035 | GO:0042035 | regulation of cytokine biosynthetic process | 30/2060 | 70/8135 | 1.69 | 9.82e-04 | 6.86e-03 | 70 |
GO:0071456 | GO:0071456 | cellular response to hypoxia | 30/2060 | 70/8135 | 1.69 | 9.82e-04 | 6.86e-03 | 70 |
GO:0001914 | GO:0001914 | regulation of T cell mediated cytotoxicity | 14/2060 | 25/8135 | 2.21 | 1.03e-03 | 7.13e-03 | 25 |
GO:0010883 | GO:0010883 | regulation of lipid storage | 14/2060 | 25/8135 | 2.21 | 1.03e-03 | 7.13e-03 | 25 |
GO:0061614 | GO:0061614 | pri-miRNA transcription by RNA polymerase II | 14/2060 | 25/8135 | 2.21 | 1.03e-03 | 7.13e-03 | 25 |
GO:0098801 | GO:0098801 | regulation of renal system process | 14/2060 | 25/8135 | 2.21 | 1.03e-03 | 7.13e-03 | 25 |
GO:0002026 | GO:0002026 | regulation of the force of heart contraction | 12/2060 | 20/8135 | 2.37 | 1.04e-03 | 7.16e-03 | 20 |
GO:0043114 | GO:0043114 | regulation of vascular permeability | 12/2060 | 20/8135 | 2.37 | 1.04e-03 | 7.16e-03 | 20 |
GO:0050999 | GO:0050999 | regulation of nitric-oxide synthase activity | 12/2060 | 20/8135 | 2.37 | 1.04e-03 | 7.16e-03 | 20 |
GO:0014074 | GO:0014074 | response to purine-containing compound | 40/2060 | 101/8135 | 1.56 | 1.05e-03 | 7.20e-03 | 101 |
GO:0003300 | GO:0003300 | cardiac muscle hypertrophy | 21/2060 | 44/8135 | 1.88 | 1.07e-03 | 7.26e-03 | 44 |
GO:1900180 | GO:1900180 | regulation of protein localization to nucleus | 21/2060 | 44/8135 | 1.88 | 1.07e-03 | 7.26e-03 | 44 |
GO:0070293 | GO:0070293 | renal absorption | 9/2060 | 13/8135 | 2.73 | 1.08e-03 | 7.35e-03 | 13 |
GO:0045833 | GO:0045833 | negative regulation of lipid metabolic process | 22/2060 | 47/8135 | 1.85 | 1.13e-03 | 7.64e-03 | 47 |
GO:0050777 | GO:0050777 | negative regulation of immune response | 36/2060 | 89/8135 | 1.60 | 1.17e-03 | 7.89e-03 | 89 |
GO:0051250 | GO:0051250 | negative regulation of lymphocyte activation | 36/2060 | 89/8135 | 1.60 | 1.17e-03 | 7.89e-03 | 89 |
GO:0043903 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 35/2060 | 86/8135 | 1.61 | 1.20e-03 | 8.02e-03 | 86 |
GO:0001913 | GO:0001913 | T cell mediated cytotoxicity | 18/2060 | 36/8135 | 1.97 | 1.22e-03 | 8.09e-03 | 36 |
GO:0006953 | GO:0006953 | acute-phase response | 18/2060 | 36/8135 | 1.97 | 1.22e-03 | 8.09e-03 | 36 |
GO:0043949 | GO:0043949 | regulation of cAMP-mediated signaling | 18/2060 | 36/8135 | 1.97 | 1.22e-03 | 8.09e-03 | 36 |
GO:0002718 | GO:0002718 | regulation of cytokine production involved in immune response | 24/2060 | 53/8135 | 1.79 | 1.23e-03 | 8.09e-03 | 53 |
GO:0055024 | GO:0055024 | regulation of cardiac muscle tissue development | 24/2060 | 53/8135 | 1.79 | 1.23e-03 | 8.09e-03 | 53 |
GO:0032649 | GO:0032649 | regulation of interferon-gamma production | 33/2060 | 80/8135 | 1.63 | 1.25e-03 | 8.19e-03 | 80 |
GO:0072676 | GO:0072676 | lymphocyte migration | 33/2060 | 80/8135 | 1.63 | 1.25e-03 | 8.19e-03 | 80 |
GO:0014743 | GO:0014743 | regulation of muscle hypertrophy | 15/2060 | 28/8135 | 2.12 | 1.26e-03 | 8.23e-03 | 28 |
GO:0042089 | GO:0042089 | cytokine biosynthetic process | 32/2060 | 77/8135 | 1.64 | 1.27e-03 | 8.23e-03 | 77 |
GO:0051209 | GO:0051209 | release of sequestered calcium ion into cytosol | 32/2060 | 77/8135 | 1.64 | 1.27e-03 | 8.23e-03 | 77 |
GO:0051283 | GO:0051283 | negative regulation of sequestering of calcium ion | 32/2060 | 77/8135 | 1.64 | 1.27e-03 | 8.23e-03 | 77 |
GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 26/2060 | 59/8135 | 1.74 | 1.28e-03 | 8.28e-03 | 59 |
GO:0071901 | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 26/2060 | 59/8135 | 1.74 | 1.28e-03 | 8.28e-03 | 59 |
GO:0043371 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation | 8/2060 | 11/8135 | 2.87 | 1.29e-03 | 8.28e-03 | 11 |
GO:0044126 | GO:0044126 | regulation of growth of symbiont in host | 8/2060 | 11/8135 | 2.87 | 1.29e-03 | 8.28e-03 | 11 |
GO:0044130 | GO:0044130 | negative regulation of growth of symbiont in host | 8/2060 | 11/8135 | 2.87 | 1.29e-03 | 8.28e-03 | 11 |
GO:1903671 | GO:1903671 | negative regulation of sprouting angiogenesis | 8/2060 | 11/8135 | 2.87 | 1.29e-03 | 8.28e-03 | 11 |
GO:0036294 | GO:0036294 | cellular response to decreased oxygen levels | 30/2060 | 71/8135 | 1.67 | 1.30e-03 | 8.28e-03 | 71 |
GO:0031341 | GO:0031341 | regulation of cell killing | 29/2060 | 68/8135 | 1.68 | 1.30e-03 | 8.30e-03 | 68 |
GO:0002294 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 19/2060 | 39/8135 | 1.92 | 1.34e-03 | 8.51e-03 | 39 |
GO:0071398 | GO:0071398 | cellular response to fatty acid | 19/2060 | 39/8135 | 1.92 | 1.34e-03 | 8.51e-03 | 39 |
GO:0051402 | GO:0051402 | neuron apoptotic process | 45/2060 | 118/8135 | 1.51 | 1.34e-03 | 8.51e-03 | 118 |
GO:0061082 | GO:0061082 | myeloid leukocyte cytokine production | 11/2060 | 18/8135 | 2.41 | 1.38e-03 | 8.70e-03 | 18 |
GO:0042311 | GO:0042311 | vasodilation | 13/2060 | 23/8135 | 2.23 | 1.39e-03 | 8.74e-03 | 23 |
GO:0043618 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 13/2060 | 23/8135 | 2.23 | 1.39e-03 | 8.74e-03 | 23 |
GO:0046636 | GO:0046636 | negative regulation of alpha-beta T cell activation | 13/2060 | 23/8135 | 2.23 | 1.39e-03 | 8.74e-03 | 23 |
GO:1904035 | GO:1904035 | regulation of epithelial cell apoptotic process | 20/2060 | 42/8135 | 1.88 | 1.44e-03 | 9.01e-03 | 42 |
GO:0086009 | GO:0086009 | membrane repolarization | 16/2060 | 31/8135 | 2.04 | 1.48e-03 | 9.17e-03 | 31 |
GO:0050810 | GO:0050810 | regulation of steroid biosynthetic process | 21/2060 | 45/8135 | 1.84 | 1.53e-03 | 9.43e-03 | 45 |
GO:1905952 | GO:1905952 | regulation of lipid localization | 35/2060 | 87/8135 | 1.59 | 1.53e-03 | 9.43e-03 | 87 |
GO:0048634 | GO:0048634 | regulation of muscle organ development | 34/2060 | 84/8135 | 1.60 | 1.57e-03 | 9.63e-03 | 84 |
GO:0014896 | GO:0014896 | muscle hypertrophy | 22/2060 | 48/8135 | 1.81 | 1.60e-03 | 9.78e-03 | 48 |
GO:0016125 | GO:0016125 | sterol metabolic process | 33/2060 | 81/8135 | 1.61 | 1.60e-03 | 9.82e-03 | 81 |
GO:0008360 | GO:0008360 | regulation of cell shape | 32/2060 | 78/8135 | 1.62 | 1.64e-03 | 9.90e-03 | 78 |
GO:0042107 | GO:0042107 | cytokine metabolic process | 32/2060 | 78/8135 | 1.62 | 1.64e-03 | 9.90e-03 | 78 |
GO:0051282 | GO:0051282 | regulation of sequestering of calcium ion | 32/2060 | 78/8135 | 1.62 | 1.64e-03 | 9.90e-03 | 78 |
GO:0002686 | GO:0002686 | negative regulation of leukocyte migration | 17/2060 | 34/8135 | 1.97 | 1.66e-03 | 9.98e-03 | 34 |
GO:0045843 | GO:0045843 | negative regulation of striated muscle tissue development | 17/2060 | 34/8135 | 1.97 | 1.66e-03 | 9.98e-03 | 34 |
GO:0048635 | GO:0048635 | negative regulation of muscle organ development | 17/2060 | 34/8135 | 1.97 | 1.66e-03 | 9.98e-03 | 34 |
GO:1905954 | GO:1905954 | positive regulation of lipid localization | 24/2060 | 54/8135 | 1.76 | 1.69e-03 | 1.01e-02 | 54 |
GO:0035296 | GO:0035296 | regulation of tube diameter | 39/2060 | 100/8135 | 1.54 | 1.69e-03 | 1.01e-02 | 100 |
GO:0097746 | GO:0097746 | regulation of blood vessel diameter | 39/2060 | 100/8135 | 1.54 | 1.69e-03 | 1.01e-02 | 100 |
GO:0015980 | GO:0015980 | energy derivation by oxidation of organic compounds | 29/2060 | 69/8135 | 1.66 | 1.71e-03 | 1.02e-02 | 69 |
GO:0060333 | GO:0060333 | interferon-gamma-mediated signaling pathway | 25/2060 | 57/8135 | 1.73 | 1.71e-03 | 1.02e-02 | 57 |
GO:0043620 | GO:0043620 | regulation of DNA-templated transcription in response to stress | 14/2060 | 26/8135 | 2.13 | 1.72e-03 | 1.02e-02 | 26 |
GO:0046323 | GO:0046323 | glucose import | 14/2060 | 26/8135 | 2.13 | 1.72e-03 | 1.02e-02 | 26 |
GO:1903428 | GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | 14/2060 | 26/8135 | 2.13 | 1.72e-03 | 1.02e-02 | 26 |
GO:0072659 | GO:0072659 | protein localization to plasma membrane | 43/2060 | 113/8135 | 1.50 | 1.79e-03 | 1.05e-02 | 113 |
GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 43/2060 | 113/8135 | 1.50 | 1.79e-03 | 1.05e-02 | 113 |
GO:0003298 | GO:0003298 | physiological muscle hypertrophy | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0003301 | GO:0003301 | physiological cardiac muscle hypertrophy | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0061049 | GO:0061049 | cell growth involved in cardiac muscle cell development | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0071379 | GO:0071379 | cellular response to prostaglandin stimulus | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0071677 | GO:0071677 | positive regulation of mononuclear cell migration | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0071875 | GO:0071875 | adrenergic receptor signaling pathway | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0072111 | GO:0072111 | cell proliferation involved in kidney development | 10/2060 | 16/8135 | 2.47 | 1.81e-03 | 1.05e-02 | 16 |
GO:0001706 | GO:0001706 | endoderm formation | 18/2060 | 37/8135 | 1.92 | 1.82e-03 | 1.05e-02 | 37 |
GO:0042093 | GO:0042093 | T-helper cell differentiation | 18/2060 | 37/8135 | 1.92 | 1.82e-03 | 1.05e-02 | 37 |
GO:0055021 | GO:0055021 | regulation of cardiac muscle tissue growth | 18/2060 | 37/8135 | 1.92 | 1.82e-03 | 1.05e-02 | 37 |
GO:0097553 | GO:0097553 | calcium ion transmembrane import into cytosol | 36/2060 | 91/8135 | 1.56 | 1.87e-03 | 1.07e-02 | 91 |
GO:0043267 | GO:0043267 | negative regulation of potassium ion transport | 12/2060 | 21/8135 | 2.26 | 1.88e-03 | 1.07e-02 | 21 |
GO:0060317 | GO:0060317 | cardiac epithelial to mesenchymal transition | 12/2060 | 21/8135 | 2.26 | 1.88e-03 | 1.07e-02 | 21 |
GO:0061036 | GO:0061036 | positive regulation of cartilage development | 12/2060 | 21/8135 | 2.26 | 1.88e-03 | 1.07e-02 | 21 |
GO:1902932 | GO:1902932 | positive regulation of alcohol biosynthetic process | 12/2060 | 21/8135 | 2.26 | 1.88e-03 | 1.07e-02 | 21 |
GO:2000725 | GO:2000725 | regulation of cardiac muscle cell differentiation | 12/2060 | 21/8135 | 2.26 | 1.88e-03 | 1.07e-02 | 21 |
GO:0002287 | GO:0002287 | alpha-beta T cell activation involved in immune response | 19/2060 | 40/8135 | 1.88 | 1.96e-03 | 1.10e-02 | 40 |
GO:0002293 | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 19/2060 | 40/8135 | 1.88 | 1.96e-03 | 1.10e-02 | 40 |
GO:0032722 | GO:0032722 | positive regulation of chemokine production | 19/2060 | 40/8135 | 1.88 | 1.96e-03 | 1.10e-02 | 40 |
GO:0045600 | GO:0045600 | positive regulation of fat cell differentiation | 19/2060 | 40/8135 | 1.88 | 1.96e-03 | 1.10e-02 | 40 |
GO:0060389 | GO:0060389 | pathway-restricted SMAD protein phosphorylation | 19/2060 | 40/8135 | 1.88 | 1.96e-03 | 1.10e-02 | 40 |
GO:0001885 | GO:0001885 | endothelial cell development | 15/2060 | 29/8135 | 2.04 | 2.01e-03 | 1.13e-02 | 29 |
GO:0016202 | GO:0016202 | regulation of striated muscle tissue development | 33/2060 | 82/8135 | 1.59 | 2.04e-03 | 1.14e-02 | 82 |
GO:0043255 | GO:0043255 | regulation of carbohydrate biosynthetic process | 20/2060 | 43/8135 | 1.84 | 2.07e-03 | 1.15e-02 | 43 |
GO:0045123 | GO:0045123 | cellular extravasation | 20/2060 | 43/8135 | 1.84 | 2.07e-03 | 1.15e-02 | 43 |
GO:0051208 | GO:0051208 | sequestering of calcium ion | 32/2060 | 79/8135 | 1.60 | 2.10e-03 | 1.16e-02 | 79 |
GO:0071453 | GO:0071453 | cellular response to oxygen levels | 32/2060 | 79/8135 | 1.60 | 2.10e-03 | 1.16e-02 | 79 |
GO:0030178 | GO:0030178 | negative regulation of Wnt signaling pathway | 38/2060 | 98/8135 | 1.53 | 2.18e-03 | 1.20e-02 | 98 |
GO:0050868 | GO:0050868 | negative regulation of T cell activation | 28/2060 | 67/8135 | 1.65 | 2.26e-03 | 1.24e-02 | 67 |
GO:0060760 | GO:0060760 | positive regulation of response to cytokine stimulus | 16/2060 | 32/8135 | 1.97 | 2.27e-03 | 1.24e-02 | 32 |
GO:0001910 | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 26/2060 | 61/8135 | 1.68 | 2.29e-03 | 1.25e-02 | 61 |
GO:0051937 | GO:0051937 | catecholamine transport | 26/2060 | 61/8135 | 1.68 | 2.29e-03 | 1.25e-02 | 61 |
GO:0090100 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 25/2060 | 58/8135 | 1.70 | 2.29e-03 | 1.25e-02 | 58 |
GO:0006635 | GO:0006635 | fatty acid beta-oxidation | 13/2060 | 24/8135 | 2.14 | 2.34e-03 | 1.26e-02 | 24 |
GO:1902622 | GO:1902622 | regulation of neutrophil migration | 13/2060 | 24/8135 | 2.14 | 2.34e-03 | 1.26e-02 | 24 |
GO:0006006 | GO:0006006 | glucose metabolic process | 36/2060 | 92/8135 | 1.55 | 2.34e-03 | 1.26e-02 | 92 |
GO:0002043 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0031649 | GO:0031649 | heat generation | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0043951 | GO:0043951 | negative regulation of cAMP-mediated signaling | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0048305 | GO:0048305 | immunoglobulin secretion | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0061437 | GO:0061437 | renal system vasculature development | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0061440 | GO:0061440 | kidney vasculature development | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0072012 | GO:0072012 | glomerulus vasculature development | 9/2060 | 14/8135 | 2.54 | 2.35e-03 | 1.26e-02 | 14 |
GO:0042133 | GO:0042133 | neurotransmitter metabolic process | 35/2060 | 89/8135 | 1.55 | 2.42e-03 | 1.29e-02 | 89 |
GO:0050715 | GO:0050715 | positive regulation of cytokine secretion | 35/2060 | 89/8135 | 1.55 | 2.42e-03 | 1.29e-02 | 89 |
GO:0072577 | GO:0072577 | endothelial cell apoptotic process | 17/2060 | 35/8135 | 1.92 | 2.48e-03 | 1.32e-02 | 35 |
GO:0010922 | GO:0010922 | positive regulation of phosphatase activity | 11/2060 | 19/8135 | 2.29 | 2.53e-03 | 1.33e-02 | 19 |
GO:0090025 | GO:0090025 | regulation of monocyte chemotaxis | 11/2060 | 19/8135 | 2.29 | 2.53e-03 | 1.33e-02 | 19 |
GO:0090317 | GO:0090317 | negative regulation of intracellular protein transport | 11/2060 | 19/8135 | 2.29 | 2.53e-03 | 1.33e-02 | 19 |
GO:0006970 | GO:0006970 | response to osmotic stress | 18/2060 | 38/8135 | 1.87 | 2.66e-03 | 1.39e-02 | 38 |
GO:0042306 | GO:0042306 | regulation of protein import into nucleus | 14/2060 | 27/8135 | 2.05 | 2.75e-03 | 1.43e-02 | 27 |
GO:1904589 | GO:1904589 | regulation of protein import | 14/2060 | 27/8135 | 2.05 | 2.75e-03 | 1.43e-02 | 27 |
GO:0008277 | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 37/2060 | 96/8135 | 1.52 | 2.80e-03 | 1.45e-02 | 96 |
GO:0046165 | GO:0046165 | alcohol biosynthetic process | 29/2060 | 71/8135 | 1.61 | 2.87e-03 | 1.48e-02 | 71 |
GO:0098754 | GO:0098754 | detoxification | 29/2060 | 71/8135 | 1.61 | 2.87e-03 | 1.48e-02 | 71 |
GO:0046635 | GO:0046635 | positive regulation of alpha-beta T cell activation | 20/2060 | 44/8135 | 1.80 | 2.90e-03 | 1.49e-02 | 44 |
GO:0045732 | GO:0045732 | positive regulation of protein catabolic process | 28/2060 | 68/8135 | 1.63 | 2.93e-03 | 1.51e-02 | 68 |
GO:0046888 | GO:0046888 | negative regulation of hormone secretion | 21/2060 | 47/8135 | 1.76 | 2.97e-03 | 1.52e-02 | 47 |
GO:0032612 | GO:0032612 | interleukin-1 production | 27/2060 | 65/8135 | 1.64 | 2.97e-03 | 1.52e-02 | 65 |
GO:0002479 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0044144 | GO:0044144 | modulation of growth of symbiont involved in interaction with host | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0044146 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0061298 | GO:0061298 | retina vasculature development in camera-type eye | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0071711 | GO:0071711 | basement membrane organization | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0090493 | GO:0090493 | catecholamine uptake | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0090494 | GO:0090494 | dopamine uptake | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:1904994 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell | 8/2060 | 12/8135 | 2.63 | 3.02e-03 | 1.52e-02 | 12 |
GO:0071706 | GO:0071706 | tumor necrosis factor superfamily cytokine production | 35/2060 | 90/8135 | 1.54 | 3.02e-03 | 1.52e-02 | 90 |
GO:1903555 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 35/2060 | 90/8135 | 1.54 | 3.02e-03 | 1.52e-02 | 90 |
GO:0097306 | GO:0097306 | cellular response to alcohol | 22/2060 | 50/8135 | 1.74 | 3.02e-03 | 1.52e-02 | 50 |
GO:0033555 | GO:0033555 | multicellular organismal response to stress | 23/2060 | 53/8135 | 1.71 | 3.05e-03 | 1.53e-02 | 53 |
GO:1904019 | GO:1904019 | epithelial cell apoptotic process | 23/2060 | 53/8135 | 1.71 | 3.05e-03 | 1.53e-02 | 53 |
GO:0022617 | GO:0022617 | extracellular matrix disassembly | 24/2060 | 56/8135 | 1.69 | 3.05e-03 | 1.53e-02 | 56 |
GO:0098869 | GO:0098869 | cellular oxidant detoxification | 24/2060 | 56/8135 | 1.69 | 3.05e-03 | 1.53e-02 | 56 |
GO:0002720 | GO:0002720 | positive regulation of cytokine production involved in immune response | 15/2060 | 30/8135 | 1.97 | 3.09e-03 | 1.54e-02 | 30 |
GO:0010633 | GO:0010633 | negative regulation of epithelial cell migration | 15/2060 | 30/8135 | 1.97 | 3.09e-03 | 1.54e-02 | 30 |
GO:1902905 | GO:1902905 | positive regulation of supramolecular fiber organization | 34/2060 | 87/8135 | 1.54 | 3.13e-03 | 1.56e-02 | 87 |
GO:0090022 | GO:0090022 | regulation of neutrophil chemotaxis | 12/2060 | 22/8135 | 2.15 | 3.18e-03 | 1.58e-02 | 22 |
GO:1901861 | GO:1901861 | regulation of muscle tissue development | 33/2060 | 84/8135 | 1.55 | 3.24e-03 | 1.61e-02 | 84 |
GO:0001890 | GO:0001890 | placenta development | 32/2060 | 81/8135 | 1.56 | 3.35e-03 | 1.65e-02 | 81 |
GO:0006109 | GO:0006109 | regulation of carbohydrate metabolic process | 32/2060 | 81/8135 | 1.56 | 3.35e-03 | 1.65e-02 | 81 |
GO:0035987 | GO:0035987 | endodermal cell differentiation | 16/2060 | 33/8135 | 1.91 | 3.38e-03 | 1.66e-02 | 33 |
GO:0070301 | GO:0070301 | cellular response to hydrogen peroxide | 16/2060 | 33/8135 | 1.91 | 3.38e-03 | 1.66e-02 | 33 |
GO:1905207 | GO:1905207 | regulation of cardiocyte differentiation | 16/2060 | 33/8135 | 1.91 | 3.38e-03 | 1.66e-02 | 33 |
GO:0034695 | GO:0034695 | response to prostaglandin E | 10/2060 | 17/8135 | 2.32 | 3.40e-03 | 1.66e-02 | 17 |
GO:0051491 | GO:0051491 | positive regulation of filopodium assembly | 10/2060 | 17/8135 | 2.32 | 3.40e-03 | 1.66e-02 | 17 |
GO:0097009 | GO:0097009 | energy homeostasis | 10/2060 | 17/8135 | 2.32 | 3.40e-03 | 1.66e-02 | 17 |
GO:0016050 | GO:0016050 | vesicle organization | 37/2060 | 97/8135 | 1.51 | 3.44e-03 | 1.67e-02 | 97 |
GO:0016999 | GO:0016999 | antibiotic metabolic process | 31/2060 | 78/8135 | 1.57 | 3.46e-03 | 1.67e-02 | 78 |
GO:0032615 | GO:0032615 | interleukin-12 production | 17/2060 | 36/8135 | 1.86 | 3.61e-03 | 1.73e-02 | 36 |
GO:0044060 | GO:0044060 | regulation of endocrine process | 17/2060 | 36/8135 | 1.86 | 3.61e-03 | 1.73e-02 | 36 |
GO:1901862 | GO:1901862 | negative regulation of muscle tissue development | 17/2060 | 36/8135 | 1.86 | 3.61e-03 | 1.73e-02 | 36 |
GO:0015844 | GO:0015844 | monoamine transport | 29/2060 | 72/8135 | 1.59 | 3.66e-03 | 1.75e-02 | 72 |
GO:0043433 | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 29/2060 | 72/8135 | 1.59 | 3.66e-03 | 1.75e-02 | 72 |
GO:0032635 | GO:0032635 | interleukin-6 production | 35/2060 | 91/8135 | 1.52 | 3.73e-03 | 1.76e-02 | 91 |
GO:0035306 | GO:0035306 | positive regulation of dephosphorylation | 13/2060 | 25/8135 | 2.05 | 3.75e-03 | 1.76e-02 | 25 |
GO:0043277 | GO:0043277 | apoptotic cell clearance | 13/2060 | 25/8135 | 2.05 | 3.75e-03 | 1.76e-02 | 25 |
GO:0045581 | GO:0045581 | negative regulation of T cell differentiation | 13/2060 | 25/8135 | 2.05 | 3.75e-03 | 1.76e-02 | 25 |
GO:0010675 | GO:0010675 | regulation of cellular carbohydrate metabolic process | 28/2060 | 69/8135 | 1.60 | 3.75e-03 | 1.76e-02 | 69 |
GO:0010614 | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:0010878 | GO:0010878 | cholesterol storage | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:0032700 | GO:0032700 | negative regulation of interleukin-17 production | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:0036303 | GO:0036303 | lymph vessel morphogenesis | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:0045623 | GO:0045623 | negative regulation of T-helper cell differentiation | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:0072203 | GO:0072203 | cell proliferation involved in metanephros development | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:1903587 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:2000833 | GO:2000833 | positive regulation of steroid hormone secretion | 7/2060 | 10/8135 | 2.76 | 3.77e-03 | 1.76e-02 | 10 |
GO:1901888 | GO:1901888 | regulation of cell junction assembly | 18/2060 | 39/8135 | 1.82 | 3.78e-03 | 1.77e-02 | 39 |
GO:0006641 | GO:0006641 | triglyceride metabolic process | 27/2060 | 66/8135 | 1.62 | 3.84e-03 | 1.79e-02 | 66 |
GO:1903076 | GO:1903076 | regulation of protein localization to plasma membrane | 19/2060 | 42/8135 | 1.79 | 3.91e-03 | 1.82e-02 | 42 |
GO:0034763 | GO:0034763 | negative regulation of transmembrane transport | 26/2060 | 63/8135 | 1.63 | 3.92e-03 | 1.82e-02 | 63 |
GO:0032637 | GO:0032637 | interleukin-8 production | 20/2060 | 45/8135 | 1.76 | 4.00e-03 | 1.85e-02 | 45 |
GO:0051101 | GO:0051101 | regulation of DNA binding | 24/2060 | 57/8135 | 1.66 | 4.03e-03 | 1.86e-02 | 57 |
GO:0032675 | GO:0032675 | regulation of interleukin-6 production | 33/2060 | 85/8135 | 1.53 | 4.03e-03 | 1.86e-02 | 85 |
GO:0032611 | GO:0032611 | interleukin-1 beta production | 23/2060 | 54/8135 | 1.68 | 4.06e-03 | 1.86e-02 | 54 |
GO:0051966 | GO:0051966 | regulation of synaptic transmission, glutamatergic | 23/2060 | 54/8135 | 1.68 | 4.06e-03 | 1.86e-02 | 54 |
GO:0051149 | GO:0051149 | positive regulation of muscle cell differentiation | 22/2060 | 51/8135 | 1.70 | 4.07e-03 | 1.86e-02 | 51 |
GO:0043123 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 31/2060 | 79/8135 | 1.55 | 4.34e-03 | 1.97e-02 | 79 |
GO:0035929 | GO:0035929 | steroid hormone secretion | 11/2060 | 20/8135 | 2.17 | 4.34e-03 | 1.97e-02 | 20 |
GO:0071276 | GO:0071276 | cellular response to cadmium ion | 11/2060 | 20/8135 | 2.17 | 4.34e-03 | 1.97e-02 | 20 |
GO:0032526 | GO:0032526 | response to retinoic acid | 30/2060 | 76/8135 | 1.56 | 4.49e-03 | 2.02e-02 | 76 |
GO:0001991 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 9/2060 | 15/8135 | 2.37 | 4.57e-03 | 2.04e-02 | 15 |
GO:0046639 | GO:0046639 | negative regulation of alpha-beta T cell differentiation | 9/2060 | 15/8135 | 2.37 | 4.57e-03 | 2.04e-02 | 15 |
GO:0055022 | GO:0055022 | negative regulation of cardiac muscle tissue growth | 9/2060 | 15/8135 | 2.37 | 4.57e-03 | 2.04e-02 | 15 |
GO:0061117 | GO:0061117 | negative regulation of heart growth | 9/2060 | 15/8135 | 2.37 | 4.57e-03 | 2.04e-02 | 15 |
GO:0071880 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 9/2060 | 15/8135 | 2.37 | 4.57e-03 | 2.04e-02 | 15 |
GO:1900181 | GO:1900181 | negative regulation of protein localization to nucleus | 9/2060 | 15/8135 | 2.37 | 4.57e-03 | 2.04e-02 | 15 |
GO:0050994 | GO:0050994 | regulation of lipid catabolic process | 15/2060 | 31/8135 | 1.91 | 4.61e-03 | 2.05e-02 | 31 |
GO:0045580 | GO:0045580 | regulation of T cell differentiation | 34/2060 | 89/8135 | 1.51 | 4.78e-03 | 2.12e-02 | 89 |
GO:0032640 | GO:0032640 | tumor necrosis factor production | 33/2060 | 86/8135 | 1.52 | 4.98e-03 | 2.20e-02 | 86 |
GO:0032680 | GO:0032680 | regulation of tumor necrosis factor production | 33/2060 | 86/8135 | 1.52 | 4.98e-03 | 2.20e-02 | 86 |
GO:0002286 | GO:0002286 | T cell activation involved in immune response | 26/2060 | 64/8135 | 1.60 | 5.04e-03 | 2.22e-02 | 64 |
GO:0051153 | GO:0051153 | regulation of striated muscle cell differentiation | 26/2060 | 64/8135 | 1.60 | 5.04e-03 | 2.22e-02 | 64 |
GO:0055026 | GO:0055026 | negative regulation of cardiac muscle tissue development | 12/2060 | 23/8135 | 2.06 | 5.14e-03 | 2.25e-02 | 23 |
GO:1903523 | GO:1903523 | negative regulation of blood circulation | 12/2060 | 23/8135 | 2.06 | 5.14e-03 | 2.25e-02 | 23 |
GO:0072329 | GO:0072329 | monocarboxylic acid catabolic process | 25/2060 | 61/8135 | 1.62 | 5.15e-03 | 2.26e-02 | 61 |
GO:1990748 | GO:1990748 | cellular detoxification | 24/2060 | 58/8135 | 1.63 | 5.25e-03 | 2.29e-02 | 58 |
GO:0032677 | GO:0032677 | regulation of interleukin-8 production | 18/2060 | 40/8135 | 1.78 | 5.27e-03 | 2.30e-02 | 40 |
GO:0042108 | GO:0042108 | positive regulation of cytokine biosynthetic process | 19/2060 | 43/8135 | 1.74 | 5.37e-03 | 2.34e-02 | 43 |
GO:0001823 | GO:0001823 | mesonephros development | 31/2060 | 80/8135 | 1.53 | 5.40e-03 | 2.34e-02 | 80 |
GO:0050918 | GO:0050918 | positive chemotaxis | 21/2060 | 49/8135 | 1.69 | 5.42e-03 | 2.35e-02 | 49 |
GO:1904375 | GO:1904375 | regulation of protein localization to cell periphery | 21/2060 | 49/8135 | 1.69 | 5.42e-03 | 2.35e-02 | 49 |
GO:0030282 | GO:0030282 | bone mineralization | 30/2060 | 77/8135 | 1.54 | 5.60e-03 | 2.42e-02 | 77 |
GO:0002823 | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 13/2060 | 26/8135 | 1.97 | 5.79e-03 | 2.48e-02 | 26 |
GO:0010543 | GO:0010543 | regulation of platelet activation | 13/2060 | 26/8135 | 1.97 | 5.79e-03 | 2.48e-02 | 26 |
GO:0033762 | GO:0033762 | response to glucagon | 13/2060 | 26/8135 | 1.97 | 5.79e-03 | 2.48e-02 | 26 |
GO:0002673 | GO:0002673 | regulation of acute inflammatory response | 29/2060 | 74/8135 | 1.55 | 5.81e-03 | 2.49e-02 | 74 |
GO:0034405 | GO:0034405 | response to fluid shear stress | 10/2060 | 18/8135 | 2.19 | 5.93e-03 | 2.53e-02 | 18 |
GO:0085029 | GO:0085029 | extracellular matrix assembly | 10/2060 | 18/8135 | 2.19 | 5.93e-03 | 2.53e-02 | 18 |
GO:0098810 | GO:0098810 | neurotransmitter reuptake | 10/2060 | 18/8135 | 2.19 | 5.93e-03 | 2.53e-02 | 18 |
GO:0032682 | GO:0032682 | negative regulation of chemokine production | 8/2060 | 13/8135 | 2.43 | 6.11e-03 | 2.58e-02 | 13 |
GO:0034390 | GO:0034390 | smooth muscle cell apoptotic process | 8/2060 | 13/8135 | 2.43 | 6.11e-03 | 2.58e-02 | 13 |
GO:0034391 | GO:0034391 | regulation of smooth muscle cell apoptotic process | 8/2060 | 13/8135 | 2.43 | 6.11e-03 | 2.58e-02 | 13 |
GO:0060330 | GO:0060330 | regulation of response to interferon-gamma | 8/2060 | 13/8135 | 2.43 | 6.11e-03 | 2.58e-02 | 13 |
GO:0060334 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 8/2060 | 13/8135 | 2.43 | 6.11e-03 | 2.58e-02 | 13 |
GO:0060713 | GO:0060713 | labyrinthine layer morphogenesis | 8/2060 | 13/8135 | 2.43 | 6.11e-03 | 2.58e-02 | 13 |
GO:0003073 | GO:0003073 | regulation of systemic arterial blood pressure | 27/2060 | 68/8135 | 1.57 | 6.22e-03 | 2.61e-02 | 68 |
GO:0033135 | GO:0033135 | regulation of peptidyl-serine phosphorylation | 27/2060 | 68/8135 | 1.57 | 6.22e-03 | 2.61e-02 | 68 |
GO:0043266 | GO:0043266 | regulation of potassium ion transport | 27/2060 | 68/8135 | 1.57 | 6.22e-03 | 2.61e-02 | 68 |
GO:0072028 | GO:0072028 | nephron morphogenesis | 26/2060 | 65/8135 | 1.58 | 6.41e-03 | 2.68e-02 | 65 |
GO:0030316 | GO:0030316 | osteoclast differentiation | 25/2060 | 62/8135 | 1.59 | 6.60e-03 | 2.75e-02 | 62 |
GO:0001990 | GO:0001990 | regulation of systemic arterial blood pressure by hormone | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:0032387 | GO:0032387 | negative regulation of intracellular transport | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:0045620 | GO:0045620 | negative regulation of lymphocyte differentiation | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:0045744 | GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:0061383 | GO:0061383 | trabecula morphogenesis | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:0071622 | GO:0071622 | regulation of granulocyte chemotaxis | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:2000351 | GO:2000351 | regulation of endothelial cell apoptotic process | 15/2060 | 32/8135 | 1.85 | 6.67e-03 | 2.76e-02 | 32 |
GO:0060021 | GO:0060021 | roof of mouth development | 24/2060 | 59/8135 | 1.61 | 6.77e-03 | 2.78e-02 | 59 |
GO:0071236 | GO:0071236 | cellular response to antibiotic | 24/2060 | 59/8135 | 1.61 | 6.77e-03 | 2.78e-02 | 59 |
GO:0046620 | GO:0046620 | regulation of organ growth | 23/2060 | 56/8135 | 1.62 | 6.92e-03 | 2.83e-02 | 56 |
GO:0032655 | GO:0032655 | regulation of interleukin-12 production | 16/2060 | 35/8135 | 1.81 | 6.94e-03 | 2.83e-02 | 35 |
GO:0042743 | GO:0042743 | hydrogen peroxide metabolic process | 16/2060 | 35/8135 | 1.81 | 6.94e-03 | 2.83e-02 | 35 |
GO:0043407 | GO:0043407 | negative regulation of MAP kinase activity | 16/2060 | 35/8135 | 1.81 | 6.94e-03 | 2.83e-02 | 35 |
GO:0051702 | GO:0051702 | interaction with symbiont | 16/2060 | 35/8135 | 1.81 | 6.94e-03 | 2.83e-02 | 35 |
GO:0045778 | GO:0045778 | positive regulation of ossification | 22/2060 | 53/8135 | 1.64 | 7.05e-03 | 2.86e-02 | 53 |
GO:0005978 | GO:0005978 | glycogen biosynthetic process | 11/2060 | 21/8135 | 2.07 | 7.06e-03 | 2.86e-02 | 21 |
GO:0009250 | GO:0009250 | glucan biosynthetic process | 11/2060 | 21/8135 | 2.07 | 7.06e-03 | 2.86e-02 | 21 |
GO:0060393 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 17/2060 | 38/8135 | 1.77 | 7.12e-03 | 2.87e-02 | 38 |
GO:1903556 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production | 17/2060 | 38/8135 | 1.77 | 7.12e-03 | 2.87e-02 | 38 |
GO:0043367 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 21/2060 | 50/8135 | 1.66 | 7.16e-03 | 2.87e-02 | 50 |
GO:0034637 | GO:0034637 | cellular carbohydrate biosynthetic process | 18/2060 | 41/8135 | 1.73 | 7.22e-03 | 2.89e-02 | 41 |
GO:0007492 | GO:0007492 | endoderm development | 20/2060 | 47/8135 | 1.68 | 7.22e-03 | 2.89e-02 | 47 |
GO:0002761 | GO:0002761 | regulation of myeloid leukocyte differentiation | 29/2060 | 75/8135 | 1.53 | 7.23e-03 | 2.89e-02 | 75 |
GO:0002292 | GO:0002292 | T cell differentiation involved in immune response | 19/2060 | 44/8135 | 1.71 | 7.25e-03 | 2.89e-02 | 44 |
GO:0010811 | GO:0010811 | positive regulation of cell-substrate adhesion | 28/2060 | 72/8135 | 1.54 | 7.51e-03 | 2.98e-02 | 72 |
GO:0051099 | GO:0051099 | positive regulation of binding | 28/2060 | 72/8135 | 1.54 | 7.51e-03 | 2.98e-02 | 72 |
GO:0055007 | GO:0055007 | cardiac muscle cell differentiation | 28/2060 | 72/8135 | 1.54 | 7.51e-03 | 2.98e-02 | 72 |
GO:0002825 | GO:0002825 | regulation of T-helper 1 type immune response | 12/2060 | 24/8135 | 1.97 | 7.94e-03 | 3.12e-02 | 24 |
GO:0006699 | GO:0006699 | bile acid biosynthetic process | 12/2060 | 24/8135 | 1.97 | 7.94e-03 | 3.12e-02 | 24 |
GO:0032735 | GO:0032735 | positive regulation of interleukin-12 production | 12/2060 | 24/8135 | 1.97 | 7.94e-03 | 3.12e-02 | 24 |
GO:0051489 | GO:0051489 | regulation of filopodium assembly | 12/2060 | 24/8135 | 1.97 | 7.94e-03 | 3.12e-02 | 24 |
GO:0060976 | GO:0060976 | coronary vasculature development | 12/2060 | 24/8135 | 1.97 | 7.94e-03 | 3.12e-02 | 24 |
GO:0099084 | GO:0099084 | postsynaptic specialization organization | 12/2060 | 24/8135 | 1.97 | 7.94e-03 | 3.12e-02 | 24 |
GO:0031122 | GO:0031122 | cytoplasmic microtubule organization | 9/2060 | 16/8135 | 2.22 | 8.11e-03 | 3.14e-02 | 16 |
GO:0035812 | GO:0035812 | renal sodium excretion | 9/2060 | 16/8135 | 2.22 | 8.11e-03 | 3.14e-02 | 16 |
GO:0035813 | GO:0035813 | regulation of renal sodium excretion | 9/2060 | 16/8135 | 2.22 | 8.11e-03 | 3.14e-02 | 16 |
GO:0042590 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 9/2060 | 16/8135 | 2.22 | 8.11e-03 | 3.14e-02 | 16 |
GO:0045601 | GO:0045601 | regulation of endothelial cell differentiation | 9/2060 | 16/8135 | 2.22 | 8.11e-03 | 3.14e-02 | 16 |
GO:0010934 | GO:0010934 | macrophage cytokine production | 7/2060 | 11/8135 | 2.51 | 8.11e-03 | 3.14e-02 | 11 |
GO:0031648 | GO:0031648 | protein destabilization | 7/2060 | 11/8135 | 2.51 | 8.11e-03 | 3.14e-02 | 11 |
GO:0033605 | GO:0033605 | positive regulation of catecholamine secretion | 7/2060 | 11/8135 | 2.51 | 8.11e-03 | 3.14e-02 | 11 |
GO:0060390 | GO:0060390 | regulation of SMAD protein signal transduction | 7/2060 | 11/8135 | 2.51 | 8.11e-03 | 3.14e-02 | 11 |
GO:0070493 | GO:0070493 | thrombin-activated receptor signaling pathway | 7/2060 | 11/8135 | 2.51 | 8.11e-03 | 3.14e-02 | 11 |
GO:1901889 | GO:1901889 | negative regulation of cell junction assembly | 7/2060 | 11/8135 | 2.51 | 8.11e-03 | 3.14e-02 | 11 |
GO:0019218 | GO:0019218 | regulation of steroid metabolic process | 25/2060 | 63/8135 | 1.57 | 8.36e-03 | 3.22e-02 | 63 |
GO:0048002 | GO:0048002 | antigen processing and presentation of peptide antigen | 25/2060 | 63/8135 | 1.57 | 8.36e-03 | 3.22e-02 | 63 |
GO:0072088 | GO:0072088 | nephron epithelium morphogenesis | 25/2060 | 63/8135 | 1.57 | 8.36e-03 | 3.22e-02 | 63 |
GO:0002090 | GO:0002090 | regulation of receptor internalization | 13/2060 | 27/8135 | 1.90 | 8.61e-03 | 3.29e-02 | 27 |
GO:0019934 | GO:0019934 | cGMP-mediated signaling | 13/2060 | 27/8135 | 1.90 | 8.61e-03 | 3.29e-02 | 27 |
GO:0045824 | GO:0045824 | negative regulation of innate immune response | 13/2060 | 27/8135 | 1.90 | 8.61e-03 | 3.29e-02 | 27 |
GO:0017038 | GO:0017038 | protein import | 24/2060 | 60/8135 | 1.58 | 8.63e-03 | 3.29e-02 | 60 |
GO:0042136 | GO:0042136 | neurotransmitter biosynthetic process | 24/2060 | 60/8135 | 1.58 | 8.63e-03 | 3.29e-02 | 60 |
GO:0002028 | GO:0002028 | regulation of sodium ion transport | 23/2060 | 57/8135 | 1.59 | 8.88e-03 | 3.37e-02 | 57 |
GO:0001657 | GO:0001657 | ureteric bud development | 29/2060 | 76/8135 | 1.51 | 8.92e-03 | 3.37e-02 | 76 |
GO:0044344 | GO:0044344 | cellular response to fibroblast growth factor stimulus | 29/2060 | 76/8135 | 1.51 | 8.92e-03 | 3.37e-02 | 76 |
GO:0072163 | GO:0072163 | mesonephric epithelium development | 29/2060 | 76/8135 | 1.51 | 8.92e-03 | 3.37e-02 | 76 |
GO:0072164 | GO:0072164 | mesonephric tubule development | 29/2060 | 76/8135 | 1.51 | 8.92e-03 | 3.37e-02 | 76 |
GO:0005977 | GO:0005977 | glycogen metabolic process | 14/2060 | 30/8135 | 1.84 | 9.09e-03 | 3.43e-02 | 30 |
GO:0010862 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 14/2060 | 30/8135 | 1.84 | 9.09e-03 | 3.43e-02 | 30 |
GO:0002478 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 22/2060 | 54/8135 | 1.61 | 9.11e-03 | 3.43e-02 | 54 |
GO:0051279 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 22/2060 | 54/8135 | 1.61 | 9.11e-03 | 3.43e-02 | 54 |
GO:0050432 | GO:0050432 | catecholamine secretion | 21/2060 | 51/8135 | 1.63 | 9.32e-03 | 3.50e-02 | 51 |
GO:0050433 | GO:0050433 | regulation of catecholamine secretion | 21/2060 | 51/8135 | 1.63 | 9.32e-03 | 3.50e-02 | 51 |
GO:1901222 | GO:1901222 | regulation of NIK/NF-kappaB signaling | 21/2060 | 51/8135 | 1.63 | 9.32e-03 | 3.50e-02 | 51 |
GO:0010660 | GO:0010660 | regulation of muscle cell apoptotic process | 15/2060 | 33/8135 | 1.80 | 9.42e-03 | 3.51e-02 | 33 |
GO:0033692 | GO:0033692 | cellular polysaccharide biosynthetic process | 15/2060 | 33/8135 | 1.80 | 9.42e-03 | 3.51e-02 | 33 |
GO:1904705 | GO:1904705 | regulation of vascular smooth muscle cell proliferation | 15/2060 | 33/8135 | 1.80 | 9.42e-03 | 3.51e-02 | 33 |
GO:1990874 | GO:1990874 | vascular smooth muscle cell proliferation | 15/2060 | 33/8135 | 1.80 | 9.42e-03 | 3.51e-02 | 33 |
GO:0032720 | GO:0032720 | negative regulation of tumor necrosis factor production | 16/2060 | 36/8135 | 1.76 | 9.61e-03 | 3.55e-02 | 36 |
GO:0060761 | GO:0060761 | negative regulation of response to cytokine stimulus | 16/2060 | 36/8135 | 1.76 | 9.61e-03 | 3.55e-02 | 36 |
GO:0032231 | GO:0032231 | regulation of actin filament bundle assembly | 19/2060 | 45/8135 | 1.67 | 9.62e-03 | 3.55e-02 | 45 |
GO:0048145 | GO:0048145 | regulation of fibroblast proliferation | 19/2060 | 45/8135 | 1.67 | 9.62e-03 | 3.55e-02 | 45 |
GO:0008630 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 18/2060 | 42/8135 | 1.69 | 9.69e-03 | 3.55e-02 | 42 |
GO:0045667 | GO:0045667 | regulation of osteoblast differentiation | 27/2060 | 70/8135 | 1.52 | 9.70e-03 | 3.55e-02 | 70 |
GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 27/2060 | 70/8135 | 1.52 | 9.70e-03 | 3.55e-02 | 70 |
GO:0050680 | GO:0050680 | negative regulation of epithelial cell proliferation | 27/2060 | 70/8135 | 1.52 | 9.70e-03 | 3.55e-02 | 70 |
GO:0001893 | GO:0001893 | maternal placenta development | 10/2060 | 19/8135 | 2.08 | 9.71e-03 | 3.55e-02 | 19 |
GO:0035767 | GO:0035767 | endothelial cell chemotaxis | 10/2060 | 19/8135 | 2.08 | 9.71e-03 | 3.55e-02 | 19 |
GO:0045589 | GO:0045589 | regulation of regulatory T cell differentiation | 10/2060 | 19/8135 | 2.08 | 9.71e-03 | 3.55e-02 | 19 |
GO:0072215 | GO:0072215 | regulation of metanephros development | 10/2060 | 19/8135 | 2.08 | 9.71e-03 | 3.55e-02 | 19 |
GO:0072539 | GO:0072539 | T-helper 17 cell differentiation | 10/2060 | 19/8135 | 2.08 | 9.71e-03 | 3.55e-02 | 19 |
GO:0030193 | GO:0030193 | regulation of blood coagulation | 25/2060 | 64/8135 | 1.54 | 1.05e-02 | 3.79e-02 | 64 |
GO:1900046 | GO:1900046 | regulation of hemostasis | 25/2060 | 64/8135 | 1.54 | 1.05e-02 | 3.79e-02 | 64 |
GO:0030177 | GO:0030177 | positive regulation of Wnt signaling pathway | 24/2060 | 61/8135 | 1.55 | 1.09e-02 | 3.90e-02 | 61 |
GO:0046545 | GO:0046545 | development of primary female sexual characteristics | 24/2060 | 61/8135 | 1.55 | 1.09e-02 | 3.90e-02 | 61 |
GO:0006706 | GO:0006706 | steroid catabolic process | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0032660 | GO:0032660 | regulation of interleukin-17 production | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0038083 | GO:0038083 | peptidyl-tyrosine autophosphorylation | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0060306 | GO:0060306 | regulation of membrane repolarization | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0061384 | GO:0061384 | heart trabecula morphogenesis | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0097106 | GO:0097106 | postsynaptic density organization | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0097194 | GO:0097194 | execution phase of apoptosis | 11/2060 | 22/8135 | 1.97 | 1.09e-02 | 3.90e-02 | 22 |
GO:0002922 | GO:0002922 | positive regulation of humoral immune response | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:0010544 | GO:0010544 | negative regulation of platelet activation | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:0032098 | GO:0032098 | regulation of appetite | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:0032770 | GO:0032770 | positive regulation of monooxygenase activity | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:0043516 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:0044117 | GO:0044117 | growth of symbiont in host | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:2000846 | GO:2000846 | regulation of corticosteroid hormone secretion | 8/2060 | 14/8135 | 2.26 | 1.11e-02 | 3.93e-02 | 14 |
GO:0038061 | GO:0038061 | NIK/NF-kappaB signaling | 22/2060 | 55/8135 | 1.58 | 1.16e-02 | 4.09e-02 | 55 |
GO:0051170 | GO:0051170 | import into nucleus | 22/2060 | 55/8135 | 1.58 | 1.16e-02 | 4.09e-02 | 55 |
GO:0055006 | GO:0055006 | cardiac cell development | 22/2060 | 55/8135 | 1.58 | 1.16e-02 | 4.09e-02 | 55 |
GO:0072171 | GO:0072171 | mesonephric tubule morphogenesis | 22/2060 | 55/8135 | 1.58 | 1.16e-02 | 4.09e-02 | 55 |
GO:0045622 | GO:0045622 | regulation of T-helper cell differentiation | 12/2060 | 25/8135 | 1.90 | 1.18e-02 | 4.13e-02 | 25 |
GO:0051154 | GO:0051154 | negative regulation of striated muscle cell differentiation | 12/2060 | 25/8135 | 1.90 | 1.18e-02 | 4.13e-02 | 25 |
GO:0051953 | GO:0051953 | negative regulation of amine transport | 12/2060 | 25/8135 | 1.90 | 1.18e-02 | 4.13e-02 | 25 |
GO:0051968 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 12/2060 | 25/8135 | 1.90 | 1.18e-02 | 4.13e-02 | 25 |
GO:0035249 | GO:0035249 | synaptic transmission, glutamatergic | 27/2060 | 71/8135 | 1.50 | 1.20e-02 | 4.17e-02 | 71 |
GO:0006606 | GO:0006606 | protein import into nucleus | 21/2060 | 52/8135 | 1.59 | 1.20e-02 | 4.17e-02 | 52 |
GO:0010906 | GO:0010906 | regulation of glucose metabolic process | 21/2060 | 52/8135 | 1.59 | 1.20e-02 | 4.17e-02 | 52 |
GO:0033138 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 21/2060 | 52/8135 | 1.59 | 1.20e-02 | 4.17e-02 | 52 |
GO:0070664 | GO:0070664 | negative regulation of leukocyte proliferation | 21/2060 | 52/8135 | 1.59 | 1.20e-02 | 4.17e-02 | 52 |
GO:1901655 | GO:1901655 | cellular response to ketone | 21/2060 | 52/8135 | 1.59 | 1.20e-02 | 4.17e-02 | 52 |
GO:0001961 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 13/2060 | 28/8135 | 1.83 | 1.24e-02 | 4.27e-02 | 28 |
GO:0002820 | GO:0002820 | negative regulation of adaptive immune response | 13/2060 | 28/8135 | 1.83 | 1.24e-02 | 4.27e-02 | 28 |
GO:0032689 | GO:0032689 | negative regulation of interferon-gamma production | 13/2060 | 28/8135 | 1.83 | 1.24e-02 | 4.27e-02 | 28 |
GO:0043388 | GO:0043388 | positive regulation of DNA binding | 13/2060 | 28/8135 | 1.83 | 1.24e-02 | 4.27e-02 | 28 |
GO:0046006 | GO:0046006 | regulation of activated T cell proliferation | 13/2060 | 28/8135 | 1.83 | 1.24e-02 | 4.27e-02 | 28 |
GO:0051281 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 13/2060 | 28/8135 | 1.83 | 1.24e-02 | 4.27e-02 | 28 |
GO:0007044 | GO:0007044 | cell-substrate junction assembly | 19/2060 | 46/8135 | 1.63 | 1.26e-02 | 4.31e-02 | 46 |
GO:0045913 | GO:0045913 | positive regulation of carbohydrate metabolic process | 19/2060 | 46/8135 | 1.63 | 1.26e-02 | 4.31e-02 | 46 |
GO:0048144 | GO:0048144 | fibroblast proliferation | 19/2060 | 46/8135 | 1.63 | 1.26e-02 | 4.31e-02 | 46 |
GO:0006073 | GO:0006073 | cellular glucan metabolic process | 14/2060 | 31/8135 | 1.78 | 1.28e-02 | 4.35e-02 | 31 |
GO:0006081 | GO:0006081 | cellular aldehyde metabolic process | 14/2060 | 31/8135 | 1.78 | 1.28e-02 | 4.35e-02 | 31 |
GO:0044042 | GO:0044042 | glucan metabolic process | 14/2060 | 31/8135 | 1.78 | 1.28e-02 | 4.35e-02 | 31 |
GO:0048566 | GO:0048566 | embryonic digestive tract development | 14/2060 | 31/8135 | 1.78 | 1.28e-02 | 4.35e-02 | 31 |
GO:0090278 | GO:0090278 | negative regulation of peptide hormone secretion | 14/2060 | 31/8135 | 1.78 | 1.28e-02 | 4.35e-02 | 31 |
GO:0046637 | GO:0046637 | regulation of alpha-beta T cell differentiation | 18/2060 | 43/8135 | 1.65 | 1.28e-02 | 4.36e-02 | 43 |
GO:0110020 | GO:0110020 | regulation of actomyosin structure organization | 17/2060 | 40/8135 | 1.68 | 1.30e-02 | 4.37e-02 | 40 |
GO:1901224 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 17/2060 | 40/8135 | 1.68 | 1.30e-02 | 4.37e-02 | 40 |
GO:1902305 | GO:1902305 | regulation of sodium ion transmembrane transport | 17/2060 | 40/8135 | 1.68 | 1.30e-02 | 4.37e-02 | 40 |
GO:2000514 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 17/2060 | 40/8135 | 1.68 | 1.30e-02 | 4.37e-02 | 40 |
GO:0000271 | GO:0000271 | polysaccharide biosynthetic process | 15/2060 | 34/8135 | 1.74 | 1.30e-02 | 4.37e-02 | 34 |
GO:0010657 | GO:0010657 | muscle cell apoptotic process | 15/2060 | 34/8135 | 1.74 | 1.30e-02 | 4.37e-02 | 34 |
GO:0010676 | GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 15/2060 | 34/8135 | 1.74 | 1.30e-02 | 4.37e-02 | 34 |
GO:0051851 | GO:0051851 | modification by host of symbiont morphology or physiology | 15/2060 | 34/8135 | 1.74 | 1.30e-02 | 4.37e-02 | 34 |
GO:0072210 | GO:0072210 | metanephric nephron development | 15/2060 | 34/8135 | 1.74 | 1.30e-02 | 4.37e-02 | 34 |
GO:0019319 | GO:0019319 | hexose biosynthetic process | 16/2060 | 37/8135 | 1.71 | 1.30e-02 | 4.37e-02 | 37 |
GO:0060986 | GO:0060986 | endocrine hormone secretion | 16/2060 | 37/8135 | 1.71 | 1.30e-02 | 4.37e-02 | 37 |
GO:0007043 | GO:0007043 | cell-cell junction assembly | 25/2060 | 65/8135 | 1.52 | 1.30e-02 | 4.37e-02 | 65 |
GO:0050818 | GO:0050818 | regulation of coagulation | 25/2060 | 65/8135 | 1.52 | 1.30e-02 | 4.37e-02 | 65 |
GO:1902106 | GO:1902106 | negative regulation of leukocyte differentiation | 25/2060 | 65/8135 | 1.52 | 1.30e-02 | 4.37e-02 | 65 |
GO:0001516 | GO:0001516 | prostaglandin biosynthetic process | 9/2060 | 17/8135 | 2.09 | 1.34e-02 | 4.44e-02 | 17 |
GO:0042533 | GO:0042533 | tumor necrosis factor biosynthetic process | 9/2060 | 17/8135 | 2.09 | 1.34e-02 | 4.44e-02 | 17 |
GO:0042534 | GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 9/2060 | 17/8135 | 2.09 | 1.34e-02 | 4.44e-02 | 17 |
GO:0046457 | GO:0046457 | prostanoid biosynthetic process | 9/2060 | 17/8135 | 2.09 | 1.34e-02 | 4.44e-02 | 17 |
GO:0046621 | GO:0046621 | negative regulation of organ growth | 9/2060 | 17/8135 | 2.09 | 1.34e-02 | 4.44e-02 | 17 |
GO:2000831 | GO:2000831 | regulation of steroid hormone secretion | 9/2060 | 17/8135 | 2.09 | 1.34e-02 | 4.44e-02 | 17 |
GO:1904894 | GO:1904894 | positive regulation of STAT cascade | 24/2060 | 62/8135 | 1.53 | 1.36e-02 | 4.49e-02 | 62 |
GO:0046427 | GO:0046427 | positive regulation of JAK-STAT cascade | 23/2060 | 59/8135 | 1.54 | 1.41e-02 | 4.67e-02 | 59 |
GO:1903524 | GO:1903524 | positive regulation of blood circulation | 22/2060 | 56/8135 | 1.55 | 1.47e-02 | 4.82e-02 | 56 |
GO:1902624 | GO:1902624 | positive regulation of neutrophil migration | 10/2060 | 20/8135 | 1.97 | 1.51e-02 | 4.94e-02 | 20 |
GO:1902893 | GO:1902893 | regulation of pri-miRNA transcription by RNA polymerase II | 10/2060 | 20/8135 | 1.97 | 1.51e-02 | 4.94e-02 | 20 |
GO:0002702 | GO:0002702 | positive regulation of production of molecular mediator of immune response | 21/2060 | 53/8135 | 1.56 | 1.52e-02 | 4.95e-02 | 53 |
GO:0032729 | GO:0032729 | positive regulation of interferon-gamma production | 21/2060 | 53/8135 | 1.56 | 1.52e-02 | 4.95e-02 | 53 |
GO:0002374 | GO:0002374 | cytokine secretion involved in immune response | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:0006525 | GO:0006525 | arginine metabolic process | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:0014741 | GO:0014741 | negative regulation of muscle hypertrophy | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:0032373 | GO:0032373 | positive regulation of sterol transport | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:0032376 | GO:0032376 | positive regulation of cholesterol transport | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:0051023 | GO:0051023 | regulation of immunoglobulin secretion | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:0072216 | GO:0072216 | positive regulation of metanephros development | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
GO:1900746 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 7/2060 | 12/8135 | 2.30 | 1.53e-02 | 4.95e-02 | 12 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0030198 | GO:0030198 | extracellular matrix organization | 152/3118 | 264/8135 | 1.50 | 9.71e-11 | 4.14e-07 | 264 |
GO:0043588 | GO:0043588 | skin development | 140/3118 | 241/8135 | 1.52 | 2.32e-10 | 4.94e-07 | 241 |
GO:0030216 | GO:0030216 | keratinocyte differentiation | 95/3118 | 162/8135 | 1.53 | 9.99e-08 | 1.06e-04 | 162 |
GO:0031424 | GO:0031424 | keratinization | 74/3118 | 123/8135 | 1.57 | 6.50e-07 | 2.61e-04 | 123 |
GO:0070268 | GO:0070268 | cornification | 60/3118 | 95/8135 | 1.65 | 7.36e-07 | 2.61e-04 | 95 |
GO:0034754 | GO:0034754 | cellular hormone metabolic process | 53/3118 | 87/8135 | 1.59 | 1.50e-05 | 2.66e-03 | 87 |
GO:0007044 | GO:0007044 | cell-substrate junction assembly | 32/3118 | 46/8135 | 1.81 | 1.66e-05 | 2.71e-03 | 46 |
GO:0018149 | GO:0018149 | peptide cross-linking | 29/3118 | 42/8135 | 1.80 | 5.15e-05 | 6.27e-03 | 42 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 52/3118 | 90/8135 | 1.51 | 1.33e-04 | 1.23e-02 | 90 |
GO:0097306 | GO:0097306 | cellular response to alcohol | 32/3118 | 50/8135 | 1.67 | 2.01e-04 | 1.68e-02 | 50 |
GO:0061844 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 33/3118 | 52/8135 | 1.66 | 2.03e-04 | 1.68e-02 | 52 |
GO:0030199 | GO:0030199 | collagen fibril organization | 25/3118 | 37/8135 | 1.76 | 2.91e-04 | 2.17e-02 | 37 |
GO:0030104 | GO:0030104 | water homeostasis | 31/3118 | 49/8135 | 1.65 | 3.42e-04 | 2.37e-02 | 49 |
GO:1902895 | GO:1902895 | positive regulation of pri-miRNA transcription by RNA polymerase II | 12/3118 | 14/8135 | 2.24 | 3.79e-04 | 2.48e-02 | 14 |
GO:0071347 | GO:0071347 | cellular response to interleukin-1 | 44/3118 | 76/8135 | 1.51 | 4.02e-04 | 2.56e-02 | 76 |
GO:0050680 | GO:0050680 | negative regulation of epithelial cell proliferation | 41/3118 | 70/8135 | 1.53 | 4.50e-04 | 2.74e-02 | 70 |
GO:0035588 | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 17/3118 | 23/8135 | 1.93 | 5.66e-04 | 3.13e-02 | 23 |
GO:0007566 | GO:0007566 | embryo implantation | 18/3118 | 25/8135 | 1.88 | 6.53e-04 | 3.52e-02 | 25 |
GO:0051893 | GO:0051893 | regulation of focal adhesion assembly | 19/3118 | 27/8135 | 1.84 | 7.30e-04 | 3.61e-02 | 27 |
GO:0090109 | GO:0090109 | regulation of cell-substrate junction assembly | 19/3118 | 27/8135 | 1.84 | 7.30e-04 | 3.61e-02 | 27 |
GO:1903391 | GO:1903391 | regulation of adherens junction organization | 19/3118 | 27/8135 | 1.84 | 7.30e-04 | 3.61e-02 | 27 |
GO:0033561 | GO:0033561 | regulation of water loss via skin | 14/3118 | 18/8135 | 2.03 | 7.66e-04 | 3.71e-02 | 18 |
GO:0061436 | GO:0061436 | establishment of skin barrier | 14/3118 | 18/8135 | 2.03 | 7.66e-04 | 3.71e-02 | 18 |
GO:0030177 | GO:0030177 | positive regulation of Wnt signaling pathway | 36/3118 | 61/8135 | 1.54 | 8.11e-04 | 3.88e-02 | 61 |
GO:0050891 | GO:0050891 | multicellular organismal water homeostasis | 29/3118 | 47/8135 | 1.61 | 9.58e-04 | 4.26e-02 | 47 |
GO:0048546 | GO:0048546 | digestive tract morphogenesis | 25/3118 | 39/8135 | 1.67 | 9.63e-04 | 4.26e-02 | 39 |
GO:1901888 | GO:1901888 | regulation of cell junction assembly | 25/3118 | 39/8135 | 1.67 | 9.63e-04 | 4.26e-02 | 39 |
GO:0006703 | GO:0006703 | estrogen biosynthetic process | 9/3118 | 10/8135 | 2.35 | 1.16e-03 | 4.80e-02 | 10 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0055123 | GO:0055123 | digestive system development | 69/3340 | 112/8135 | 1.50 | 8.10e-06 | 0.0174 | 112 |
GO:0030514 | GO:0030514 | negative regulation of BMP signaling pathway | 25/3340 | 34/8135 | 1.79 | 1.23e-04 | 0.0439 | 34 |
GO:0090101 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 44/3340 | 70/8135 | 1.53 | 1.80e-04 | 0.0439 | 70 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0050778 | GO:0050778 | positive regulation of immune response | 201/1801 | 423/8135 | 2.15 | 1.60e-32 | 4.68e-29 | 423 |
GO:0046649 | GO:0046649 | lymphocyte activation | 192/1801 | 397/8135 | 2.18 | 2.40e-32 | 4.68e-29 | 397 |
GO:0045087 | GO:0045087 | innate immune response | 220/1801 | 485/8135 | 2.05 | 7.07e-32 | 9.19e-29 | 485 |
GO:0002250 | GO:0002250 | adaptive immune response | 146/1801 | 269/8135 | 2.45 | 1.50e-31 | 1.46e-28 | 269 |
GO:0042110 | GO:0042110 | T cell activation | 144/1801 | 285/8135 | 2.28 | 8.37e-27 | 6.52e-24 | 285 |
GO:0002253 | GO:0002253 | activation of immune response | 146/1801 | 302/8135 | 2.18 | 1.21e-24 | 7.83e-22 | 302 |
GO:0002443 | GO:0002443 | leukocyte mediated immunity | 180/1801 | 410/8135 | 1.98 | 5.10e-24 | 2.84e-21 | 410 |
GO:0002764 | GO:0002764 | immune response-regulating signaling pathway | 130/1801 | 270/8135 | 2.17 | 7.97e-22 | 3.89e-19 | 270 |
GO:0051607 | GO:0051607 | defense response to virus | 74/1801 | 118/8135 | 2.83 | 1.61e-21 | 6.97e-19 | 118 |
GO:0002757 | GO:0002757 | immune response-activating signal transduction | 121/1801 | 249/8135 | 2.19 | 8.46e-21 | 3.30e-18 | 249 |
GO:0051249 | GO:0051249 | regulation of lymphocyte activation | 124/1801 | 260/8135 | 2.15 | 2.05e-20 | 7.26e-18 | 260 |
GO:0034340 | GO:0034340 | response to type I interferon | 40/1801 | 47/8135 | 3.84 | 5.39e-20 | 1.50e-17 | 47 |
GO:0060337 | GO:0060337 | type I interferon signaling pathway | 40/1801 | 47/8135 | 3.84 | 5.39e-20 | 1.50e-17 | 47 |
GO:0071357 | GO:0071357 | cellular response to type I interferon | 40/1801 | 47/8135 | 3.84 | 5.39e-20 | 1.50e-17 | 47 |
GO:0009615 | GO:0009615 | response to virus | 88/1801 | 162/8135 | 2.45 | 2.09e-19 | 5.44e-17 | 162 |
GO:0002460 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 90/1801 | 168/8135 | 2.42 | 2.78e-19 | 6.77e-17 | 168 |
GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 152/1801 | 354/8135 | 1.94 | 3.07e-19 | 7.03e-17 | 354 |
GO:0002263 | GO:0002263 | cell activation involved in immune response | 152/1801 | 356/8135 | 1.93 | 5.84e-19 | 1.22e-16 | 356 |
GO:0002521 | GO:0002521 | leukocyte differentiation | 140/1801 | 318/8135 | 1.99 | 5.97e-19 | 1.22e-16 | 318 |
GO:0002697 | GO:0002697 | regulation of immune effector process | 118/1801 | 251/8135 | 2.12 | 7.59e-19 | 1.48e-16 | 251 |
GO:0050863 | GO:0050863 | regulation of T cell activation | 101/1801 | 203/8135 | 2.25 | 1.89e-18 | 3.50e-16 | 203 |
GO:0098542 | GO:0098542 | defense response to other organism | 122/1801 | 268/8135 | 2.06 | 4.85e-18 | 8.59e-16 | 268 |
GO:0002694 | GO:0002694 | regulation of leukocyte activation | 137/1801 | 316/8135 | 1.96 | 7.38e-18 | 1.25e-15 | 316 |
GO:0031347 | GO:0031347 | regulation of defense response | 170/1801 | 425/8135 | 1.81 | 1.17e-17 | 1.90e-15 | 425 |
GO:0019221 | GO:0019221 | cytokine-mediated signaling pathway | 179/1801 | 459/8135 | 1.76 | 3.16e-17 | 4.93e-15 | 459 |
GO:0001816 | GO:0001816 | cytokine production | 174/1801 | 444/8135 | 1.77 | 5.21e-17 | 7.81e-15 | 444 |
GO:0002768 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 93/1801 | 189/8135 | 2.22 | 1.11e-16 | 1.61e-14 | 189 |
GO:0050865 | GO:0050865 | regulation of cell activation | 142/1801 | 344/8135 | 1.86 | 3.05e-16 | 4.25e-14 | 344 |
GO:0070661 | GO:0070661 | leukocyte proliferation | 93/1801 | 193/8135 | 2.18 | 6.14e-16 | 8.13e-14 | 193 |
GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 94/1801 | 196/8135 | 2.17 | 6.26e-16 | 8.13e-14 | 196 |
GO:0019882 | GO:0019882 | antigen processing and presentation | 52/1801 | 83/8135 | 2.83 | 1.81e-15 | 2.27e-13 | 83 |
GO:0030098 | GO:0030098 | lymphocyte differentiation | 99/1801 | 214/8135 | 2.09 | 2.07e-15 | 2.52e-13 | 214 |
GO:0002429 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 83/1801 | 167/8135 | 2.24 | 2.45e-15 | 2.89e-13 | 167 |
GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 100/1801 | 218/8135 | 2.07 | 2.98e-15 | 3.41e-13 | 218 |
GO:0034341 | GO:0034341 | response to interferon-gamma | 68/1801 | 126/8135 | 2.44 | 4.39e-15 | 4.89e-13 | 126 |
GO:0030097 | GO:0030097 | hemopoiesis | 173/1801 | 459/8135 | 1.70 | 5.12e-15 | 5.54e-13 | 459 |
GO:0050851 | GO:0050851 | antigen receptor-mediated signaling pathway | 61/1801 | 108/8135 | 2.55 | 6.93e-15 | 7.30e-13 | 108 |
GO:0001817 | GO:0001817 | regulation of cytokine production | 157/1801 | 406/8135 | 1.75 | 8.01e-15 | 8.05e-13 | 406 |
GO:0002449 | GO:0002449 | lymphocyte mediated immunity | 80/1801 | 161/8135 | 2.24 | 8.05e-15 | 8.05e-13 | 161 |
GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 83/1801 | 170/8135 | 2.21 | 9.10e-15 | 8.87e-13 | 170 |
GO:0050870 | GO:0050870 | positive regulation of T cell activation | 72/1801 | 139/8135 | 2.34 | 1.17e-14 | 1.11e-12 | 139 |
GO:0002683 | GO:0002683 | negative regulation of immune system process | 116/1801 | 273/8135 | 1.92 | 1.63e-14 | 1.51e-12 | 273 |
GO:0048534 | GO:0048534 | hematopoietic or lymphoid organ development | 179/1801 | 487/8135 | 1.66 | 2.62e-14 | 2.37e-12 | 487 |
GO:0032943 | GO:0032943 | mononuclear cell proliferation | 85/1801 | 179/8135 | 2.14 | 3.30e-14 | 2.92e-12 | 179 |
GO:0045088 | GO:0045088 | regulation of innate immune response | 91/1801 | 198/8135 | 2.08 | 4.76e-14 | 4.12e-12 | 198 |
GO:0002274 | GO:0002274 | myeloid leukocyte activation | 131/1801 | 328/8135 | 1.80 | 9.46e-14 | 8.02e-12 | 328 |
GO:0046651 | GO:0046651 | lymphocyte proliferation | 83/1801 | 177/8135 | 2.12 | 1.60e-13 | 1.33e-11 | 177 |
GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 91/1801 | 202/8135 | 2.03 | 2.06e-13 | 1.67e-11 | 202 |
GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 73/1801 | 149/8135 | 2.21 | 3.08e-13 | 2.45e-11 | 149 |
GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 108/1801 | 260/8135 | 1.88 | 8.11e-13 | 6.33e-11 | 260 |
GO:0030155 | GO:0030155 | regulation of cell adhesion | 155/1801 | 419/8135 | 1.67 | 9.10e-13 | 6.96e-11 | 419 |
GO:0002275 | GO:0002275 | myeloid cell activation involved in immune response | 108/1801 | 261/8135 | 1.87 | 1.09e-12 | 8.18e-11 | 261 |
GO:0050867 | GO:0050867 | positive regulation of cell activation | 92/1801 | 210/8135 | 1.98 | 1.13e-12 | 8.29e-11 | 210 |
GO:0071346 | GO:0071346 | cellular response to interferon-gamma | 59/1801 | 112/8135 | 2.38 | 1.17e-12 | 8.46e-11 | 112 |
GO:0032609 | GO:0032609 | interferon-gamma production | 50/1801 | 88/8135 | 2.57 | 1.42e-12 | 1.01e-10 | 88 |
GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 81/1801 | 177/8135 | 2.07 | 1.61e-12 | 1.12e-10 | 177 |
GO:0002819 | GO:0002819 | regulation of adaptive immune response | 56/1801 | 105/8135 | 2.41 | 2.26e-12 | 1.55e-10 | 105 |
GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 74/1801 | 158/8135 | 2.12 | 3.67e-12 | 2.47e-10 | 158 |
GO:0009617 | GO:0009617 | response to bacterium | 147/1801 | 398/8135 | 1.67 | 4.25e-12 | 2.81e-10 | 398 |
GO:0060333 | GO:0060333 | interferon-gamma-mediated signaling pathway | 37/1801 | 57/8135 | 2.93 | 4.56e-12 | 2.96e-10 | 57 |
GO:0032479 | GO:0032479 | regulation of type I interferon production | 29/1801 | 39/8135 | 3.36 | 5.08e-12 | 3.20e-10 | 39 |
GO:0032606 | GO:0032606 | type I interferon production | 29/1801 | 39/8135 | 3.36 | 5.08e-12 | 3.20e-10 | 39 |
GO:0046631 | GO:0046631 | alpha-beta T cell activation | 51/1801 | 93/8135 | 2.48 | 5.40e-12 | 3.34e-10 | 93 |
GO:0001819 | GO:0001819 | positive regulation of cytokine production | 109/1801 | 271/8135 | 1.82 | 7.40e-12 | 4.51e-10 | 271 |
GO:0045089 | GO:0045089 | positive regulation of innate immune response | 77/1801 | 169/8135 | 2.06 | 7.58e-12 | 4.55e-10 | 169 |
GO:0030217 | GO:0030217 | T cell differentiation | 71/1801 | 151/8135 | 2.12 | 8.02e-12 | 4.74e-10 | 151 |
GO:0002444 | GO:0002444 | myeloid leukocyte mediated immunity | 106/1801 | 262/8135 | 1.83 | 9.49e-12 | 5.52e-10 | 262 |
GO:0031349 | GO:0031349 | positive regulation of defense response | 104/1801 | 257/8135 | 1.83 | 1.48e-11 | 8.47e-10 | 257 |
GO:0002822 | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 51/1801 | 95/8135 | 2.42 | 1.58e-11 | 8.92e-10 | 95 |
GO:0043299 | GO:0043299 | leukocyte degranulation | 103/1801 | 254/8135 | 1.83 | 1.60e-11 | 8.92e-10 | 254 |
GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 70/1801 | 151/8135 | 2.09 | 2.57e-11 | 1.41e-09 | 151 |
GO:0002699 | GO:0002699 | positive regulation of immune effector process | 66/1801 | 140/8135 | 2.13 | 3.81e-11 | 2.06e-09 | 140 |
GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 69/1801 | 150/8135 | 2.08 | 5.53e-11 | 2.95e-09 | 150 |
GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 104/1801 | 262/8135 | 1.79 | 5.77e-11 | 3.04e-09 | 262 |
GO:0036230 | GO:0036230 | granulocyte activation | 95/1801 | 233/8135 | 1.84 | 7.04e-11 | 3.66e-09 | 233 |
GO:0002446 | GO:0002446 | neutrophil mediated immunity | 93/1801 | 227/8135 | 1.85 | 8.21e-11 | 4.21e-09 | 227 |
GO:0042113 | GO:0042113 | B cell activation | 63/1801 | 134/8135 | 2.12 | 1.23e-10 | 6.22e-09 | 134 |
GO:0002283 | GO:0002283 | neutrophil activation involved in immune response | 91/1801 | 222/8135 | 1.85 | 1.27e-10 | 6.37e-09 | 222 |
GO:0032649 | GO:0032649 | regulation of interferon-gamma production | 44/1801 | 80/8135 | 2.48 | 1.37e-10 | 6.70e-09 | 80 |
GO:0050852 | GO:0050852 | T cell receptor signaling pathway | 44/1801 | 80/8135 | 2.48 | 1.37e-10 | 6.70e-09 | 80 |
GO:0035456 | GO:0035456 | response to interferon-beta | 15/1801 | 15/8135 | 4.52 | 1.44e-10 | 6.92e-09 | 15 |
GO:1902105 | GO:1902105 | regulation of leukocyte differentiation | 76/1801 | 175/8135 | 1.96 | 1.79e-10 | 8.52e-09 | 175 |
GO:0042119 | GO:0042119 | neutrophil activation | 93/1801 | 230/8135 | 1.83 | 1.92e-10 | 9.01e-09 | 230 |
GO:0002703 | GO:0002703 | regulation of leukocyte mediated immunity | 62/1801 | 133/8135 | 2.11 | 2.68e-10 | 1.24e-08 | 133 |
GO:0043312 | GO:0043312 | neutrophil degranulation | 89/1801 | 219/8135 | 1.84 | 3.49e-10 | 1.60e-08 | 219 |
GO:0002821 | GO:0002821 | positive regulation of adaptive immune response | 39/1801 | 69/8135 | 2.55 | 5.21e-10 | 2.36e-08 | 69 |
GO:0019884 | GO:0019884 | antigen processing and presentation of exogenous antigen | 35/1801 | 59/8135 | 2.68 | 6.66e-10 | 2.99e-08 | 59 |
GO:0002474 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 17/1801 | 19/8135 | 4.04 | 7.47e-10 | 3.31e-08 | 19 |
GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 51/1801 | 104/8135 | 2.22 | 1.14e-09 | 5.02e-08 | 104 |
GO:0032103 | GO:0032103 | positive regulation of response to external stimulus | 84/1801 | 208/8135 | 1.82 | 1.59e-09 | 6.87e-08 | 208 |
GO:0042590 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 15/1801 | 16/8135 | 4.23 | 1.83e-09 | 7.82e-08 | 16 |
GO:0042098 | GO:0042098 | T cell proliferation | 56/1801 | 120/8135 | 2.11 | 1.87e-09 | 7.93e-08 | 120 |
GO:0032729 | GO:0032729 | positive regulation of interferon-gamma production | 32/1801 | 53/8135 | 2.73 | 1.94e-09 | 8.14e-08 | 53 |
GO:0002824 | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 37/1801 | 66/8135 | 2.53 | 1.98e-09 | 8.23e-08 | 66 |
GO:0002218 | GO:0002218 | activation of innate immune response | 59/1801 | 130/8135 | 2.05 | 2.63e-09 | 1.08e-07 | 130 |
GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 57/1801 | 125/8135 | 2.06 | 3.93e-09 | 1.60e-07 | 125 |
GO:0031295 | GO:0031295 | T cell costimulation | 25/1801 | 37/8135 | 3.05 | 4.08e-09 | 1.64e-07 | 37 |
GO:0042129 | GO:0042129 | regulation of T cell proliferation | 51/1801 | 108/8135 | 2.13 | 5.99e-09 | 2.38e-07 | 108 |
GO:0050900 | GO:0050900 | leukocyte migration | 111/1801 | 306/8135 | 1.64 | 6.70e-09 | 2.64e-07 | 306 |
GO:0048002 | GO:0048002 | antigen processing and presentation of peptide antigen | 35/1801 | 63/8135 | 2.51 | 7.50e-09 | 2.92e-07 | 63 |
GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 58/1801 | 130/8135 | 2.02 | 7.85e-09 | 3.03e-07 | 130 |
GO:0016032 | GO:0016032 | viral process | 83/1801 | 211/8135 | 1.78 | 8.62e-09 | 3.30e-07 | 211 |
GO:0031294 | GO:0031294 | lymphocyte costimulation | 25/1801 | 38/8135 | 2.97 | 9.41e-09 | 3.56e-07 | 38 |
GO:0042100 | GO:0042100 | B cell proliferation | 34/1801 | 61/8135 | 2.52 | 1.10e-08 | 4.12e-07 | 61 |
GO:0002706 | GO:0002706 | regulation of lymphocyte mediated immunity | 47/1801 | 98/8135 | 2.17 | 1.27e-08 | 4.73e-07 | 98 |
GO:0002475 | GO:0002475 | antigen processing and presentation via MHC class Ib | 12/1801 | 12/8135 | 4.52 | 1.35e-08 | 4.96e-07 | 12 |
GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 59/1801 | 135/8135 | 1.97 | 1.49e-08 | 5.44e-07 | 135 |
GO:0002831 | GO:0002831 | regulation of response to biotic stimulus | 36/1801 | 67/8135 | 2.43 | 1.51e-08 | 5.47e-07 | 67 |
GO:1903901 | GO:1903901 | negative regulation of viral life cycle | 25/1801 | 39/8135 | 2.90 | 2.07e-08 | 7.41e-07 | 39 |
GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 39/1801 | 76/8135 | 2.32 | 2.10e-08 | 7.43e-07 | 76 |
GO:0002440 | GO:0002440 | production of molecular mediator of immune response | 52/1801 | 115/8135 | 2.04 | 2.69e-08 | 9.44e-07 | 115 |
GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 49/1801 | 106/8135 | 2.09 | 2.82e-08 | 9.71e-07 | 106 |
GO:0019724 | GO:0019724 | B cell mediated immunity | 37/1801 | 71/8135 | 2.35 | 2.83e-08 | 9.71e-07 | 71 |
GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 48/1801 | 103/8135 | 2.10 | 2.84e-08 | 9.71e-07 | 103 |
GO:0050727 | GO:0050727 | regulation of inflammatory response | 93/1801 | 251/8135 | 1.67 | 3.61e-08 | 1.22e-06 | 251 |
GO:0032655 | GO:0032655 | regulation of interleukin-12 production | 23/1801 | 35/8135 | 2.97 | 3.86e-08 | 1.30e-06 | 35 |
GO:0019883 | GO:0019883 | antigen processing and presentation of endogenous antigen | 14/1801 | 16/8135 | 3.95 | 4.95e-08 | 1.65e-06 | 16 |
GO:0045071 | GO:0045071 | negative regulation of viral genome replication | 22/1801 | 33/8135 | 3.01 | 5.18e-08 | 1.71e-06 | 33 |
GO:0046634 | GO:0046634 | regulation of alpha-beta T cell activation | 34/1801 | 64/8135 | 2.40 | 5.54e-08 | 1.81e-06 | 64 |
GO:0045619 | GO:0045619 | regulation of lymphocyte differentiation | 49/1801 | 108/8135 | 2.05 | 5.92e-08 | 1.92e-06 | 108 |
GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 47/1801 | 102/8135 | 2.08 | 6.12e-08 | 1.97e-06 | 102 |
GO:0016064 | GO:0016064 | immunoglobulin mediated immune response | 36/1801 | 70/8135 | 2.32 | 6.80e-08 | 2.16e-06 | 70 |
GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 36/1801 | 70/8135 | 2.32 | 6.80e-08 | 2.16e-06 | 70 |
GO:0050854 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 21/1801 | 31/8135 | 3.06 | 6.88e-08 | 2.16e-06 | 31 |
GO:0032615 | GO:0032615 | interleukin-12 production | 23/1801 | 36/8135 | 2.89 | 8.45e-08 | 2.64e-06 | 36 |
GO:0045069 | GO:0045069 | regulation of viral genome replication | 25/1801 | 41/8135 | 2.75 | 8.85e-08 | 2.73e-06 | 41 |
GO:0002478 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 30/1801 | 54/8135 | 2.51 | 8.90e-08 | 2.73e-06 | 54 |
GO:0030595 | GO:0030595 | leukocyte chemotaxis | 68/1801 | 170/8135 | 1.81 | 9.01e-08 | 2.74e-06 | 170 |
GO:0002221 | GO:0002221 | pattern recognition receptor signaling pathway | 43/1801 | 91/8135 | 2.13 | 9.08e-08 | 2.74e-06 | 91 |
GO:0044403 | GO:0044403 | symbiont process | 90/1801 | 245/8135 | 1.66 | 9.55e-08 | 2.86e-06 | 245 |
GO:0002758 | GO:0002758 | innate immune response-activating signal transduction | 54/1801 | 125/8135 | 1.95 | 9.77e-08 | 2.91e-06 | 125 |
GO:0002673 | GO:0002673 | regulation of acute inflammatory response | 37/1801 | 74/8135 | 2.26 | 1.16e-07 | 3.42e-06 | 74 |
GO:0002685 | GO:0002685 | regulation of leukocyte migration | 56/1801 | 132/8135 | 1.92 | 1.20e-07 | 3.53e-06 | 132 |
GO:0043065 | GO:0043065 | positive regulation of apoptotic process | 101/1801 | 285/8135 | 1.60 | 1.25e-07 | 3.65e-06 | 285 |
GO:0001818 | GO:0001818 | negative regulation of cytokine production | 66/1801 | 165/8135 | 1.81 | 1.39e-07 | 4.02e-06 | 165 |
GO:0002708 | GO:0002708 | positive regulation of lymphocyte mediated immunity | 35/1801 | 69/8135 | 2.29 | 1.61e-07 | 4.62e-06 | 69 |
GO:0032496 | GO:0032496 | response to lipopolysaccharide | 80/1801 | 213/8135 | 1.70 | 1.70e-07 | 4.80e-06 | 213 |
GO:0007249 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 49/1801 | 111/8135 | 1.99 | 1.70e-07 | 4.80e-06 | 111 |
GO:0002695 | GO:0002695 | negative regulation of leukocyte activation | 48/1801 | 108/8135 | 2.01 | 1.76e-07 | 4.94e-06 | 108 |
GO:0043068 | GO:0043068 | positive regulation of programmed cell death | 101/1801 | 287/8135 | 1.59 | 1.85e-07 | 5.16e-06 | 287 |
GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 39/1801 | 81/8135 | 2.17 | 1.93e-07 | 5.33e-06 | 81 |
GO:0010942 | GO:0010942 | positive regulation of cell death | 110/1801 | 320/8135 | 1.55 | 2.10e-07 | 5.77e-06 | 320 |
GO:0060326 | GO:0060326 | cell chemotaxis | 82/1801 | 221/8135 | 1.68 | 2.18e-07 | 5.95e-06 | 221 |
GO:0002286 | GO:0002286 | T cell activation involved in immune response | 33/1801 | 64/8135 | 2.33 | 2.21e-07 | 5.98e-06 | 64 |
GO:0032480 | GO:0032480 | negative regulation of type I interferon production | 14/1801 | 17/8135 | 3.72 | 2.23e-07 | 6.00e-06 | 17 |
GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 82/1801 | 222/8135 | 1.67 | 2.72e-07 | 7.28e-06 | 222 |
GO:0035458 | GO:0035458 | cellular response to interferon-beta | 10/1801 | 10/8135 | 4.52 | 2.77e-07 | 7.36e-06 | 10 |
GO:0002526 | GO:0002526 | acute inflammatory response | 51/1801 | 119/8135 | 1.94 | 2.99e-07 | 7.89e-06 | 119 |
GO:0001912 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 25/1801 | 43/8135 | 2.63 | 3.26e-07 | 8.49e-06 | 43 |
GO:0042108 | GO:0042108 | positive regulation of cytokine biosynthetic process | 25/1801 | 43/8135 | 2.63 | 3.26e-07 | 8.49e-06 | 43 |
GO:0050688 | GO:0050688 | regulation of defense response to virus | 21/1801 | 33/8135 | 2.87 | 3.45e-07 | 8.91e-06 | 33 |
GO:1903706 | GO:1903706 | regulation of hemopoiesis | 87/1801 | 241/8135 | 1.63 | 3.80e-07 | 9.68e-06 | 241 |
GO:0044419 | GO:0044419 | interspecies interaction between organisms | 96/1801 | 273/8135 | 1.59 | 3.90e-07 | 9.87e-06 | 273 |
GO:0050920 | GO:0050920 | regulation of chemotaxis | 59/1801 | 146/8135 | 1.83 | 4.23e-07 | 1.06e-05 | 146 |
GO:0051250 | GO:0051250 | negative regulation of lymphocyte activation | 41/1801 | 89/8135 | 2.08 | 4.27e-07 | 1.07e-05 | 89 |
GO:0050853 | GO:0050853 | B cell receptor signaling pathway | 22/1801 | 36/8135 | 2.76 | 5.04e-07 | 1.25e-05 | 36 |
GO:0006959 | GO:0006959 | humoral immune response | 71/1801 | 187/8135 | 1.71 | 5.20e-07 | 1.28e-05 | 187 |
GO:0002479 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 11/1801 | 12/8135 | 4.14 | 5.86e-07 | 1.42e-05 | 12 |
GO:0035455 | GO:0035455 | response to interferon-alpha | 11/1801 | 12/8135 | 4.14 | 5.86e-07 | 1.42e-05 | 12 |
GO:0098586 | GO:0098586 | cellular response to virus | 16/1801 | 22/8135 | 3.29 | 5.89e-07 | 1.42e-05 | 22 |
GO:0046635 | GO:0046635 | positive regulation of alpha-beta T cell activation | 25/1801 | 44/8135 | 2.57 | 5.98e-07 | 1.43e-05 | 44 |
GO:0071706 | GO:0071706 | tumor necrosis factor superfamily cytokine production | 41/1801 | 90/8135 | 2.06 | 6.19e-07 | 1.46e-05 | 90 |
GO:1903555 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 41/1801 | 90/8135 | 2.06 | 6.19e-07 | 1.46e-05 | 90 |
GO:0001909 | GO:0001909 | leukocyte mediated cytotoxicity | 36/1801 | 75/8135 | 2.17 | 6.23e-07 | 1.46e-05 | 75 |
GO:1903900 | GO:1903900 | regulation of viral life cycle | 30/1801 | 58/8135 | 2.34 | 7.18e-07 | 1.67e-05 | 58 |
GO:0048525 | GO:0048525 | negative regulation of viral process | 26/1801 | 47/8135 | 2.50 | 7.24e-07 | 1.67e-05 | 47 |
GO:0001910 | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 31/1801 | 61/8135 | 2.30 | 7.78e-07 | 1.78e-05 | 61 |
GO:0002705 | GO:0002705 | positive regulation of leukocyte mediated immunity | 39/1801 | 85/8135 | 2.07 | 9.25e-07 | 2.11e-05 | 85 |
GO:0050866 | GO:0050866 | negative regulation of cell activation | 51/1801 | 123/8135 | 1.87 | 1.02e-06 | 2.31e-05 | 123 |
GO:2000106 | GO:2000106 | regulation of leukocyte apoptotic process | 31/1801 | 62/8135 | 2.26 | 1.23e-06 | 2.75e-05 | 62 |
GO:0045580 | GO:0045580 | regulation of T cell differentiation | 40/1801 | 89/8135 | 2.03 | 1.30e-06 | 2.90e-05 | 89 |
GO:0043903 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 39/1801 | 86/8135 | 2.05 | 1.34e-06 | 2.96e-05 | 86 |
GO:0019079 | GO:0019079 | viral genome replication | 27/1801 | 51/8135 | 2.39 | 1.42e-06 | 3.13e-05 | 51 |
GO:0032481 | GO:0032481 | positive regulation of type I interferon production | 16/1801 | 23/8135 | 3.14 | 1.54e-06 | 3.35e-05 | 23 |
GO:0046633 | GO:0046633 | alpha-beta T cell proliferation | 16/1801 | 23/8135 | 3.14 | 1.54e-06 | 3.35e-05 | 23 |
GO:0030888 | GO:0030888 | regulation of B cell proliferation | 25/1801 | 46/8135 | 2.45 | 1.84e-06 | 3.97e-05 | 46 |
GO:0050663 | GO:0050663 | cytokine secretion | 57/1801 | 145/8135 | 1.78 | 1.91e-06 | 4.09e-05 | 145 |
GO:1903038 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 35/1801 | 75/8135 | 2.11 | 2.04e-06 | 4.36e-05 | 75 |
GO:0031343 | GO:0031343 | positive regulation of cell killing | 26/1801 | 49/8135 | 2.40 | 2.10e-06 | 4.46e-05 | 49 |
GO:0070664 | GO:0070664 | negative regulation of leukocyte proliferation | 27/1801 | 52/8135 | 2.35 | 2.34e-06 | 4.90e-05 | 52 |
GO:0051767 | GO:0051767 | nitric-oxide synthase biosynthetic process | 10/1801 | 11/8135 | 4.11 | 2.44e-06 | 5.06e-05 | 11 |
GO:0051769 | GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 10/1801 | 11/8135 | 4.11 | 2.44e-06 | 5.06e-05 | 11 |
GO:0043901 | GO:0043901 | negative regulation of multi-organism process | 40/1801 | 91/8135 | 1.99 | 2.60e-06 | 5.37e-05 | 91 |
GO:0045058 | GO:0045058 | T cell selection | 21/1801 | 36/8135 | 2.63 | 2.69e-06 | 5.52e-05 | 36 |
GO:0050792 | GO:0050792 | regulation of viral process | 33/1801 | 70/8135 | 2.13 | 3.02e-06 | 6.16e-05 | 70 |
GO:0051271 | GO:0051271 | negative regulation of cellular component movement | 67/1801 | 181/8135 | 1.67 | 3.07e-06 | 6.20e-05 | 181 |
GO:0002577 | GO:0002577 | regulation of antigen processing and presentation | 12/1801 | 15/8135 | 3.61 | 3.10e-06 | 6.20e-05 | 15 |
GO:0032607 | GO:0032607 | interferon-alpha production | 12/1801 | 15/8135 | 3.61 | 3.10e-06 | 6.20e-05 | 15 |
GO:0032647 | GO:0032647 | regulation of interferon-alpha production | 12/1801 | 15/8135 | 3.61 | 3.10e-06 | 6.20e-05 | 15 |
GO:0097529 | GO:0097529 | myeloid leukocyte migration | 59/1801 | 154/8135 | 1.73 | 3.37e-06 | 6.71e-05 | 154 |
GO:0032640 | GO:0032640 | tumor necrosis factor production | 38/1801 | 86/8135 | 2.00 | 3.96e-06 | 7.80e-05 | 86 |
GO:0032680 | GO:0032680 | regulation of tumor necrosis factor production | 38/1801 | 86/8135 | 2.00 | 3.96e-06 | 7.80e-05 | 86 |
GO:0031341 | GO:0031341 | regulation of cell killing | 32/1801 | 68/8135 | 2.13 | 4.46e-06 | 8.67e-05 | 68 |
GO:0071887 | GO:0071887 | leukocyte apoptotic process | 32/1801 | 68/8135 | 2.13 | 4.46e-06 | 8.67e-05 | 68 |
GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 61/1801 | 162/8135 | 1.70 | 4.47e-06 | 8.67e-05 | 162 |
GO:0040013 | GO:0040013 | negative regulation of locomotion | 67/1801 | 183/8135 | 1.65 | 4.76e-06 | 9.19e-05 | 183 |
GO:0051091 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 49/1801 | 122/8135 | 1.81 | 4.90e-06 | 9.40e-05 | 122 |
GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 51/1801 | 129/8135 | 1.79 | 5.42e-06 | 1.04e-04 | 129 |
GO:0030449 | GO:0030449 | regulation of complement activation | 22/1801 | 40/8135 | 2.48 | 5.92e-06 | 1.13e-04 | 40 |
GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 29/1801 | 60/8135 | 2.18 | 6.43e-06 | 1.22e-04 | 60 |
GO:0050864 | GO:0050864 | regulation of B cell activation | 33/1801 | 72/8135 | 2.07 | 6.49e-06 | 1.22e-04 | 72 |
GO:0051090 | GO:0051090 | regulation of DNA-binding transcription factor activity | 70/1801 | 195/8135 | 1.62 | 6.52e-06 | 1.22e-04 | 195 |
GO:0002224 | GO:0002224 | toll-like receptor signaling pathway | 32/1801 | 69/8135 | 2.09 | 6.57e-06 | 1.23e-04 | 69 |
GO:0001914 | GO:0001914 | regulation of T cell mediated cytotoxicity | 16/1801 | 25/8135 | 2.89 | 8.08e-06 | 1.50e-04 | 25 |
GO:0032102 | GO:0032102 | negative regulation of response to external stimulus | 73/1801 | 207/8135 | 1.59 | 8.60e-06 | 1.59e-04 | 207 |
GO:0002455 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 21/1801 | 38/8135 | 2.50 | 8.73e-06 | 1.60e-04 | 38 |
GO:0002456 | GO:0002456 | T cell mediated immunity | 32/1801 | 70/8135 | 2.06 | 9.56e-06 | 1.75e-04 | 70 |
GO:0030183 | GO:0030183 | B cell differentiation | 31/1801 | 67/8135 | 2.09 | 9.69e-06 | 1.76e-04 | 67 |
GO:0050868 | GO:0050868 | negative regulation of T cell activation | 31/1801 | 67/8135 | 2.09 | 9.69e-06 | 1.76e-04 | 67 |
GO:0045621 | GO:0045621 | positive regulation of lymphocyte differentiation | 30/1801 | 64/8135 | 2.12 | 9.74e-06 | 1.76e-04 | 64 |
GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 39/1801 | 92/8135 | 1.91 | 1.00e-05 | 1.80e-04 | 92 |
GO:0002483 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 9/1801 | 10/8135 | 4.07 | 1.01e-05 | 1.80e-04 | 10 |
GO:2000257 | GO:2000257 | regulation of protein activation cascade | 22/1801 | 41/8135 | 2.42 | 1.01e-05 | 1.80e-04 | 41 |
GO:0050777 | GO:0050777 | negative regulation of immune response | 38/1801 | 89/8135 | 1.93 | 1.06e-05 | 1.88e-04 | 89 |
GO:0022408 | GO:0022408 | negative regulation of cell-cell adhesion | 42/1801 | 102/8135 | 1.86 | 1.11e-05 | 1.96e-04 | 102 |
GO:0002709 | GO:0002709 | regulation of T cell mediated immunity | 24/1801 | 47/8135 | 2.31 | 1.23e-05 | 2.17e-04 | 47 |
GO:0050707 | GO:0050707 | regulation of cytokine secretion | 50/1801 | 129/8135 | 1.75 | 1.28e-05 | 2.23e-04 | 129 |
GO:0042089 | GO:0042089 | cytokine biosynthetic process | 34/1801 | 77/8135 | 1.99 | 1.29e-05 | 2.24e-04 | 77 |
GO:0043367 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 25/1801 | 50/8135 | 2.26 | 1.31e-05 | 2.28e-04 | 50 |
GO:0043900 | GO:0043900 | regulation of multi-organism process | 67/1801 | 188/8135 | 1.61 | 1.35e-05 | 2.33e-04 | 188 |
GO:0002920 | GO:0002920 | regulation of humoral immune response | 27/1801 | 56/8135 | 2.18 | 1.41e-05 | 2.43e-04 | 56 |
GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 28/1801 | 59/8135 | 2.14 | 1.43e-05 | 2.45e-04 | 59 |
GO:0001773 | GO:0001773 | myeloid dendritic cell activation | 14/1801 | 21/8135 | 3.01 | 1.53e-05 | 2.59e-04 | 21 |
GO:0046640 | GO:0046640 | regulation of alpha-beta T cell proliferation | 14/1801 | 21/8135 | 3.01 | 1.53e-05 | 2.59e-04 | 21 |
GO:0043122 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 41/1801 | 100/8135 | 1.85 | 1.59e-05 | 2.69e-04 | 100 |
GO:0043368 | GO:0043368 | positive T cell selection | 16/1801 | 26/8135 | 2.78 | 1.67e-05 | 2.81e-04 | 26 |
GO:0045807 | GO:0045807 | positive regulation of endocytosis | 35/1801 | 81/8135 | 1.95 | 1.72e-05 | 2.87e-04 | 81 |
GO:0042107 | GO:0042107 | cytokine metabolic process | 34/1801 | 78/8135 | 1.97 | 1.80e-05 | 3.00e-04 | 78 |
GO:0002686 | GO:0002686 | negative regulation of leukocyte migration | 19/1801 | 34/8135 | 2.52 | 1.90e-05 | 3.15e-04 | 34 |
GO:0002698 | GO:0002698 | negative regulation of immune effector process | 31/1801 | 69/8135 | 2.03 | 2.02e-05 | 3.32e-04 | 69 |
GO:0002377 | GO:0002377 | immunoglobulin production | 25/1801 | 51/8135 | 2.21 | 2.04e-05 | 3.32e-04 | 51 |
GO:0001916 | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 13/1801 | 19/8135 | 3.09 | 2.05e-05 | 3.32e-04 | 19 |
GO:0002753 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway | 13/1801 | 19/8135 | 3.09 | 2.05e-05 | 3.32e-04 | 19 |
GO:0002755 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 13/1801 | 19/8135 | 3.09 | 2.05e-05 | 3.32e-04 | 19 |
GO:0032613 | GO:0032613 | interleukin-10 production | 20/1801 | 37/8135 | 2.44 | 2.22e-05 | 3.58e-04 | 37 |
GO:0030336 | GO:0030336 | negative regulation of cell migration | 56/1801 | 152/8135 | 1.66 | 2.29e-05 | 3.68e-04 | 152 |
GO:0032735 | GO:0032735 | positive regulation of interleukin-12 production | 15/1801 | 24/8135 | 2.82 | 2.37e-05 | 3.79e-04 | 24 |
GO:0043123 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 34/1801 | 79/8135 | 1.94 | 2.50e-05 | 3.96e-04 | 79 |
GO:2000514 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 21/1801 | 40/8135 | 2.37 | 2.50e-05 | 3.96e-04 | 40 |
GO:0032608 | GO:0032608 | interferon-beta production | 12/1801 | 17/8135 | 3.19 | 2.69e-05 | 4.21e-04 | 17 |
GO:0032648 | GO:0032648 | regulation of interferon-beta production | 12/1801 | 17/8135 | 3.19 | 2.69e-05 | 4.21e-04 | 17 |
GO:0046641 | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 12/1801 | 17/8135 | 3.19 | 2.69e-05 | 4.21e-04 | 17 |
GO:0002711 | GO:0002711 | positive regulation of T cell mediated immunity | 18/1801 | 32/8135 | 2.54 | 2.79e-05 | 4.35e-04 | 32 |
GO:0042035 | GO:0042035 | regulation of cytokine biosynthetic process | 31/1801 | 70/8135 | 2.00 | 2.86e-05 | 4.43e-04 | 70 |
GO:0051092 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 31/1801 | 70/8135 | 2.00 | 2.86e-05 | 4.43e-04 | 70 |
GO:0019058 | GO:0019058 | viral life cycle | 46/1801 | 119/8135 | 1.75 | 3.04e-05 | 4.69e-04 | 119 |
GO:1903557 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 26/1801 | 55/8135 | 2.14 | 3.15e-05 | 4.83e-04 | 55 |
GO:1902107 | GO:1902107 | positive regulation of leukocyte differentiation | 39/1801 | 96/8135 | 1.84 | 3.27e-05 | 5.00e-04 | 96 |
GO:0050702 | GO:0050702 | interleukin-1 beta secretion | 19/1801 | 35/8135 | 2.45 | 3.29e-05 | 5.01e-04 | 35 |
GO:0032733 | GO:0032733 | positive regulation of interleukin-10 production | 14/1801 | 22/8135 | 2.87 | 3.35e-05 | 5.06e-04 | 22 |
GO:0050691 | GO:0050691 | regulation of defense response to virus by host | 14/1801 | 22/8135 | 2.87 | 3.35e-05 | 5.06e-04 | 22 |
GO:0002230 | GO:0002230 | positive regulation of defense response to virus by host | 11/1801 | 15/8135 | 3.31 | 3.39e-05 | 5.11e-04 | 15 |
GO:2000146 | GO:2000146 | negative regulation of cell motility | 58/1801 | 161/8135 | 1.63 | 3.52e-05 | 5.29e-04 | 161 |
GO:0050857 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 10/1801 | 13/8135 | 3.47 | 4.06e-05 | 6.02e-04 | 13 |
GO:0032623 | GO:0032623 | interleukin-2 production | 21/1801 | 41/8135 | 2.31 | 4.06e-05 | 6.02e-04 | 41 |
GO:0050701 | GO:0050701 | interleukin-1 secretion | 21/1801 | 41/8135 | 2.31 | 4.06e-05 | 6.02e-04 | 41 |
GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 36/1801 | 87/8135 | 1.87 | 4.08e-05 | 6.03e-04 | 87 |
GO:0042088 | GO:0042088 | T-helper 1 type immune response | 17/1801 | 30/8135 | 2.56 | 4.11e-05 | 6.05e-04 | 30 |
GO:0002367 | GO:0002367 | cytokine production involved in immune response | 29/1801 | 65/8135 | 2.02 | 4.35e-05 | 6.38e-04 | 65 |
GO:0045086 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 9/1801 | 11/8135 | 3.70 | 4.45e-05 | 6.49e-04 | 11 |
GO:0032945 | GO:0032945 | negative regulation of mononuclear cell proliferation | 23/1801 | 47/8135 | 2.21 | 4.51e-05 | 6.54e-04 | 47 |
GO:0050672 | GO:0050672 | negative regulation of lymphocyte proliferation | 23/1801 | 47/8135 | 2.21 | 4.51e-05 | 6.54e-04 | 47 |
GO:0030101 | GO:0030101 | natural killer cell activation | 24/1801 | 50/8135 | 2.17 | 4.62e-05 | 6.67e-04 | 50 |
GO:0060759 | GO:0060759 | regulation of response to cytokine stimulus | 34/1801 | 81/8135 | 1.90 | 4.67e-05 | 6.72e-04 | 81 |
GO:0043370 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 18/1801 | 33/8135 | 2.46 | 4.88e-05 | 6.99e-04 | 33 |
GO:0048872 | GO:0048872 | homeostasis of number of cells | 48/1801 | 128/8135 | 1.69 | 5.15e-05 | 7.35e-04 | 128 |
GO:0070613 | GO:0070613 | regulation of protein processing | 32/1801 | 75/8135 | 1.93 | 5.28e-05 | 7.51e-04 | 75 |
GO:0001913 | GO:0001913 | T cell mediated cytotoxicity | 19/1801 | 36/8135 | 2.38 | 5.53e-05 | 7.81e-04 | 36 |
GO:0032653 | GO:0032653 | regulation of interleukin-10 production | 19/1801 | 36/8135 | 2.38 | 5.53e-05 | 7.81e-04 | 36 |
GO:0006958 | GO:0006958 | complement activation, classical pathway | 16/1801 | 28/8135 | 2.58 | 6.05e-05 | 8.49e-04 | 28 |
GO:0014015 | GO:0014015 | positive regulation of gliogenesis | 20/1801 | 39/8135 | 2.32 | 6.05e-05 | 8.49e-04 | 39 |
GO:0032743 | GO:0032743 | positive regulation of interleukin-2 production | 12/1801 | 18/8135 | 3.01 | 6.43e-05 | 8.96e-04 | 18 |
GO:0036037 | GO:0036037 | CD8-positive, alpha-beta T cell activation | 12/1801 | 18/8135 | 3.01 | 6.43e-05 | 8.96e-04 | 18 |
GO:0001776 | GO:0001776 | leukocyte homeostasis | 27/1801 | 60/8135 | 2.03 | 6.60e-05 | 9.16e-04 | 60 |
GO:0006909 | GO:0006909 | phagocytosis | 47/1801 | 126/8135 | 1.68 | 7.15e-05 | 9.89e-04 | 126 |
GO:1903317 | GO:1903317 | regulation of protein maturation | 32/1801 | 76/8135 | 1.90 | 7.21e-05 | 9.93e-04 | 76 |
GO:0045926 | GO:0045926 | negative regulation of growth | 53/1801 | 147/8135 | 1.63 | 7.37e-05 | 1.01e-03 | 147 |
GO:0001906 | GO:0001906 | cell killing | 41/1801 | 106/8135 | 1.75 | 7.95e-05 | 1.09e-03 | 106 |
GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 43/1801 | 113/8135 | 1.72 | 8.40e-05 | 1.15e-03 | 113 |
GO:0050729 | GO:0050729 | positive regulation of inflammatory response | 39/1801 | 100/8135 | 1.76 | 9.55e-05 | 1.29e-03 | 100 |
GO:0010596 | GO:0010596 | negative regulation of endothelial cell migration | 13/1801 | 21/8135 | 2.80 | 9.78e-05 | 1.32e-03 | 21 |
GO:0032753 | GO:0032753 | positive regulation of interleukin-4 production | 13/1801 | 21/8135 | 2.80 | 9.78e-05 | 1.32e-03 | 21 |
GO:0045861 | GO:0045861 | negative regulation of proteolysis | 69/1801 | 206/8135 | 1.51 | 9.85e-05 | 1.32e-03 | 206 |
GO:0032760 | GO:0032760 | positive regulation of tumor necrosis factor production | 24/1801 | 52/8135 | 2.08 | 1.02e-04 | 1.36e-03 | 52 |
GO:0032757 | GO:0032757 | positive regulation of interleukin-8 production | 16/1801 | 29/8135 | 2.49 | 1.07e-04 | 1.43e-03 | 29 |
GO:0050855 | GO:0050855 | regulation of B cell receptor signaling pathway | 10/1801 | 14/8135 | 3.23 | 1.14e-04 | 1.51e-03 | 14 |
GO:0032612 | GO:0032612 | interleukin-1 production | 28/1801 | 65/8135 | 1.95 | 1.25e-04 | 1.65e-03 | 65 |
GO:0002825 | GO:0002825 | regulation of T-helper 1 type immune response | 14/1801 | 24/8135 | 2.63 | 1.30e-04 | 1.71e-03 | 24 |
GO:1902622 | GO:1902622 | regulation of neutrophil migration | 14/1801 | 24/8135 | 2.63 | 1.30e-04 | 1.71e-03 | 24 |
GO:0050856 | GO:0050856 | regulation of T cell receptor signaling pathway | 12/1801 | 19/8135 | 2.85 | 1.39e-04 | 1.82e-03 | 19 |
GO:0002761 | GO:0002761 | regulation of myeloid leukocyte differentiation | 31/1801 | 75/8135 | 1.87 | 1.41e-04 | 1.83e-03 | 75 |
GO:0032728 | GO:0032728 | positive regulation of interferon-beta production | 9/1801 | 12/8135 | 3.39 | 1.43e-04 | 1.86e-03 | 12 |
GO:0034121 | GO:0034121 | regulation of toll-like receptor signaling pathway | 20/1801 | 41/8135 | 2.20 | 1.49e-04 | 1.93e-03 | 41 |
GO:0002292 | GO:0002292 | T cell differentiation involved in immune response | 21/1801 | 44/8135 | 2.16 | 1.52e-04 | 1.96e-03 | 44 |
GO:2000516 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 15/1801 | 27/8135 | 2.51 | 1.59e-04 | 2.05e-03 | 27 |
GO:0030889 | GO:0030889 | negative regulation of B cell proliferation | 8/1801 | 10/8135 | 3.61 | 1.66e-04 | 2.11e-03 | 10 |
GO:0032727 | GO:0032727 | positive regulation of interferon-alpha production | 8/1801 | 10/8135 | 3.61 | 1.66e-04 | 2.11e-03 | 10 |
GO:0045078 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 8/1801 | 10/8135 | 3.61 | 1.66e-04 | 2.11e-03 | 10 |
GO:0072376 | GO:0072376 | protein activation cascade | 31/1801 | 76/8135 | 1.84 | 1.88e-04 | 2.39e-03 | 76 |
GO:0002828 | GO:0002828 | regulation of type 2 immune response | 13/1801 | 22/8135 | 2.67 | 1.91e-04 | 2.40e-03 | 22 |
GO:0032660 | GO:0032660 | regulation of interleukin-17 production | 13/1801 | 22/8135 | 2.67 | 1.91e-04 | 2.40e-03 | 22 |
GO:0090022 | GO:0090022 | regulation of neutrophil chemotaxis | 13/1801 | 22/8135 | 2.67 | 1.91e-04 | 2.40e-03 | 22 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 39/1801 | 103/8135 | 1.71 | 2.00e-04 | 2.50e-03 | 103 |
GO:0031348 | GO:0031348 | negative regulation of defense response | 43/1801 | 117/8135 | 1.66 | 2.10e-04 | 2.62e-03 | 117 |
GO:0002700 | GO:0002700 | regulation of production of molecular mediator of immune response | 33/1801 | 83/8135 | 1.80 | 2.10e-04 | 2.62e-03 | 83 |
GO:0050764 | GO:0050764 | regulation of phagocytosis | 23/1801 | 51/8135 | 2.04 | 2.17e-04 | 2.70e-03 | 51 |
GO:0042267 | GO:0042267 | natural killer cell mediated cytotoxicity | 19/1801 | 39/8135 | 2.20 | 2.22e-04 | 2.73e-03 | 39 |
GO:0050766 | GO:0050766 | positive regulation of phagocytosis | 19/1801 | 39/8135 | 2.20 | 2.22e-04 | 2.73e-03 | 39 |
GO:0010951 | GO:0010951 | negative regulation of endopeptidase activity | 57/1801 | 167/8135 | 1.54 | 2.22e-04 | 2.73e-03 | 167 |
GO:0033077 | GO:0033077 | T cell differentiation in thymus | 20/1801 | 42/8135 | 2.15 | 2.26e-04 | 2.76e-03 | 42 |
GO:0043154 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 20/1801 | 42/8135 | 2.15 | 2.26e-04 | 2.76e-03 | 42 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 35/1801 | 90/8135 | 1.76 | 2.29e-04 | 2.79e-03 | 90 |
GO:0010466 | GO:0010466 | negative regulation of peptidase activity | 59/1801 | 175/8135 | 1.52 | 2.53e-04 | 3.07e-03 | 175 |
GO:0033209 | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 26/1801 | 61/8135 | 1.93 | 2.65e-04 | 3.21e-03 | 61 |
GO:0042095 | GO:0042095 | interferon-gamma biosynthetic process | 10/1801 | 15/8135 | 3.01 | 2.74e-04 | 3.29e-03 | 15 |
GO:0045061 | GO:0045061 | thymic T cell selection | 10/1801 | 15/8135 | 3.01 | 2.74e-04 | 3.29e-03 | 15 |
GO:1902624 | GO:1902624 | positive regulation of neutrophil migration | 12/1801 | 20/8135 | 2.71 | 2.78e-04 | 3.34e-03 | 20 |
GO:0006956 | GO:0006956 | complement activation | 24/1801 | 55/8135 | 1.97 | 2.95e-04 | 3.53e-03 | 55 |
GO:0002704 | GO:0002704 | negative regulation of leukocyte mediated immunity | 16/1801 | 31/8135 | 2.33 | 3.01e-04 | 3.58e-03 | 31 |
GO:0002715 | GO:0002715 | regulation of natural killer cell mediated immunity | 17/1801 | 34/8135 | 2.26 | 3.20e-04 | 3.79e-03 | 34 |
GO:0006968 | GO:0006968 | cellular defense response | 22/1801 | 49/8135 | 2.03 | 3.20e-04 | 3.79e-03 | 49 |
GO:0097530 | GO:0097530 | granulocyte migration | 41/1801 | 112/8135 | 1.65 | 3.22e-04 | 3.79e-03 | 112 |
GO:2000117 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 21/1801 | 46/8135 | 2.06 | 3.29e-04 | 3.87e-03 | 46 |
GO:0002228 | GO:0002228 | natural killer cell mediated immunity | 20/1801 | 43/8135 | 2.10 | 3.35e-04 | 3.87e-03 | 43 |
GO:0046637 | GO:0046637 | regulation of alpha-beta T cell differentiation | 20/1801 | 43/8135 | 2.10 | 3.35e-04 | 3.87e-03 | 43 |
GO:0072678 | GO:0072678 | T cell migration | 20/1801 | 43/8135 | 2.10 | 3.35e-04 | 3.87e-03 | 43 |
GO:0002287 | GO:0002287 | alpha-beta T cell activation involved in immune response | 19/1801 | 40/8135 | 2.15 | 3.36e-04 | 3.87e-03 | 40 |
GO:0002293 | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 19/1801 | 40/8135 | 2.15 | 3.36e-04 | 3.87e-03 | 40 |
GO:2000107 | GO:2000107 | negative regulation of leukocyte apoptotic process | 19/1801 | 40/8135 | 2.15 | 3.36e-04 | 3.87e-03 | 40 |
GO:0032620 | GO:0032620 | interleukin-17 production | 13/1801 | 23/8135 | 2.55 | 3.50e-04 | 4.02e-03 | 23 |
GO:0043372 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 13/1801 | 23/8135 | 2.55 | 3.50e-04 | 4.02e-03 | 23 |
GO:0016485 | GO:0016485 | protein processing | 51/1801 | 148/8135 | 1.56 | 3.60e-04 | 4.11e-03 | 148 |
GO:0032740 | GO:0032740 | positive regulation of interleukin-17 production | 9/1801 | 13/8135 | 3.13 | 3.73e-04 | 4.22e-03 | 13 |
GO:0051403 | GO:0051403 | stress-activated MAPK cascade | 49/1801 | 141/8135 | 1.57 | 3.73e-04 | 4.22e-03 | 141 |
GO:0043542 | GO:0043542 | endothelial cell migration | 37/1801 | 99/8135 | 1.69 | 3.89e-04 | 4.37e-03 | 99 |
GO:0070304 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 37/1801 | 99/8135 | 1.69 | 3.89e-04 | 4.37e-03 | 99 |
GO:2000116 | GO:2000116 | regulation of cysteine-type endopeptidase activity | 41/1801 | 113/8135 | 1.64 | 3.99e-04 | 4.47e-03 | 113 |
GO:0042094 | GO:0042094 | interleukin-2 biosynthetic process | 11/1801 | 18/8135 | 2.76 | 4.05e-04 | 4.51e-03 | 18 |
GO:0090023 | GO:0090023 | positive regulation of neutrophil chemotaxis | 11/1801 | 18/8135 | 2.76 | 4.05e-04 | 4.51e-03 | 18 |
GO:0042092 | GO:0042092 | type 2 immune response | 14/1801 | 26/8135 | 2.43 | 4.08e-04 | 4.53e-03 | 26 |
GO:1990266 | GO:1990266 | neutrophil migration | 36/1801 | 96/8135 | 1.69 | 4.30e-04 | 4.76e-03 | 96 |
GO:0002718 | GO:0002718 | regulation of cytokine production involved in immune response | 23/1801 | 53/8135 | 1.96 | 4.33e-04 | 4.78e-03 | 53 |
GO:0050706 | GO:0050706 | regulation of interleukin-1 beta secretion | 15/1801 | 29/8135 | 2.34 | 4.50e-04 | 4.95e-03 | 29 |
GO:0097028 | GO:0097028 | dendritic cell differentiation | 15/1801 | 29/8135 | 2.34 | 4.50e-04 | 4.95e-03 | 29 |
GO:0001959 | GO:0001959 | regulation of cytokine-mediated signaling pathway | 30/1801 | 76/8135 | 1.78 | 4.65e-04 | 5.09e-03 | 76 |
GO:0002762 | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 16/1801 | 32/8135 | 2.26 | 4.79e-04 | 5.19e-03 | 32 |
GO:0042269 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 16/1801 | 32/8135 | 2.26 | 4.79e-04 | 5.19e-03 | 32 |
GO:0046638 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 16/1801 | 32/8135 | 2.26 | 4.79e-04 | 5.19e-03 | 32 |
GO:0071622 | GO:0071622 | regulation of granulocyte chemotaxis | 16/1801 | 32/8135 | 2.26 | 4.79e-04 | 5.19e-03 | 32 |
GO:0002504 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 20/1801 | 44/8135 | 2.05 | 4.88e-04 | 5.22e-03 | 44 |
GO:0030852 | GO:0030852 | regulation of granulocyte differentiation | 8/1801 | 11/8135 | 3.29 | 4.90e-04 | 5.22e-03 | 11 |
GO:0032695 | GO:0032695 | negative regulation of interleukin-12 production | 8/1801 | 11/8135 | 3.29 | 4.90e-04 | 5.22e-03 | 11 |
GO:0034162 | GO:0034162 | toll-like receptor 9 signaling pathway | 8/1801 | 11/8135 | 3.29 | 4.90e-04 | 5.22e-03 | 11 |
GO:0039528 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus | 8/1801 | 11/8135 | 3.29 | 4.90e-04 | 5.22e-03 | 11 |
GO:0043374 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 8/1801 | 11/8135 | 3.29 | 4.90e-04 | 5.22e-03 | 11 |
GO:0032663 | GO:0032663 | regulation of interleukin-2 production | 17/1801 | 35/8135 | 2.19 | 4.95e-04 | 5.24e-03 | 35 |
GO:0050704 | GO:0050704 | regulation of interleukin-1 secretion | 17/1801 | 35/8135 | 2.19 | 4.95e-04 | 5.24e-03 | 35 |
GO:1903556 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production | 18/1801 | 38/8135 | 2.14 | 5.00e-04 | 5.28e-03 | 38 |
GO:0032652 | GO:0032652 | regulation of interleukin-1 production | 24/1801 | 57/8135 | 1.90 | 5.61e-04 | 5.87e-03 | 57 |
GO:0045582 | GO:0045582 | positive regulation of T cell differentiation | 24/1801 | 57/8135 | 1.90 | 5.61e-04 | 5.87e-03 | 57 |
GO:0045076 | GO:0045076 | regulation of interleukin-2 biosynthetic process | 10/1801 | 16/8135 | 2.82 | 5.85e-04 | 6.08e-03 | 16 |
GO:1903010 | GO:1903010 | regulation of bone development | 10/1801 | 16/8135 | 2.82 | 5.85e-04 | 6.08e-03 | 16 |
GO:0032611 | GO:0032611 | interleukin-1 beta production | 23/1801 | 54/8135 | 1.92 | 5.98e-04 | 6.18e-03 | 54 |
GO:0038093 | GO:0038093 | Fc receptor signaling pathway | 23/1801 | 54/8135 | 1.92 | 5.98e-04 | 6.18e-03 | 54 |
GO:0007254 | GO:0007254 | JNK cascade | 41/1801 | 115/8135 | 1.61 | 6.05e-04 | 6.24e-03 | 115 |
GO:0032673 | GO:0032673 | regulation of interleukin-4 production | 13/1801 | 24/8135 | 2.45 | 6.10e-04 | 6.28e-03 | 24 |
GO:1901222 | GO:1901222 | regulation of NIK/NF-kappaB signaling | 22/1801 | 51/8135 | 1.95 | 6.34e-04 | 6.48e-03 | 51 |
GO:0046330 | GO:0046330 | positive regulation of JNK cascade | 32/1801 | 84/8135 | 1.72 | 6.39e-04 | 6.53e-03 | 84 |
GO:0030193 | GO:0030193 | regulation of blood coagulation | 26/1801 | 64/8135 | 1.84 | 6.52e-04 | 6.62e-03 | 64 |
GO:1900046 | GO:1900046 | regulation of hemostasis | 26/1801 | 64/8135 | 1.84 | 6.52e-04 | 6.62e-03 | 64 |
GO:0032874 | GO:0032874 | positive regulation of stress-activated MAPK cascade | 36/1801 | 98/8135 | 1.66 | 6.76e-04 | 6.82e-03 | 98 |
GO:0045824 | GO:0045824 | negative regulation of innate immune response | 14/1801 | 27/8135 | 2.34 | 6.76e-04 | 6.82e-03 | 27 |
GO:0046328 | GO:0046328 | regulation of JNK cascade | 38/1801 | 105/8135 | 1.63 | 6.79e-04 | 6.84e-03 | 105 |
GO:0032637 | GO:0032637 | interleukin-8 production | 20/1801 | 45/8135 | 2.01 | 6.97e-04 | 7.01e-03 | 45 |
GO:0010633 | GO:0010633 | negative regulation of epithelial cell migration | 15/1801 | 30/8135 | 2.26 | 7.18e-04 | 7.18e-03 | 30 |
GO:0050922 | GO:0050922 | negative regulation of chemotaxis | 19/1801 | 42/8135 | 2.04 | 7.22e-04 | 7.20e-03 | 42 |
GO:0031098 | GO:0031098 | stress-activated protein kinase signaling cascade | 51/1801 | 152/8135 | 1.52 | 7.31e-04 | 7.25e-03 | 152 |
GO:0002294 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 18/1801 | 39/8135 | 2.08 | 7.39e-04 | 7.31e-03 | 39 |
GO:0032720 | GO:0032720 | negative regulation of tumor necrosis factor production | 17/1801 | 36/8135 | 2.13 | 7.46e-04 | 7.35e-03 | 36 |
GO:0038061 | GO:0038061 | NIK/NF-kappaB signaling | 23/1801 | 55/8135 | 1.89 | 8.15e-04 | 8.01e-03 | 55 |
GO:0045072 | GO:0045072 | regulation of interferon-gamma biosynthetic process | 9/1801 | 14/8135 | 2.90 | 8.38e-04 | 8.19e-03 | 14 |
GO:0030100 | GO:0030100 | regulation of endocytosis | 45/1801 | 131/8135 | 1.55 | 8.41e-04 | 8.20e-03 | 131 |
GO:0010594 | GO:0010594 | regulation of endothelial cell migration | 29/1801 | 75/8135 | 1.75 | 8.53e-04 | 8.30e-03 | 75 |
GO:0050818 | GO:0050818 | regulation of coagulation | 26/1801 | 65/8135 | 1.81 | 8.61e-04 | 8.35e-03 | 65 |
GO:0045954 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 12/1801 | 22/8135 | 2.46 | 9.14e-04 | 8.82e-03 | 22 |
GO:0050718 | GO:0050718 | positive regulation of interleukin-1 beta secretion | 12/1801 | 22/8135 | 2.46 | 9.14e-04 | 8.82e-03 | 22 |
GO:0002675 | GO:0002675 | positive regulation of acute inflammatory response | 13/1801 | 25/8135 | 2.35 | 1.02e-03 | 9.72e-03 | 25 |
GO:0034122 | GO:0034122 | negative regulation of toll-like receptor signaling pathway | 13/1801 | 25/8135 | 2.35 | 1.02e-03 | 9.72e-03 | 25 |
GO:0045622 | GO:0045622 | regulation of T-helper cell differentiation | 13/1801 | 25/8135 | 2.35 | 1.02e-03 | 9.72e-03 | 25 |
GO:1903034 | GO:1903034 | regulation of response to wounding | 38/1801 | 107/8135 | 1.60 | 1.03e-03 | 9.78e-03 | 107 |
GO:0002495 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 19/1801 | 43/8135 | 2.00 | 1.03e-03 | 9.78e-03 | 43 |
GO:0032677 | GO:0032677 | regulation of interleukin-8 production | 18/1801 | 40/8135 | 2.03 | 1.07e-03 | 1.01e-02 | 40 |
GO:1901224 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 18/1801 | 40/8135 | 2.03 | 1.07e-03 | 1.01e-02 | 40 |
GO:0032633 | GO:0032633 | interleukin-4 production | 14/1801 | 28/8135 | 2.26 | 1.08e-03 | 1.02e-02 | 28 |
GO:0019722 | GO:0019722 | calcium-mediated signaling | 49/1801 | 147/8135 | 1.51 | 1.08e-03 | 1.02e-02 | 147 |
GO:0042093 | GO:0042093 | T-helper cell differentiation | 17/1801 | 37/8135 | 2.08 | 1.10e-03 | 1.03e-02 | 37 |
GO:1903670 | GO:1903670 | regulation of sprouting angiogenesis | 17/1801 | 37/8135 | 2.08 | 1.10e-03 | 1.03e-02 | 37 |
GO:0031663 | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 16/1801 | 34/8135 | 2.13 | 1.11e-03 | 1.04e-02 | 34 |
GO:2000108 | GO:2000108 | positive regulation of leukocyte apoptotic process | 10/1801 | 17/8135 | 2.66 | 1.14e-03 | 1.06e-02 | 17 |
GO:0043281 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 35/1801 | 97/8135 | 1.63 | 1.15e-03 | 1.07e-02 | 97 |
GO:0043537 | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 8/1801 | 12/8135 | 3.01 | 1.18e-03 | 1.09e-02 | 12 |
GO:0045862 | GO:0045862 | positive regulation of proteolysis | 48/1801 | 144/8135 | 1.51 | 1.21e-03 | 1.11e-02 | 144 |
GO:0070302 | GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 43/1801 | 126/8135 | 1.54 | 1.26e-03 | 1.15e-02 | 126 |
GO:0050869 | GO:0050869 | negative regulation of B cell activation | 11/1801 | 20/8135 | 2.48 | 1.37e-03 | 1.25e-02 | 20 |
GO:0071624 | GO:0071624 | positive regulation of granulocyte chemotaxis | 11/1801 | 20/8135 | 2.48 | 1.37e-03 | 1.25e-02 | 20 |
GO:0032635 | GO:0032635 | interleukin-6 production | 33/1801 | 91/8135 | 1.64 | 1.43e-03 | 1.30e-02 | 91 |
GO:0002260 | GO:0002260 | lymphocyte homeostasis | 19/1801 | 44/8135 | 1.95 | 1.44e-03 | 1.30e-02 | 44 |
GO:0034113 | GO:0034113 | heterotypic cell-cell adhesion | 19/1801 | 44/8135 | 1.95 | 1.44e-03 | 1.30e-02 | 44 |
GO:0045670 | GO:0045670 | regulation of osteoclast differentiation | 19/1801 | 44/8135 | 1.95 | 1.44e-03 | 1.30e-02 | 44 |
GO:0002717 | GO:0002717 | positive regulation of natural killer cell mediated immunity | 12/1801 | 23/8135 | 2.36 | 1.53e-03 | 1.36e-02 | 23 |
GO:0014009 | GO:0014009 | glial cell proliferation | 12/1801 | 23/8135 | 2.36 | 1.53e-03 | 1.36e-02 | 23 |
GO:0043535 | GO:0043535 | regulation of blood vessel endothelial cell migration | 17/1801 | 38/8135 | 2.02 | 1.58e-03 | 1.41e-02 | 38 |
GO:2000401 | GO:2000401 | regulation of lymphocyte migration | 17/1801 | 38/8135 | 2.02 | 1.58e-03 | 1.41e-02 | 38 |
GO:0050716 | GO:0050716 | positive regulation of interleukin-1 secretion | 13/1801 | 26/8135 | 2.26 | 1.62e-03 | 1.43e-02 | 26 |
GO:0002418 | GO:0002418 | immune response to tumor cell | 7/1801 | 10/8135 | 3.16 | 1.63e-03 | 1.43e-02 | 10 |
GO:0045063 | GO:0045063 | T-helper 1 cell differentiation | 7/1801 | 10/8135 | 3.16 | 1.63e-03 | 1.43e-02 | 10 |
GO:0060252 | GO:0060252 | positive regulation of glial cell proliferation | 7/1801 | 10/8135 | 3.16 | 1.63e-03 | 1.43e-02 | 10 |
GO:1903587 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 7/1801 | 10/8135 | 3.16 | 1.63e-03 | 1.43e-02 | 10 |
GO:2001185 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation | 7/1801 | 10/8135 | 3.16 | 1.63e-03 | 1.43e-02 | 10 |
GO:0042130 | GO:0042130 | negative regulation of T cell proliferation | 16/1801 | 35/8135 | 2.06 | 1.64e-03 | 1.43e-02 | 35 |
GO:0060760 | GO:0060760 | positive regulation of response to cytokine stimulus | 15/1801 | 32/8135 | 2.12 | 1.67e-03 | 1.45e-02 | 32 |
GO:0002092 | GO:0002092 | positive regulation of receptor internalization | 9/1801 | 15/8135 | 2.71 | 1.68e-03 | 1.46e-02 | 15 |
GO:0042832 | GO:0042832 | defense response to protozoan | 9/1801 | 15/8135 | 2.71 | 1.68e-03 | 1.46e-02 | 15 |
GO:0043243 | GO:0043243 | positive regulation of protein complex disassembly | 9/1801 | 15/8135 | 2.71 | 1.68e-03 | 1.46e-02 | 15 |
GO:0032675 | GO:0032675 | regulation of interleukin-6 production | 31/1801 | 85/8135 | 1.65 | 1.77e-03 | 1.52e-02 | 85 |
GO:0030308 | GO:0030308 | negative regulation of cell growth | 34/1801 | 96/8135 | 1.60 | 1.94e-03 | 1.66e-02 | 96 |
GO:0050715 | GO:0050715 | positive regulation of cytokine secretion | 32/1801 | 89/8135 | 1.62 | 1.97e-03 | 1.68e-02 | 89 |
GO:0045576 | GO:0045576 | mast cell activation | 19/1801 | 45/8135 | 1.91 | 1.98e-03 | 1.68e-02 | 45 |
GO:0050871 | GO:0050871 | positive regulation of B cell activation | 19/1801 | 45/8135 | 1.91 | 1.98e-03 | 1.68e-02 | 45 |
GO:0032872 | GO:0032872 | regulation of stress-activated MAPK cascade | 42/1801 | 125/8135 | 1.52 | 2.00e-03 | 1.70e-02 | 125 |
GO:0002827 | GO:0002827 | positive regulation of T-helper 1 type immune response | 10/1801 | 18/8135 | 2.51 | 2.06e-03 | 1.72e-02 | 18 |
GO:0002832 | GO:0002832 | negative regulation of response to biotic stimulus | 10/1801 | 18/8135 | 2.51 | 2.06e-03 | 1.72e-02 | 18 |
GO:0045577 | GO:0045577 | regulation of B cell differentiation | 10/1801 | 18/8135 | 2.51 | 2.06e-03 | 1.72e-02 | 18 |
GO:0002040 | GO:0002040 | sprouting angiogenesis | 25/1801 | 65/8135 | 1.74 | 2.07e-03 | 1.72e-02 | 65 |
GO:1902106 | GO:1902106 | negative regulation of leukocyte differentiation | 25/1801 | 65/8135 | 1.74 | 2.07e-03 | 1.72e-02 | 65 |
GO:0061041 | GO:0061041 | regulation of wound healing | 33/1801 | 93/8135 | 1.60 | 2.17e-03 | 1.80e-02 | 93 |
GO:0043534 | GO:0043534 | blood vessel endothelial cell migration | 21/1801 | 52/8135 | 1.82 | 2.29e-03 | 1.90e-02 | 52 |
GO:0032732 | GO:0032732 | positive regulation of interleukin-1 production | 15/1801 | 33/8135 | 2.05 | 2.44e-03 | 2.00e-02 | 33 |
GO:1904705 | GO:1904705 | regulation of vascular smooth muscle cell proliferation | 15/1801 | 33/8135 | 2.05 | 2.44e-03 | 2.00e-02 | 33 |
GO:1990874 | GO:1990874 | vascular smooth muscle cell proliferation | 15/1801 | 33/8135 | 2.05 | 2.44e-03 | 2.00e-02 | 33 |
GO:0050858 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 8/1801 | 13/8135 | 2.78 | 2.48e-03 | 2.03e-02 | 13 |
GO:2000484 | GO:2000484 | positive regulation of interleukin-8 secretion | 8/1801 | 13/8135 | 2.78 | 2.48e-03 | 2.03e-02 | 13 |
GO:0002833 | GO:0002833 | positive regulation of response to biotic stimulus | 13/1801 | 27/8135 | 2.17 | 2.50e-03 | 2.03e-02 | 27 |
GO:2000404 | GO:2000404 | regulation of T cell migration | 13/1801 | 27/8135 | 2.17 | 2.50e-03 | 2.03e-02 | 27 |
GO:0032651 | GO:0032651 | regulation of interleukin-1 beta production | 19/1801 | 46/8135 | 1.87 | 2.69e-03 | 2.18e-02 | 46 |
GO:0072676 | GO:0072676 | lymphocyte migration | 29/1801 | 80/8135 | 1.64 | 2.73e-03 | 2.20e-02 | 80 |
GO:0014066 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | 24/1801 | 63/8135 | 1.72 | 2.92e-03 | 2.34e-02 | 63 |
GO:0016525 | GO:0016525 | negative regulation of angiogenesis | 24/1801 | 63/8135 | 1.72 | 2.92e-03 | 2.34e-02 | 63 |
GO:0007259 | GO:0007259 | JAK-STAT cascade | 30/1801 | 84/8135 | 1.61 | 3.02e-03 | 2.41e-02 | 84 |
GO:0001562 | GO:0001562 | response to protozoan | 9/1801 | 16/8135 | 2.54 | 3.10e-03 | 2.46e-02 | 16 |
GO:0042454 | GO:0042454 | ribonucleoside catabolic process | 9/1801 | 16/8135 | 2.54 | 3.10e-03 | 2.46e-02 | 16 |
GO:0045624 | GO:0045624 | positive regulation of T-helper cell differentiation | 9/1801 | 16/8135 | 2.54 | 3.10e-03 | 2.46e-02 | 16 |
GO:0002312 | GO:0002312 | B cell activation involved in immune response | 17/1801 | 40/8135 | 1.92 | 3.10e-03 | 2.46e-02 | 40 |
GO:0019886 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 17/1801 | 40/8135 | 1.92 | 3.10e-03 | 2.46e-02 | 40 |
GO:0097696 | GO:0097696 | STAT cascade | 31/1801 | 88/8135 | 1.59 | 3.30e-03 | 2.61e-02 | 88 |
GO:0048640 | GO:0048640 | negative regulation of developmental growth | 25/1801 | 67/8135 | 1.69 | 3.34e-03 | 2.63e-02 | 67 |
GO:0001782 | GO:0001782 | B cell homeostasis | 10/1801 | 19/8135 | 2.38 | 3.49e-03 | 2.73e-02 | 19 |
GO:0002507 | GO:0002507 | tolerance induction | 10/1801 | 19/8135 | 2.38 | 3.49e-03 | 2.73e-02 | 19 |
GO:0036035 | GO:0036035 | osteoclast development | 7/1801 | 11/8135 | 2.87 | 3.63e-03 | 2.83e-02 | 11 |
GO:0043383 | GO:0043383 | negative T cell selection | 7/1801 | 11/8135 | 2.87 | 3.63e-03 | 2.83e-02 | 11 |
GO:0046629 | GO:0046629 | gamma-delta T cell activation | 7/1801 | 11/8135 | 2.87 | 3.63e-03 | 2.83e-02 | 11 |
GO:0032689 | GO:0032689 | negative regulation of interferon-gamma production | 13/1801 | 28/8135 | 2.10 | 3.73e-03 | 2.88e-02 | 28 |
GO:0032731 | GO:0032731 | positive regulation of interleukin-1 beta production | 13/1801 | 28/8135 | 2.10 | 3.73e-03 | 2.88e-02 | 28 |
GO:1902667 | GO:1902667 | regulation of axon guidance | 13/1801 | 28/8135 | 2.10 | 3.73e-03 | 2.88e-02 | 28 |
GO:0001936 | GO:0001936 | regulation of endothelial cell proliferation | 26/1801 | 71/8135 | 1.65 | 3.77e-03 | 2.89e-02 | 71 |
GO:0002701 | GO:0002701 | negative regulation of production of molecular mediator of immune response | 12/1801 | 25/8135 | 2.17 | 3.77e-03 | 2.89e-02 | 25 |
GO:0030225 | GO:0030225 | macrophage differentiation | 12/1801 | 25/8135 | 2.17 | 3.77e-03 | 2.89e-02 | 25 |
GO:0070555 | GO:0070555 | response to interleukin-1 | 31/1801 | 89/8135 | 1.57 | 4.02e-03 | 3.07e-02 | 89 |
GO:2000181 | GO:2000181 | negative regulation of blood vessel morphogenesis | 24/1801 | 65/8135 | 1.67 | 4.67e-03 | 3.54e-02 | 65 |
GO:0002043 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 8/1801 | 14/8135 | 2.58 | 4.67e-03 | 3.54e-02 | 14 |
GO:0006957 | GO:0006957 | complement activation, alternative pathway | 8/1801 | 14/8135 | 2.58 | 4.67e-03 | 3.54e-02 | 14 |
GO:1904706 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation | 8/1801 | 14/8135 | 2.58 | 4.67e-03 | 3.54e-02 | 14 |
GO:0048662 | GO:0048662 | negative regulation of smooth muscle cell proliferation | 15/1801 | 35/8135 | 1.94 | 4.86e-03 | 3.67e-02 | 35 |
GO:0030890 | GO:0030890 | positive regulation of B cell proliferation | 14/1801 | 32/8135 | 1.98 | 5.16e-03 | 3.87e-02 | 32 |
GO:0043551 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 14/1801 | 32/8135 | 1.98 | 5.16e-03 | 3.87e-02 | 32 |
GO:0071675 | GO:0071675 | regulation of mononuclear cell migration | 14/1801 | 32/8135 | 1.98 | 5.16e-03 | 3.87e-02 | 32 |
GO:1903035 | GO:1903035 | negative regulation of response to wounding | 23/1801 | 62/8135 | 1.68 | 5.19e-03 | 3.89e-02 | 62 |
GO:0002861 | GO:0002861 | regulation of inflammatory response to antigenic stimulus | 9/1801 | 17/8135 | 2.39 | 5.30e-03 | 3.95e-02 | 17 |
GO:0046627 | GO:0046627 | negative regulation of insulin receptor signaling pathway | 9/1801 | 17/8135 | 2.39 | 5.30e-03 | 3.95e-02 | 17 |
GO:1900077 | GO:1900077 | negative regulation of cellular response to insulin stimulus | 9/1801 | 17/8135 | 2.39 | 5.30e-03 | 3.95e-02 | 17 |
GO:0006911 | GO:0006911 | phagocytosis, engulfment | 13/1801 | 29/8135 | 2.02 | 5.42e-03 | 3.99e-02 | 29 |
GO:0038095 | GO:0038095 | Fc-epsilon receptor signaling pathway | 13/1801 | 29/8135 | 2.02 | 5.42e-03 | 3.99e-02 | 29 |
GO:0002200 | GO:0002200 | somatic diversification of immune receptors | 12/1801 | 26/8135 | 2.08 | 5.61e-03 | 4.09e-02 | 26 |
GO:0002823 | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 12/1801 | 26/8135 | 2.08 | 5.61e-03 | 4.09e-02 | 26 |
GO:0007202 | GO:0007202 | activation of phospholipase C activity | 12/1801 | 26/8135 | 2.08 | 5.61e-03 | 4.09e-02 | 26 |
GO:0048260 | GO:0048260 | positive regulation of receptor-mediated endocytosis | 12/1801 | 26/8135 | 2.08 | 5.61e-03 | 4.09e-02 | 26 |
GO:0010950 | GO:0010950 | positive regulation of endopeptidase activity | 28/1801 | 80/8135 | 1.58 | 5.63e-03 | 4.10e-02 | 80 |
GO:0002707 | GO:0002707 | negative regulation of lymphocyte mediated immunity | 11/1801 | 23/8135 | 2.16 | 5.69e-03 | 4.12e-02 | 23 |
GO:0030851 | GO:0030851 | granulocyte differentiation | 11/1801 | 23/8135 | 2.16 | 5.69e-03 | 4.12e-02 | 23 |
GO:0071320 | GO:0071320 | cellular response to cAMP | 15/1801 | 36/8135 | 1.88 | 6.66e-03 | 4.75e-02 | 36 |
GO:0002374 | GO:0002374 | cytokine secretion involved in immune response | 7/1801 | 12/8135 | 2.63 | 7.06e-03 | 4.98e-02 | 12 |
GO:0046133 | GO:0046133 | pyrimidine ribonucleoside catabolic process | 7/1801 | 12/8135 | 2.63 | 7.06e-03 | 4.98e-02 | 12 |
GO:0071871 | GO:0071871 | response to epinephrine | 7/1801 | 12/8135 | 2.63 | 7.06e-03 | 4.98e-02 | 12 |
GO:0001938 | GO:0001938 | positive regulation of endothelial cell proliferation | 20/1801 | 53/8135 | 1.70 | 7.12e-03 | 5.00e-02 | 53 |
GO:0061045 | GO:0061045 | negative regulation of wound healing | 20/1801 | 53/8135 | 1.70 | 7.12e-03 | 5.00e-02 | 53 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0060602 | GO:0060602 | branch elongation of an epithelium | 17/3586 | 18/8135 | 2.14 | 9.23e-06 | 0.0426 | 18 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0001525 | GO:0001525 | angiogenesis | 114/1611 | 306/8135 | 1.88 | 3.77e-13 | 1.19e-09 | 306 |
GO:0001944 | GO:0001944 | vasculature development | 143/1611 | 417/8135 | 1.73 | 7.01e-13 | 1.19e-09 | 417 |
GO:0072358 | GO:0072358 | cardiovascular system development | 144/1611 | 422/8135 | 1.72 | 8.95e-13 | 1.19e-09 | 422 |
GO:0001568 | GO:0001568 | blood vessel development | 138/1611 | 401/8135 | 1.74 | 1.35e-12 | 1.24e-09 | 401 |
GO:0048514 | GO:0048514 | blood vessel morphogenesis | 127/1611 | 360/8135 | 1.78 | 1.57e-12 | 1.24e-09 | 360 |
GO:0030334 | GO:0030334 | regulation of cell migration | 153/1611 | 490/8135 | 1.58 | 3.82e-10 | 2.53e-07 | 490 |
GO:0098657 | GO:0098657 | import into cell | 141/1611 | 445/8135 | 1.60 | 6.56e-10 | 3.72e-07 | 445 |
GO:0006897 | GO:0006897 | endocytosis | 117/1611 | 357/8135 | 1.65 | 2.29e-09 | 1.14e-06 | 357 |
GO:0035239 | GO:0035239 | tube morphogenesis | 151/1611 | 499/8135 | 1.53 | 5.76e-09 | 2.45e-06 | 499 |
GO:0043062 | GO:0043062 | extracellular structure organization | 101/1611 | 300/8135 | 1.70 | 6.16e-09 | 2.45e-06 | 300 |
GO:0030198 | GO:0030198 | extracellular matrix organization | 91/1611 | 264/8135 | 1.74 | 9.72e-09 | 3.51e-06 | 264 |
GO:0030335 | GO:0030335 | positive regulation of cell migration | 96/1611 | 287/8135 | 1.69 | 2.14e-08 | 7.07e-06 | 287 |
GO:0002263 | GO:0002263 | cell activation involved in immune response | 112/1611 | 356/8135 | 1.59 | 6.39e-08 | 1.95e-05 | 356 |
GO:0001935 | GO:0001935 | endothelial cell proliferation | 37/1611 | 80/8135 | 2.34 | 7.21e-08 | 2.05e-05 | 80 |
GO:0001936 | GO:0001936 | regulation of endothelial cell proliferation | 34/1611 | 71/8135 | 2.42 | 8.44e-08 | 2.09e-05 | 71 |
GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 111/1611 | 354/8135 | 1.58 | 8.92e-08 | 2.09e-05 | 354 |
GO:0003158 | GO:0003158 | endothelium development | 30/1611 | 59/8135 | 2.57 | 8.93e-08 | 2.09e-05 | 59 |
GO:0040017 | GO:0040017 | positive regulation of locomotion | 102/1611 | 319/8135 | 1.61 | 1.04e-07 | 2.29e-05 | 319 |
GO:1901342 | GO:1901342 | regulation of vasculature development | 71/1611 | 200/8135 | 1.79 | 1.13e-07 | 2.36e-05 | 200 |
GO:2000147 | GO:2000147 | positive regulation of cell motility | 97/1611 | 302/8135 | 1.62 | 1.69e-07 | 3.35e-05 | 302 |
GO:0051272 | GO:0051272 | positive regulation of cellular component movement | 99/1611 | 311/8135 | 1.61 | 2.04e-07 | 3.86e-05 | 311 |
GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 64/1611 | 177/8135 | 1.83 | 2.23e-07 | 3.91e-05 | 177 |
GO:0045446 | GO:0045446 | endothelial cell differentiation | 27/1611 | 52/8135 | 2.62 | 2.26e-07 | 3.91e-05 | 52 |
GO:0045765 | GO:0045765 | regulation of angiogenesis | 64/1611 | 178/8135 | 1.82 | 2.82e-07 | 4.67e-05 | 178 |
GO:0001667 | GO:0001667 | ameboidal-type cell migration | 71/1611 | 208/8135 | 1.72 | 6.39e-07 | 1.01e-04 | 208 |
GO:0050900 | GO:0050900 | leukocyte migration | 96/1611 | 306/8135 | 1.58 | 6.61e-07 | 1.01e-04 | 306 |
GO:0003013 | GO:0003013 | circulatory system process | 104/1611 | 342/8135 | 1.54 | 1.19e-06 | 1.75e-04 | 342 |
GO:0001938 | GO:0001938 | positive regulation of endothelial cell proliferation | 26/1611 | 53/8135 | 2.48 | 1.57e-06 | 2.23e-04 | 53 |
GO:0043542 | GO:0043542 | endothelial cell migration | 40/1611 | 99/8135 | 2.04 | 1.77e-06 | 2.38e-04 | 99 |
GO:0090130 | GO:0090130 | tissue migration | 54/1611 | 149/8135 | 1.83 | 1.80e-06 | 2.38e-04 | 149 |
GO:0003018 | GO:0003018 | vascular process in circulatory system | 45/1611 | 117/8135 | 1.94 | 2.05e-06 | 2.55e-04 | 117 |
GO:0002275 | GO:0002275 | myeloid cell activation involved in immune response | 83/1611 | 261/8135 | 1.61 | 2.09e-06 | 2.55e-04 | 261 |
GO:0003170 | GO:0003170 | heart valve development | 20/1611 | 36/8135 | 2.81 | 2.12e-06 | 2.55e-04 | 36 |
GO:0008015 | GO:0008015 | blood circulation | 102/1611 | 338/8135 | 1.52 | 2.22e-06 | 2.59e-04 | 338 |
GO:0002444 | GO:0002444 | myeloid leukocyte mediated immunity | 83/1611 | 262/8135 | 1.60 | 2.48e-06 | 2.81e-04 | 262 |
GO:0043299 | GO:0043299 | leukocyte degranulation | 80/1611 | 254/8135 | 1.59 | 4.82e-06 | 5.29e-04 | 254 |
GO:0031623 | GO:0031623 | receptor internalization | 28/1611 | 62/8135 | 2.28 | 4.98e-06 | 5.29e-04 | 62 |
GO:0002274 | GO:0002274 | myeloid leukocyte activation | 98/1611 | 328/8135 | 1.51 | 5.66e-06 | 5.63e-04 | 328 |
GO:0090132 | GO:0090132 | epithelium migration | 51/1611 | 143/8135 | 1.80 | 5.90e-06 | 5.72e-04 | 143 |
GO:0048844 | GO:0048844 | artery morphogenesis | 20/1611 | 38/8135 | 2.66 | 6.47e-06 | 6.00e-04 | 38 |
GO:0090066 | GO:0090066 | regulation of anatomical structure size | 87/1611 | 284/8135 | 1.55 | 6.49e-06 | 6.00e-04 | 284 |
GO:0072001 | GO:0072001 | renal system development | 64/1611 | 194/8135 | 1.67 | 8.22e-06 | 7.43e-04 | 194 |
GO:0007507 | GO:0007507 | heart development | 94/1611 | 315/8135 | 1.51 | 9.30e-06 | 8.22e-04 | 315 |
GO:0003179 | GO:0003179 | heart valve morphogenesis | 18/1611 | 33/8135 | 2.75 | 9.77e-06 | 8.44e-04 | 33 |
GO:0010631 | GO:0010631 | epithelial cell migration | 50/1611 | 142/8135 | 1.78 | 1.09e-05 | 9.24e-04 | 142 |
GO:0008360 | GO:0008360 | regulation of cell shape | 32/1611 | 78/8135 | 2.07 | 1.29e-05 | 1.07e-03 | 78 |
GO:0043114 | GO:0043114 | regulation of vascular permeability | 13/1611 | 20/8135 | 3.28 | 1.32e-05 | 1.07e-03 | 20 |
GO:0036230 | GO:0036230 | granulocyte activation | 73/1611 | 233/8135 | 1.58 | 1.53e-05 | 1.22e-03 | 233 |
GO:0045123 | GO:0045123 | cellular extravasation | 21/1611 | 43/8135 | 2.47 | 1.73e-05 | 1.35e-03 | 43 |
GO:0002283 | GO:0002283 | neutrophil activation involved in immune response | 70/1611 | 222/8135 | 1.59 | 1.80e-05 | 1.35e-03 | 222 |
GO:0042119 | GO:0042119 | neutrophil activation | 72/1611 | 230/8135 | 1.58 | 1.80e-05 | 1.35e-03 | 230 |
GO:0043312 | GO:0043312 | neutrophil degranulation | 69/1611 | 219/8135 | 1.59 | 2.12e-05 | 1.54e-03 | 219 |
GO:0002446 | GO:0002446 | neutrophil mediated immunity | 71/1611 | 227/8135 | 1.58 | 2.13e-05 | 1.54e-03 | 227 |
GO:1904018 | GO:1904018 | positive regulation of vasculature development | 43/1611 | 119/8135 | 1.82 | 2.16e-05 | 1.54e-03 | 119 |
GO:0060326 | GO:0060326 | cell chemotaxis | 69/1611 | 221/8135 | 1.58 | 2.95e-05 | 2.02e-03 | 221 |
GO:0045926 | GO:0045926 | negative regulation of growth | 50/1611 | 147/8135 | 1.72 | 3.18e-05 | 2.08e-03 | 147 |
GO:0060485 | GO:0060485 | mesenchyme development | 56/1611 | 171/8135 | 1.65 | 3.77e-05 | 2.37e-03 | 171 |
GO:0033627 | GO:0033627 | cell adhesion mediated by integrin | 22/1611 | 48/8135 | 2.31 | 3.85e-05 | 2.37e-03 | 48 |
GO:0048762 | GO:0048762 | mesenchymal cell differentiation | 45/1611 | 129/8135 | 1.76 | 3.87e-05 | 2.37e-03 | 129 |
GO:0001655 | GO:0001655 | urogenital system development | 68/1611 | 219/8135 | 1.57 | 4.09e-05 | 2.43e-03 | 219 |
GO:0010594 | GO:0010594 | regulation of endothelial cell migration | 30/1611 | 75/8135 | 2.02 | 4.27e-05 | 2.50e-03 | 75 |
GO:0050919 | GO:0050919 | negative chemotaxis | 16/1611 | 30/8135 | 2.69 | 4.45e-05 | 2.55e-03 | 30 |
GO:0002040 | GO:0002040 | sprouting angiogenesis | 27/1611 | 65/8135 | 2.10 | 4.67e-05 | 2.61e-03 | 65 |
GO:0043534 | GO:0043534 | blood vessel endothelial cell migration | 23/1611 | 52/8135 | 2.23 | 5.19e-05 | 2.85e-03 | 52 |
GO:0003205 | GO:0003205 | cardiac chamber development | 39/1611 | 108/8135 | 1.82 | 5.24e-05 | 2.85e-03 | 108 |
GO:0060840 | GO:0060840 | artery development | 22/1611 | 49/8135 | 2.27 | 5.70e-05 | 3.06e-03 | 49 |
GO:0097529 | GO:0097529 | myeloid leukocyte migration | 51/1611 | 154/8135 | 1.67 | 5.95e-05 | 3.10e-03 | 154 |
GO:0034329 | GO:0034329 | cell junction assembly | 41/1611 | 116/8135 | 1.78 | 6.00e-05 | 3.10e-03 | 116 |
GO:0035150 | GO:0035150 | regulation of tube size | 38/1611 | 105/8135 | 1.83 | 6.16e-05 | 3.14e-03 | 105 |
GO:0050673 | GO:0050673 | epithelial cell proliferation | 70/1611 | 230/8135 | 1.54 | 6.47e-05 | 3.25e-03 | 230 |
GO:0001822 | GO:0001822 | kidney development | 58/1611 | 182/8135 | 1.61 | 6.62e-05 | 3.27e-03 | 182 |
GO:0001570 | GO:0001570 | vasculogenesis | 20/1611 | 43/8135 | 2.35 | 6.66e-05 | 3.27e-03 | 43 |
GO:0003007 | GO:0003007 | heart morphogenesis | 53/1611 | 163/8135 | 1.64 | 7.47e-05 | 3.57e-03 | 163 |
GO:0035924 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 16/1611 | 31/8135 | 2.61 | 7.51e-05 | 3.57e-03 | 31 |
GO:0003279 | GO:0003279 | cardiac septum development | 27/1611 | 67/8135 | 2.03 | 8.76e-05 | 4.05e-03 | 67 |
GO:0045766 | GO:0045766 | positive regulation of angiogenesis | 38/1611 | 107/8135 | 1.79 | 9.82e-05 | 4.49e-03 | 107 |
GO:1905314 | GO:1905314 | semi-lunar valve development | 13/1611 | 23/8135 | 2.85 | 1.07e-04 | 4.79e-03 | 23 |
GO:0050678 | GO:0050678 | regulation of epithelial cell proliferation | 61/1611 | 197/8135 | 1.56 | 1.10e-04 | 4.84e-03 | 197 |
GO:0050880 | GO:0050880 | regulation of blood vessel size | 37/1611 | 104/8135 | 1.80 | 1.16e-04 | 4.95e-03 | 104 |
GO:0034330 | GO:0034330 | cell junction organization | 48/1611 | 146/8135 | 1.66 | 1.19e-04 | 4.98e-03 | 146 |
GO:0001885 | GO:0001885 | endothelial cell development | 15/1611 | 29/8135 | 2.61 | 1.22e-04 | 5.01e-03 | 29 |
GO:0060412 | GO:0060412 | ventricular septum morphogenesis | 15/1611 | 29/8135 | 2.61 | 1.22e-04 | 5.01e-03 | 29 |
GO:0043112 | GO:0043112 | receptor metabolic process | 32/1611 | 86/8135 | 1.88 | 1.26e-04 | 5.09e-03 | 86 |
GO:0031589 | GO:0031589 | cell-substrate adhesion | 63/1611 | 206/8135 | 1.54 | 1.27e-04 | 5.09e-03 | 206 |
GO:0021954 | GO:0021954 | central nervous system neuron development | 21/1611 | 48/8135 | 2.21 | 1.32e-04 | 5.26e-03 | 48 |
GO:0014031 | GO:0014031 | mesenchymal cell development | 23/1611 | 55/8135 | 2.11 | 1.49e-04 | 5.79e-03 | 55 |
GO:0002698 | GO:0002698 | negative regulation of immune effector process | 27/1611 | 69/8135 | 1.98 | 1.58e-04 | 6.10e-03 | 69 |
GO:0016525 | GO:0016525 | negative regulation of angiogenesis | 25/1611 | 63/8135 | 2.00 | 2.12e-04 | 7.93e-03 | 63 |
GO:0050679 | GO:0050679 | positive regulation of epithelial cell proliferation | 41/1611 | 122/8135 | 1.70 | 2.14e-04 | 7.96e-03 | 122 |
GO:0001945 | GO:0001945 | lymph vessel development | 10/1611 | 16/8135 | 3.16 | 2.24e-04 | 8.15e-03 | 16 |
GO:0050920 | GO:0050920 | regulation of chemotaxis | 47/1611 | 146/8135 | 1.63 | 2.43e-04 | 8.79e-03 | 146 |
GO:0030168 | GO:0030168 | platelet activation | 35/1611 | 100/8135 | 1.77 | 2.53e-04 | 8.81e-03 | 100 |
GO:0035296 | GO:0035296 | regulation of tube diameter | 35/1611 | 100/8135 | 1.77 | 2.53e-04 | 8.81e-03 | 100 |
GO:0097746 | GO:0097746 | regulation of blood vessel diameter | 35/1611 | 100/8135 | 1.77 | 2.53e-04 | 8.81e-03 | 100 |
GO:0050777 | GO:0050777 | negative regulation of immune response | 32/1611 | 89/8135 | 1.82 | 2.63e-04 | 9.08e-03 | 89 |
GO:0032102 | GO:0032102 | negative regulation of response to external stimulus | 62/1611 | 207/8135 | 1.51 | 2.72e-04 | 9.23e-03 | 207 |
GO:0060348 | GO:0060348 | bone development | 44/1611 | 135/8135 | 1.65 | 2.79e-04 | 9.29e-03 | 135 |
GO:0072132 | GO:0072132 | mesenchyme morphogenesis | 17/1611 | 37/8135 | 2.32 | 2.81e-04 | 9.29e-03 | 37 |
GO:0040013 | GO:0040013 | negative regulation of locomotion | 56/1611 | 183/8135 | 1.55 | 2.90e-04 | 9.45e-03 | 183 |
GO:0003281 | GO:0003281 | ventricular septum development | 20/1611 | 47/8135 | 2.15 | 3.00e-04 | 9.69e-03 | 47 |
GO:0038084 | GO:0038084 | vascular endothelial growth factor signaling pathway | 12/1611 | 22/8135 | 2.75 | 3.10e-04 | 9.95e-03 | 22 |
GO:0003206 | GO:0003206 | cardiac chamber morphogenesis | 32/1611 | 90/8135 | 1.80 | 3.31e-04 | 1.05e-02 | 90 |
GO:0086065 | GO:0086065 | cell communication involved in cardiac conduction | 19/1611 | 44/8135 | 2.18 | 3.37e-04 | 1.05e-02 | 44 |
GO:0010632 | GO:0010632 | regulation of epithelial cell migration | 37/1611 | 109/8135 | 1.71 | 3.42e-04 | 1.06e-02 | 109 |
GO:0003177 | GO:0003177 | pulmonary valve development | 9/1611 | 14/8135 | 3.25 | 3.48e-04 | 1.07e-02 | 14 |
GO:0031348 | GO:0031348 | negative regulation of defense response | 39/1611 | 117/8135 | 1.68 | 3.65e-04 | 1.10e-02 | 117 |
GO:0060411 | GO:0060411 | cardiac septum morphogenesis | 21/1611 | 51/8135 | 2.08 | 3.68e-04 | 1.10e-02 | 51 |
GO:2000181 | GO:2000181 | negative regulation of blood vessel morphogenesis | 25/1611 | 65/8135 | 1.94 | 3.74e-04 | 1.11e-02 | 65 |
GO:0048864 | GO:0048864 | stem cell development | 22/1611 | 55/8135 | 2.02 | 4.38e-04 | 1.26e-02 | 55 |
GO:0003231 | GO:0003231 | cardiac ventricle development | 30/1611 | 84/8135 | 1.80 | 4.61e-04 | 1.30e-02 | 84 |
GO:0006909 | GO:0006909 | phagocytosis | 41/1611 | 126/8135 | 1.64 | 4.62e-04 | 1.30e-02 | 126 |
GO:1901343 | GO:1901343 | negative regulation of vasculature development | 27/1611 | 73/8135 | 1.87 | 4.63e-04 | 1.30e-02 | 73 |
GO:0032387 | GO:0032387 | negative regulation of intracellular transport | 15/1611 | 32/8135 | 2.37 | 4.89e-04 | 1.35e-02 | 32 |
GO:0033628 | GO:0033628 | regulation of cell adhesion mediated by integrin | 15/1611 | 32/8135 | 2.37 | 4.89e-04 | 1.35e-02 | 32 |
GO:0045216 | GO:0045216 | cell-cell junction organization | 31/1611 | 88/8135 | 1.78 | 4.91e-04 | 1.35e-02 | 88 |
GO:0010595 | GO:0010595 | positive regulation of endothelial cell migration | 21/1611 | 52/8135 | 2.04 | 5.04e-04 | 1.36e-02 | 52 |
GO:0014032 | GO:0014032 | neural crest cell development | 21/1611 | 52/8135 | 2.04 | 5.04e-04 | 1.36e-02 | 52 |
GO:0035904 | GO:0035904 | aorta development | 14/1611 | 29/8135 | 2.44 | 5.17e-04 | 1.38e-02 | 29 |
GO:0048846 | GO:0048846 | axon extension involved in axon guidance | 13/1611 | 26/8135 | 2.52 | 5.34e-04 | 1.40e-02 | 26 |
GO:1902284 | GO:1902284 | neuron projection extension involved in neuron projection guidance | 13/1611 | 26/8135 | 2.52 | 5.34e-04 | 1.40e-02 | 26 |
GO:0030308 | GO:0030308 | negative regulation of cell growth | 33/1611 | 96/8135 | 1.74 | 5.44e-04 | 1.41e-02 | 96 |
GO:0048863 | GO:0048863 | stem cell differentiation | 41/1611 | 127/8135 | 1.63 | 5.54e-04 | 1.42e-02 | 127 |
GO:0036293 | GO:0036293 | response to decreased oxygen levels | 52/1611 | 171/8135 | 1.54 | 5.55e-04 | 1.42e-02 | 171 |
GO:0003151 | GO:0003151 | outflow tract morphogenesis | 22/1611 | 56/8135 | 1.98 | 5.88e-04 | 1.49e-02 | 56 |
GO:0014909 | GO:0014909 | smooth muscle cell migration | 17/1611 | 39/8135 | 2.20 | 6.01e-04 | 1.50e-02 | 39 |
GO:0001666 | GO:0001666 | response to hypoxia | 51/1611 | 168/8135 | 1.53 | 6.53e-04 | 1.61e-02 | 168 |
GO:0007160 | GO:0007160 | cell-matrix adhesion | 41/1611 | 128/8135 | 1.62 | 6.62e-04 | 1.62e-02 | 128 |
GO:0042310 | GO:0042310 | vasoconstriction | 23/1611 | 60/8135 | 1.94 | 6.70e-04 | 1.62e-02 | 60 |
GO:0051216 | GO:0051216 | cartilage development | 46/1611 | 148/8135 | 1.57 | 6.73e-04 | 1.62e-02 | 148 |
GO:1904019 | GO:1904019 | epithelial cell apoptotic process | 21/1611 | 53/8135 | 2.00 | 6.82e-04 | 1.63e-02 | 53 |
GO:0001991 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 9/1611 | 15/8135 | 3.03 | 7.18e-04 | 1.70e-02 | 15 |
GO:1900181 | GO:1900181 | negative regulation of protein localization to nucleus | 9/1611 | 15/8135 | 3.03 | 7.18e-04 | 1.70e-02 | 15 |
GO:0051271 | GO:0051271 | negative regulation of cellular component movement | 54/1611 | 181/8135 | 1.51 | 7.29e-04 | 1.71e-02 | 181 |
GO:0010977 | GO:0010977 | negative regulation of neuron projection development | 31/1611 | 90/8135 | 1.74 | 7.61e-04 | 1.78e-02 | 90 |
GO:0014033 | GO:0014033 | neural crest cell differentiation | 22/1611 | 57/8135 | 1.95 | 7.81e-04 | 1.81e-02 | 57 |
GO:0036303 | GO:0036303 | lymph vessel morphogenesis | 7/1611 | 10/8135 | 3.53 | 8.05e-04 | 1.81e-02 | 10 |
GO:0048484 | GO:0048484 | enteric nervous system development | 7/1611 | 10/8135 | 3.53 | 8.05e-04 | 1.81e-02 | 10 |
GO:0086016 | GO:0086016 | AV node cell action potential | 7/1611 | 10/8135 | 3.53 | 8.05e-04 | 1.81e-02 | 10 |
GO:0086027 | GO:0086027 | AV node cell to bundle of His cell signaling | 7/1611 | 10/8135 | 3.53 | 8.05e-04 | 1.81e-02 | 10 |
GO:0086067 | GO:0086067 | AV node cell to bundle of His cell communication | 7/1611 | 10/8135 | 3.53 | 8.05e-04 | 1.81e-02 | 10 |
GO:0035909 | GO:0035909 | aorta morphogenesis | 10/1611 | 18/8135 | 2.81 | 8.27e-04 | 1.84e-02 | 18 |
GO:0043536 | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 13/1611 | 27/8135 | 2.43 | 8.45e-04 | 1.85e-02 | 27 |
GO:0086019 | GO:0086019 | cell-cell signaling involved in cardiac conduction | 13/1611 | 27/8135 | 2.43 | 8.45e-04 | 1.85e-02 | 27 |
GO:0003203 | GO:0003203 | endocardial cushion morphogenesis | 12/1611 | 24/8135 | 2.52 | 8.75e-04 | 1.90e-02 | 24 |
GO:0071526 | GO:0071526 | semaphorin-plexin signaling pathway | 12/1611 | 24/8135 | 2.52 | 8.75e-04 | 1.90e-02 | 24 |
GO:0019935 | GO:0019935 | cyclic-nucleotide-mediated signaling | 48/1611 | 158/8135 | 1.53 | 9.12e-04 | 1.97e-02 | 158 |
GO:0007043 | GO:0007043 | cell-cell junction assembly | 24/1611 | 65/8135 | 1.86 | 9.68e-04 | 2.06e-02 | 65 |
GO:0007229 | GO:0007229 | integrin-mediated signaling pathway | 24/1611 | 65/8135 | 1.86 | 9.68e-04 | 2.06e-02 | 65 |
GO:0003184 | GO:0003184 | pulmonary valve morphogenesis | 8/1611 | 13/8135 | 3.11 | 1.15e-03 | 2.38e-02 | 13 |
GO:0010919 | GO:0010919 | regulation of inositol phosphate biosynthetic process | 8/1611 | 13/8135 | 3.11 | 1.15e-03 | 2.38e-02 | 13 |
GO:0045648 | GO:0045648 | positive regulation of erythrocyte differentiation | 8/1611 | 13/8135 | 3.11 | 1.15e-03 | 2.38e-02 | 13 |
GO:0002704 | GO:0002704 | negative regulation of leukocyte mediated immunity | 14/1611 | 31/8135 | 2.28 | 1.19e-03 | 2.45e-02 | 31 |
GO:0030336 | GO:0030336 | negative regulation of cell migration | 46/1611 | 152/8135 | 1.53 | 1.26e-03 | 2.58e-02 | 152 |
GO:0097530 | GO:0097530 | granulocyte migration | 36/1611 | 112/8135 | 1.62 | 1.28e-03 | 2.61e-02 | 112 |
GO:0002685 | GO:0002685 | regulation of leukocyte migration | 41/1611 | 132/8135 | 1.57 | 1.31e-03 | 2.65e-02 | 132 |
GO:0003171 | GO:0003171 | atrioventricular valve development | 9/1611 | 16/8135 | 2.84 | 1.35e-03 | 2.72e-02 | 16 |
GO:0043535 | GO:0043535 | regulation of blood vessel endothelial cell migration | 16/1611 | 38/8135 | 2.13 | 1.36e-03 | 2.72e-02 | 38 |
GO:0061756 | GO:0061756 | leukocyte adhesion to vascular endothelial cell | 12/1611 | 25/8135 | 2.42 | 1.38e-03 | 2.73e-02 | 25 |
GO:0072677 | GO:0072677 | eosinophil migration | 12/1611 | 25/8135 | 2.42 | 1.38e-03 | 2.73e-02 | 25 |
GO:1902668 | GO:1902668 | negative regulation of axon guidance | 10/1611 | 19/8135 | 2.66 | 1.44e-03 | 2.83e-02 | 19 |
GO:0097756 | GO:0097756 | negative regulation of blood vessel diameter | 23/1611 | 63/8135 | 1.84 | 1.46e-03 | 2.86e-02 | 63 |
GO:0051145 | GO:0051145 | smooth muscle cell differentiation | 15/1611 | 35/8135 | 2.16 | 1.54e-03 | 2.99e-02 | 35 |
GO:0050918 | GO:0050918 | positive chemotaxis | 19/1611 | 49/8135 | 1.96 | 1.64e-03 | 3.14e-02 | 49 |
GO:0097755 | GO:0097755 | positive regulation of blood vessel diameter | 17/1611 | 42/8135 | 2.04 | 1.64e-03 | 3.14e-02 | 42 |
GO:0030856 | GO:0030856 | regulation of epithelial cell differentiation | 30/1611 | 90/8135 | 1.68 | 1.67e-03 | 3.17e-02 | 90 |
GO:0002523 | GO:0002523 | leukocyte migration involved in inflammatory response | 7/1611 | 11/8135 | 3.21 | 1.83e-03 | 3.39e-02 | 11 |
GO:0061162 | GO:0061162 | establishment of monopolar cell polarity | 7/1611 | 11/8135 | 3.21 | 1.83e-03 | 3.39e-02 | 11 |
GO:1901888 | GO:1901888 | regulation of cell junction assembly | 16/1611 | 39/8135 | 2.07 | 1.89e-03 | 3.47e-02 | 39 |
GO:0003073 | GO:0003073 | regulation of systemic arterial blood pressure | 24/1611 | 68/8135 | 1.78 | 1.99e-03 | 3.62e-02 | 68 |
GO:0051495 | GO:0051495 | positive regulation of cytoskeleton organization | 31/1611 | 95/8135 | 1.65 | 2.07e-03 | 3.75e-02 | 95 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 33/1611 | 103/8135 | 1.62 | 2.12e-03 | 3.82e-02 | 103 |
GO:0042157 | GO:0042157 | lipoprotein metabolic process | 19/1611 | 50/8135 | 1.92 | 2.16e-03 | 3.86e-02 | 50 |
GO:0014910 | GO:0014910 | regulation of smooth muscle cell migration | 15/1611 | 36/8135 | 2.10 | 2.17e-03 | 3.86e-02 | 36 |
GO:0003181 | GO:0003181 | atrioventricular valve morphogenesis | 8/1611 | 14/8135 | 2.89 | 2.22e-03 | 3.91e-02 | 14 |
GO:0014912 | GO:0014912 | negative regulation of smooth muscle cell migration | 8/1611 | 14/8135 | 2.89 | 2.22e-03 | 3.91e-02 | 14 |
GO:0045646 | GO:0045646 | regulation of erythrocyte differentiation | 10/1611 | 20/8135 | 2.52 | 2.37e-03 | 4.10e-02 | 20 |
GO:0086014 | GO:0086014 | atrial cardiac muscle cell action potential | 9/1611 | 17/8135 | 2.67 | 2.38e-03 | 4.10e-02 | 17 |
GO:0086026 | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 9/1611 | 17/8135 | 2.67 | 2.38e-03 | 4.10e-02 | 17 |
GO:0086066 | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 9/1611 | 17/8135 | 2.67 | 2.38e-03 | 4.10e-02 | 17 |
GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 33/1611 | 104/8135 | 1.60 | 2.53e-03 | 4.30e-02 | 104 |
GO:0030323 | GO:0030323 | respiratory tube development | 35/1611 | 112/8135 | 1.58 | 2.54e-03 | 4.30e-02 | 112 |
GO:0003044 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 16/1611 | 40/8135 | 2.02 | 2.58e-03 | 4.34e-02 | 40 |
GO:0001942 | GO:0001942 | hair follicle development | 21/1611 | 58/8135 | 1.83 | 2.60e-03 | 4.36e-02 | 58 |
GO:0003197 | GO:0003197 | endocardial cushion development | 13/1611 | 30/8135 | 2.19 | 2.79e-03 | 4.56e-02 | 30 |
GO:0043300 | GO:0043300 | regulation of leukocyte degranulation | 13/1611 | 30/8135 | 2.19 | 2.79e-03 | 4.56e-02 | 30 |
GO:0048659 | GO:0048659 | smooth muscle cell proliferation | 29/1611 | 89/8135 | 1.65 | 2.91e-03 | 4.71e-02 | 89 |
GO:0034113 | GO:0034113 | heterotypic cell-cell adhesion | 17/1611 | 44/8135 | 1.95 | 2.97e-03 | 4.79e-02 | 44 |
GO:0014074 | GO:0014074 | response to purine-containing compound | 32/1611 | 101/8135 | 1.60 | 3.00e-03 | 4.82e-02 | 101 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0046649 | GO:0046649 | lymphocyte activation | 217/1389 | 397/8135 | 3.20 | 4.94e-69 | 1.80e-65 | 397 |
GO:0002250 | GO:0002250 | adaptive immune response | 163/1389 | 269/8135 | 3.55 | 4.22e-60 | 7.71e-57 | 269 |
GO:0042110 | GO:0042110 | T cell activation | 166/1389 | 285/8135 | 3.41 | 1.01e-57 | 1.23e-54 | 285 |
GO:0045087 | GO:0045087 | innate immune response | 227/1389 | 485/8135 | 2.74 | 5.34e-56 | 4.87e-53 | 485 |
GO:0050778 | GO:0050778 | positive regulation of immune response | 206/1389 | 423/8135 | 2.85 | 3.49e-54 | 2.54e-51 | 423 |
GO:0019221 | GO:0019221 | cytokine-mediated signaling pathway | 213/1389 | 459/8135 | 2.72 | 1.33e-51 | 8.08e-49 | 459 |
GO:0002694 | GO:0002694 | regulation of leukocyte activation | 166/1389 | 316/8135 | 3.08 | 3.61e-49 | 1.88e-46 | 316 |
GO:0050865 | GO:0050865 | regulation of cell activation | 170/1389 | 344/8135 | 2.89 | 1.41e-45 | 6.44e-43 | 344 |
GO:0051249 | GO:0051249 | regulation of lymphocyte activation | 143/1389 | 260/8135 | 3.22 | 1.86e-45 | 7.56e-43 | 260 |
GO:0050863 | GO:0050863 | regulation of T cell activation | 120/1389 | 203/8135 | 3.46 | 1.48e-42 | 5.39e-40 | 203 |
GO:0007159 | GO:0007159 | leukocyte cell-cell adhesion | 125/1389 | 218/8135 | 3.36 | 2.41e-42 | 8.01e-40 | 218 |
GO:0030098 | GO:0030098 | lymphocyte differentiation | 120/1389 | 214/8135 | 3.28 | 2.66e-39 | 8.10e-37 | 214 |
GO:1903037 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 112/1389 | 196/8135 | 3.35 | 9.00e-38 | 2.53e-35 | 196 |
GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 114/1389 | 202/8135 | 3.31 | 1.01e-37 | 2.65e-35 | 202 |
GO:0050867 | GO:0050867 | positive regulation of cell activation | 116/1389 | 210/8135 | 3.24 | 3.91e-37 | 9.51e-35 | 210 |
GO:0002521 | GO:0002521 | leukocyte differentiation | 150/1389 | 318/8135 | 2.76 | 4.36e-37 | 9.95e-35 | 318 |
GO:0002253 | GO:0002253 | activation of immune response | 144/1389 | 302/8135 | 2.79 | 2.87e-36 | 6.17e-34 | 302 |
GO:0002443 | GO:0002443 | leukocyte mediated immunity | 174/1389 | 410/8135 | 2.49 | 1.49e-35 | 3.03e-33 | 410 |
GO:0001816 | GO:0001816 | cytokine production | 182/1389 | 444/8135 | 2.40 | 8.72e-35 | 1.68e-32 | 444 |
GO:0051251 | GO:0051251 | positive regulation of lymphocyte activation | 99/1389 | 170/8135 | 3.41 | 2.05e-34 | 3.74e-32 | 170 |
GO:0002757 | GO:0002757 | immune response-activating signal transduction | 125/1389 | 249/8135 | 2.94 | 2.41e-34 | 4.19e-32 | 249 |
GO:0009615 | GO:0009615 | response to virus | 96/1389 | 162/8135 | 3.47 | 2.88e-34 | 4.78e-32 | 162 |
GO:0002764 | GO:0002764 | immune response-regulating signaling pathway | 131/1389 | 270/8135 | 2.84 | 5.41e-34 | 8.34e-32 | 270 |
GO:1903039 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 91/1389 | 149/8135 | 3.58 | 5.48e-34 | 8.34e-32 | 149 |
GO:0002460 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 97/1389 | 168/8135 | 3.38 | 2.64e-33 | 3.86e-31 | 168 |
GO:0030097 | GO:0030097 | hemopoiesis | 183/1389 | 459/8135 | 2.34 | 4.40e-33 | 6.17e-31 | 459 |
GO:0002449 | GO:0002449 | lymphocyte mediated immunity | 94/1389 | 161/8135 | 3.42 | 7.75e-33 | 1.05e-30 | 161 |
GO:0050870 | GO:0050870 | positive regulation of T cell activation | 86/1389 | 139/8135 | 3.62 | 8.98e-33 | 1.17e-30 | 139 |
GO:0002429 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 96/1389 | 167/8135 | 3.37 | 9.42e-33 | 1.19e-30 | 167 |
GO:0002768 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 103/1389 | 189/8135 | 3.19 | 2.38e-32 | 2.89e-30 | 189 |
GO:0001817 | GO:0001817 | regulation of cytokine production | 167/1389 | 406/8135 | 2.41 | 4.27e-32 | 5.03e-30 | 406 |
GO:0002697 | GO:0002697 | regulation of immune effector process | 122/1389 | 251/8135 | 2.85 | 8.94e-32 | 1.02e-29 | 251 |
GO:0048534 | GO:0048534 | hematopoietic or lymphoid organ development | 187/1389 | 487/8135 | 2.25 | 2.83e-31 | 3.13e-29 | 487 |
GO:0051607 | GO:0051607 | defense response to virus | 76/1389 | 118/8135 | 3.77 | 8.84e-31 | 9.43e-29 | 118 |
GO:0046651 | GO:0046651 | lymphocyte proliferation | 97/1389 | 177/8135 | 3.21 | 9.04e-31 | 9.43e-29 | 177 |
GO:0030217 | GO:0030217 | T cell differentiation | 88/1389 | 151/8135 | 3.41 | 1.04e-30 | 1.06e-28 | 151 |
GO:0070661 | GO:0070661 | leukocyte proliferation | 102/1389 | 193/8135 | 3.10 | 1.53e-30 | 1.51e-28 | 193 |
GO:0031347 | GO:0031347 | regulation of defense response | 169/1389 | 425/8135 | 2.33 | 2.35e-30 | 2.26e-28 | 425 |
GO:0098542 | GO:0098542 | defense response to other organism | 125/1389 | 268/8135 | 2.73 | 2.50e-30 | 2.34e-28 | 268 |
GO:0032943 | GO:0032943 | mononuclear cell proliferation | 97/1389 | 179/8135 | 3.17 | 3.06e-30 | 2.79e-28 | 179 |
GO:0050851 | GO:0050851 | antigen receptor-mediated signaling pathway | 71/1389 | 108/8135 | 3.85 | 1.16e-29 | 1.03e-27 | 108 |
GO:0022409 | GO:0022409 | positive regulation of cell-cell adhesion | 95/1389 | 177/8135 | 3.14 | 3.40e-29 | 2.95e-27 | 177 |
GO:0022407 | GO:0022407 | regulation of cell-cell adhesion | 119/1389 | 260/8135 | 2.68 | 5.89e-28 | 5.00e-26 | 260 |
GO:0001819 | GO:0001819 | positive regulation of cytokine production | 122/1389 | 271/8135 | 2.64 | 8.09e-28 | 6.72e-26 | 271 |
GO:0070663 | GO:0070663 | regulation of leukocyte proliferation | 86/1389 | 158/8135 | 3.19 | 4.31e-27 | 3.50e-25 | 158 |
GO:0050670 | GO:0050670 | regulation of lymphocyte proliferation | 83/1389 | 150/8135 | 3.24 | 7.60e-27 | 6.03e-25 | 150 |
GO:0032944 | GO:0032944 | regulation of mononuclear cell proliferation | 83/1389 | 151/8135 | 3.22 | 1.41e-26 | 1.10e-24 | 151 |
GO:0002263 | GO:0002263 | cell activation involved in immune response | 143/1389 | 356/8135 | 2.35 | 3.22e-26 | 2.45e-24 | 356 |
GO:0002366 | GO:0002366 | leukocyte activation involved in immune response | 142/1389 | 354/8135 | 2.35 | 5.77e-26 | 4.30e-24 | 354 |
GO:0042113 | GO:0042113 | B cell activation | 76/1389 | 134/8135 | 3.32 | 1.34e-25 | 9.80e-24 | 134 |
GO:0034341 | GO:0034341 | response to interferon-gamma | 72/1389 | 126/8135 | 3.35 | 1.41e-24 | 1.01e-22 | 126 |
GO:0002819 | GO:0002819 | regulation of adaptive immune response | 64/1389 | 105/8135 | 3.57 | 3.98e-24 | 2.79e-22 | 105 |
GO:0042098 | GO:0042098 | T cell proliferation | 69/1389 | 120/8135 | 3.37 | 8.09e-24 | 5.57e-22 | 120 |
GO:0070665 | GO:0070665 | positive regulation of leukocyte proliferation | 64/1389 | 106/8135 | 3.54 | 8.41e-24 | 5.69e-22 | 106 |
GO:0046631 | GO:0046631 | alpha-beta T cell activation | 59/1389 | 93/8135 | 3.72 | 1.25e-23 | 8.29e-22 | 93 |
GO:0030155 | GO:0030155 | regulation of cell adhesion | 154/1389 | 419/8135 | 2.15 | 2.13e-23 | 1.39e-21 | 419 |
GO:0050671 | GO:0050671 | positive regulation of lymphocyte proliferation | 62/1389 | 102/8135 | 3.56 | 2.57e-23 | 1.65e-21 | 102 |
GO:0032946 | GO:0032946 | positive regulation of mononuclear cell proliferation | 62/1389 | 103/8135 | 3.53 | 5.41e-23 | 3.40e-21 | 103 |
GO:0002822 | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 59/1389 | 95/8135 | 3.64 | 6.21e-23 | 3.84e-21 | 95 |
GO:0045785 | GO:0045785 | positive regulation of cell adhesion | 111/1389 | 262/8135 | 2.48 | 1.07e-22 | 6.49e-21 | 262 |
GO:0002683 | GO:0002683 | negative regulation of immune system process | 114/1389 | 273/8135 | 2.45 | 1.16e-22 | 6.86e-21 | 273 |
GO:0002703 | GO:0002703 | regulation of leukocyte mediated immunity | 72/1389 | 133/8135 | 3.17 | 1.16e-22 | 6.86e-21 | 133 |
GO:0042102 | GO:0042102 | positive regulation of T cell proliferation | 51/1389 | 76/8135 | 3.93 | 3.05e-22 | 1.77e-20 | 76 |
GO:0002285 | GO:0002285 | lymphocyte activation involved in immune response | 61/1389 | 104/8135 | 3.44 | 8.22e-22 | 4.69e-20 | 104 |
GO:0050852 | GO:0050852 | T cell receptor signaling pathway | 52/1389 | 80/8135 | 3.81 | 1.10e-21 | 6.19e-20 | 80 |
GO:0034340 | GO:0034340 | response to type I interferon | 38/1389 | 47/8135 | 4.74 | 1.22e-21 | 6.54e-20 | 47 |
GO:0060337 | GO:0060337 | type I interferon signaling pathway | 38/1389 | 47/8135 | 4.74 | 1.22e-21 | 6.54e-20 | 47 |
GO:0071357 | GO:0071357 | cellular response to type I interferon | 38/1389 | 47/8135 | 4.74 | 1.22e-21 | 6.54e-20 | 47 |
GO:0042129 | GO:0042129 | regulation of T cell proliferation | 62/1389 | 108/8135 | 3.36 | 1.82e-21 | 9.60e-20 | 108 |
GO:0002824 | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 46/1389 | 66/8135 | 4.08 | 3.05e-21 | 1.59e-19 | 66 |
GO:0071346 | GO:0071346 | cellular response to interferon-gamma | 63/1389 | 112/8135 | 3.29 | 3.77e-21 | 1.94e-19 | 112 |
GO:0002706 | GO:0002706 | regulation of lymphocyte mediated immunity | 58/1389 | 98/8135 | 3.47 | 4.55e-21 | 2.31e-19 | 98 |
GO:0002821 | GO:0002821 | positive regulation of adaptive immune response | 47/1389 | 69/8135 | 3.99 | 5.15e-21 | 2.57e-19 | 69 |
GO:0002699 | GO:0002699 | positive regulation of immune effector process | 72/1389 | 140/8135 | 3.01 | 6.26e-21 | 3.09e-19 | 140 |
GO:0050900 | GO:0050900 | leukocyte migration | 118/1389 | 306/8135 | 2.26 | 5.30e-20 | 2.55e-18 | 306 |
GO:0002708 | GO:0002708 | positive regulation of lymphocyte mediated immunity | 46/1389 | 69/8135 | 3.90 | 5.30e-20 | 2.55e-18 | 69 |
GO:0032609 | GO:0032609 | interferon-gamma production | 53/1389 | 88/8135 | 3.53 | 7.61e-20 | 3.61e-18 | 88 |
GO:0031349 | GO:0031349 | positive regulation of defense response | 104/1389 | 257/8135 | 2.37 | 1.58e-19 | 7.38e-18 | 257 |
GO:0045088 | GO:0045088 | regulation of innate immune response | 87/1389 | 198/8135 | 2.57 | 3.15e-19 | 1.45e-17 | 198 |
GO:0002274 | GO:0002274 | myeloid leukocyte activation | 122/1389 | 328/8135 | 2.18 | 3.87e-19 | 1.77e-17 | 328 |
GO:0002705 | GO:0002705 | positive regulation of leukocyte mediated immunity | 51/1389 | 85/8135 | 3.51 | 4.85e-19 | 2.17e-17 | 85 |
GO:0045619 | GO:0045619 | regulation of lymphocyte differentiation | 59/1389 | 108/8135 | 3.20 | 4.87e-19 | 2.17e-17 | 108 |
GO:0002286 | GO:0002286 | T cell activation involved in immune response | 43/1389 | 64/8135 | 3.93 | 5.62e-19 | 2.47e-17 | 64 |
GO:0016032 | GO:0016032 | viral process | 90/1389 | 211/8135 | 2.50 | 8.21e-19 | 3.57e-17 | 211 |
GO:0002695 | GO:0002695 | negative regulation of leukocyte activation | 58/1389 | 108/8135 | 3.15 | 2.91e-18 | 1.25e-16 | 108 |
GO:0032649 | GO:0032649 | regulation of interferon-gamma production | 48/1389 | 80/8135 | 3.51 | 5.39e-18 | 2.29e-16 | 80 |
GO:0001909 | GO:0001909 | leukocyte mediated cytotoxicity | 46/1389 | 75/8135 | 3.59 | 7.75e-18 | 3.25e-16 | 75 |
GO:0045580 | GO:0045580 | regulation of T cell differentiation | 51/1389 | 89/8135 | 3.36 | 7.89e-18 | 3.27e-16 | 89 |
GO:0044419 | GO:0044419 | interspecies interaction between organisms | 105/1389 | 273/8135 | 2.25 | 8.48e-18 | 3.45e-16 | 273 |
GO:1902105 | GO:1902105 | regulation of leukocyte differentiation | 78/1389 | 175/8135 | 2.61 | 8.50e-18 | 3.45e-16 | 175 |
GO:0032729 | GO:0032729 | positive regulation of interferon-gamma production | 37/1389 | 53/8135 | 4.09 | 2.30e-17 | 9.22e-16 | 53 |
GO:0044403 | GO:0044403 | symbiont process | 96/1389 | 245/8135 | 2.29 | 5.51e-17 | 2.19e-15 | 245 |
GO:0046632 | GO:0046632 | alpha-beta T cell differentiation | 43/1389 | 70/8135 | 3.60 | 8.58e-17 | 3.37e-15 | 70 |
GO:0060333 | GO:0060333 | interferon-gamma-mediated signaling pathway | 38/1389 | 57/8135 | 3.90 | 9.67e-17 | 3.75e-15 | 57 |
GO:0031341 | GO:0031341 | regulation of cell killing | 42/1389 | 68/8135 | 3.62 | 1.48e-16 | 5.69e-15 | 68 |
GO:0009617 | GO:0009617 | response to bacterium | 133/1389 | 398/8135 | 1.96 | 3.02e-16 | 1.15e-14 | 398 |
GO:0051250 | GO:0051250 | negative regulation of lymphocyte activation | 49/1389 | 89/8135 | 3.22 | 3.29e-16 | 1.23e-14 | 89 |
GO:0001910 | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 39/1389 | 61/8135 | 3.74 | 3.29e-16 | 1.23e-14 | 61 |
GO:0050864 | GO:0050864 | regulation of B cell activation | 43/1389 | 72/8135 | 3.50 | 3.79e-16 | 1.40e-14 | 72 |
GO:0046634 | GO:0046634 | regulation of alpha-beta T cell activation | 40/1389 | 64/8135 | 3.66 | 4.36e-16 | 1.59e-14 | 64 |
GO:0006968 | GO:0006968 | cellular defense response | 34/1389 | 49/8135 | 4.06 | 6.25e-16 | 2.26e-14 | 49 |
GO:0002456 | GO:0002456 | T cell mediated immunity | 42/1389 | 70/8135 | 3.51 | 6.63e-16 | 2.37e-14 | 70 |
GO:0050866 | GO:0050866 | negative regulation of cell activation | 59/1389 | 123/8135 | 2.81 | 1.50e-15 | 5.31e-14 | 123 |
GO:1903706 | GO:1903706 | regulation of hemopoiesis | 92/1389 | 241/8135 | 2.24 | 1.76e-15 | 6.16e-14 | 241 |
GO:0045089 | GO:0045089 | positive regulation of innate immune response | 72/1389 | 169/8135 | 2.50 | 3.03e-15 | 1.05e-13 | 169 |
GO:0050663 | GO:0050663 | cytokine secretion | 65/1389 | 145/8135 | 2.63 | 3.52e-15 | 1.20e-13 | 145 |
GO:0050727 | GO:0050727 | regulation of inflammatory response | 94/1389 | 251/8135 | 2.19 | 3.52e-15 | 1.20e-13 | 251 |
GO:0001906 | GO:0001906 | cell killing | 53/1389 | 106/8135 | 2.93 | 4.67e-15 | 1.58e-13 | 106 |
GO:0035710 | GO:0035710 | CD4-positive, alpha-beta T cell activation | 37/1389 | 59/8135 | 3.67 | 4.79e-15 | 1.60e-13 | 59 |
GO:0031295 | GO:0031295 | T cell costimulation | 28/1389 | 37/8135 | 4.43 | 6.47e-15 | 2.15e-13 | 37 |
GO:0001818 | GO:0001818 | negative regulation of cytokine production | 70/1389 | 165/8135 | 2.48 | 9.65e-15 | 3.17e-13 | 165 |
GO:0002440 | GO:0002440 | production of molecular mediator of immune response | 55/1389 | 115/8135 | 2.80 | 1.63e-14 | 5.32e-13 | 115 |
GO:0031294 | GO:0031294 | lymphocyte costimulation | 28/1389 | 38/8135 | 4.32 | 2.06e-14 | 6.66e-13 | 38 |
GO:0045058 | GO:0045058 | T cell selection | 27/1389 | 36/8135 | 4.39 | 2.92e-14 | 9.34e-13 | 36 |
GO:0050868 | GO:0050868 | negative regulation of T cell activation | 39/1389 | 67/8135 | 3.41 | 3.01e-14 | 9.55e-13 | 67 |
GO:0031343 | GO:0031343 | positive regulation of cell killing | 32/1389 | 49/8135 | 3.82 | 6.47e-14 | 2.03e-12 | 49 |
GO:0019882 | GO:0019882 | antigen processing and presentation | 44/1389 | 83/8135 | 3.10 | 6.78e-14 | 2.12e-12 | 83 |
GO:0002292 | GO:0002292 | T cell differentiation involved in immune response | 30/1389 | 44/8135 | 3.99 | 6.94e-14 | 2.15e-12 | 44 |
GO:0050707 | GO:0050707 | regulation of cytokine secretion | 58/1389 | 129/8135 | 2.63 | 9.44e-14 | 2.90e-12 | 129 |
GO:1903038 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 41/1389 | 75/8135 | 3.20 | 1.23e-13 | 3.75e-12 | 75 |
GO:0043367 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 32/1389 | 50/8135 | 3.75 | 1.50e-13 | 4.54e-12 | 50 |
GO:0043900 | GO:0043900 | regulation of multi-organism process | 74/1389 | 188/8135 | 2.31 | 1.79e-13 | 5.35e-12 | 188 |
GO:0043901 | GO:0043901 | negative regulation of multi-organism process | 46/1389 | 91/8135 | 2.96 | 1.83e-13 | 5.42e-12 | 91 |
GO:0001912 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 29/1389 | 43/8135 | 3.95 | 2.82e-13 | 8.32e-12 | 43 |
GO:0002377 | GO:0002377 | immunoglobulin production | 32/1389 | 51/8135 | 3.67 | 3.38e-13 | 9.88e-12 | 51 |
GO:0071887 | GO:0071887 | leukocyte apoptotic process | 38/1389 | 68/8135 | 3.27 | 3.86e-13 | 1.12e-11 | 68 |
GO:0072676 | GO:0072676 | lymphocyte migration | 42/1389 | 80/8135 | 3.07 | 3.92e-13 | 1.12e-11 | 80 |
GO:0050853 | GO:0050853 | B cell receptor signaling pathway | 26/1389 | 36/8135 | 4.23 | 3.94e-13 | 1.12e-11 | 36 |
GO:1903901 | GO:1903901 | negative regulation of viral life cycle | 27/1389 | 39/8135 | 4.05 | 7.14e-13 | 2.02e-11 | 39 |
GO:0002709 | GO:0002709 | regulation of T cell mediated immunity | 30/1389 | 47/8135 | 3.74 | 9.74e-13 | 2.73e-11 | 47 |
GO:1903900 | GO:1903900 | regulation of viral life cycle | 34/1389 | 58/8135 | 3.43 | 1.03e-12 | 2.88e-11 | 58 |
GO:0042100 | GO:0042100 | B cell proliferation | 35/1389 | 61/8135 | 3.36 | 1.15e-12 | 3.18e-11 | 61 |
GO:0045621 | GO:0045621 | positive regulation of lymphocyte differentiation | 36/1389 | 64/8135 | 3.29 | 1.24e-12 | 3.39e-11 | 64 |
GO:0043368 | GO:0043368 | positive T cell selection | 21/1389 | 26/8135 | 4.73 | 1.83e-12 | 4.98e-11 | 26 |
GO:1902107 | GO:1902107 | positive regulation of leukocyte differentiation | 46/1389 | 96/8135 | 2.81 | 2.17e-12 | 5.86e-11 | 96 |
GO:2000106 | GO:2000106 | regulation of leukocyte apoptotic process | 35/1389 | 62/8135 | 3.31 | 2.21e-12 | 5.94e-11 | 62 |
GO:0045071 | GO:0045071 | negative regulation of viral genome replication | 24/1389 | 33/8135 | 4.26 | 2.53e-12 | 6.73e-11 | 33 |
GO:0002228 | GO:0002228 | natural killer cell mediated immunity | 28/1389 | 43/8135 | 3.81 | 2.73e-12 | 7.23e-11 | 43 |
GO:0019058 | GO:0019058 | viral life cycle | 52/1389 | 119/8135 | 2.56 | 7.09e-12 | 1.86e-10 | 119 |
GO:0048525 | GO:0048525 | negative regulation of viral process | 29/1389 | 47/8135 | 3.61 | 8.12e-12 | 2.12e-10 | 47 |
GO:0001914 | GO:0001914 | regulation of T cell mediated cytotoxicity | 20/1389 | 25/8135 | 4.69 | 8.76e-12 | 2.27e-10 | 25 |
GO:0002711 | GO:0002711 | positive regulation of T cell mediated immunity | 23/1389 | 32/8135 | 4.21 | 1.09e-11 | 2.81e-10 | 32 |
GO:0043122 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 46/1389 | 100/8135 | 2.69 | 1.32e-11 | 3.38e-10 | 100 |
GO:0019724 | GO:0019724 | B cell mediated immunity | 37/1389 | 71/8135 | 3.05 | 1.33e-11 | 3.38e-10 | 71 |
GO:0034612 | GO:0034612 | response to tumor necrosis factor | 60/1389 | 150/8135 | 2.34 | 1.65e-11 | 4.15e-10 | 150 |
GO:0002287 | GO:0002287 | alpha-beta T cell activation involved in immune response | 26/1389 | 40/8135 | 3.81 | 1.78e-11 | 4.38e-10 | 40 |
GO:0002293 | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 26/1389 | 40/8135 | 3.81 | 1.78e-11 | 4.38e-10 | 40 |
GO:2000107 | GO:2000107 | negative regulation of leukocyte apoptotic process | 26/1389 | 40/8135 | 3.81 | 1.78e-11 | 4.38e-10 | 40 |
GO:0032103 | GO:0032103 | positive regulation of response to external stimulus | 75/1389 | 208/8135 | 2.11 | 2.07e-11 | 5.08e-10 | 208 |
GO:0002275 | GO:0002275 | myeloid cell activation involved in immune response | 88/1389 | 261/8135 | 1.97 | 2.48e-11 | 6.03e-10 | 261 |
GO:0060326 | GO:0060326 | cell chemotaxis | 78/1389 | 221/8135 | 2.07 | 2.78e-11 | 6.72e-10 | 221 |
GO:0002444 | GO:0002444 | myeloid leukocyte mediated immunity | 88/1389 | 262/8135 | 1.97 | 3.12e-11 | 7.50e-10 | 262 |
GO:0071356 | GO:0071356 | cellular response to tumor necrosis factor | 57/1389 | 141/8135 | 2.37 | 3.23e-11 | 7.70e-10 | 141 |
GO:1903708 | GO:1903708 | positive regulation of hemopoiesis | 49/1389 | 113/8135 | 2.54 | 4.04e-11 | 9.57e-10 | 113 |
GO:0045069 | GO:0045069 | regulation of viral genome replication | 26/1389 | 41/8135 | 3.71 | 4.07e-11 | 9.59e-10 | 41 |
GO:0016064 | GO:0016064 | immunoglobulin mediated immune response | 36/1389 | 70/8135 | 3.01 | 4.17e-11 | 9.69e-10 | 70 |
GO:0050792 | GO:0050792 | regulation of viral process | 36/1389 | 70/8135 | 3.01 | 4.17e-11 | 9.69e-10 | 70 |
GO:0043903 | GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 41/1389 | 86/8135 | 2.79 | 4.23e-11 | 9.77e-10 | 86 |
GO:0002831 | GO:0002831 | regulation of response to biotic stimulus | 35/1389 | 67/8135 | 3.06 | 4.38e-11 | 9.98e-10 | 67 |
GO:0030183 | GO:0030183 | B cell differentiation | 35/1389 | 67/8135 | 3.06 | 4.38e-11 | 9.98e-10 | 67 |
GO:0050854 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 22/1389 | 31/8135 | 4.16 | 4.67e-11 | 1.06e-09 | 31 |
GO:0001913 | GO:0001913 | T cell mediated cytotoxicity | 24/1389 | 36/8135 | 3.90 | 4.84e-11 | 1.09e-09 | 36 |
GO:0002685 | GO:0002685 | regulation of leukocyte migration | 54/1389 | 132/8135 | 2.40 | 6.24e-11 | 1.40e-09 | 132 |
GO:0002294 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 25/1389 | 39/8135 | 3.75 | 6.88e-11 | 1.53e-09 | 39 |
GO:0007249 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 48/1389 | 111/8135 | 2.53 | 7.20e-11 | 1.59e-09 | 111 |
GO:0036230 | GO:0036230 | granulocyte activation | 80/1389 | 233/8135 | 2.01 | 7.45e-11 | 1.64e-09 | 233 |
GO:0043299 | GO:0043299 | leukocyte degranulation | 85/1389 | 254/8135 | 1.96 | 8.51e-11 | 1.86e-09 | 254 |
GO:0042119 | GO:0042119 | neutrophil activation | 79/1389 | 230/8135 | 2.01 | 9.62e-11 | 2.09e-09 | 230 |
GO:0050871 | GO:0050871 | positive regulation of B cell activation | 27/1389 | 45/8135 | 3.51 | 1.09e-10 | 2.35e-09 | 45 |
GO:0019079 | GO:0019079 | viral genome replication | 29/1389 | 51/8135 | 3.33 | 1.37e-10 | 2.94e-09 | 51 |
GO:0001776 | GO:0001776 | leukocyte homeostasis | 32/1389 | 60/8135 | 3.12 | 1.47e-10 | 3.14e-09 | 60 |
GO:0045582 | GO:0045582 | positive regulation of T cell differentiation | 31/1389 | 57/8135 | 3.19 | 1.48e-10 | 3.14e-09 | 57 |
GO:2000514 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 25/1389 | 40/8135 | 3.66 | 1.54e-10 | 3.25e-09 | 40 |
GO:0050777 | GO:0050777 | negative regulation of immune response | 41/1389 | 89/8135 | 2.70 | 1.63e-10 | 3.42e-09 | 89 |
GO:0072678 | GO:0072678 | T cell migration | 26/1389 | 43/8135 | 3.54 | 1.90e-10 | 3.96e-09 | 43 |
GO:0048872 | GO:0048872 | homeostasis of number of cells | 52/1389 | 128/8135 | 2.38 | 1.92e-10 | 3.98e-09 | 128 |
GO:0035456 | GO:0035456 | response to interferon-beta | 14/1389 | 15/8135 | 5.47 | 2.14e-10 | 4.41e-09 | 15 |
GO:0030888 | GO:0030888 | regulation of B cell proliferation | 27/1389 | 46/8135 | 3.44 | 2.21e-10 | 4.53e-09 | 46 |
GO:0030595 | GO:0030595 | leukocyte chemotaxis | 63/1389 | 170/8135 | 2.17 | 2.35e-10 | 4.80e-09 | 170 |
GO:0001773 | GO:0001773 | myeloid dendritic cell activation | 17/1389 | 21/8135 | 4.74 | 2.45e-10 | 4.97e-09 | 21 |
GO:0033209 | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 32/1389 | 61/8135 | 3.07 | 2.60e-10 | 5.24e-09 | 61 |
GO:0002237 | GO:0002237 | response to molecule of bacterial origin | 76/1389 | 222/8135 | 2.01 | 2.64e-10 | 5.26e-09 | 222 |
GO:0002283 | GO:0002283 | neutrophil activation involved in immune response | 76/1389 | 222/8135 | 2.01 | 2.64e-10 | 5.26e-09 | 222 |
GO:0001916 | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 16/1389 | 19/8135 | 4.93 | 2.80e-10 | 5.55e-09 | 19 |
GO:0050688 | GO:0050688 | regulation of defense response to virus | 22/1389 | 33/8135 | 3.90 | 3.16e-10 | 6.24e-09 | 33 |
GO:0046635 | GO:0046635 | positive regulation of alpha-beta T cell activation | 26/1389 | 44/8135 | 3.46 | 3.90e-10 | 7.65e-09 | 44 |
GO:0030101 | GO:0030101 | natural killer cell activation | 28/1389 | 50/8135 | 3.28 | 4.66e-10 | 9.09e-09 | 50 |
GO:0032496 | GO:0032496 | response to lipopolysaccharide | 73/1389 | 213/8135 | 2.01 | 5.66e-10 | 1.10e-08 | 213 |
GO:0042267 | GO:0042267 | natural killer cell mediated cytotoxicity | 24/1389 | 39/8135 | 3.60 | 5.74e-10 | 1.11e-08 | 39 |
GO:0043123 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 37/1389 | 79/8135 | 2.74 | 7.15e-10 | 1.37e-08 | 79 |
GO:0002715 | GO:0002715 | regulation of natural killer cell mediated immunity | 22/1389 | 34/8135 | 3.79 | 7.52e-10 | 1.44e-08 | 34 |
GO:1990868 | GO:1990868 | response to chemokine | 39/1389 | 86/8135 | 2.66 | 8.12e-10 | 1.54e-08 | 86 |
GO:1990869 | GO:1990869 | cellular response to chemokine | 39/1389 | 86/8135 | 2.66 | 8.12e-10 | 1.54e-08 | 86 |
GO:0002446 | GO:0002446 | neutrophil mediated immunity | 76/1389 | 227/8135 | 1.96 | 8.53e-10 | 1.60e-08 | 227 |
GO:0050729 | GO:0050729 | positive regulation of inflammatory response | 43/1389 | 100/8135 | 2.52 | 8.78e-10 | 1.64e-08 | 100 |
GO:0043312 | GO:0043312 | neutrophil degranulation | 74/1389 | 219/8135 | 1.98 | 8.94e-10 | 1.67e-08 | 219 |
GO:0002700 | GO:0002700 | regulation of production of molecular mediator of immune response | 38/1389 | 83/8135 | 2.68 | 9.54e-10 | 1.77e-08 | 83 |
GO:0042093 | GO:0042093 | T-helper cell differentiation | 23/1389 | 37/8135 | 3.64 | 9.90e-10 | 1.82e-08 | 37 |
GO:0042035 | GO:0042035 | regulation of cytokine biosynthetic process | 34/1389 | 70/8135 | 2.84 | 1.05e-09 | 1.93e-08 | 70 |
GO:0070098 | GO:0070098 | chemokine-mediated signaling pathway | 37/1389 | 80/8135 | 2.71 | 1.11e-09 | 2.03e-08 | 80 |
GO:0006909 | GO:0006909 | phagocytosis | 50/1389 | 126/8135 | 2.32 | 1.14e-09 | 2.07e-08 | 126 |
GO:0002218 | GO:0002218 | activation of innate immune response | 51/1389 | 130/8135 | 2.30 | 1.25e-09 | 2.26e-08 | 130 |
GO:0046637 | GO:0046637 | regulation of alpha-beta T cell differentiation | 25/1389 | 43/8135 | 3.41 | 1.37e-09 | 2.47e-08 | 43 |
GO:0019883 | GO:0019883 | antigen processing and presentation of endogenous antigen | 14/1389 | 16/8135 | 5.12 | 1.44e-09 | 2.58e-08 | 16 |
GO:0007259 | GO:0007259 | JAK-STAT cascade | 38/1389 | 84/8135 | 2.65 | 1.46e-09 | 2.60e-08 | 84 |
GO:0032655 | GO:0032655 | regulation of interleukin-12 production | 22/1389 | 35/8135 | 3.68 | 1.70e-09 | 3.01e-08 | 35 |
GO:0022408 | GO:0022408 | negative regulation of cell-cell adhesion | 43/1389 | 102/8135 | 2.47 | 1.85e-09 | 3.26e-08 | 102 |
GO:0097696 | GO:0097696 | STAT cascade | 39/1389 | 88/8135 | 2.60 | 1.85e-09 | 3.26e-08 | 88 |
GO:0007162 | GO:0007162 | negative regulation of cell adhesion | 59/1389 | 162/8135 | 2.13 | 1.92e-09 | 3.35e-08 | 162 |
GO:0042088 | GO:0042088 | T-helper 1 type immune response | 20/1389 | 30/8135 | 3.90 | 2.07e-09 | 3.60e-08 | 30 |
GO:0031348 | GO:0031348 | negative regulation of defense response | 47/1389 | 117/8135 | 2.35 | 2.24e-09 | 3.88e-08 | 117 |
GO:0019884 | GO:0019884 | antigen processing and presentation of exogenous antigen | 30/1389 | 59/8135 | 2.98 | 2.52e-09 | 4.35e-08 | 59 |
GO:0002637 | GO:0002637 | regulation of immunoglobulin production | 21/1389 | 33/8135 | 3.73 | 2.90e-09 | 4.94e-08 | 33 |
GO:0043370 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 21/1389 | 33/8135 | 3.73 | 2.90e-09 | 4.94e-08 | 33 |
GO:0046633 | GO:0046633 | alpha-beta T cell proliferation | 17/1389 | 23/8135 | 4.33 | 2.92e-09 | 4.96e-08 | 23 |
GO:0007204 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 76/1389 | 233/8135 | 1.91 | 3.24e-09 | 5.48e-08 | 233 |
GO:0032615 | GO:0032615 | interleukin-12 production | 22/1389 | 36/8135 | 3.58 | 3.67e-09 | 6.14e-08 | 36 |
GO:0032653 | GO:0032653 | regulation of interleukin-10 production | 22/1389 | 36/8135 | 3.58 | 3.67e-09 | 6.14e-08 | 36 |
GO:0071219 | GO:0071219 | cellular response to molecule of bacterial origin | 50/1389 | 130/8135 | 2.25 | 4.03e-09 | 6.71e-08 | 130 |
GO:0032479 | GO:0032479 | regulation of type I interferon production | 23/1389 | 39/8135 | 3.45 | 4.30e-09 | 7.11e-08 | 39 |
GO:0032606 | GO:0032606 | type I interferon production | 23/1389 | 39/8135 | 3.45 | 4.30e-09 | 7.11e-08 | 39 |
GO:0002687 | GO:0002687 | positive regulation of leukocyte migration | 38/1389 | 87/8135 | 2.56 | 4.94e-09 | 8.12e-08 | 87 |
GO:0048247 | GO:0048247 | lymphocyte chemotaxis | 27/1389 | 51/8135 | 3.10 | 5.06e-09 | 8.28e-08 | 51 |
GO:0042089 | GO:0042089 | cytokine biosynthetic process | 35/1389 | 77/8135 | 2.66 | 5.56e-09 | 9.06e-08 | 77 |
GO:0032613 | GO:0032613 | interleukin-10 production | 22/1389 | 37/8135 | 3.48 | 7.59e-09 | 1.23e-07 | 37 |
GO:0042107 | GO:0042107 | cytokine metabolic process | 35/1389 | 78/8135 | 2.63 | 8.45e-09 | 1.37e-07 | 78 |
GO:0002312 | GO:0002312 | B cell activation involved in immune response | 23/1389 | 40/8135 | 3.37 | 8.50e-09 | 1.37e-07 | 40 |
GO:0042108 | GO:0042108 | positive regulation of cytokine biosynthetic process | 24/1389 | 43/8135 | 3.27 | 9.05e-09 | 1.44e-07 | 43 |
GO:0045123 | GO:0045123 | cellular extravasation | 24/1389 | 43/8135 | 3.27 | 9.05e-09 | 1.44e-07 | 43 |
GO:0050715 | GO:0050715 | positive regulation of cytokine secretion | 38/1389 | 89/8135 | 2.50 | 1.06e-08 | 1.69e-07 | 89 |
GO:0042269 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 20/1389 | 32/8135 | 3.66 | 1.10e-08 | 1.73e-07 | 32 |
GO:0032660 | GO:0032660 | regulation of interleukin-17 production | 16/1389 | 22/8135 | 4.26 | 1.28e-08 | 2.02e-07 | 22 |
GO:0002698 | GO:0002698 | negative regulation of immune effector process | 32/1389 | 69/8135 | 2.72 | 1.37e-08 | 2.15e-07 | 69 |
GO:0002260 | GO:0002260 | lymphocyte homeostasis | 24/1389 | 44/8135 | 3.19 | 1.67e-08 | 2.61e-07 | 44 |
GO:0071216 | GO:0071216 | cellular response to biotic stimulus | 50/1389 | 135/8135 | 2.17 | 1.75e-08 | 2.72e-07 | 135 |
GO:0048002 | GO:0048002 | antigen processing and presentation of peptide antigen | 30/1389 | 63/8135 | 2.79 | 1.82e-08 | 2.81e-07 | 63 |
GO:0006959 | GO:0006959 | humoral immune response | 63/1389 | 187/8135 | 1.97 | 1.85e-08 | 2.85e-07 | 187 |
GO:0036336 | GO:0036336 | dendritic cell migration | 15/1389 | 20/8135 | 4.39 | 1.88e-08 | 2.88e-07 | 20 |
GO:0051345 | GO:0051345 | positive regulation of hydrolase activity | 102/1389 | 356/8135 | 1.68 | 1.95e-08 | 2.98e-07 | 356 |
GO:0002758 | GO:0002758 | innate immune response-activating signal transduction | 47/1389 | 125/8135 | 2.20 | 2.72e-08 | 4.12e-07 | 125 |
GO:0071222 | GO:0071222 | cellular response to lipopolysaccharide | 47/1389 | 125/8135 | 2.20 | 2.72e-08 | 4.12e-07 | 125 |
GO:0002475 | GO:0002475 | antigen processing and presentation via MHC class Ib | 11/1389 | 12/8135 | 5.37 | 3.53e-08 | 5.32e-07 | 12 |
GO:0032620 | GO:0032620 | interleukin-17 production | 16/1389 | 23/8135 | 4.07 | 3.55e-08 | 5.33e-07 | 23 |
GO:0043373 | GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 12/1389 | 14/8135 | 5.02 | 3.82e-08 | 5.69e-07 | 14 |
GO:0050855 | GO:0050855 | regulation of B cell receptor signaling pathway | 12/1389 | 14/8135 | 5.02 | 3.82e-08 | 5.69e-07 | 14 |
GO:0097529 | GO:0097529 | myeloid leukocyte migration | 54/1389 | 154/8135 | 2.05 | 4.22e-08 | 6.26e-07 | 154 |
GO:0006897 | GO:0006897 | endocytosis | 101/1389 | 357/8135 | 1.66 | 4.66e-08 | 6.88e-07 | 357 |
GO:0006874 | GO:0006874 | cellular calcium ion homeostasis | 91/1389 | 312/8135 | 1.71 | 4.69e-08 | 6.90e-07 | 312 |
GO:0070227 | GO:0070227 | lymphocyte apoptotic process | 24/1389 | 46/8135 | 3.06 | 5.27e-08 | 7.73e-07 | 46 |
GO:0045066 | GO:0045066 | regulatory T cell differentiation | 15/1389 | 21/8135 | 4.18 | 5.53e-08 | 8.02e-07 | 21 |
GO:0046640 | GO:0046640 | regulation of alpha-beta T cell proliferation | 15/1389 | 21/8135 | 4.18 | 5.53e-08 | 8.02e-07 | 21 |
GO:0072538 | GO:0072538 | T-helper 17 type immune response | 15/1389 | 21/8135 | 4.18 | 5.53e-08 | 8.02e-07 | 21 |
GO:0097028 | GO:0097028 | dendritic cell differentiation | 18/1389 | 29/8135 | 3.64 | 7.09e-08 | 1.02e-06 | 29 |
GO:0072539 | GO:0072539 | T-helper 17 cell differentiation | 14/1389 | 19/8135 | 4.32 | 8.35e-08 | 1.20e-06 | 19 |
GO:0070231 | GO:0070231 | T cell apoptotic process | 19/1389 | 32/8135 | 3.48 | 8.44e-08 | 1.21e-06 | 32 |
GO:0002825 | GO:0002825 | regulation of T-helper 1 type immune response | 16/1389 | 24/8135 | 3.90 | 8.95e-08 | 1.27e-06 | 24 |
GO:0032735 | GO:0032735 | positive regulation of interleukin-12 production | 16/1389 | 24/8135 | 3.90 | 8.95e-08 | 1.27e-06 | 24 |
GO:0002690 | GO:0002690 | positive regulation of leukocyte chemotaxis | 28/1389 | 60/8135 | 2.73 | 9.36e-08 | 1.32e-06 | 60 |
GO:0032623 | GO:0032623 | interleukin-2 production | 22/1389 | 41/8135 | 3.14 | 9.86e-08 | 1.38e-06 | 41 |
GO:0070228 | GO:0070228 | regulation of lymphocyte apoptotic process | 22/1389 | 41/8135 | 3.14 | 9.86e-08 | 1.38e-06 | 41 |
GO:0002688 | GO:0002688 | regulation of leukocyte chemotaxis | 34/1389 | 81/8135 | 2.46 | 1.05e-07 | 1.47e-06 | 81 |
GO:0051480 | GO:0051480 | regulation of cytosolic calcium ion concentration | 79/1389 | 264/8135 | 1.75 | 1.13e-07 | 1.58e-06 | 264 |
GO:1990266 | GO:1990266 | neutrophil migration | 38/1389 | 96/8135 | 2.32 | 1.22e-07 | 1.68e-06 | 96 |
GO:0002478 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 26/1389 | 54/8135 | 2.82 | 1.23e-07 | 1.68e-06 | 54 |
GO:0007260 | GO:0007260 | tyrosine phosphorylation of STAT protein | 26/1389 | 54/8135 | 2.82 | 1.23e-07 | 1.68e-06 | 54 |
GO:0038093 | GO:0038093 | Fc receptor signaling pathway | 26/1389 | 54/8135 | 2.82 | 1.23e-07 | 1.68e-06 | 54 |
GO:0006887 | GO:0006887 | exocytosis | 123/1389 | 466/8135 | 1.55 | 1.23e-07 | 1.68e-06 | 466 |
GO:0050691 | GO:0050691 | regulation of defense response to virus by host | 15/1389 | 22/8135 | 3.99 | 1.46e-07 | 1.99e-06 | 22 |
GO:0002437 | GO:0002437 | inflammatory response to antigenic stimulus | 18/1389 | 30/8135 | 3.51 | 1.49e-07 | 2.02e-06 | 30 |
GO:0002363 | GO:0002363 | alpha-beta T cell lineage commitment | 12/1389 | 15/8135 | 4.69 | 1.61e-07 | 2.17e-06 | 15 |
GO:0002577 | GO:0002577 | regulation of antigen processing and presentation | 12/1389 | 15/8135 | 4.69 | 1.61e-07 | 2.17e-06 | 15 |
GO:0033077 | GO:0033077 | T cell differentiation in thymus | 22/1389 | 42/8135 | 3.07 | 1.74e-07 | 2.33e-06 | 42 |
GO:0072540 | GO:0072540 | T-helper 17 cell lineage commitment | 10/1389 | 11/8135 | 5.32 | 1.91e-07 | 2.54e-06 | 11 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 36/1389 | 90/8135 | 2.34 | 1.92e-07 | 2.54e-06 | 90 |
GO:0071706 | GO:0071706 | tumor necrosis factor superfamily cytokine production | 36/1389 | 90/8135 | 2.34 | 1.92e-07 | 2.54e-06 | 90 |
GO:1903555 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 36/1389 | 90/8135 | 2.34 | 1.92e-07 | 2.54e-06 | 90 |
GO:0002295 | GO:0002295 | T-helper cell lineage commitment | 11/1389 | 13/8135 | 4.96 | 1.94e-07 | 2.55e-06 | 13 |
GO:0042509 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 25/1389 | 52/8135 | 2.82 | 2.22e-07 | 2.92e-06 | 52 |
GO:0002714 | GO:0002714 | positive regulation of B cell mediated immunity | 14/1389 | 20/8135 | 4.10 | 2.35e-07 | 3.06e-06 | 20 |
GO:0002891 | GO:0002891 | positive regulation of immunoglobulin mediated immune response | 14/1389 | 20/8135 | 4.10 | 2.35e-07 | 3.06e-06 | 20 |
GO:0002573 | GO:0002573 | myeloid leukocyte differentiation | 46/1389 | 129/8135 | 2.09 | 2.41e-07 | 3.13e-06 | 129 |
GO:0002820 | GO:0002820 | negative regulation of adaptive immune response | 17/1389 | 28/8135 | 3.56 | 2.62e-07 | 3.38e-06 | 28 |
GO:0070232 | GO:0070232 | regulation of T cell apoptotic process | 17/1389 | 28/8135 | 3.56 | 2.62e-07 | 3.38e-06 | 28 |
GO:0055074 | GO:0055074 | calcium ion homeostasis | 91/1389 | 323/8135 | 1.65 | 2.72e-07 | 3.50e-06 | 323 |
GO:0002704 | GO:0002704 | negative regulation of leukocyte mediated immunity | 18/1389 | 31/8135 | 3.40 | 2.99e-07 | 3.83e-06 | 31 |
GO:0002717 | GO:0002717 | positive regulation of natural killer cell mediated immunity | 15/1389 | 23/8135 | 3.82 | 3.55e-07 | 4.51e-06 | 23 |
GO:0046636 | GO:0046636 | negative regulation of alpha-beta T cell activation | 15/1389 | 23/8135 | 3.82 | 3.55e-07 | 4.51e-06 | 23 |
GO:0072503 | GO:0072503 | cellular divalent inorganic cation homeostasis | 93/1389 | 334/8135 | 1.63 | 3.60e-07 | 4.57e-06 | 334 |
GO:0002360 | GO:0002360 | T cell lineage commitment | 13/1389 | 18/8135 | 4.23 | 3.65e-07 | 4.59e-06 | 18 |
GO:0002407 | GO:0002407 | dendritic cell chemotaxis | 13/1389 | 18/8135 | 4.23 | 3.65e-07 | 4.59e-06 | 18 |
GO:0060759 | GO:0060759 | regulation of response to cytokine stimulus | 33/1389 | 81/8135 | 2.39 | 3.74e-07 | 4.69e-06 | 81 |
GO:0002823 | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 16/1389 | 26/8135 | 3.60 | 4.58e-07 | 5.70e-06 | 26 |
GO:0042092 | GO:0042092 | type 2 immune response | 16/1389 | 26/8135 | 3.60 | 4.58e-07 | 5.70e-06 | 26 |
GO:0046425 | GO:0046425 | regulation of JAK-STAT cascade | 32/1389 | 78/8135 | 2.40 | 4.64e-07 | 5.76e-06 | 78 |
GO:0097530 | GO:0097530 | granulocyte migration | 41/1389 | 112/8135 | 2.14 | 4.85e-07 | 6.00e-06 | 112 |
GO:1904892 | GO:1904892 | regulation of STAT cascade | 33/1389 | 82/8135 | 2.36 | 5.24e-07 | 6.46e-06 | 82 |
GO:0002712 | GO:0002712 | regulation of B cell mediated immunity | 17/1389 | 29/8135 | 3.43 | 5.32e-07 | 6.50e-06 | 29 |
GO:0002889 | GO:0002889 | regulation of immunoglobulin mediated immune response | 17/1389 | 29/8135 | 3.43 | 5.32e-07 | 6.50e-06 | 29 |
GO:0038094 | GO:0038094 | Fc-gamma receptor signaling pathway | 17/1389 | 29/8135 | 3.43 | 5.32e-07 | 6.50e-06 | 29 |
GO:0043369 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 12/1389 | 16/8135 | 4.39 | 5.44e-07 | 6.62e-06 | 16 |
GO:0150076 | GO:0150076 | neuroinflammatory response | 20/1389 | 38/8135 | 3.08 | 5.74e-07 | 6.94e-06 | 38 |
GO:0030890 | GO:0030890 | positive regulation of B cell proliferation | 18/1389 | 32/8135 | 3.29 | 5.74e-07 | 6.94e-06 | 32 |
GO:0032640 | GO:0032640 | tumor necrosis factor production | 34/1389 | 86/8135 | 2.32 | 5.81e-07 | 6.98e-06 | 86 |
GO:0032680 | GO:0032680 | regulation of tumor necrosis factor production | 34/1389 | 86/8135 | 2.32 | 5.81e-07 | 6.98e-06 | 86 |
GO:2000116 | GO:2000116 | regulation of cysteine-type endopeptidase activity | 41/1389 | 113/8135 | 2.13 | 6.38e-07 | 7.63e-06 | 113 |
GO:0045055 | GO:0045055 | regulated exocytosis | 111/1389 | 423/8135 | 1.54 | 7.20e-07 | 8.59e-06 | 423 |
GO:0002367 | GO:0002367 | cytokine production involved in immune response | 28/1389 | 65/8135 | 2.52 | 7.36e-07 | 8.76e-06 | 65 |
GO:0048305 | GO:0048305 | immunoglobulin secretion | 11/1389 | 14/8135 | 4.60 | 7.63e-07 | 9.05e-06 | 14 |
GO:0001959 | GO:0001959 | regulation of cytokine-mediated signaling pathway | 31/1389 | 76/8135 | 2.39 | 8.14e-07 | 9.62e-06 | 76 |
GO:0030099 | GO:0030099 | myeloid cell differentiation | 65/1389 | 214/8135 | 1.78 | 8.54e-07 | 1.01e-05 | 214 |
GO:0002221 | GO:0002221 | pattern recognition receptor signaling pathway | 35/1389 | 91/8135 | 2.25 | 8.64e-07 | 1.01e-05 | 91 |
GO:1904894 | GO:1904894 | positive regulation of STAT cascade | 27/1389 | 62/8135 | 2.55 | 8.93e-07 | 1.04e-05 | 62 |
GO:2000516 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 16/1389 | 27/8135 | 3.47 | 9.46e-07 | 1.10e-05 | 27 |
GO:0072507 | GO:0072507 | divalent inorganic cation homeostasis | 95/1389 | 350/8135 | 1.59 | 9.52e-07 | 1.11e-05 | 350 |
GO:0002507 | GO:0002507 | tolerance induction | 13/1389 | 19/8135 | 4.01 | 9.74e-07 | 1.12e-05 | 19 |
GO:0045589 | GO:0045589 | regulation of regulatory T cell differentiation | 13/1389 | 19/8135 | 4.01 | 9.74e-07 | 1.12e-05 | 19 |
GO:0150077 | GO:0150077 | regulation of neuroinflammatory response | 13/1389 | 19/8135 | 4.01 | 9.74e-07 | 1.12e-05 | 19 |
GO:0070664 | GO:0070664 | negative regulation of leukocyte proliferation | 24/1389 | 52/8135 | 2.70 | 9.97e-07 | 1.14e-05 | 52 |
GO:0019722 | GO:0019722 | calcium-mediated signaling | 49/1389 | 147/8135 | 1.95 | 1.01e-06 | 1.16e-05 | 147 |
GO:0002418 | GO:0002418 | immune response to tumor cell | 9/1389 | 10/8135 | 5.27 | 1.02e-06 | 1.16e-05 | 10 |
GO:0002483 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 9/1389 | 10/8135 | 5.27 | 1.02e-06 | 1.16e-05 | 10 |
GO:0035458 | GO:0035458 | cellular response to interferon-beta | 9/1389 | 10/8135 | 5.27 | 1.02e-06 | 1.16e-05 | 10 |
GO:0046427 | GO:0046427 | positive regulation of JAK-STAT cascade | 26/1389 | 59/8135 | 2.58 | 1.08e-06 | 1.22e-05 | 59 |
GO:0002828 | GO:0002828 | regulation of type 2 immune response | 14/1389 | 22/8135 | 3.73 | 1.37e-06 | 1.54e-05 | 22 |
GO:0032733 | GO:0032733 | positive regulation of interleukin-10 production | 14/1389 | 22/8135 | 3.73 | 1.37e-06 | 1.54e-05 | 22 |
GO:0045954 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 14/1389 | 22/8135 | 3.73 | 1.37e-06 | 1.54e-05 | 22 |
GO:0051090 | GO:0051090 | regulation of DNA-binding transcription factor activity | 60/1389 | 195/8135 | 1.80 | 1.40e-06 | 1.57e-05 | 195 |
GO:0002702 | GO:0002702 | positive regulation of production of molecular mediator of immune response | 24/1389 | 53/8135 | 2.65 | 1.53e-06 | 1.70e-05 | 53 |
GO:0071674 | GO:0071674 | mononuclear cell migration | 28/1389 | 67/8135 | 2.45 | 1.55e-06 | 1.72e-05 | 67 |
GO:0032480 | GO:0032480 | negative regulation of type I interferon production | 12/1389 | 17/8135 | 4.13 | 1.56e-06 | 1.72e-05 | 17 |
GO:0046641 | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 12/1389 | 17/8135 | 4.13 | 1.56e-06 | 1.72e-05 | 17 |
GO:0045622 | GO:0045622 | regulation of T-helper cell differentiation | 15/1389 | 25/8135 | 3.51 | 1.68e-06 | 1.83e-05 | 25 |
GO:0061756 | GO:0061756 | leukocyte adhesion to vascular endothelial cell | 15/1389 | 25/8135 | 3.51 | 1.68e-06 | 1.83e-05 | 25 |
GO:0070229 | GO:0070229 | negative regulation of lymphocyte apoptotic process | 15/1389 | 25/8135 | 3.51 | 1.68e-06 | 1.83e-05 | 25 |
GO:0032945 | GO:0032945 | negative regulation of mononuclear cell proliferation | 22/1389 | 47/8135 | 2.74 | 2.10e-06 | 2.28e-05 | 47 |
GO:0050672 | GO:0050672 | negative regulation of lymphocyte proliferation | 22/1389 | 47/8135 | 2.74 | 2.10e-06 | 2.28e-05 | 47 |
GO:0010818 | GO:0010818 | T cell chemotaxis | 13/1389 | 20/8135 | 3.81 | 2.35e-06 | 2.54e-05 | 20 |
GO:0050869 | GO:0050869 | negative regulation of B cell activation | 13/1389 | 20/8135 | 3.81 | 2.35e-06 | 2.54e-05 | 20 |
GO:0002230 | GO:0002230 | positive regulation of defense response to virus by host | 11/1389 | 15/8135 | 4.29 | 2.42e-06 | 2.59e-05 | 15 |
GO:0042832 | GO:0042832 | defense response to protozoan | 11/1389 | 15/8135 | 4.29 | 2.42e-06 | 2.59e-05 | 15 |
GO:2000515 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 11/1389 | 15/8135 | 4.29 | 2.42e-06 | 2.59e-05 | 15 |
GO:0034121 | GO:0034121 | regulation of toll-like receptor signaling pathway | 20/1389 | 41/8135 | 2.86 | 2.73e-06 | 2.92e-05 | 41 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 37/1389 | 103/8135 | 2.10 | 2.94e-06 | 3.12e-05 | 103 |
GO:0002639 | GO:0002639 | positive regulation of immunoglobulin production | 14/1389 | 23/8135 | 3.56 | 2.96e-06 | 3.12e-05 | 23 |
GO:0032481 | GO:0032481 | positive regulation of type I interferon production | 14/1389 | 23/8135 | 3.56 | 2.96e-06 | 3.12e-05 | 23 |
GO:0043372 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 14/1389 | 23/8135 | 3.56 | 2.96e-06 | 3.12e-05 | 23 |
GO:0032663 | GO:0032663 | regulation of interleukin-2 production | 18/1389 | 35/8135 | 3.01 | 3.29e-06 | 3.45e-05 | 35 |
GO:0043030 | GO:0043030 | regulation of macrophage activation | 18/1389 | 35/8135 | 3.01 | 3.29e-06 | 3.45e-05 | 35 |
GO:0002369 | GO:0002369 | T cell cytokine production | 15/1389 | 26/8135 | 3.38 | 3.34e-06 | 3.49e-05 | 26 |
GO:0046638 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 17/1389 | 32/8135 | 3.11 | 3.46e-06 | 3.60e-05 | 32 |
GO:0061900 | GO:0061900 | glial cell activation | 17/1389 | 32/8135 | 3.11 | 3.46e-06 | 3.60e-05 | 32 |
GO:0002431 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 16/1389 | 29/8135 | 3.23 | 3.49e-06 | 3.62e-05 | 29 |
GO:0006875 | GO:0006875 | cellular metal ion homeostasis | 98/1389 | 374/8135 | 1.53 | 3.53e-06 | 3.65e-05 | 374 |
GO:0032740 | GO:0032740 | positive regulation of interleukin-17 production | 10/1389 | 13/8135 | 4.51 | 3.55e-06 | 3.65e-05 | 13 |
GO:0050857 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 10/1389 | 13/8135 | 4.51 | 3.55e-06 | 3.65e-05 | 13 |
GO:0050921 | GO:0050921 | positive regulation of chemotaxis | 34/1389 | 92/8135 | 2.16 | 3.56e-06 | 3.65e-05 | 92 |
GO:0002335 | GO:0002335 | mature B cell differentiation | 12/1389 | 18/8135 | 3.90 | 3.96e-06 | 4.01e-05 | 18 |
GO:0002832 | GO:0002832 | negative regulation of response to biotic stimulus | 12/1389 | 18/8135 | 3.90 | 3.96e-06 | 4.01e-05 | 18 |
GO:0070233 | GO:0070233 | negative regulation of T cell apoptotic process | 12/1389 | 18/8135 | 3.90 | 3.96e-06 | 4.01e-05 | 18 |
GO:0090023 | GO:0090023 | positive regulation of neutrophil chemotaxis | 12/1389 | 18/8135 | 3.90 | 3.96e-06 | 4.01e-05 | 18 |
GO:0051092 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 28/1389 | 70/8135 | 2.34 | 4.36e-06 | 4.41e-05 | 70 |
GO:0030335 | GO:0030335 | positive regulation of cell migration | 79/1389 | 287/8135 | 1.61 | 4.49e-06 | 4.53e-05 | 287 |
GO:0018108 | GO:0018108 | peptidyl-tyrosine phosphorylation | 68/1389 | 237/8135 | 1.68 | 4.52e-06 | 4.53e-05 | 237 |
GO:0018212 | GO:0018212 | peptidyl-tyrosine modification | 68/1389 | 237/8135 | 1.68 | 4.52e-06 | 4.53e-05 | 237 |
GO:0070555 | GO:0070555 | response to interleukin-1 | 33/1389 | 89/8135 | 2.17 | 4.54e-06 | 4.53e-05 | 89 |
GO:0090087 | GO:0090087 | regulation of peptide transport | 98/1389 | 376/8135 | 1.53 | 4.54e-06 | 4.53e-05 | 376 |
GO:0043011 | GO:0043011 | myeloid dendritic cell differentiation | 9/1389 | 11/8135 | 4.79 | 4.77e-06 | 4.74e-05 | 11 |
GO:0002790 | GO:0002790 | peptide secretion | 96/1389 | 367/8135 | 1.53 | 4.82e-06 | 4.79e-05 | 367 |
GO:0051223 | GO:0051223 | regulation of protein transport | 93/1389 | 353/8135 | 1.54 | 4.94e-06 | 4.89e-05 | 353 |
GO:0042531 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 22/1389 | 49/8135 | 2.63 | 4.96e-06 | 4.90e-05 | 49 |
GO:0032753 | GO:0032753 | positive regulation of interleukin-4 production | 13/1389 | 21/8135 | 3.63 | 5.20e-06 | 5.12e-05 | 21 |
GO:0002718 | GO:0002718 | regulation of cytokine production involved in immune response | 23/1389 | 53/8135 | 2.54 | 6.16e-06 | 6.01e-05 | 53 |
GO:0042116 | GO:0042116 | macrophage activation | 23/1389 | 53/8135 | 2.54 | 6.16e-06 | 6.01e-05 | 53 |
GO:0002381 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 15/1389 | 27/8135 | 3.25 | 6.33e-06 | 6.16e-05 | 27 |
GO:0001562 | GO:0001562 | response to protozoan | 11/1389 | 16/8135 | 4.03 | 6.54e-06 | 6.35e-05 | 16 |
GO:0046718 | GO:0046718 | viral entry into host cell | 26/1389 | 64/8135 | 2.38 | 6.81e-06 | 6.59e-05 | 64 |
GO:0050710 | GO:0050710 | negative regulation of cytokine secretion | 20/1389 | 43/8135 | 2.72 | 6.89e-06 | 6.65e-05 | 43 |
GO:0002791 | GO:0002791 | regulation of peptide secretion | 82/1389 | 305/8135 | 1.57 | 7.95e-06 | 7.65e-05 | 305 |
GO:0070374 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 53/1389 | 174/8135 | 1.78 | 7.96e-06 | 7.65e-05 | 174 |
GO:0070201 | GO:0070201 | regulation of establishment of protein localization | 94/1389 | 362/8135 | 1.52 | 8.42e-06 | 8.07e-05 | 362 |
GO:0043068 | GO:0043068 | positive regulation of programmed cell death | 78/1389 | 287/8135 | 1.59 | 8.63e-06 | 8.24e-05 | 287 |
GO:0010942 | GO:0010942 | positive regulation of cell death | 85/1389 | 320/8135 | 1.56 | 9.03e-06 | 8.61e-05 | 320 |
GO:0050856 | GO:0050856 | regulation of T cell receptor signaling pathway | 12/1389 | 19/8135 | 3.70 | 9.07e-06 | 8.62e-05 | 19 |
GO:0010950 | GO:0010950 | positive regulation of endopeptidase activity | 30/1389 | 80/8135 | 2.20 | 9.40e-06 | 8.91e-05 | 80 |
GO:0050708 | GO:0050708 | regulation of protein secretion | 77/1389 | 283/8135 | 1.59 | 9.42e-06 | 8.91e-05 | 283 |
GO:0032612 | GO:0032612 | interleukin-1 production | 26/1389 | 65/8135 | 2.34 | 9.53e-06 | 8.99e-05 | 65 |
GO:2000147 | GO:2000147 | positive regulation of cell motility | 81/1389 | 302/8135 | 1.57 | 9.95e-06 | 9.36e-05 | 302 |
GO:0010952 | GO:0010952 | positive regulation of peptidase activity | 32/1389 | 88/8135 | 2.13 | 1.01e-05 | 9.50e-05 | 88 |
GO:0009306 | GO:0009306 | protein secretion | 89/1389 | 340/8135 | 1.53 | 1.04e-05 | 9.75e-05 | 340 |
GO:0002224 | GO:0002224 | toll-like receptor signaling pathway | 27/1389 | 69/8135 | 2.29 | 1.05e-05 | 9.75e-05 | 69 |
GO:2001056 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 27/1389 | 69/8135 | 2.29 | 1.05e-05 | 9.75e-05 | 69 |
GO:0046596 | GO:0046596 | regulation of viral entry into host cell | 10/1389 | 14/8135 | 4.18 | 1.05e-05 | 9.77e-05 | 14 |
GO:0002504 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 20/1389 | 44/8135 | 2.66 | 1.06e-05 | 9.84e-05 | 44 |
GO:0050901 | GO:0050901 | leukocyte tethering or rolling | 13/1389 | 22/8135 | 3.46 | 1.07e-05 | 9.91e-05 | 22 |
GO:1901222 | GO:1901222 | regulation of NIK/NF-kappaB signaling | 22/1389 | 51/8135 | 2.53 | 1.10e-05 | 1.01e-04 | 51 |
GO:0030162 | GO:0030162 | regulation of proteolysis | 96/1389 | 374/8135 | 1.50 | 1.13e-05 | 1.04e-04 | 374 |
GO:0002701 | GO:0002701 | negative regulation of production of molecular mediator of immune response | 14/1389 | 25/8135 | 3.28 | 1.15e-05 | 1.05e-04 | 25 |
GO:0045581 | GO:0045581 | negative regulation of T cell differentiation | 14/1389 | 25/8135 | 3.28 | 1.15e-05 | 1.05e-04 | 25 |
GO:0032633 | GO:0032633 | interleukin-4 production | 15/1389 | 28/8135 | 3.14 | 1.15e-05 | 1.05e-04 | 28 |
GO:0046006 | GO:0046006 | regulation of activated T cell proliferation | 15/1389 | 28/8135 | 3.14 | 1.15e-05 | 1.05e-04 | 28 |
GO:0050920 | GO:0050920 | regulation of chemotaxis | 46/1389 | 146/8135 | 1.85 | 1.19e-05 | 1.08e-04 | 146 |
GO:0043065 | GO:0043065 | positive regulation of apoptotic process | 77/1389 | 285/8135 | 1.58 | 1.24e-05 | 1.12e-04 | 285 |
GO:0050701 | GO:0050701 | interleukin-1 secretion | 19/1389 | 41/8135 | 2.71 | 1.25e-05 | 1.13e-04 | 41 |
GO:0043547 | GO:0043547 | positive regulation of GTPase activity | 54/1389 | 181/8135 | 1.75 | 1.28e-05 | 1.15e-04 | 181 |
GO:0038061 | GO:0038061 | NIK/NF-kappaB signaling | 23/1389 | 55/8135 | 2.45 | 1.30e-05 | 1.16e-04 | 55 |
GO:1903557 | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 23/1389 | 55/8135 | 2.45 | 1.30e-05 | 1.16e-04 | 55 |
GO:0043281 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 34/1389 | 97/8135 | 2.05 | 1.35e-05 | 1.21e-04 | 97 |
GO:2000401 | GO:2000401 | regulation of lymphocyte migration | 18/1389 | 38/8135 | 2.77 | 1.45e-05 | 1.29e-04 | 38 |
GO:0032693 | GO:0032693 | negative regulation of interleukin-10 production | 11/1389 | 17/8135 | 3.79 | 1.57e-05 | 1.39e-04 | 17 |
GO:0042742 | GO:0042742 | defense response to bacterium | 48/1389 | 156/8135 | 1.80 | 1.57e-05 | 1.39e-04 | 156 |
GO:0032760 | GO:0032760 | positive regulation of tumor necrosis factor production | 22/1389 | 52/8135 | 2.48 | 1.60e-05 | 1.41e-04 | 52 |
GO:0035455 | GO:0035455 | response to interferon-alpha | 9/1389 | 12/8135 | 4.39 | 1.62e-05 | 1.41e-04 | 12 |
GO:0051023 | GO:0051023 | regulation of immunoglobulin secretion | 9/1389 | 12/8135 | 4.39 | 1.62e-05 | 1.41e-04 | 12 |
GO:1903978 | GO:1903978 | regulation of microglial cell activation | 9/1389 | 12/8135 | 4.39 | 1.62e-05 | 1.41e-04 | 12 |
GO:0050702 | GO:0050702 | interleukin-1 beta secretion | 17/1389 | 35/8135 | 2.84 | 1.65e-05 | 1.44e-04 | 35 |
GO:0051272 | GO:0051272 | positive regulation of cellular component movement | 82/1389 | 311/8135 | 1.54 | 1.75e-05 | 1.52e-04 | 311 |
GO:0030260 | GO:0030260 | entry into host cell | 26/1389 | 67/8135 | 2.27 | 1.81e-05 | 1.56e-04 | 67 |
GO:0044409 | GO:0044409 | entry into host | 26/1389 | 67/8135 | 2.27 | 1.81e-05 | 1.56e-04 | 67 |
GO:0051806 | GO:0051806 | entry into cell of other organism involved in symbiotic interaction | 26/1389 | 67/8135 | 2.27 | 1.81e-05 | 1.56e-04 | 67 |
GO:0051828 | GO:0051828 | entry into other organism involved in symbiotic interaction | 26/1389 | 67/8135 | 2.27 | 1.81e-05 | 1.56e-04 | 67 |
GO:0002920 | GO:0002920 | regulation of humoral immune response | 23/1389 | 56/8135 | 2.41 | 1.86e-05 | 1.60e-04 | 56 |
GO:0070372 | GO:0070372 | regulation of ERK1 and ERK2 cascade | 62/1389 | 219/8135 | 1.66 | 1.88e-05 | 1.61e-04 | 219 |
GO:0071624 | GO:0071624 | positive regulation of granulocyte chemotaxis | 12/1389 | 20/8135 | 3.51 | 1.92e-05 | 1.64e-04 | 20 |
GO:1902624 | GO:1902624 | positive regulation of neutrophil migration | 12/1389 | 20/8135 | 3.51 | 1.92e-05 | 1.64e-04 | 20 |
GO:0006911 | GO:0006911 | phagocytosis, engulfment | 15/1389 | 29/8135 | 3.03 | 2.01e-05 | 1.71e-04 | 29 |
GO:0050798 | GO:0050798 | activated T cell proliferation | 15/1389 | 29/8135 | 3.03 | 2.01e-05 | 1.71e-04 | 29 |
GO:0002707 | GO:0002707 | negative regulation of lymphocyte mediated immunity | 13/1389 | 23/8135 | 3.31 | 2.08e-05 | 1.76e-04 | 23 |
GO:0001774 | GO:0001774 | microglial cell activation | 14/1389 | 26/8135 | 3.15 | 2.10e-05 | 1.76e-04 | 26 |
GO:0002200 | GO:0002200 | somatic diversification of immune receptors | 14/1389 | 26/8135 | 3.15 | 2.10e-05 | 1.76e-04 | 26 |
GO:0002269 | GO:0002269 | leukocyte activation involved in inflammatory response | 14/1389 | 26/8135 | 3.15 | 2.10e-05 | 1.76e-04 | 26 |
GO:0002433 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 14/1389 | 26/8135 | 3.15 | 2.10e-05 | 1.76e-04 | 26 |
GO:0038096 | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 14/1389 | 26/8135 | 3.15 | 2.10e-05 | 1.76e-04 | 26 |
GO:0060402 | GO:0060402 | calcium ion transport into cytosol | 35/1389 | 103/8135 | 1.99 | 2.19e-05 | 1.83e-04 | 103 |
GO:0050728 | GO:0050728 | negative regulation of inflammatory response | 31/1389 | 87/8135 | 2.09 | 2.22e-05 | 1.85e-04 | 87 |
GO:0001771 | GO:0001771 | immunological synapse formation | 8/1389 | 10/8135 | 4.69 | 2.30e-05 | 1.91e-04 | 10 |
GO:0001911 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 8/1389 | 10/8135 | 4.69 | 2.30e-05 | 1.91e-04 | 10 |
GO:2001185 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation | 8/1389 | 10/8135 | 4.69 | 2.30e-05 | 1.91e-04 | 10 |
GO:0032102 | GO:0032102 | negative regulation of response to external stimulus | 59/1389 | 207/8135 | 1.67 | 2.39e-05 | 1.98e-04 | 207 |
GO:0050730 | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 46/1389 | 150/8135 | 1.80 | 2.58e-05 | 2.13e-04 | 150 |
GO:0032652 | GO:0032652 | regulation of interleukin-1 production | 23/1389 | 57/8135 | 2.36 | 2.61e-05 | 2.15e-04 | 57 |
GO:0040017 | GO:0040017 | positive regulation of locomotion | 83/1389 | 319/8135 | 1.52 | 2.64e-05 | 2.17e-04 | 319 |
GO:0002313 | GO:0002313 | mature B cell differentiation involved in immune response | 10/1389 | 15/8135 | 3.90 | 2.67e-05 | 2.18e-04 | 15 |
GO:0045061 | GO:0045061 | thymic T cell selection | 10/1389 | 15/8135 | 3.90 | 2.67e-05 | 2.18e-04 | 15 |
GO:2000316 | GO:2000316 | regulation of T-helper 17 type immune response | 10/1389 | 15/8135 | 3.90 | 2.67e-05 | 2.18e-04 | 15 |
GO:0060401 | GO:0060401 | cytosolic calcium ion transport | 35/1389 | 104/8135 | 1.97 | 2.77e-05 | 2.25e-04 | 104 |
GO:0002495 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 19/1389 | 43/8135 | 2.59 | 2.89e-05 | 2.35e-04 | 43 |
GO:0002548 | GO:0002548 | monocyte chemotaxis | 22/1389 | 54/8135 | 2.39 | 3.27e-05 | 2.63e-04 | 54 |
GO:0032611 | GO:0032611 | interleukin-1 beta production | 22/1389 | 54/8135 | 2.39 | 3.27e-05 | 2.63e-04 | 54 |
GO:0032743 | GO:0032743 | positive regulation of interleukin-2 production | 11/1389 | 18/8135 | 3.58 | 3.41e-05 | 2.72e-04 | 18 |
GO:0035743 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production | 11/1389 | 18/8135 | 3.58 | 3.41e-05 | 2.72e-04 | 18 |
GO:0036037 | GO:0036037 | CD8-positive, alpha-beta T cell activation | 11/1389 | 18/8135 | 3.58 | 3.41e-05 | 2.72e-04 | 18 |
GO:1901623 | GO:1901623 | regulation of lymphocyte chemotaxis | 11/1389 | 18/8135 | 3.58 | 3.41e-05 | 2.72e-04 | 18 |
GO:0006919 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 18/1389 | 40/8135 | 2.64 | 3.47e-05 | 2.76e-04 | 40 |
GO:0019886 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 18/1389 | 40/8135 | 2.64 | 3.47e-05 | 2.76e-04 | 40 |
GO:0051209 | GO:0051209 | release of sequestered calcium ion into cytosol | 28/1389 | 77/8135 | 2.13 | 3.58e-05 | 2.83e-04 | 77 |
GO:0051283 | GO:0051283 | negative regulation of sequestering of calcium ion | 28/1389 | 77/8135 | 2.13 | 3.58e-05 | 2.83e-04 | 77 |
GO:0045824 | GO:0045824 | negative regulation of innate immune response | 14/1389 | 27/8135 | 3.04 | 3.68e-05 | 2.90e-04 | 27 |
GO:2000404 | GO:2000404 | regulation of T cell migration | 14/1389 | 27/8135 | 3.04 | 3.68e-05 | 2.90e-04 | 27 |
GO:0051091 | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 39/1389 | 122/8135 | 1.87 | 3.74e-05 | 2.94e-04 | 122 |
GO:0052548 | GO:0052548 | regulation of endopeptidase activity | 66/1389 | 242/8135 | 1.60 | 3.75e-05 | 2.95e-04 | 242 |
GO:0070670 | GO:0070670 | response to interleukin-4 | 12/1389 | 21/8135 | 3.35 | 3.78e-05 | 2.96e-04 | 21 |
GO:0002562 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 13/1389 | 24/8135 | 3.17 | 3.84e-05 | 2.98e-04 | 24 |
GO:0009164 | GO:0009164 | nucleoside catabolic process | 13/1389 | 24/8135 | 3.17 | 3.84e-05 | 2.98e-04 | 24 |
GO:0016444 | GO:0016444 | somatic cell DNA recombination | 13/1389 | 24/8135 | 3.17 | 3.84e-05 | 2.98e-04 | 24 |
GO:0032673 | GO:0032673 | regulation of interleukin-4 production | 13/1389 | 24/8135 | 3.17 | 3.84e-05 | 2.98e-04 | 24 |
GO:0070371 | GO:0070371 | ERK1 and ERK2 cascade | 63/1389 | 229/8135 | 1.61 | 4.22e-05 | 3.27e-04 | 229 |
GO:0002710 | GO:0002710 | negative regulation of T cell mediated immunity | 9/1389 | 13/8135 | 4.05 | 4.45e-05 | 3.41e-04 | 13 |
GO:0002830 | GO:0002830 | positive regulation of type 2 immune response | 9/1389 | 13/8135 | 4.05 | 4.45e-05 | 3.41e-04 | 13 |
GO:0006925 | GO:0006925 | inflammatory cell apoptotic process | 9/1389 | 13/8135 | 4.05 | 4.45e-05 | 3.41e-04 | 13 |
GO:0050858 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 9/1389 | 13/8135 | 4.05 | 4.45e-05 | 3.41e-04 | 13 |
GO:0150078 | GO:0150078 | positive regulation of neuroinflammatory response | 9/1389 | 13/8135 | 4.05 | 4.45e-05 | 3.41e-04 | 13 |
GO:2000319 | GO:2000319 | regulation of T-helper 17 cell differentiation | 9/1389 | 13/8135 | 4.05 | 4.45e-05 | 3.41e-04 | 13 |
GO:0002673 | GO:0002673 | regulation of acute inflammatory response | 27/1389 | 74/8135 | 2.14 | 4.59e-05 | 3.50e-04 | 74 |
GO:0051282 | GO:0051282 | regulation of sequestering of calcium ion | 28/1389 | 78/8135 | 2.10 | 4.69e-05 | 3.57e-04 | 78 |
GO:0002526 | GO:0002526 | acute inflammatory response | 38/1389 | 119/8135 | 1.87 | 4.81e-05 | 3.66e-04 | 119 |
GO:0052547 | GO:0052547 | regulation of peptidase activity | 69/1389 | 258/8135 | 1.57 | 4.97e-05 | 3.77e-04 | 258 |
GO:0010324 | GO:0010324 | membrane invagination | 15/1389 | 31/8135 | 2.83 | 5.53e-05 | 4.18e-04 | 31 |
GO:0099024 | GO:0099024 | plasma membrane invagination | 15/1389 | 31/8135 | 2.83 | 5.53e-05 | 4.18e-04 | 31 |
GO:0042590 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 10/1389 | 16/8135 | 3.66 | 6.03e-05 | 4.54e-04 | 16 |
GO:0045076 | GO:0045076 | regulation of interleukin-2 biosynthetic process | 10/1389 | 16/8135 | 3.66 | 6.03e-05 | 4.54e-04 | 16 |
GO:0051208 | GO:0051208 | sequestering of calcium ion | 28/1389 | 79/8135 | 2.08 | 6.10e-05 | 4.58e-04 | 79 |
GO:0002455 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 17/1389 | 38/8135 | 2.62 | 6.27e-05 | 4.70e-04 | 38 |
GO:0043029 | GO:0043029 | T cell homeostasis | 13/1389 | 25/8135 | 3.05 | 6.75e-05 | 5.04e-04 | 25 |
GO:0043277 | GO:0043277 | apoptotic cell clearance | 13/1389 | 25/8135 | 3.05 | 6.75e-05 | 5.04e-04 | 25 |
GO:0001782 | GO:0001782 | B cell homeostasis | 11/1389 | 19/8135 | 3.39 | 6.85e-05 | 5.06e-04 | 19 |
GO:0002474 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 11/1389 | 19/8135 | 3.39 | 6.85e-05 | 5.06e-04 | 19 |
GO:0042104 | GO:0042104 | positive regulation of activated T cell proliferation | 11/1389 | 19/8135 | 3.39 | 6.85e-05 | 5.06e-04 | 19 |
GO:0071353 | GO:0071353 | cellular response to interleukin-4 | 11/1389 | 19/8135 | 3.39 | 6.85e-05 | 5.06e-04 | 19 |
GO:2000406 | GO:2000406 | positive regulation of T cell migration | 11/1389 | 19/8135 | 3.39 | 6.85e-05 | 5.06e-04 | 19 |
GO:0016445 | GO:0016445 | somatic diversification of immunoglobulins | 12/1389 | 22/8135 | 3.19 | 7.02e-05 | 5.17e-04 | 22 |
GO:0090022 | GO:0090022 | regulation of neutrophil chemotaxis | 12/1389 | 22/8135 | 3.19 | 7.02e-05 | 5.17e-04 | 22 |
GO:0010819 | GO:0010819 | regulation of T cell chemotaxis | 8/1389 | 11/8135 | 4.26 | 7.18e-05 | 5.23e-04 | 11 |
GO:0031342 | GO:0031342 | negative regulation of cell killing | 8/1389 | 11/8135 | 4.26 | 7.18e-05 | 5.23e-04 | 11 |
GO:0043383 | GO:0043383 | negative T cell selection | 8/1389 | 11/8135 | 4.26 | 7.18e-05 | 5.23e-04 | 11 |
GO:0045086 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 8/1389 | 11/8135 | 4.26 | 7.18e-05 | 5.23e-04 | 11 |
GO:0046629 | GO:0046629 | gamma-delta T cell activation | 8/1389 | 11/8135 | 4.26 | 7.18e-05 | 5.23e-04 | 11 |
GO:0050704 | GO:0050704 | regulation of interleukin-1 secretion | 16/1389 | 35/8135 | 2.68 | 7.47e-05 | 5.43e-04 | 35 |
GO:0050709 | GO:0050709 | negative regulation of protein secretion | 27/1389 | 76/8135 | 2.08 | 7.84e-05 | 5.69e-04 | 76 |
GO:0045620 | GO:0045620 | negative regulation of lymphocyte differentiation | 15/1389 | 32/8135 | 2.75 | 8.77e-05 | 6.33e-04 | 32 |
GO:0060760 | GO:0060760 | positive regulation of response to cytokine stimulus | 15/1389 | 32/8135 | 2.75 | 8.77e-05 | 6.33e-04 | 32 |
GO:0032651 | GO:0032651 | regulation of interleukin-1 beta production | 19/1389 | 46/8135 | 2.42 | 8.95e-05 | 6.44e-04 | 46 |
GO:0045862 | GO:0045862 | positive regulation of proteolysis | 43/1389 | 144/8135 | 1.75 | 9.34e-05 | 6.71e-04 | 144 |
GO:1902106 | GO:1902106 | negative regulation of leukocyte differentiation | 24/1389 | 65/8135 | 2.16 | 9.63e-05 | 6.91e-04 | 65 |
GO:0050706 | GO:0050706 | regulation of interleukin-1 beta secretion | 14/1389 | 29/8135 | 2.83 | 1.01e-04 | 7.24e-04 | 29 |
GO:0045072 | GO:0045072 | regulation of interferon-gamma biosynthetic process | 9/1389 | 14/8135 | 3.77 | 1.06e-04 | 7.56e-04 | 14 |
GO:0051224 | GO:0051224 | negative regulation of protein transport | 31/1389 | 94/8135 | 1.93 | 1.20e-04 | 8.55e-04 | 94 |
GO:0002544 | GO:0002544 | chronic inflammatory response | 10/1389 | 17/8135 | 3.45 | 1.24e-04 | 8.79e-04 | 17 |
GO:0002861 | GO:0002861 | regulation of inflammatory response to antigenic stimulus | 10/1389 | 17/8135 | 3.45 | 1.24e-04 | 8.79e-04 | 17 |
GO:0002204 | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0002208 | GO:0002208 | somatic diversification of immunoglobulins involved in immune response | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0016447 | GO:0016447 | somatic recombination of immunoglobulin gene segments | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0032814 | GO:0032814 | regulation of natural killer cell activation | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0033028 | GO:0033028 | myeloid cell apoptotic process | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0043032 | GO:0043032 | positive regulation of macrophage activation | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0045190 | GO:0045190 | isotype switching | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0046135 | GO:0046135 | pyrimidine nucleoside catabolic process | 11/1389 | 20/8135 | 3.22 | 1.29e-04 | 8.99e-04 | 20 |
GO:0097191 | GO:0097191 | extrinsic apoptotic signaling pathway | 34/1389 | 107/8135 | 1.86 | 1.32e-04 | 9.19e-04 | 107 |
GO:1901224 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 17/1389 | 40/8135 | 2.49 | 1.37e-04 | 9.53e-04 | 40 |
GO:1904950 | GO:1904950 | negative regulation of establishment of protein localization | 31/1389 | 95/8135 | 1.91 | 1.50e-04 | 1.04e-03 | 95 |
GO:0032715 | GO:0032715 | negative regulation of interleukin-6 production | 14/1389 | 30/8135 | 2.73 | 1.60e-04 | 1.11e-03 | 30 |
GO:0002792 | GO:0002792 | negative regulation of peptide secretion | 28/1389 | 83/8135 | 1.98 | 1.63e-04 | 1.13e-03 | 83 |
GO:0002793 | GO:0002793 | positive regulation of peptide secretion | 50/1389 | 179/8135 | 1.64 | 1.70e-04 | 1.17e-03 | 179 |
GO:0043087 | GO:0043087 | regulation of GTPase activity | 58/1389 | 216/8135 | 1.57 | 1.73e-04 | 1.19e-03 | 216 |
GO:0051222 | GO:0051222 | positive regulation of protein transport | 58/1389 | 216/8135 | 1.57 | 1.73e-04 | 1.19e-03 | 216 |
GO:0002479 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 8/1389 | 12/8135 | 3.90 | 1.83e-04 | 1.25e-03 | 12 |
GO:1901658 | GO:1901658 | glycosyl compound catabolic process | 13/1389 | 27/8135 | 2.82 | 1.86e-04 | 1.27e-03 | 27 |
GO:0002686 | GO:0002686 | negative regulation of leukocyte migration | 15/1389 | 34/8135 | 2.58 | 2.05e-04 | 1.39e-03 | 34 |
GO:0030224 | GO:0030224 | monocyte differentiation | 12/1389 | 24/8135 | 2.93 | 2.10e-04 | 1.42e-03 | 24 |
GO:1902622 | GO:1902622 | regulation of neutrophil migration | 12/1389 | 24/8135 | 2.93 | 2.10e-04 | 1.42e-03 | 24 |
GO:1903131 | GO:1903131 | mononuclear cell differentiation | 12/1389 | 24/8135 | 2.93 | 2.10e-04 | 1.42e-03 | 24 |
GO:2000403 | GO:2000403 | positive regulation of lymphocyte migration | 12/1389 | 24/8135 | 2.93 | 2.10e-04 | 1.42e-03 | 24 |
GO:0071347 | GO:0071347 | cellular response to interleukin-1 | 26/1389 | 76/8135 | 2.00 | 2.14e-04 | 1.44e-03 | 76 |
GO:0031334 | GO:0031334 | positive regulation of protein complex assembly | 32/1389 | 101/8135 | 1.86 | 2.18e-04 | 1.47e-03 | 101 |
GO:0001779 | GO:0001779 | natural killer cell differentiation | 9/1389 | 15/8135 | 3.51 | 2.24e-04 | 1.49e-03 | 15 |
GO:0002347 | GO:0002347 | response to tumor cell | 9/1389 | 15/8135 | 3.51 | 2.24e-04 | 1.49e-03 | 15 |
GO:0032607 | GO:0032607 | interferon-alpha production | 9/1389 | 15/8135 | 3.51 | 2.24e-04 | 1.49e-03 | 15 |
GO:0032647 | GO:0032647 | regulation of interferon-alpha production | 9/1389 | 15/8135 | 3.51 | 2.24e-04 | 1.49e-03 | 15 |
GO:0033622 | GO:0033622 | integrin activation | 9/1389 | 15/8135 | 3.51 | 2.24e-04 | 1.49e-03 | 15 |
GO:0042095 | GO:0042095 | interferon-gamma biosynthetic process | 9/1389 | 15/8135 | 3.51 | 2.24e-04 | 1.49e-03 | 15 |
GO:0043552 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 11/1389 | 21/8135 | 3.07 | 2.29e-04 | 1.51e-03 | 21 |
GO:1904951 | GO:1904951 | positive regulation of establishment of protein localization | 59/1389 | 223/8135 | 1.55 | 2.35e-04 | 1.55e-03 | 223 |
GO:0002827 | GO:0002827 | positive regulation of T-helper 1 type immune response | 10/1389 | 18/8135 | 3.25 | 2.37e-04 | 1.55e-03 | 18 |
GO:0030866 | GO:0030866 | cortical actin cytoskeleton organization | 10/1389 | 18/8135 | 3.25 | 2.37e-04 | 1.55e-03 | 18 |
GO:0042094 | GO:0042094 | interleukin-2 biosynthetic process | 10/1389 | 18/8135 | 3.25 | 2.37e-04 | 1.55e-03 | 18 |
GO:0045577 | GO:0045577 | regulation of B cell differentiation | 10/1389 | 18/8135 | 3.25 | 2.37e-04 | 1.55e-03 | 18 |
GO:0032088 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 14/1389 | 31/8135 | 2.64 | 2.47e-04 | 1.61e-03 | 31 |
GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 49/1389 | 177/8135 | 1.62 | 2.48e-04 | 1.62e-03 | 177 |
GO:0051701 | GO:0051701 | interaction with host | 28/1389 | 85/8135 | 1.93 | 2.58e-04 | 1.68e-03 | 85 |
GO:0043280 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 21/1389 | 57/8135 | 2.16 | 2.69e-04 | 1.75e-03 | 57 |
GO:0050714 | GO:0050714 | positive regulation of protein secretion | 46/1389 | 164/8135 | 1.64 | 2.75e-04 | 1.79e-03 | 164 |
GO:0010522 | GO:0010522 | regulation of calcium ion transport into cytosol | 24/1389 | 69/8135 | 2.04 | 2.79e-04 | 1.81e-03 | 69 |
GO:0001961 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 13/1389 | 28/8135 | 2.72 | 2.93e-04 | 1.89e-03 | 28 |
GO:0034656 | GO:0034656 | nucleobase-containing small molecule catabolic process | 13/1389 | 28/8135 | 2.72 | 2.93e-04 | 1.89e-03 | 28 |
GO:0042130 | GO:0042130 | negative regulation of T cell proliferation | 15/1389 | 35/8135 | 2.51 | 3.02e-04 | 1.94e-03 | 35 |
GO:0043550 | GO:0043550 | regulation of lipid kinase activity | 15/1389 | 35/8135 | 2.51 | 3.02e-04 | 1.94e-03 | 35 |
GO:0009116 | GO:0009116 | nucleoside metabolic process | 18/1389 | 46/8135 | 2.29 | 3.08e-04 | 1.96e-03 | 46 |
GO:0010820 | GO:0010820 | positive regulation of T cell chemotaxis | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0032700 | GO:0032700 | negative regulation of interleukin-17 production | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0035745 | GO:0035745 | T-helper 2 cell cytokine production | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0035747 | GO:0035747 | natural killer cell chemotaxis | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0045060 | GO:0045060 | negative thymic T cell selection | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0045063 | GO:0045063 | T-helper 1 cell differentiation | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0045078 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0045591 | GO:0045591 | positive regulation of regulatory T cell differentiation | 7/1389 | 10/8135 | 4.10 | 3.10e-04 | 1.96e-03 | 10 |
GO:0002534 | GO:0002534 | cytokine production involved in inflammatory response | 12/1389 | 25/8135 | 2.81 | 3.41e-04 | 2.15e-03 | 25 |
GO:0034122 | GO:0034122 | negative regulation of toll-like receptor signaling pathway | 12/1389 | 25/8135 | 2.81 | 3.41e-04 | 2.15e-03 | 25 |
GO:0050766 | GO:0050766 | positive regulation of phagocytosis | 16/1389 | 39/8135 | 2.40 | 3.50e-04 | 2.20e-03 | 39 |
GO:0043551 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 14/1389 | 32/8135 | 2.56 | 3.70e-04 | 2.32e-03 | 32 |
GO:0071622 | GO:0071622 | regulation of granulocyte chemotaxis | 14/1389 | 32/8135 | 2.56 | 3.70e-04 | 2.32e-03 | 32 |
GO:0032635 | GO:0032635 | interleukin-6 production | 29/1389 | 91/8135 | 1.87 | 3.80e-04 | 2.37e-03 | 91 |
GO:0097553 | GO:0097553 | calcium ion transmembrane import into cytosol | 29/1389 | 91/8135 | 1.87 | 3.80e-04 | 2.37e-03 | 91 |
GO:0032692 | GO:0032692 | negative regulation of interleukin-1 production | 11/1389 | 22/8135 | 2.93 | 3.87e-04 | 2.41e-03 | 22 |
GO:0098586 | GO:0098586 | cellular response to virus | 11/1389 | 22/8135 | 2.93 | 3.87e-04 | 2.41e-03 | 22 |
GO:0002643 | GO:0002643 | regulation of tolerance induction | 8/1389 | 13/8135 | 3.60 | 4.05e-04 | 2.51e-03 | 13 |
GO:0033033 | GO:0033033 | negative regulation of myeloid cell apoptotic process | 8/1389 | 13/8135 | 3.60 | 4.05e-04 | 2.51e-03 | 13 |
GO:0045637 | GO:0045637 | regulation of myeloid cell differentiation | 39/1389 | 135/8135 | 1.69 | 4.11e-04 | 2.55e-03 | 135 |
GO:0002719 | GO:0002719 | negative regulation of cytokine production involved in immune response | 10/1389 | 19/8135 | 3.08 | 4.23e-04 | 2.60e-03 | 19 |
GO:0002724 | GO:0002724 | regulation of T cell cytokine production | 10/1389 | 19/8135 | 3.08 | 4.23e-04 | 2.60e-03 | 19 |
GO:0002753 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway | 10/1389 | 19/8135 | 3.08 | 4.23e-04 | 2.60e-03 | 19 |
GO:0033032 | GO:0033032 | regulation of myeloid cell apoptotic process | 10/1389 | 19/8135 | 3.08 | 4.23e-04 | 2.60e-03 | 19 |
GO:0060142 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 10/1389 | 19/8135 | 3.08 | 4.23e-04 | 2.60e-03 | 19 |
GO:0034103 | GO:0034103 | regulation of tissue remodeling | 19/1389 | 51/8135 | 2.18 | 4.42e-04 | 2.70e-03 | 51 |
GO:0002761 | GO:0002761 | regulation of myeloid leukocyte differentiation | 25/1389 | 75/8135 | 1.95 | 4.43e-04 | 2.70e-03 | 75 |
GO:0070613 | GO:0070613 | regulation of protein processing | 25/1389 | 75/8135 | 1.95 | 4.43e-04 | 2.70e-03 | 75 |
GO:1903727 | GO:1903727 | positive regulation of phospholipid metabolic process | 13/1389 | 29/8135 | 2.63 | 4.48e-04 | 2.73e-03 | 29 |
GO:0006956 | GO:0006956 | complement activation | 20/1389 | 55/8135 | 2.13 | 4.56e-04 | 2.77e-03 | 55 |
GO:0051048 | GO:0051048 | negative regulation of secretion | 41/1389 | 145/8135 | 1.66 | 4.83e-04 | 2.93e-03 | 145 |
GO:0030449 | GO:0030449 | regulation of complement activation | 16/1389 | 40/8135 | 2.34 | 4.92e-04 | 2.99e-03 | 40 |
GO:1903531 | GO:1903531 | negative regulation of secretion by cell | 36/1389 | 123/8135 | 1.71 | 5.16e-04 | 3.12e-03 | 123 |
GO:1903725 | GO:1903725 | regulation of phospholipid metabolic process | 17/1389 | 44/8135 | 2.26 | 5.35e-04 | 3.23e-03 | 44 |
GO:1903317 | GO:1903317 | regulation of protein maturation | 25/1389 | 76/8135 | 1.93 | 5.55e-04 | 3.35e-03 | 76 |
GO:0050731 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 37/1389 | 128/8135 | 1.69 | 5.65e-04 | 3.41e-03 | 128 |
GO:0002220 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 15/1389 | 37/8135 | 2.37 | 6.21e-04 | 3.73e-03 | 37 |
GO:0002532 | GO:0002532 | production of molecular mediator involved in inflammatory response | 15/1389 | 37/8135 | 2.37 | 6.21e-04 | 3.73e-03 | 37 |
GO:0045730 | GO:0045730 | respiratory burst | 11/1389 | 23/8135 | 2.80 | 6.29e-04 | 3.76e-03 | 23 |
GO:0090218 | GO:0090218 | positive regulation of lipid kinase activity | 11/1389 | 23/8135 | 2.80 | 6.29e-04 | 3.76e-03 | 23 |
GO:0032675 | GO:0032675 | regulation of interleukin-6 production | 27/1389 | 85/8135 | 1.86 | 6.32e-04 | 3.78e-03 | 85 |
GO:0002720 | GO:0002720 | positive regulation of cytokine production involved in immune response | 13/1389 | 30/8135 | 2.54 | 6.69e-04 | 3.99e-03 | 30 |
GO:2000257 | GO:2000257 | regulation of protein activation cascade | 16/1389 | 41/8135 | 2.29 | 6.81e-04 | 4.06e-03 | 41 |
GO:0030865 | GO:0030865 | cortical cytoskeleton organization | 10/1389 | 20/8135 | 2.93 | 7.18e-04 | 4.27e-03 | 20 |
GO:0032816 | GO:0032816 | positive regulation of natural killer cell activation | 7/1389 | 11/8135 | 3.73 | 7.26e-04 | 4.29e-03 | 11 |
GO:0043371 | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation | 7/1389 | 11/8135 | 3.73 | 7.26e-04 | 4.29e-03 | 11 |
GO:0043374 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 7/1389 | 11/8135 | 3.73 | 7.26e-04 | 4.29e-03 | 11 |
GO:0050711 | GO:0050711 | negative regulation of interleukin-1 secretion | 7/1389 | 11/8135 | 3.73 | 7.26e-04 | 4.29e-03 | 11 |
GO:0002262 | GO:0002262 | myeloid cell homeostasis | 21/1389 | 61/8135 | 2.02 | 7.70e-04 | 4.54e-03 | 61 |
GO:2000108 | GO:2000108 | positive regulation of leukocyte apoptotic process | 9/1389 | 17/8135 | 3.10 | 7.86e-04 | 4.63e-03 | 17 |
GO:0045191 | GO:0045191 | regulation of isotype switching | 8/1389 | 14/8135 | 3.35 | 8.03e-04 | 4.71e-03 | 14 |
GO:0140131 | GO:0140131 | positive regulation of lymphocyte chemotaxis | 8/1389 | 14/8135 | 3.35 | 8.03e-04 | 4.71e-03 | 14 |
GO:1901739 | GO:1901739 | regulation of myoblast fusion | 8/1389 | 14/8135 | 3.35 | 8.03e-04 | 4.71e-03 | 14 |
GO:0030100 | GO:0030100 | regulation of endocytosis | 37/1389 | 131/8135 | 1.65 | 9.13e-04 | 5.33e-03 | 131 |
GO:0006213 | GO:0006213 | pyrimidine nucleoside metabolic process | 11/1389 | 24/8135 | 2.68 | 9.83e-04 | 5.73e-03 | 24 |
GO:0072529 | GO:0072529 | pyrimidine-containing compound catabolic process | 11/1389 | 24/8135 | 2.68 | 9.83e-04 | 5.73e-03 | 24 |
GO:0045639 | GO:0045639 | positive regulation of myeloid cell differentiation | 19/1389 | 54/8135 | 2.06 | 1.00e-03 | 5.82e-03 | 54 |
GO:0032689 | GO:0032689 | negative regulation of interferon-gamma production | 12/1389 | 28/8135 | 2.51 | 1.21e-03 | 7.02e-03 | 28 |
GO:0048771 | GO:0048771 | tissue remodeling | 31/1389 | 106/8135 | 1.71 | 1.24e-03 | 7.21e-03 | 106 |
GO:0002438 | GO:0002438 | acute inflammatory response to antigenic stimulus | 9/1389 | 18/8135 | 2.93 | 1.33e-03 | 7.70e-03 | 18 |
GO:0033081 | GO:0033081 | regulation of T cell differentiation in thymus | 9/1389 | 18/8135 | 2.93 | 1.33e-03 | 7.70e-03 | 18 |
GO:0060143 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion | 9/1389 | 18/8135 | 2.93 | 1.33e-03 | 7.70e-03 | 18 |
GO:0033628 | GO:0033628 | regulation of cell adhesion mediated by integrin | 13/1389 | 32/8135 | 2.38 | 1.39e-03 | 7.99e-03 | 32 |
GO:0043433 | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 23/1389 | 72/8135 | 1.87 | 1.43e-03 | 8.20e-03 | 72 |
GO:0046639 | GO:0046639 | negative regulation of alpha-beta T cell differentiation | 8/1389 | 15/8135 | 3.12 | 1.46e-03 | 8.41e-03 | 15 |
GO:0002726 | GO:0002726 | positive regulation of T cell cytokine production | 7/1389 | 12/8135 | 3.42 | 1.49e-03 | 8.47e-03 | 12 |
GO:0045655 | GO:0045655 | regulation of monocyte differentiation | 7/1389 | 12/8135 | 3.42 | 1.49e-03 | 8.47e-03 | 12 |
GO:1904994 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell | 7/1389 | 12/8135 | 3.42 | 1.49e-03 | 8.47e-03 | 12 |
GO:0007520 | GO:0007520 | myoblast fusion | 11/1389 | 25/8135 | 2.58 | 1.49e-03 | 8.47e-03 | 25 |
GO:0072677 | GO:0072677 | eosinophil migration | 11/1389 | 25/8135 | 2.58 | 1.49e-03 | 8.47e-03 | 25 |
GO:0002763 | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 14/1389 | 36/8135 | 2.28 | 1.52e-03 | 8.62e-03 | 36 |
GO:0002886 | GO:0002886 | regulation of myeloid leukocyte mediated immunity | 14/1389 | 36/8135 | 2.28 | 1.52e-03 | 8.62e-03 | 36 |
GO:0045807 | GO:0045807 | positive regulation of endocytosis | 25/1389 | 81/8135 | 1.81 | 1.56e-03 | 8.87e-03 | 81 |
GO:0050848 | GO:0050848 | regulation of calcium-mediated signaling | 20/1389 | 60/8135 | 1.95 | 1.60e-03 | 9.06e-03 | 60 |
GO:0010524 | GO:0010524 | positive regulation of calcium ion transport into cytosol | 15/1389 | 40/8135 | 2.20 | 1.60e-03 | 9.06e-03 | 40 |
GO:0032722 | GO:0032722 | positive regulation of chemokine production | 15/1389 | 40/8135 | 2.20 | 1.60e-03 | 9.06e-03 | 40 |
GO:0033627 | GO:0033627 | cell adhesion mediated by integrin | 17/1389 | 48/8135 | 2.07 | 1.67e-03 | 9.43e-03 | 48 |
GO:0038095 | GO:0038095 | Fc-epsilon receptor signaling pathway | 12/1389 | 29/8135 | 2.42 | 1.75e-03 | 9.81e-03 | 29 |
GO:0051482 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway | 12/1389 | 29/8135 | 2.42 | 1.75e-03 | 9.81e-03 | 29 |
GO:0050718 | GO:0050718 | positive regulation of interleukin-1 beta secretion | 10/1389 | 22/8135 | 2.66 | 1.81e-03 | 1.01e-02 | 22 |
GO:0000768 | GO:0000768 | syncytium formation by plasma membrane fusion | 13/1389 | 33/8135 | 2.31 | 1.94e-03 | 1.08e-02 | 33 |
GO:0006949 | GO:0006949 | syncytium formation | 13/1389 | 33/8135 | 2.31 | 1.94e-03 | 1.08e-02 | 33 |
GO:0032732 | GO:0032732 | positive regulation of interleukin-1 production | 13/1389 | 33/8135 | 2.31 | 1.94e-03 | 1.08e-02 | 33 |
GO:0140253 | GO:0140253 | cell-cell fusion | 13/1389 | 33/8135 | 2.31 | 1.94e-03 | 1.08e-02 | 33 |
GO:0030168 | GO:0030168 | platelet activation | 29/1389 | 100/8135 | 1.70 | 2.03e-03 | 1.12e-02 | 100 |
GO:0002244 | GO:0002244 | hematopoietic progenitor cell differentiation | 18/1389 | 53/8135 | 1.99 | 2.13e-03 | 1.18e-02 | 53 |
GO:0045576 | GO:0045576 | mast cell activation | 16/1389 | 45/8135 | 2.08 | 2.17e-03 | 1.20e-02 | 45 |
GO:0050716 | GO:0050716 | positive regulation of interleukin-1 secretion | 11/1389 | 26/8135 | 2.48 | 2.19e-03 | 1.21e-02 | 26 |
GO:0043300 | GO:0043300 | regulation of leukocyte degranulation | 12/1389 | 30/8135 | 2.34 | 2.46e-03 | 1.36e-02 | 30 |
GO:0032691 | GO:0032691 | negative regulation of interleukin-1 beta production | 8/1389 | 16/8135 | 2.93 | 2.49e-03 | 1.37e-02 | 16 |
GO:0042454 | GO:0042454 | ribonucleoside catabolic process | 8/1389 | 16/8135 | 2.93 | 2.49e-03 | 1.37e-02 | 16 |
GO:0045624 | GO:0045624 | positive regulation of T-helper cell differentiation | 8/1389 | 16/8135 | 2.93 | 2.49e-03 | 1.37e-02 | 16 |
GO:0051354 | GO:0051354 | negative regulation of oxidoreductase activity | 8/1389 | 16/8135 | 2.93 | 2.49e-03 | 1.37e-02 | 16 |
GO:0030316 | GO:0030316 | osteoclast differentiation | 20/1389 | 62/8135 | 1.89 | 2.50e-03 | 1.37e-02 | 62 |
GO:0002223 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway | 13/1389 | 34/8135 | 2.24 | 2.65e-03 | 1.44e-02 | 34 |
GO:0031663 | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 13/1389 | 34/8135 | 2.24 | 2.65e-03 | 1.44e-02 | 34 |
GO:1905517 | GO:1905517 | macrophage migration | 13/1389 | 34/8135 | 2.24 | 2.65e-03 | 1.44e-02 | 34 |
GO:0051279 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 18/1389 | 54/8135 | 1.95 | 2.70e-03 | 1.46e-02 | 54 |
GO:1900015 | GO:1900015 | regulation of cytokine production involved in inflammatory response | 10/1389 | 23/8135 | 2.55 | 2.71e-03 | 1.47e-02 | 23 |
GO:0048535 | GO:0048535 | lymph node development | 7/1389 | 13/8135 | 3.15 | 2.75e-03 | 1.47e-02 | 13 |
GO:0060330 | GO:0060330 | regulation of response to interferon-gamma | 7/1389 | 13/8135 | 3.15 | 2.75e-03 | 1.47e-02 | 13 |
GO:0060334 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 7/1389 | 13/8135 | 3.15 | 2.75e-03 | 1.47e-02 | 13 |
GO:0090195 | GO:0090195 | chemokine secretion | 7/1389 | 13/8135 | 3.15 | 2.75e-03 | 1.47e-02 | 13 |
GO:1901741 | GO:1901741 | positive regulation of myoblast fusion | 7/1389 | 13/8135 | 3.15 | 2.75e-03 | 1.47e-02 | 13 |
GO:0002517 | GO:0002517 | T cell tolerance induction | 6/1389 | 10/8135 | 3.51 | 2.76e-03 | 1.47e-02 | 10 |
GO:0030889 | GO:0030889 | negative regulation of B cell proliferation | 6/1389 | 10/8135 | 3.51 | 2.76e-03 | 1.47e-02 | 10 |
GO:0032727 | GO:0032727 | positive regulation of interferon-alpha production | 6/1389 | 10/8135 | 3.51 | 2.76e-03 | 1.47e-02 | 10 |
GO:0045623 | GO:0045623 | negative regulation of T-helper cell differentiation | 6/1389 | 10/8135 | 3.51 | 2.76e-03 | 1.47e-02 | 10 |
GO:0045830 | GO:0045830 | positive regulation of isotype switching | 6/1389 | 10/8135 | 3.51 | 2.76e-03 | 1.47e-02 | 10 |
GO:1903556 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production | 14/1389 | 38/8135 | 2.16 | 2.76e-03 | 1.47e-02 | 38 |
GO:2000117 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 16/1389 | 46/8135 | 2.04 | 2.81e-03 | 1.49e-02 | 46 |
GO:0043154 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 15/1389 | 42/8135 | 2.09 | 2.81e-03 | 1.49e-02 | 42 |
GO:0072527 | GO:0072527 | pyrimidine-containing compound metabolic process | 15/1389 | 42/8135 | 2.09 | 2.81e-03 | 1.49e-02 | 42 |
GO:0014066 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | 20/1389 | 63/8135 | 1.86 | 3.09e-03 | 1.64e-02 | 63 |
GO:0032642 | GO:0032642 | regulation of chemokine production | 18/1389 | 55/8135 | 1.92 | 3.38e-03 | 1.79e-02 | 55 |
GO:0050764 | GO:0050764 | regulation of phagocytosis | 17/1389 | 51/8135 | 1.95 | 3.50e-03 | 1.85e-02 | 51 |
GO:0008625 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 13/1389 | 35/8135 | 2.18 | 3.57e-03 | 1.88e-02 | 35 |
GO:0072577 | GO:0072577 | endothelial cell apoptotic process | 13/1389 | 35/8135 | 2.18 | 3.57e-03 | 1.88e-02 | 35 |
GO:0032602 | GO:0032602 | chemokine production | 19/1389 | 60/8135 | 1.85 | 4.00e-03 | 2.08e-02 | 60 |
GO:0061025 | GO:0061025 | membrane fusion | 19/1389 | 60/8135 | 1.85 | 4.00e-03 | 2.08e-02 | 60 |
GO:0032608 | GO:0032608 | interferon-beta production | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0032648 | GO:0032648 | regulation of interferon-beta production | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0032703 | GO:0032703 | negative regulation of interleukin-2 production | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0034695 | GO:0034695 | response to prostaglandin E | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0035722 | GO:0035722 | interleukin-12-mediated signaling pathway | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0043124 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0043330 | GO:0043330 | response to exogenous dsRNA | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0070671 | GO:0070671 | response to interleukin-12 | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:0071349 | GO:0071349 | cellular response to interleukin-12 | 8/1389 | 17/8135 | 2.76 | 4.01e-03 | 2.08e-02 | 17 |
GO:1901657 | GO:1901657 | glycosyl compound metabolic process | 18/1389 | 56/8135 | 1.88 | 4.20e-03 | 2.17e-02 | 56 |
GO:1903707 | GO:1903707 | negative regulation of hemopoiesis | 26/1389 | 91/8135 | 1.67 | 4.21e-03 | 2.17e-02 | 91 |
GO:0006958 | GO:0006958 | complement activation, classical pathway | 11/1389 | 28/8135 | 2.30 | 4.37e-03 | 2.24e-02 | 28 |
GO:0032731 | GO:0032731 | positive regulation of interleukin-1 beta production | 11/1389 | 28/8135 | 2.30 | 4.37e-03 | 2.24e-02 | 28 |
GO:1902041 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 11/1389 | 28/8135 | 2.30 | 4.37e-03 | 2.24e-02 | 28 |
GO:2001236 | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 23/1389 | 78/8135 | 1.73 | 4.50e-03 | 2.31e-02 | 78 |
GO:0007229 | GO:0007229 | integrin-mediated signaling pathway | 20/1389 | 65/8135 | 1.80 | 4.61e-03 | 2.36e-02 | 65 |
GO:2000351 | GO:2000351 | regulation of endothelial cell apoptotic process | 12/1389 | 32/8135 | 2.20 | 4.62e-03 | 2.36e-02 | 32 |
GO:0030838 | GO:0030838 | positive regulation of actin filament polymerization | 15/1389 | 44/8135 | 2.00 | 4.68e-03 | 2.38e-02 | 44 |
GO:0002922 | GO:0002922 | positive regulation of humoral immune response | 7/1389 | 14/8135 | 2.93 | 4.69e-03 | 2.38e-02 | 14 |
GO:0045911 | GO:0045911 | positive regulation of DNA recombination | 7/1389 | 14/8135 | 2.93 | 4.69e-03 | 2.38e-02 | 14 |
GO:0072643 | GO:0072643 | interferon-gamma secretion | 7/1389 | 14/8135 | 2.93 | 4.69e-03 | 2.38e-02 | 14 |
GO:1903306 | GO:1903306 | negative regulation of regulated secretory pathway | 7/1389 | 14/8135 | 2.93 | 4.69e-03 | 2.38e-02 | 14 |
GO:0009119 | GO:0009119 | ribonucleoside metabolic process | 13/1389 | 36/8135 | 2.11 | 4.73e-03 | 2.39e-02 | 36 |
GO:0032720 | GO:0032720 | negative regulation of tumor necrosis factor production | 13/1389 | 36/8135 | 2.11 | 4.73e-03 | 2.39e-02 | 36 |
GO:0032677 | GO:0032677 | regulation of interleukin-8 production | 14/1389 | 40/8135 | 2.05 | 4.74e-03 | 2.39e-02 | 40 |
GO:0048245 | GO:0048245 | eosinophil chemotaxis | 9/1389 | 21/8135 | 2.51 | 4.96e-03 | 2.50e-02 | 21 |
GO:0002756 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0006216 | GO:0006216 | cytidine catabolic process | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0009972 | GO:0009972 | cytidine deamination | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0016554 | GO:0016554 | cytidine to uridine editing | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0032695 | GO:0032695 | negative regulation of interleukin-12 production | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0032823 | GO:0032823 | regulation of natural killer cell differentiation | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0033089 | GO:0033089 | positive regulation of T cell differentiation in thymus | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0034162 | GO:0034162 | toll-like receptor 9 signaling pathway | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0039528 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0042976 | GO:0042976 | activation of Janus kinase activity | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0046087 | GO:0046087 | cytidine metabolic process | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0051767 | GO:0051767 | nitric-oxide synthase biosynthetic process | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0051769 | GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0070230 | GO:0070230 | positive regulation of lymphocyte apoptotic process | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0071636 | GO:0071636 | positive regulation of transforming growth factor beta production | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0090197 | GO:0090197 | positive regulation of chemokine secretion | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:1904469 | GO:1904469 | positive regulation of tumor necrosis factor secretion | 6/1389 | 11/8135 | 3.19 | 5.19e-03 | 2.55e-02 | 11 |
GO:0032637 | GO:0032637 | interleukin-8 production | 15/1389 | 45/8135 | 1.95 | 5.93e-03 | 2.91e-02 | 45 |
GO:0032757 | GO:0032757 | positive regulation of interleukin-8 production | 11/1389 | 29/8135 | 2.22 | 5.97e-03 | 2.92e-02 | 29 |
GO:0035587 | GO:0035587 | purinergic receptor signaling pathway | 11/1389 | 29/8135 | 2.22 | 5.97e-03 | 2.92e-02 | 29 |
GO:0019835 | GO:0019835 | cytolysis | 12/1389 | 33/8135 | 2.13 | 6.15e-03 | 2.99e-02 | 33 |
GO:0002691 | GO:0002691 | regulation of cellular extravasation | 8/1389 | 18/8135 | 2.60 | 6.16e-03 | 2.99e-02 | 18 |
GO:0009595 | GO:0009595 | detection of biotic stimulus | 8/1389 | 18/8135 | 2.60 | 6.16e-03 | 2.99e-02 | 18 |
GO:0061028 | GO:0061028 | establishment of endothelial barrier | 8/1389 | 18/8135 | 2.60 | 6.16e-03 | 2.99e-02 | 18 |
GO:0072376 | GO:0072376 | protein activation cascade | 22/1389 | 76/8135 | 1.70 | 6.85e-03 | 3.33e-02 | 76 |
GO:0034142 | GO:0034142 | toll-like receptor 4 signaling pathway | 9/1389 | 22/8135 | 2.40 | 7.14e-03 | 3.46e-02 | 22 |
GO:0010661 | GO:0010661 | positive regulation of muscle cell apoptotic process | 7/1389 | 15/8135 | 2.73 | 7.51e-03 | 3.62e-02 | 15 |
GO:0032604 | GO:0032604 | granulocyte macrophage colony-stimulating factor production | 7/1389 | 15/8135 | 2.73 | 7.51e-03 | 3.62e-02 | 15 |
GO:0043243 | GO:0043243 | positive regulation of protein complex disassembly | 7/1389 | 15/8135 | 2.73 | 7.51e-03 | 3.62e-02 | 15 |
GO:1904037 | GO:1904037 | positive regulation of epithelial cell apoptotic process | 7/1389 | 15/8135 | 2.73 | 7.51e-03 | 3.62e-02 | 15 |
GO:0045453 | GO:0045453 | bone resorption | 14/1389 | 42/8135 | 1.95 | 7.73e-03 | 3.72e-02 | 42 |
GO:1904035 | GO:1904035 | regulation of epithelial cell apoptotic process | 14/1389 | 42/8135 | 1.95 | 7.73e-03 | 3.72e-02 | 42 |
GO:0008037 | GO:0008037 | cell recognition | 29/1389 | 109/8135 | 1.56 | 7.84e-03 | 3.76e-02 | 109 |
GO:0048017 | GO:0048017 | inositol lipid-mediated signaling | 27/1389 | 100/8135 | 1.58 | 8.20e-03 | 3.93e-02 | 100 |
GO:0046488 | GO:0046488 | phosphatidylinositol metabolic process | 31/1389 | 119/8135 | 1.53 | 8.46e-03 | 4.05e-02 | 119 |
GO:0014065 | GO:0014065 | phosphatidylinositol 3-kinase signaling | 23/1389 | 82/8135 | 1.64 | 8.71e-03 | 4.16e-02 | 82 |
GO:0032728 | GO:0032728 | positive regulation of interferon-beta production | 6/1389 | 12/8135 | 2.93 | 8.89e-03 | 4.20e-02 | 12 |
GO:0033004 | GO:0033004 | negative regulation of mast cell activation | 6/1389 | 12/8135 | 2.93 | 8.89e-03 | 4.20e-02 | 12 |
GO:0046133 | GO:0046133 | pyrimidine ribonucleoside catabolic process | 6/1389 | 12/8135 | 2.93 | 8.89e-03 | 4.20e-02 | 12 |
GO:0048143 | GO:0048143 | astrocyte activation | 6/1389 | 12/8135 | 2.93 | 8.89e-03 | 4.20e-02 | 12 |
GO:0090196 | GO:0090196 | regulation of chemokine secretion | 6/1389 | 12/8135 | 2.93 | 8.89e-03 | 4.20e-02 | 12 |
GO:2000353 | GO:2000353 | positive regulation of endothelial cell apoptotic process | 6/1389 | 12/8135 | 2.93 | 8.89e-03 | 4.20e-02 | 12 |
GO:0002755 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 8/1389 | 19/8135 | 2.47 | 9.07e-03 | 4.25e-02 | 19 |
GO:0043331 | GO:0043331 | response to dsRNA | 8/1389 | 19/8135 | 2.47 | 9.07e-03 | 4.25e-02 | 19 |
GO:0045920 | GO:0045920 | negative regulation of exocytosis | 8/1389 | 19/8135 | 2.47 | 9.07e-03 | 4.25e-02 | 19 |
GO:2000482 | GO:2000482 | regulation of interleukin-8 secretion | 8/1389 | 19/8135 | 2.47 | 9.07e-03 | 4.25e-02 | 19 |
GO:0001954 | GO:0001954 | positive regulation of cell-matrix adhesion | 9/1389 | 23/8135 | 2.29 | 9.98e-03 | 4.65e-02 | 23 |
GO:0035588 | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 9/1389 | 23/8135 | 2.29 | 9.98e-03 | 4.65e-02 | 23 |
GO:0042036 | GO:0042036 | negative regulation of cytokine biosynthetic process | 9/1389 | 23/8135 | 2.29 | 9.98e-03 | 4.65e-02 | 23 |
GO:1905521 | GO:1905521 | regulation of macrophage migration | 9/1389 | 23/8135 | 2.29 | 9.98e-03 | 4.65e-02 | 23 |
GO:0001960 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 12/1389 | 35/8135 | 2.01 | 1.04e-02 | 4.84e-02 | 35 |
GO:0002833 | GO:0002833 | positive regulation of response to biotic stimulus | 10/1389 | 27/8135 | 2.17 | 1.04e-02 | 4.84e-02 | 27 |
GO:0050850 | GO:0050850 | positive regulation of calcium-mediated signaling | 10/1389 | 27/8135 | 2.17 | 1.04e-02 | 4.84e-02 | 27 |
GO:0045124 | GO:0045124 | regulation of bone resorption | 11/1389 | 31/8135 | 2.08 | 1.05e-02 | 4.88e-02 | 31 |
Factor | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
Signif_GO_terms | 0 | 14 | 4 | 197 | 913 | 1 | 0 | 2 | 77 | 0 |
Factor | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
Signif_GO_terms | 10 | 3 | 281 | 736 | 28 | 3 | 495 | 1 | 188 | 756 |
4: angiogenesis; all kinds of cell & tissue development/migration; regulation of Wnt signaling pathway
5: activation of immune response
9: microtubule-based movement; synaptic vesicle cycle
11: DNA repair; (cell cycle)
13: mitotic cell cycle
14: blood vessel development; regulation of cell migration; endothelial & epithelial cell proliferation
17: activation of immune response
19: blood vessel development; endothelium development
20: T cell activation; leukocyte cell-cell adhesion
Target: Genes w/ GSFA lfsr < 0.05 under each condition, stratefied by sign of effect;
Backgroud: all 10000 genes used in factor analysis.
GO terms that passed over-representation test fold change \(\geq\) 1.5 and q value \(<\) 0.05:
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:1903047 | GO:1903047 | mitotic cell cycle process | 171/2757 | 267/8135 | 1.89 | 1.51e-24 | 6.84e-21 | 267 |
GO:0000278 | GO:0000278 | mitotic cell cycle | 197/2757 | 326/8135 | 1.78 | 1.48e-23 | 3.35e-20 | 326 |
GO:0022402 | GO:0022402 | cell cycle process | 251/2757 | 470/8135 | 1.58 | 2.80e-19 | 4.24e-16 | 470 |
GO:0140014 | GO:0140014 | mitotic nuclear division | 79/2757 | 107/8135 | 2.18 | 2.31e-17 | 2.61e-14 | 107 |
GO:0000070 | GO:0000070 | mitotic sister chromatid segregation | 49/2757 | 56/8135 | 2.58 | 1.02e-16 | 9.20e-14 | 56 |
GO:0000819 | GO:0000819 | sister chromatid segregation | 56/2757 | 68/8135 | 2.43 | 2.04e-16 | 1.54e-13 | 68 |
GO:0000280 | GO:0000280 | nuclear division | 119/2757 | 192/8135 | 1.83 | 8.29e-16 | 5.36e-13 | 192 |
GO:0044772 | GO:0044772 | mitotic cell cycle phase transition | 105/2757 | 164/8135 | 1.89 | 1.75e-15 | 9.90e-13 | 164 |
GO:0051276 | GO:0051276 | chromosome organization | 204/2757 | 385/8135 | 1.56 | 2.46e-15 | 1.24e-12 | 385 |
GO:0044770 | GO:0044770 | cell cycle phase transition | 110/2757 | 177/8135 | 1.83 | 7.99e-15 | 3.62e-12 | 177 |
GO:0007059 | GO:0007059 | chromosome segregation | 81/2757 | 118/8135 | 2.03 | 9.24e-15 | 3.81e-12 | 118 |
GO:0048285 | GO:0048285 | organelle fission | 122/2757 | 206/8135 | 1.75 | 4.54e-14 | 1.71e-11 | 206 |
GO:0098813 | GO:0098813 | nuclear chromosome segregation | 72/2757 | 106/8135 | 2.00 | 6.57e-13 | 2.29e-10 | 106 |
GO:0006260 | GO:0006260 | DNA replication | 56/2757 | 77/8135 | 2.15 | 3.13e-12 | 1.01e-09 | 77 |
GO:0071103 | GO:0071103 | DNA conformation change | 78/2757 | 121/8135 | 1.90 | 4.63e-12 | 1.40e-09 | 121 |
GO:0007346 | GO:0007346 | regulation of mitotic cell cycle | 117/2757 | 207/8135 | 1.67 | 1.20e-11 | 3.40e-09 | 207 |
GO:0051301 | GO:0051301 | cell division | 121/2757 | 219/8135 | 1.63 | 4.14e-11 | 1.04e-08 | 219 |
GO:1902850 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 38/2757 | 47/8135 | 2.39 | 4.53e-11 | 1.08e-08 | 47 |
GO:0010564 | GO:0010564 | regulation of cell cycle process | 131/2757 | 243/8135 | 1.59 | 6.30e-11 | 1.43e-08 | 243 |
GO:0007052 | GO:0007052 | mitotic spindle organization | 33/2757 | 39/8135 | 2.50 | 8.37e-11 | 1.81e-08 | 39 |
GO:0070268 | GO:0070268 | cornification | 63/2757 | 95/8135 | 1.96 | 8.98e-11 | 1.85e-08 | 95 |
GO:0006259 | GO:0006259 | DNA metabolic process | 154/2757 | 301/8135 | 1.51 | 2.49e-10 | 4.90e-08 | 301 |
GO:0007088 | GO:0007088 | regulation of mitotic nuclear division | 53/2757 | 79/8135 | 1.98 | 1.50e-09 | 2.82e-07 | 79 |
GO:0007051 | GO:0007051 | spindle organization | 38/2757 | 51/8135 | 2.20 | 3.26e-09 | 5.91e-07 | 51 |
GO:0006261 | GO:0006261 | DNA-dependent DNA replication | 33/2757 | 42/8135 | 2.32 | 3.51e-09 | 6.11e-07 | 42 |
GO:0006281 | GO:0006281 | DNA repair | 76/2757 | 130/8135 | 1.73 | 6.58e-09 | 1.10e-06 | 130 |
GO:0051783 | GO:0051783 | regulation of nuclear division | 60/2757 | 96/8135 | 1.84 | 8.00e-09 | 1.29e-06 | 96 |
GO:0032392 | GO:0032392 | DNA geometric change | 21/2757 | 23/8135 | 2.69 | 1.50e-08 | 2.32e-06 | 23 |
GO:0032508 | GO:0032508 | DNA duplex unwinding | 19/2757 | 20/8135 | 2.80 | 1.54e-08 | 2.32e-06 | 20 |
GO:0051983 | GO:0051983 | regulation of chromosome segregation | 28/2757 | 35/8135 | 2.36 | 2.74e-08 | 4.00e-06 | 35 |
GO:0051321 | GO:0051321 | meiotic cell cycle | 80/2757 | 143/8135 | 1.65 | 4.10e-08 | 5.61e-06 | 143 |
GO:0031424 | GO:0031424 | keratinization | 71/2757 | 123/8135 | 1.70 | 4.27e-08 | 5.61e-06 | 123 |
GO:0034502 | GO:0034502 | protein localization to chromosome | 18/2757 | 19/8135 | 2.80 | 4.33e-08 | 5.61e-06 | 19 |
GO:0051310 | GO:0051310 | metaphase plate congression | 18/2757 | 19/8135 | 2.80 | 4.33e-08 | 5.61e-06 | 19 |
GO:0044839 | GO:0044839 | cell cycle G2/M phase transition | 48/2757 | 74/8135 | 1.91 | 4.60e-08 | 5.79e-06 | 74 |
GO:1901990 | GO:1901990 | regulation of mitotic cell cycle phase transition | 66/2757 | 113/8135 | 1.72 | 6.83e-08 | 8.35e-06 | 113 |
GO:0006323 | GO:0006323 | DNA packaging | 60/2757 | 100/8135 | 1.77 | 7.01e-08 | 8.35e-06 | 100 |
GO:1901987 | GO:1901987 | regulation of cell cycle phase transition | 71/2757 | 125/8135 | 1.68 | 1.04e-07 | 1.21e-05 | 125 |
GO:0030216 | GO:0030216 | keratinocyte differentiation | 87/2757 | 162/8135 | 1.58 | 1.34e-07 | 1.51e-05 | 162 |
GO:0045786 | GO:0045786 | negative regulation of cell cycle | 108/2757 | 212/8135 | 1.50 | 1.66e-07 | 1.83e-05 | 212 |
GO:0065004 | GO:0065004 | protein-DNA complex assembly | 58/2757 | 98/8135 | 1.75 | 2.26e-07 | 2.44e-05 | 98 |
GO:0007080 | GO:0007080 | mitotic metaphase plate congression | 14/2757 | 14/8135 | 2.95 | 2.58e-07 | 2.72e-05 | 14 |
GO:0006302 | GO:0006302 | double-strand break repair | 49/2757 | 79/8135 | 1.83 | 2.64e-07 | 2.72e-05 | 79 |
GO:1903046 | GO:1903046 | meiotic cell cycle process | 64/2757 | 112/8135 | 1.69 | 3.28e-07 | 3.30e-05 | 112 |
GO:0000075 | GO:0000075 | cell cycle checkpoint | 43/2757 | 67/8135 | 1.89 | 3.61e-07 | 3.56e-05 | 67 |
GO:0000082 | GO:0000082 | G1/S transition of mitotic cell cycle | 51/2757 | 84/8135 | 1.79 | 3.98e-07 | 3.83e-05 | 84 |
GO:1902749 | GO:1902749 | regulation of cell cycle G2/M phase transition | 36/2757 | 53/8135 | 2.00 | 4.09e-07 | 3.86e-05 | 53 |
GO:0044843 | GO:0044843 | cell cycle G1/S phase transition | 54/2757 | 91/8135 | 1.75 | 5.22e-07 | 4.82e-05 | 91 |
GO:0071824 | GO:0071824 | protein-DNA complex subunit organization | 62/2757 | 109/8135 | 1.68 | 6.23e-07 | 5.64e-05 | 109 |
GO:0000086 | GO:0000086 | G2/M transition of mitotic cell cycle | 43/2757 | 68/8135 | 1.87 | 6.62e-07 | 5.78e-05 | 68 |
GO:0031497 | GO:0031497 | chromatin assembly | 51/2757 | 85/8135 | 1.77 | 6.69e-07 | 5.78e-05 | 85 |
GO:0140013 | GO:0140013 | meiotic nuclear division | 61/2757 | 107/8135 | 1.68 | 6.89e-07 | 5.78e-05 | 107 |
GO:0010965 | GO:0010965 | regulation of mitotic sister chromatid separation | 20/2757 | 24/8135 | 2.46 | 8.63e-07 | 6.86e-05 | 24 |
GO:0033047 | GO:0033047 | regulation of mitotic sister chromatid segregation | 20/2757 | 24/8135 | 2.46 | 8.63e-07 | 6.86e-05 | 24 |
GO:0051306 | GO:0051306 | mitotic sister chromatid separation | 20/2757 | 24/8135 | 2.46 | 8.63e-07 | 6.86e-05 | 24 |
GO:0006334 | GO:0006334 | nucleosome assembly | 47/2757 | 77/8135 | 1.80 | 9.08e-07 | 7.10e-05 | 77 |
GO:0033045 | GO:0033045 | regulation of sister chromatid segregation | 22/2757 | 28/8135 | 2.32 | 1.59e-06 | 1.22e-04 | 28 |
GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 33/2757 | 49/8135 | 1.99 | 1.68e-06 | 1.27e-04 | 49 |
GO:0006333 | GO:0006333 | chromatin assembly or disassembly | 52/2757 | 90/8135 | 1.70 | 2.62e-06 | 1.95e-04 | 90 |
GO:0051304 | GO:0051304 | chromosome separation | 26/2757 | 36/8135 | 2.13 | 2.86e-06 | 2.09e-04 | 36 |
GO:1905818 | GO:1905818 | regulation of chromosome separation | 20/2757 | 25/8135 | 2.36 | 2.94e-06 | 2.11e-04 | 25 |
GO:0061844 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 34/2757 | 52/8135 | 1.93 | 3.27e-06 | 2.32e-04 | 52 |
GO:0000724 | GO:0000724 | double-strand break repair via homologous recombination | 30/2757 | 44/8135 | 2.01 | 3.39e-06 | 2.33e-04 | 44 |
GO:0000725 | GO:0000725 | recombinational repair | 30/2757 | 44/8135 | 2.01 | 3.39e-06 | 2.33e-04 | 44 |
GO:0090307 | GO:0090307 | mitotic spindle assembly | 17/2757 | 20/8135 | 2.51 | 3.59e-06 | 2.43e-04 | 20 |
GO:0051784 | GO:0051784 | negative regulation of nuclear division | 22/2757 | 29/8135 | 2.24 | 4.48e-06 | 2.98e-04 | 29 |
GO:0034728 | GO:0034728 | nucleosome organization | 50/2757 | 87/8135 | 1.70 | 5.02e-06 | 3.30e-04 | 87 |
GO:0040029 | GO:0040029 | regulation of gene expression, epigenetic | 52/2757 | 92/8135 | 1.67 | 6.38e-06 | 4.13e-04 | 92 |
GO:0010389 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 31/2757 | 47/8135 | 1.95 | 6.78e-06 | 4.27e-04 | 47 |
GO:0045931 | GO:0045931 | positive regulation of mitotic cell cycle | 40/2757 | 66/8135 | 1.79 | 7.53e-06 | 4.67e-04 | 66 |
GO:0010948 | GO:0010948 | negative regulation of cell cycle process | 53/2757 | 95/8135 | 1.65 | 8.76e-06 | 5.36e-04 | 95 |
GO:0033046 | GO:0033046 | negative regulation of sister chromatid segregation | 16/2757 | 19/8135 | 2.48 | 9.07e-06 | 5.41e-04 | 19 |
GO:0051985 | GO:0051985 | negative regulation of chromosome segregation | 16/2757 | 19/8135 | 2.48 | 9.07e-06 | 5.41e-04 | 19 |
GO:0007091 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 17/2757 | 21/8135 | 2.39 | 1.29e-05 | 7.47e-04 | 21 |
GO:0006342 | GO:0006342 | chromatin silencing | 29/2757 | 44/8135 | 1.94 | 1.38e-05 | 7.89e-04 | 44 |
GO:0051052 | GO:0051052 | regulation of DNA metabolic process | 68/2757 | 131/8135 | 1.53 | 1.43e-05 | 8.10e-04 | 131 |
GO:0071459 | GO:0071459 | protein localization to chromosome, centromeric region | 10/2757 | 10/8135 | 2.95 | 1.98e-05 | 1.11e-03 | 10 |
GO:0006310 | GO:0006310 | DNA recombination | 56/2757 | 104/8135 | 1.59 | 2.04e-05 | 1.12e-03 | 104 |
GO:0034508 | GO:0034508 | centromere complex assembly | 20/2757 | 27/8135 | 2.19 | 2.27e-05 | 1.15e-03 | 27 |
GO:0050000 | GO:0050000 | chromosome localization | 20/2757 | 27/8135 | 2.19 | 2.27e-05 | 1.15e-03 | 27 |
GO:0051303 | GO:0051303 | establishment of chromosome localization | 20/2757 | 27/8135 | 2.19 | 2.27e-05 | 1.15e-03 | 27 |
GO:0033048 | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 15/2757 | 18/8135 | 2.46 | 2.28e-05 | 1.15e-03 | 18 |
GO:1905819 | GO:1905819 | negative regulation of chromosome separation | 15/2757 | 18/8135 | 2.46 | 2.28e-05 | 1.15e-03 | 18 |
GO:2000816 | GO:2000816 | negative regulation of mitotic sister chromatid separation | 15/2757 | 18/8135 | 2.46 | 2.28e-05 | 1.15e-03 | 18 |
GO:0090068 | GO:0090068 | positive regulation of cell cycle process | 61/2757 | 116/8135 | 1.55 | 2.33e-05 | 1.16e-03 | 116 |
GO:0051225 | GO:0051225 | spindle assembly | 21/2757 | 29/8135 | 2.14 | 2.50e-05 | 1.23e-03 | 29 |
GO:2001251 | GO:2001251 | negative regulation of chromosome organization | 29/2757 | 45/8135 | 1.90 | 2.62e-05 | 1.27e-03 | 45 |
GO:0030071 | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 16/2757 | 20/8135 | 2.36 | 3.10e-05 | 1.48e-03 | 20 |
GO:0016458 | GO:0016458 | gene silencing | 48/2757 | 87/8135 | 1.63 | 3.41e-05 | 1.61e-03 | 87 |
GO:0006270 | GO:0006270 | DNA replication initiation | 13/2757 | 15/8135 | 2.56 | 3.78e-05 | 1.77e-03 | 15 |
GO:0044784 | GO:0044784 | metaphase/anaphase transition of cell cycle | 17/2757 | 22/8135 | 2.28 | 3.86e-05 | 1.79e-03 | 22 |
GO:0045839 | GO:0045839 | negative regulation of mitotic nuclear division | 18/2757 | 24/8135 | 2.21 | 4.51e-05 | 2.07e-03 | 24 |
GO:0000083 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 11/2757 | 12/8135 | 2.70 | 5.54e-05 | 2.48e-03 | 12 |
GO:0031145 | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 11/2757 | 12/8135 | 2.70 | 5.54e-05 | 2.48e-03 | 12 |
GO:0007062 | GO:0007062 | sister chromatid cohesion | 14/2757 | 17/8135 | 2.43 | 5.65e-05 | 2.51e-03 | 17 |
GO:0019730 | GO:0019730 | antimicrobial humoral response | 47/2757 | 87/8135 | 1.59 | 8.30e-05 | 3.65e-03 | 87 |
GO:0045930 | GO:0045930 | negative regulation of mitotic cell cycle | 53/2757 | 101/8135 | 1.55 | 8.46e-05 | 3.69e-03 | 101 |
GO:1902099 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 16/2757 | 21/8135 | 2.25 | 8.92e-05 | 3.85e-03 | 21 |
GO:0008608 | GO:0008608 | attachment of spindle microtubules to kinetochore | 12/2757 | 14/8135 | 2.53 | 9.75e-05 | 4.17e-03 | 14 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 48/2757 | 90/8135 | 1.57 | 1.07e-04 | 4.53e-03 | 90 |
GO:0031055 | GO:0031055 | chromatin remodeling at centromere | 18/2757 | 25/8135 | 2.12 | 1.10e-04 | 4.62e-03 | 25 |
GO:0006275 | GO:0006275 | regulation of DNA replication | 22/2757 | 33/8135 | 1.97 | 1.19e-04 | 4.94e-03 | 33 |
GO:0032200 | GO:0032200 | telomere organization | 28/2757 | 46/8135 | 1.80 | 1.58e-04 | 6.50e-03 | 46 |
GO:0061982 | GO:0061982 | meiosis I cell cycle process | 41/2757 | 75/8135 | 1.61 | 1.64e-04 | 6.67e-03 | 75 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 53/2757 | 103/8135 | 1.52 | 1.65e-04 | 6.67e-03 | 103 |
GO:1990266 | GO:1990266 | neutrophil migration | 50/2757 | 96/8135 | 1.54 | 1.70e-04 | 6.81e-03 | 96 |
GO:1901989 | GO:1901989 | positive regulation of cell cycle phase transition | 26/2757 | 42/8135 | 1.83 | 1.83e-04 | 7.20e-03 | 42 |
GO:0007093 | GO:0007093 | mitotic cell cycle checkpoint | 32/2757 | 55/8135 | 1.72 | 1.83e-04 | 7.20e-03 | 55 |
GO:0051054 | GO:0051054 | positive regulation of DNA metabolic process | 39/2757 | 71/8135 | 1.62 | 2.06e-04 | 8.05e-03 | 71 |
GO:0033044 | GO:0033044 | regulation of chromosome organization | 50/2757 | 97/8135 | 1.52 | 2.37e-04 | 9.04e-03 | 97 |
GO:0006336 | GO:0006336 | DNA replication-independent nucleosome assembly | 17/2757 | 24/8135 | 2.09 | 2.37e-04 | 9.04e-03 | 24 |
GO:0034724 | GO:0034724 | DNA replication-independent nucleosome organization | 17/2757 | 24/8135 | 2.09 | 2.37e-04 | 9.04e-03 | 24 |
GO:0000281 | GO:0000281 | mitotic cytokinesis | 19/2757 | 28/8135 | 2.00 | 2.46e-04 | 9.30e-03 | 28 |
GO:0031570 | GO:0031570 | DNA integrity checkpoint | 27/2757 | 45/8135 | 1.77 | 2.89e-04 | 1.08e-02 | 45 |
GO:0007127 | GO:0007127 | meiosis I | 39/2757 | 72/8135 | 1.60 | 3.04e-04 | 1.13e-02 | 72 |
GO:0007094 | GO:0007094 | mitotic spindle assembly checkpoint | 12/2757 | 15/8135 | 2.36 | 3.36e-04 | 1.19e-02 | 15 |
GO:0031577 | GO:0031577 | spindle checkpoint | 12/2757 | 15/8135 | 2.36 | 3.36e-04 | 1.19e-02 | 15 |
GO:0045841 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 12/2757 | 15/8135 | 2.36 | 3.36e-04 | 1.19e-02 | 15 |
GO:0071173 | GO:0071173 | spindle assembly checkpoint | 12/2757 | 15/8135 | 2.36 | 3.36e-04 | 1.19e-02 | 15 |
GO:0071174 | GO:0071174 | mitotic spindle checkpoint | 12/2757 | 15/8135 | 2.36 | 3.36e-04 | 1.19e-02 | 15 |
GO:1902100 | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 12/2757 | 15/8135 | 2.36 | 3.36e-04 | 1.19e-02 | 15 |
GO:1901992 | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 22/2757 | 35/8135 | 1.85 | 4.21e-04 | 1.47e-02 | 35 |
GO:1901988 | GO:1901988 | negative regulation of cell cycle phase transition | 36/2757 | 66/8135 | 1.61 | 4.29e-04 | 1.48e-02 | 66 |
GO:0000910 | GO:0000910 | cytokinesis | 31/2757 | 55/8135 | 1.66 | 4.98e-04 | 1.68e-02 | 55 |
GO:0043486 | GO:0043486 | histone exchange | 18/2757 | 27/8135 | 1.97 | 5.02e-04 | 1.68e-02 | 27 |
GO:0034080 | GO:0034080 | CENP-A containing nucleosome assembly | 16/2757 | 23/8135 | 2.05 | 5.04e-04 | 1.68e-02 | 23 |
GO:0045840 | GO:0045840 | positive regulation of mitotic nuclear division | 16/2757 | 23/8135 | 2.05 | 5.04e-04 | 1.68e-02 | 23 |
GO:0061641 | GO:0061641 | CENP-A containing chromatin organization | 16/2757 | 23/8135 | 2.05 | 5.04e-04 | 1.68e-02 | 23 |
GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 21/2757 | 34/8135 | 1.82 | 7.96e-04 | 2.59e-02 | 34 |
GO:0044786 | GO:0044786 | cell cycle DNA replication | 11/2757 | 14/8135 | 2.32 | 8.03e-04 | 2.60e-02 | 14 |
GO:0007098 | GO:0007098 | centrosome cycle | 20/2757 | 32/8135 | 1.84 | 8.54e-04 | 2.74e-02 | 32 |
GO:0007143 | GO:0007143 | female meiotic nuclear division | 12/2757 | 16/8135 | 2.21 | 9.29e-04 | 2.94e-02 | 16 |
GO:0006338 | GO:0006338 | chromatin remodeling | 32/2757 | 59/8135 | 1.60 | 1.00e-03 | 3.15e-02 | 59 |
GO:1902751 | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 13/2757 | 18/8135 | 2.13 | 1.01e-03 | 3.15e-02 | 18 |
GO:0034660 | GO:0034660 | ncRNA metabolic process | 34/2757 | 64/8135 | 1.57 | 1.15e-03 | 3.56e-02 | 64 |
GO:0006282 | GO:0006282 | regulation of DNA repair | 22/2757 | 37/8135 | 1.75 | 1.24e-03 | 3.82e-02 | 37 |
GO:0045132 | GO:0045132 | meiotic chromosome segregation | 29/2757 | 53/8135 | 1.61 | 1.42e-03 | 4.23e-02 | 53 |
GO:0060968 | GO:0060968 | regulation of gene silencing | 29/2757 | 53/8135 | 1.61 | 1.42e-03 | 4.23e-02 | 53 |
GO:1901991 | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 32/2757 | 60/8135 | 1.57 | 1.46e-03 | 4.32e-02 | 60 |
GO:0000022 | GO:0000022 | mitotic spindle elongation | 9/2757 | 11/8135 | 2.41 | 1.56e-03 | 4.50e-02 | 11 |
GO:0051231 | GO:0051231 | spindle elongation | 9/2757 | 11/8135 | 2.41 | 1.56e-03 | 4.50e-02 | 11 |
GO:0090224 | GO:0090224 | regulation of spindle organization | 9/2757 | 11/8135 | 2.41 | 1.56e-03 | 4.50e-02 | 11 |
GO:0043044 | GO:0043044 | ATP-dependent chromatin remodeling | 18/2757 | 29/8135 | 1.83 | 1.74e-03 | 4.95e-02 | 29 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0003341 | GO:0003341 | cilium movement | 36/3093 | 46/8135 | 2.06 | 2.83e-08 | 0.000066 | 46 |
GO:0035082 | GO:0035082 | axoneme assembly | 36/3093 | 46/8135 | 2.06 | 2.83e-08 | 0.000066 | 46 |
GO:0044782 | GO:0044782 | cilium organization | 80/3093 | 132/8135 | 1.59 | 9.90e-08 | 0.000154 | 132 |
GO:0060271 | GO:0060271 | cilium assembly | 74/3093 | 123/8135 | 1.58 | 4.50e-07 | 0.000525 | 123 |
GO:0070286 | GO:0070286 | axonemal dynein complex assembly | 21/3093 | 25/8135 | 2.21 | 3.07e-06 | 0.002860 | 25 |
GO:0001578 | GO:0001578 | microtubule bundle formation | 41/3093 | 62/8135 | 1.74 | 6.35e-06 | 0.004933 | 62 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:1903047 | GO:1903047 | mitotic cell cycle process | 159/2722 | 267/8135 | 1.78 | 6.48e-19 | 2.59e-15 | 267 |
GO:0000278 | GO:0000278 | mitotic cell cycle | 185/2722 | 326/8135 | 1.70 | 1.17e-18 | 2.59e-15 | 326 |
GO:0022402 | GO:0022402 | cell cycle process | 239/2722 | 470/8135 | 1.52 | 8.75e-16 | 1.29e-12 | 470 |
GO:0051276 | GO:0051276 | chromosome organization | 203/2722 | 385/8135 | 1.58 | 1.25e-15 | 1.38e-12 | 385 |
GO:0071103 | GO:0071103 | DNA conformation change | 80/2722 | 121/8135 | 1.98 | 1.50e-13 | 1.14e-10 | 121 |
GO:0140014 | GO:0140014 | mitotic nuclear division | 73/2722 | 107/8135 | 2.04 | 1.55e-13 | 1.14e-10 | 107 |
GO:0000819 | GO:0000819 | sister chromatid segregation | 52/2722 | 68/8135 | 2.29 | 3.81e-13 | 2.41e-10 | 68 |
GO:0044772 | GO:0044772 | mitotic cell cycle phase transition | 98/2722 | 164/8135 | 1.79 | 3.03e-12 | 1.68e-09 | 164 |
GO:0000070 | GO:0000070 | mitotic sister chromatid segregation | 44/2722 | 56/8135 | 2.35 | 4.89e-12 | 2.40e-09 | 56 |
GO:0044770 | GO:0044770 | cell cycle phase transition | 103/2722 | 177/8135 | 1.74 | 8.29e-12 | 3.67e-09 | 177 |
GO:0007059 | GO:0007059 | chromosome segregation | 75/2722 | 118/8135 | 1.90 | 1.65e-11 | 6.44e-09 | 118 |
GO:0000280 | GO:0000280 | nuclear division | 109/2722 | 192/8135 | 1.70 | 1.75e-11 | 6.44e-09 | 192 |
GO:0006260 | GO:0006260 | DNA replication | 54/2722 | 77/8135 | 2.10 | 4.44e-11 | 1.51e-08 | 77 |
GO:0051301 | GO:0051301 | cell division | 118/2722 | 219/8135 | 1.61 | 2.44e-10 | 7.72e-08 | 219 |
GO:0048285 | GO:0048285 | organelle fission | 112/2722 | 206/8135 | 1.62 | 3.43e-10 | 1.01e-07 | 206 |
GO:0098813 | GO:0098813 | nuclear chromosome segregation | 66/2722 | 106/8135 | 1.86 | 9.85e-10 | 2.73e-07 | 106 |
GO:0006323 | GO:0006323 | DNA packaging | 63/2722 | 100/8135 | 1.88 | 1.19e-09 | 3.09e-07 | 100 |
GO:0070268 | GO:0070268 | cornification | 60/2722 | 95/8135 | 1.89 | 2.56e-09 | 6.30e-07 | 95 |
GO:0019730 | GO:0019730 | antimicrobial humoral response | 56/2722 | 87/8135 | 1.92 | 3.13e-09 | 7.29e-07 | 87 |
GO:0007346 | GO:0007346 | regulation of mitotic cell cycle | 109/2722 | 207/8135 | 1.57 | 6.67e-09 | 1.48e-06 | 207 |
GO:0010564 | GO:0010564 | regulation of cell cycle process | 124/2722 | 243/8135 | 1.53 | 7.51e-09 | 1.58e-06 | 243 |
GO:0030216 | GO:0030216 | keratinocyte differentiation | 89/2722 | 162/8135 | 1.64 | 1.16e-08 | 2.23e-06 | 162 |
GO:0006261 | GO:0006261 | DNA-dependent DNA replication | 32/2722 | 42/8135 | 2.28 | 1.64e-08 | 2.91e-06 | 42 |
GO:0051983 | GO:0051983 | regulation of chromosome segregation | 28/2722 | 35/8135 | 2.39 | 2.00e-08 | 3.40e-06 | 35 |
GO:0031424 | GO:0031424 | keratinization | 71/2722 | 123/8135 | 1.73 | 2.36e-08 | 3.88e-06 | 123 |
GO:0034502 | GO:0034502 | protein localization to chromosome | 18/2722 | 19/8135 | 2.83 | 3.46e-08 | 5.47e-06 | 19 |
GO:0043588 | GO:0043588 | skin development | 121/2722 | 241/8135 | 1.50 | 3.83e-08 | 5.84e-06 | 241 |
GO:1902850 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 34/2722 | 47/8135 | 2.16 | 5.38e-08 | 7.94e-06 | 47 |
GO:0061844 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 36/2722 | 52/8135 | 2.07 | 1.35e-07 | 1.88e-05 | 52 |
GO:0031497 | GO:0031497 | chromatin assembly | 52/2722 | 85/8135 | 1.83 | 1.36e-07 | 1.88e-05 | 85 |
GO:0032392 | GO:0032392 | DNA geometric change | 20/2722 | 23/8135 | 2.60 | 1.67e-07 | 2.21e-05 | 23 |
GO:0007088 | GO:0007088 | regulation of mitotic nuclear division | 49/2722 | 79/8135 | 1.85 | 1.70e-07 | 2.21e-05 | 79 |
GO:0007052 | GO:0007052 | mitotic spindle organization | 29/2722 | 39/8135 | 2.22 | 1.96e-07 | 2.42e-05 | 39 |
GO:0032508 | GO:0032508 | DNA duplex unwinding | 18/2722 | 20/8135 | 2.69 | 2.37e-07 | 2.81e-05 | 20 |
GO:0000075 | GO:0000075 | cell cycle checkpoint | 43/2722 | 67/8135 | 1.92 | 2.41e-07 | 2.81e-05 | 67 |
GO:0007051 | GO:0007051 | spindle organization | 35/2722 | 51/8135 | 2.05 | 2.84e-07 | 3.22e-05 | 51 |
GO:0065004 | GO:0065004 | protein-DNA complex assembly | 57/2722 | 98/8135 | 1.74 | 4.00e-07 | 4.42e-05 | 98 |
GO:0006333 | GO:0006333 | chromatin assembly or disassembly | 53/2722 | 90/8135 | 1.76 | 5.91e-07 | 6.30e-05 | 90 |
GO:0006334 | GO:0006334 | nucleosome assembly | 47/2722 | 77/8135 | 1.82 | 5.98e-07 | 6.30e-05 | 77 |
GO:0010965 | GO:0010965 | regulation of mitotic sister chromatid separation | 20/2722 | 24/8135 | 2.49 | 6.84e-07 | 6.73e-05 | 24 |
GO:0033047 | GO:0033047 | regulation of mitotic sister chromatid segregation | 20/2722 | 24/8135 | 2.49 | 6.84e-07 | 6.73e-05 | 24 |
GO:0051306 | GO:0051306 | mitotic sister chromatid separation | 20/2722 | 24/8135 | 2.49 | 6.84e-07 | 6.73e-05 | 24 |
GO:0010948 | GO:0010948 | negative regulation of cell cycle process | 55/2722 | 95/8135 | 1.73 | 7.84e-07 | 7.38e-05 | 95 |
GO:0044843 | GO:0044843 | cell cycle G1/S phase transition | 53/2722 | 91/8135 | 1.74 | 9.59e-07 | 8.85e-05 | 91 |
GO:0071824 | GO:0071824 | protein-DNA complex subunit organization | 61/2722 | 109/8135 | 1.67 | 9.99e-07 | 9.03e-05 | 109 |
GO:0006281 | GO:0006281 | DNA repair | 70/2722 | 130/8135 | 1.61 | 1.15e-06 | 1.01e-04 | 130 |
GO:0034728 | GO:0034728 | nucleosome organization | 51/2722 | 87/8135 | 1.75 | 1.17e-06 | 1.01e-04 | 87 |
GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 33/2722 | 49/8135 | 2.01 | 1.22e-06 | 1.02e-04 | 49 |
GO:0051783 | GO:0051783 | regulation of nuclear division | 55/2722 | 96/8135 | 1.71 | 1.24e-06 | 1.02e-04 | 96 |
GO:0033045 | GO:0033045 | regulation of sister chromatid segregation | 22/2722 | 28/8135 | 2.35 | 1.24e-06 | 1.02e-04 | 28 |
GO:1901990 | GO:1901990 | regulation of mitotic cell cycle phase transition | 62/2722 | 113/8135 | 1.64 | 2.03e-06 | 1.63e-04 | 113 |
GO:0051304 | GO:0051304 | chromosome separation | 26/2722 | 36/8135 | 2.16 | 2.18e-06 | 1.72e-04 | 36 |
GO:0000082 | GO:0000082 | G1/S transition of mitotic cell cycle | 49/2722 | 84/8135 | 1.74 | 2.30e-06 | 1.79e-04 | 84 |
GO:1905818 | GO:1905818 | regulation of chromosome separation | 20/2722 | 25/8135 | 2.39 | 2.34e-06 | 1.79e-04 | 25 |
GO:1901987 | GO:1901987 | regulation of cell cycle phase transition | 67/2722 | 125/8135 | 1.60 | 2.41e-06 | 1.81e-04 | 125 |
GO:0051784 | GO:0051784 | negative regulation of nuclear division | 22/2722 | 29/8135 | 2.27 | 3.52e-06 | 2.60e-04 | 29 |
GO:0051321 | GO:0051321 | meiotic cell cycle | 74/2722 | 143/8135 | 1.55 | 4.16e-06 | 2.97e-04 | 143 |
GO:0007062 | GO:0007062 | sister chromatid cohesion | 15/2722 | 17/8135 | 2.64 | 4.63e-06 | 3.25e-04 | 17 |
GO:0006302 | GO:0006302 | double-strand break repair | 46/2722 | 79/8135 | 1.74 | 5.01e-06 | 3.46e-04 | 79 |
GO:0007080 | GO:0007080 | mitotic metaphase plate congression | 13/2722 | 14/8135 | 2.78 | 6.25e-06 | 4.26e-04 | 14 |
GO:0033046 | GO:0033046 | negative regulation of sister chromatid segregation | 16/2722 | 19/8135 | 2.52 | 7.52e-06 | 4.83e-04 | 19 |
GO:0051310 | GO:0051310 | metaphase plate congression | 16/2722 | 19/8135 | 2.52 | 7.52e-06 | 4.83e-04 | 19 |
GO:0051985 | GO:0051985 | negative regulation of chromosome segregation | 16/2722 | 19/8135 | 2.52 | 7.52e-06 | 4.83e-04 | 19 |
GO:1903046 | GO:1903046 | meiotic cell cycle process | 60/2722 | 112/8135 | 1.60 | 8.21e-06 | 5.19e-04 | 112 |
GO:0006342 | GO:0006342 | chromatin silencing | 29/2722 | 44/8135 | 1.97 | 1.04e-05 | 6.48e-04 | 44 |
GO:0007091 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 17/2722 | 21/8135 | 2.42 | 1.06e-05 | 6.51e-04 | 21 |
GO:0044839 | GO:0044839 | cell cycle G2/M phase transition | 43/2722 | 74/8135 | 1.74 | 1.09e-05 | 6.56e-04 | 74 |
GO:0040029 | GO:0040029 | regulation of gene expression, epigenetic | 51/2722 | 92/8135 | 1.66 | 1.10e-05 | 6.56e-04 | 92 |
GO:0000086 | GO:0000086 | G2/M transition of mitotic cell cycle | 40/2722 | 68/8135 | 1.76 | 1.47e-05 | 8.34e-04 | 68 |
GO:0140013 | GO:0140013 | meiotic nuclear division | 57/2722 | 107/8135 | 1.59 | 1.71e-05 | 9.48e-04 | 107 |
GO:0071459 | GO:0071459 | protein localization to chromosome, centromeric region | 10/2722 | 10/8135 | 2.99 | 1.74e-05 | 9.51e-04 | 10 |
GO:0034508 | GO:0034508 | centromere complex assembly | 20/2722 | 27/8135 | 2.21 | 1.83e-05 | 9.91e-04 | 27 |
GO:0033048 | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 15/2722 | 18/8135 | 2.49 | 1.91e-05 | 9.95e-04 | 18 |
GO:1905819 | GO:1905819 | negative regulation of chromosome separation | 15/2722 | 18/8135 | 2.49 | 1.91e-05 | 9.95e-04 | 18 |
GO:2000816 | GO:2000816 | negative regulation of mitotic sister chromatid separation | 15/2722 | 18/8135 | 2.49 | 1.91e-05 | 9.95e-04 | 18 |
GO:0016458 | GO:0016458 | gene silencing | 48/2722 | 87/8135 | 1.65 | 2.34e-05 | 1.19e-03 | 87 |
GO:0030071 | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 16/2722 | 20/8135 | 2.39 | 2.59e-05 | 1.30e-03 | 20 |
GO:0006310 | GO:0006310 | DNA recombination | 55/2722 | 104/8135 | 1.58 | 3.15e-05 | 1.57e-03 | 104 |
GO:0044784 | GO:0044784 | metaphase/anaphase transition of cell cycle | 17/2722 | 22/8135 | 2.31 | 3.20e-05 | 1.57e-03 | 22 |
GO:0006270 | GO:0006270 | DNA replication initiation | 13/2722 | 15/8135 | 2.59 | 3.24e-05 | 1.58e-03 | 15 |
GO:0045839 | GO:0045839 | negative regulation of mitotic nuclear division | 18/2722 | 24/8135 | 2.24 | 3.71e-05 | 1.77e-03 | 24 |
GO:0000724 | GO:0000724 | double-strand break repair via homologous recombination | 28/2722 | 44/8135 | 1.90 | 3.90e-05 | 1.82e-03 | 44 |
GO:0000725 | GO:0000725 | recombinational repair | 28/2722 | 44/8135 | 1.90 | 3.90e-05 | 1.82e-03 | 44 |
GO:0051052 | GO:0051052 | regulation of DNA metabolic process | 66/2722 | 131/8135 | 1.51 | 4.12e-05 | 1.90e-03 | 131 |
GO:0000083 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 11/2722 | 12/8135 | 2.74 | 4.84e-05 | 2.16e-03 | 12 |
GO:0031145 | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 11/2722 | 12/8135 | 2.74 | 4.84e-05 | 2.16e-03 | 12 |
GO:1902749 | GO:1902749 | regulation of cell cycle G2/M phase transition | 32/2722 | 53/8135 | 1.80 | 5.12e-05 | 2.27e-03 | 53 |
GO:0010389 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 29/2722 | 47/8135 | 1.84 | 6.54e-05 | 2.84e-03 | 47 |
GO:0031570 | GO:0031570 | DNA integrity checkpoint | 28/2722 | 45/8135 | 1.86 | 7.04e-05 | 3.00e-03 | 45 |
GO:2001251 | GO:2001251 | negative regulation of chromosome organization | 28/2722 | 45/8135 | 1.86 | 7.04e-05 | 3.00e-03 | 45 |
GO:0090068 | GO:0090068 | positive regulation of cell cycle process | 59/2722 | 116/8135 | 1.52 | 7.33e-05 | 3.09e-03 | 116 |
GO:1902099 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 16/2722 | 21/8135 | 2.28 | 7.48e-05 | 3.12e-03 | 21 |
GO:0008608 | GO:0008608 | attachment of spindle microtubules to kinetochore | 12/2722 | 14/8135 | 2.56 | 8.46e-05 | 3.50e-03 | 14 |
GO:0031055 | GO:0031055 | chromatin remodeling at centromere | 18/2722 | 25/8135 | 2.15 | 9.11e-05 | 3.74e-03 | 25 |
GO:0043486 | GO:0043486 | histone exchange | 19/2722 | 27/8135 | 2.10 | 9.53e-05 | 3.78e-03 | 27 |
GO:0050000 | GO:0050000 | chromosome localization | 19/2722 | 27/8135 | 2.10 | 9.53e-05 | 3.78e-03 | 27 |
GO:0051303 | GO:0051303 | establishment of chromosome localization | 19/2722 | 27/8135 | 2.10 | 9.53e-05 | 3.78e-03 | 27 |
GO:0006275 | GO:0006275 | regulation of DNA replication | 22/2722 | 33/8135 | 1.99 | 9.57e-05 | 3.78e-03 | 33 |
GO:0006338 | GO:0006338 | chromatin remodeling | 34/2722 | 59/8135 | 1.72 | 1.13e-04 | 4.37e-03 | 59 |
GO:0071621 | GO:0071621 | granulocyte chemotaxis | 53/2722 | 103/8135 | 1.54 | 1.14e-04 | 4.37e-03 | 103 |
GO:0045931 | GO:0045931 | positive regulation of mitotic cell cycle | 37/2722 | 66/8135 | 1.68 | 1.27e-04 | 4.79e-03 | 66 |
GO:1901988 | GO:1901988 | negative regulation of cell cycle phase transition | 37/2722 | 66/8135 | 1.68 | 1.27e-04 | 4.79e-03 | 66 |
GO:0007093 | GO:0007093 | mitotic cell cycle checkpoint | 32/2722 | 55/8135 | 1.74 | 1.39e-04 | 5.23e-03 | 55 |
GO:0051054 | GO:0051054 | positive regulation of DNA metabolic process | 39/2722 | 71/8135 | 1.64 | 1.52e-04 | 5.65e-03 | 71 |
GO:0006336 | GO:0006336 | DNA replication-independent nucleosome assembly | 17/2722 | 24/8135 | 2.12 | 1.99e-04 | 7.10e-03 | 24 |
GO:0034724 | GO:0034724 | DNA replication-independent nucleosome organization | 17/2722 | 24/8135 | 2.12 | 1.99e-04 | 7.10e-03 | 24 |
GO:0000281 | GO:0000281 | mitotic cytokinesis | 19/2722 | 28/8135 | 2.03 | 2.04e-04 | 7.21e-03 | 28 |
GO:0045930 | GO:0045930 | negative regulation of mitotic cell cycle | 51/2722 | 101/8135 | 1.51 | 2.78e-04 | 9.46e-03 | 101 |
GO:0007094 | GO:0007094 | mitotic spindle assembly checkpoint | 12/2722 | 15/8135 | 2.39 | 2.93e-04 | 9.48e-03 | 15 |
GO:0031577 | GO:0031577 | spindle checkpoint | 12/2722 | 15/8135 | 2.39 | 2.93e-04 | 9.48e-03 | 15 |
GO:0045841 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 12/2722 | 15/8135 | 2.39 | 2.93e-04 | 9.48e-03 | 15 |
GO:0071173 | GO:0071173 | spindle assembly checkpoint | 12/2722 | 15/8135 | 2.39 | 2.93e-04 | 9.48e-03 | 15 |
GO:0071174 | GO:0071174 | mitotic spindle checkpoint | 12/2722 | 15/8135 | 2.39 | 2.93e-04 | 9.48e-03 | 15 |
GO:1902100 | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 12/2722 | 15/8135 | 2.39 | 2.93e-04 | 9.48e-03 | 15 |
GO:0033044 | GO:0033044 | regulation of chromosome organization | 49/2722 | 97/8135 | 1.51 | 3.59e-04 | 1.15e-02 | 97 |
GO:0032200 | GO:0032200 | telomere organization | 27/2722 | 46/8135 | 1.75 | 3.77e-04 | 1.19e-02 | 46 |
GO:0030593 | GO:0030593 | neutrophil chemotaxis | 46/2722 | 90/8135 | 1.53 | 3.83e-04 | 1.20e-02 | 90 |
GO:0043044 | GO:0043044 | ATP-dependent chromatin remodeling | 19/2722 | 29/8135 | 1.96 | 4.06e-04 | 1.26e-02 | 29 |
GO:0034080 | GO:0034080 | CENP-A containing nucleosome assembly | 16/2722 | 23/8135 | 2.08 | 4.28e-04 | 1.31e-02 | 23 |
GO:0061641 | GO:0061641 | CENP-A containing chromatin organization | 16/2722 | 23/8135 | 2.08 | 4.28e-04 | 1.31e-02 | 23 |
GO:0060968 | GO:0060968 | regulation of gene silencing | 30/2722 | 53/8135 | 1.69 | 4.33e-04 | 1.31e-02 | 53 |
GO:1901991 | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 33/2722 | 60/8135 | 1.64 | 4.66e-04 | 1.40e-02 | 60 |
GO:0070555 | GO:0070555 | response to interleukin-1 | 45/2722 | 89/8135 | 1.51 | 5.99e-04 | 1.73e-02 | 89 |
GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 21/2722 | 34/8135 | 1.85 | 6.57e-04 | 1.88e-02 | 34 |
GO:0044786 | GO:0044786 | cell cycle DNA replication | 11/2722 | 14/8135 | 2.35 | 7.10e-04 | 2.01e-02 | 14 |
GO:0090307 | GO:0090307 | mitotic spindle assembly | 14/2722 | 20/8135 | 2.09 | 9.05e-04 | 2.52e-02 | 20 |
GO:0071347 | GO:0071347 | cellular response to interleukin-1 | 39/2722 | 76/8135 | 1.53 | 9.40e-04 | 2.60e-02 | 76 |
GO:0000910 | GO:0000910 | cytokinesis | 30/2722 | 55/8135 | 1.63 | 1.00e-03 | 2.75e-02 | 55 |
GO:1901992 | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 21/2722 | 35/8135 | 1.79 | 1.13e-03 | 3.06e-02 | 35 |
GO:0018149 | GO:0018149 | peptide cross-linking | 24/2722 | 42/8135 | 1.71 | 1.34e-03 | 3.58e-02 | 42 |
GO:1901989 | GO:1901989 | positive regulation of cell cycle phase transition | 24/2722 | 42/8135 | 1.71 | 1.34e-03 | 3.58e-02 | 42 |
GO:0006586 | GO:0006586 | indolalkylamine metabolic process | 9/2722 | 11/8135 | 2.45 | 1.41e-03 | 3.73e-02 | 11 |
GO:0007398 | GO:0007398 | ectoderm development | 9/2722 | 11/8135 | 2.45 | 1.41e-03 | 3.73e-02 | 11 |
GO:0051225 | GO:0051225 | spindle assembly | 18/2722 | 29/8135 | 1.86 | 1.47e-03 | 3.87e-02 | 29 |
GO:0061982 | GO:0061982 | meiosis I cell cycle process | 38/2722 | 75/8135 | 1.51 | 1.48e-03 | 3.87e-02 | 75 |
GO:0045780 | GO:0045780 | positive regulation of bone resorption | 10/2722 | 13/8135 | 2.30 | 1.69e-03 | 4.35e-02 | 13 |
GO:0046852 | GO:0046852 | positive regulation of bone remodeling | 10/2722 | 13/8135 | 2.30 | 1.69e-03 | 4.35e-02 | 13 |
GO:0051782 | GO:0051782 | negative regulation of cell division | 10/2722 | 13/8135 | 2.30 | 1.69e-03 | 4.35e-02 | 13 |
GO:0000183 | GO:0000183 | chromatin silencing at rDNA | 16/2722 | 25/8135 | 1.91 | 1.70e-03 | 4.35e-02 | 25 |
GO:0034105 | GO:0034105 | positive regulation of tissue remodeling | 14/2722 | 21/8135 | 1.99 | 1.88e-03 | 4.76e-02 | 21 |
GO:0002544 | GO:0002544 | chronic inflammatory response | 12/2722 | 17/8135 | 2.11 | 1.93e-03 | 4.82e-02 | 17 |
GO:0006890 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 12/2722 | 17/8135 | 2.11 | 1.93e-03 | 4.82e-02 | 17 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0044782 | GO:0044782 | cilium organization | 85/3053 | 132/8135 | 1.72 | 2.68e-10 | 9.59e-07 | 132 |
GO:0035082 | GO:0035082 | axoneme assembly | 38/3053 | 46/8135 | 2.20 | 4.13e-10 | 9.59e-07 | 46 |
GO:0060271 | GO:0060271 | cilium assembly | 79/3053 | 123/8135 | 1.71 | 1.38e-09 | 2.14e-06 | 123 |
GO:0003341 | GO:0003341 | cilium movement | 36/3053 | 46/8135 | 2.09 | 1.91e-08 | 2.21e-05 | 46 |
GO:0001578 | GO:0001578 | microtubule bundle formation | 44/3053 | 62/8135 | 1.89 | 8.49e-08 | 5.64e-05 | 62 |
GO:0070286 | GO:0070286 | axonemal dynein complex assembly | 21/3053 | 25/8135 | 2.24 | 2.40e-06 | 1.39e-03 | 25 |
GO:0044458 | GO:0044458 | motile cilium assembly | 11/3053 | 12/8135 | 2.44 | 1.62e-04 | 4.71e-02 | 12 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:1901020 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity | 17/3155 | 20/8135 | 2.19 | 2.90e-05 | 0.0161 | 20 |
GO:0030241 | GO:0030241 | skeletal muscle myosin thick filament assembly | 11/3155 | 11/8135 | 2.58 | 2.95e-05 | 0.0161 | 11 |
GO:0031033 | GO:0031033 | myosin filament organization | 11/3155 | 11/8135 | 2.58 | 2.95e-05 | 0.0161 | 11 |
GO:0031034 | GO:0031034 | myosin filament assembly | 11/3155 | 11/8135 | 2.58 | 2.95e-05 | 0.0161 | 11 |
GO:0071688 | GO:0071688 | striated muscle myosin thick filament assembly | 11/3155 | 11/8135 | 2.58 | 2.95e-05 | 0.0161 | 11 |
GO:1903170 | GO:1903170 | negative regulation of calcium ion transmembrane transport | 18/3155 | 22/8135 | 2.11 | 4.54e-05 | 0.0213 | 22 |
GO:1901019 | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 36/3155 | 55/8135 | 1.69 | 5.37e-05 | 0.0213 | 55 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0051276 | GO:0051276 | chromosome organization | 156/1142 | 385/8135 | 2.89 | 1.20e-39 | 4.93e-36 | 385 |
GO:1903047 | GO:1903047 | mitotic cell cycle process | 114/1142 | 267/8135 | 3.04 | 2.09e-31 | 4.30e-28 | 267 |
GO:0000278 | GO:0000278 | mitotic cell cycle | 128/1142 | 326/8135 | 2.80 | 7.82e-31 | 1.07e-27 | 326 |
GO:0071103 | GO:0071103 | DNA conformation change | 71/1142 | 121/8135 | 4.18 | 1.17e-30 | 1.20e-27 | 121 |
GO:0007059 | GO:0007059 | chromosome segregation | 69/1142 | 118/8135 | 4.17 | 1.08e-29 | 8.93e-27 | 118 |
GO:0022402 | GO:0022402 | cell cycle process | 156/1142 | 470/8135 | 2.36 | 7.90e-28 | 5.43e-25 | 470 |
GO:0006323 | GO:0006323 | DNA packaging | 59/1142 | 100/8135 | 4.20 | 7.98e-26 | 4.70e-23 | 100 |
GO:0000819 | GO:0000819 | sister chromatid segregation | 47/1142 | 68/8135 | 4.92 | 3.47e-25 | 1.79e-22 | 68 |
GO:0098813 | GO:0098813 | nuclear chromosome segregation | 60/1142 | 106/8135 | 4.03 | 6.58e-25 | 3.01e-22 | 106 |
GO:0006334 | GO:0006334 | nucleosome assembly | 50/1142 | 77/8135 | 4.63 | 8.57e-25 | 3.54e-22 | 77 |
GO:0140014 | GO:0140014 | mitotic nuclear division | 60/1142 | 107/8135 | 3.99 | 1.30e-24 | 4.87e-22 | 107 |
GO:0065004 | GO:0065004 | protein-DNA complex assembly | 57/1142 | 98/8135 | 4.14 | 1.52e-24 | 5.23e-22 | 98 |
GO:0051301 | GO:0051301 | cell division | 91/1142 | 219/8135 | 2.96 | 3.77e-24 | 1.20e-21 | 219 |
GO:0031497 | GO:0031497 | chromatin assembly | 52/1142 | 85/8135 | 4.36 | 6.13e-24 | 1.81e-21 | 85 |
GO:0000070 | GO:0000070 | mitotic sister chromatid segregation | 41/1142 | 56/8135 | 5.22 | 1.12e-23 | 3.09e-21 | 56 |
GO:0000280 | GO:0000280 | nuclear division | 83/1142 | 192/8135 | 3.08 | 1.78e-23 | 4.58e-21 | 192 |
GO:0048285 | GO:0048285 | organelle fission | 86/1142 | 206/8135 | 2.97 | 4.91e-23 | 1.19e-20 | 206 |
GO:0006333 | GO:0006333 | chromatin assembly or disassembly | 52/1142 | 90/8135 | 4.12 | 2.63e-22 | 5.82e-20 | 90 |
GO:0034728 | GO:0034728 | nucleosome organization | 51/1142 | 87/8135 | 4.18 | 2.69e-22 | 5.82e-20 | 87 |
GO:0071824 | GO:0071824 | protein-DNA complex subunit organization | 58/1142 | 109/8135 | 3.79 | 2.82e-22 | 5.82e-20 | 109 |
GO:0006259 | GO:0006259 | DNA metabolic process | 107/1142 | 301/8135 | 2.53 | 8.86e-22 | 1.74e-19 | 301 |
GO:0044770 | GO:0044770 | cell cycle phase transition | 74/1142 | 177/8135 | 2.98 | 5.33e-20 | 9.99e-18 | 177 |
GO:0044772 | GO:0044772 | mitotic cell cycle phase transition | 70/1142 | 164/8135 | 3.04 | 1.40e-19 | 2.51e-17 | 164 |
GO:0006302 | GO:0006302 | double-strand break repair | 45/1142 | 79/8135 | 4.06 | 3.99e-19 | 6.81e-17 | 79 |
GO:0006325 | GO:0006325 | chromatin organization | 93/1142 | 261/8135 | 2.54 | 4.13e-19 | 6.81e-17 | 261 |
GO:0006281 | GO:0006281 | DNA repair | 60/1142 | 130/8135 | 3.29 | 5.65e-19 | 8.95e-17 | 130 |
GO:0006974 | GO:0006974 | cellular response to DNA damage stimulus | 82/1142 | 230/8135 | 2.54 | 5.57e-17 | 8.50e-15 | 230 |
GO:0006260 | GO:0006260 | DNA replication | 41/1142 | 77/8135 | 3.79 | 4.04e-16 | 5.95e-14 | 77 |
GO:0010564 | GO:0010564 | regulation of cell cycle process | 82/1142 | 243/8135 | 2.40 | 2.22e-15 | 3.15e-13 | 243 |
GO:0006342 | GO:0006342 | chromatin silencing | 29/1142 | 44/8135 | 4.70 | 3.73e-15 | 5.13e-13 | 44 |
GO:1901987 | GO:1901987 | regulation of cell cycle phase transition | 53/1142 | 125/8135 | 3.02 | 5.75e-15 | 7.65e-13 | 125 |
GO:0051983 | GO:0051983 | regulation of chromosome segregation | 25/1142 | 35/8135 | 5.09 | 1.70e-14 | 2.19e-12 | 35 |
GO:0000075 | GO:0000075 | cell cycle checkpoint | 36/1142 | 67/8135 | 3.83 | 1.79e-14 | 2.23e-12 | 67 |
GO:0007346 | GO:0007346 | regulation of mitotic cell cycle | 72/1142 | 207/8135 | 2.48 | 2.09e-14 | 2.53e-12 | 207 |
GO:1901990 | GO:1901990 | regulation of mitotic cell cycle phase transition | 49/1142 | 113/8135 | 3.09 | 2.15e-14 | 2.53e-12 | 113 |
GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 30/1142 | 49/8135 | 4.36 | 2.38e-14 | 2.72e-12 | 49 |
GO:0007088 | GO:0007088 | regulation of mitotic nuclear division | 39/1142 | 79/8135 | 3.52 | 5.67e-14 | 6.32e-12 | 79 |
GO:0051726 | GO:0051726 | regulation of cell cycle | 114/1142 | 412/8135 | 1.97 | 7.69e-14 | 8.35e-12 | 412 |
GO:0006261 | GO:0006261 | DNA-dependent DNA replication | 27/1142 | 42/8135 | 4.58 | 8.50e-14 | 8.99e-12 | 42 |
GO:0007051 | GO:0007051 | spindle organization | 30/1142 | 51/8135 | 4.19 | 1.09e-13 | 1.12e-11 | 51 |
GO:1902850 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 28/1142 | 47/8135 | 4.24 | 4.67e-13 | 4.70e-11 | 47 |
GO:0051304 | GO:0051304 | chromosome separation | 24/1142 | 36/8135 | 4.75 | 6.35e-13 | 6.24e-11 | 36 |
GO:0007052 | GO:0007052 | mitotic spindle organization | 25/1142 | 39/8135 | 4.57 | 7.93e-13 | 7.61e-11 | 39 |
GO:0044839 | GO:0044839 | cell cycle G2/M phase transition | 36/1142 | 74/8135 | 3.47 | 9.39e-13 | 8.80e-11 | 74 |
GO:0006310 | GO:0006310 | DNA recombination | 44/1142 | 104/8135 | 3.01 | 1.33e-12 | 1.21e-10 | 104 |
GO:0007093 | GO:0007093 | mitotic cell cycle checkpoint | 30/1142 | 55/8135 | 3.89 | 1.66e-12 | 1.49e-10 | 55 |
GO:0034508 | GO:0034508 | centromere complex assembly | 20/1142 | 27/8135 | 5.28 | 2.53e-12 | 2.22e-10 | 27 |
GO:0060968 | GO:0060968 | regulation of gene silencing | 29/1142 | 53/8135 | 3.90 | 3.52e-12 | 2.93e-10 | 53 |
GO:1902749 | GO:1902749 | regulation of cell cycle G2/M phase transition | 29/1142 | 53/8135 | 3.90 | 3.52e-12 | 2.93e-10 | 53 |
GO:0010948 | GO:0010948 | negative regulation of cell cycle process | 41/1142 | 95/8135 | 3.07 | 3.56e-12 | 2.93e-10 | 95 |
GO:0006335 | GO:0006335 | DNA replication-dependent nucleosome assembly | 18/1142 | 23/8135 | 5.57 | 6.65e-12 | 5.28e-10 | 23 |
GO:0034723 | GO:0034723 | DNA replication-dependent nucleosome organization | 18/1142 | 23/8135 | 5.57 | 6.65e-12 | 5.28e-10 | 23 |
GO:0033045 | GO:0033045 | regulation of sister chromatid segregation | 20/1142 | 28/8135 | 5.09 | 7.69e-12 | 5.99e-10 | 28 |
GO:0000086 | GO:0000086 | G2/M transition of mitotic cell cycle | 33/1142 | 68/8135 | 3.46 | 9.17e-12 | 7.01e-10 | 68 |
GO:0032200 | GO:0032200 | telomere organization | 26/1142 | 46/8135 | 4.03 | 1.73e-11 | 1.30e-09 | 46 |
GO:1901988 | GO:1901988 | negative regulation of cell cycle phase transition | 32/1142 | 66/8135 | 3.45 | 1.96e-11 | 1.44e-09 | 66 |
GO:0006336 | GO:0006336 | DNA replication-independent nucleosome assembly | 18/1142 | 24/8135 | 5.34 | 2.31e-11 | 1.56e-09 | 24 |
GO:0010965 | GO:0010965 | regulation of mitotic sister chromatid separation | 18/1142 | 24/8135 | 5.34 | 2.31e-11 | 1.56e-09 | 24 |
GO:0033047 | GO:0033047 | regulation of mitotic sister chromatid segregation | 18/1142 | 24/8135 | 5.34 | 2.31e-11 | 1.56e-09 | 24 |
GO:0034724 | GO:0034724 | DNA replication-independent nucleosome organization | 18/1142 | 24/8135 | 5.34 | 2.31e-11 | 1.56e-09 | 24 |
GO:0051306 | GO:0051306 | mitotic sister chromatid separation | 18/1142 | 24/8135 | 5.34 | 2.31e-11 | 1.56e-09 | 24 |
GO:0010389 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 26/1142 | 47/8135 | 3.94 | 3.36e-11 | 2.24e-09 | 47 |
GO:0051321 | GO:0051321 | meiotic cell cycle | 51/1142 | 143/8135 | 2.54 | 5.03e-11 | 3.30e-09 | 143 |
GO:0030071 | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 16/1142 | 20/8135 | 5.70 | 5.75e-11 | 3.71e-09 | 20 |
GO:0031570 | GO:0031570 | DNA integrity checkpoint | 25/1142 | 45/8135 | 3.96 | 7.12e-11 | 4.35e-09 | 45 |
GO:0000183 | GO:0000183 | chromatin silencing at rDNA | 18/1142 | 25/8135 | 5.13 | 7.18e-11 | 4.35e-09 | 25 |
GO:0031055 | GO:0031055 | chromatin remodeling at centromere | 18/1142 | 25/8135 | 5.13 | 7.18e-11 | 4.35e-09 | 25 |
GO:1905818 | GO:1905818 | regulation of chromosome separation | 18/1142 | 25/8135 | 5.13 | 7.18e-11 | 4.35e-09 | 25 |
GO:0000910 | GO:0000910 | cytokinesis | 28/1142 | 55/8135 | 3.63 | 8.23e-11 | 4.92e-09 | 55 |
GO:0040029 | GO:0040029 | regulation of gene expression, epigenetic | 38/1142 | 92/8135 | 2.94 | 1.08e-10 | 6.38e-09 | 92 |
GO:1903046 | GO:1903046 | meiotic cell cycle process | 43/1142 | 112/8135 | 2.73 | 1.11e-10 | 6.42e-09 | 112 |
GO:0051783 | GO:0051783 | regulation of nuclear division | 39/1142 | 96/8135 | 2.89 | 1.12e-10 | 6.42e-09 | 96 |
GO:0034080 | GO:0034080 | CENP-A containing nucleosome assembly | 17/1142 | 23/8135 | 5.27 | 1.25e-10 | 6.99e-09 | 23 |
GO:0061641 | GO:0061641 | CENP-A containing chromatin organization | 17/1142 | 23/8135 | 5.27 | 1.25e-10 | 6.99e-09 | 23 |
GO:1901991 | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 29/1142 | 60/8135 | 3.44 | 1.91e-10 | 1.05e-08 | 60 |
GO:0007091 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 16/1142 | 21/8135 | 5.43 | 2.10e-10 | 1.13e-08 | 21 |
GO:1902099 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 16/1142 | 21/8135 | 5.43 | 2.10e-10 | 1.13e-08 | 21 |
GO:0043044 | GO:0043044 | ATP-dependent chromatin remodeling | 19/1142 | 29/8135 | 4.67 | 2.71e-10 | 1.43e-08 | 29 |
GO:0000724 | GO:0000724 | double-strand break repair via homologous recombination | 24/1142 | 44/8135 | 3.89 | 2.88e-10 | 1.48e-08 | 44 |
GO:0000725 | GO:0000725 | recombinational repair | 24/1142 | 44/8135 | 3.89 | 2.88e-10 | 1.48e-08 | 44 |
GO:0034502 | GO:0034502 | protein localization to chromosome | 15/1142 | 19/8135 | 5.62 | 3.32e-10 | 1.67e-08 | 19 |
GO:0051310 | GO:0051310 | metaphase plate congression | 15/1142 | 19/8135 | 5.62 | 3.32e-10 | 1.67e-08 | 19 |
GO:0043486 | GO:0043486 | histone exchange | 18/1142 | 27/8135 | 4.75 | 5.29e-10 | 2.63e-08 | 27 |
GO:2001251 | GO:2001251 | negative regulation of chromosome organization | 24/1142 | 45/8135 | 3.80 | 5.36e-10 | 2.63e-08 | 45 |
GO:0044784 | GO:0044784 | metaphase/anaphase transition of cell cycle | 16/1142 | 22/8135 | 5.18 | 6.70e-10 | 3.23e-08 | 22 |
GO:0045930 | GO:0045930 | negative regulation of mitotic cell cycle | 39/1142 | 101/8135 | 2.75 | 6.73e-10 | 3.23e-08 | 101 |
GO:0140013 | GO:0140013 | meiotic nuclear division | 40/1142 | 107/8135 | 2.66 | 1.26e-09 | 5.98e-08 | 107 |
GO:0016458 | GO:0016458 | gene silencing | 35/1142 | 87/8135 | 2.87 | 1.39e-09 | 6.50e-08 | 87 |
GO:0044843 | GO:0044843 | cell cycle G1/S phase transition | 36/1142 | 91/8135 | 2.82 | 1.40e-09 | 6.50e-08 | 91 |
GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 20/1142 | 34/8135 | 4.19 | 1.48e-09 | 6.78e-08 | 34 |
GO:0090068 | GO:0090068 | positive regulation of cell cycle process | 42/1142 | 116/8135 | 2.58 | 1.53e-09 | 6.92e-08 | 116 |
GO:0045786 | GO:0045786 | negative regulation of cell cycle | 63/1142 | 212/8135 | 2.12 | 1.75e-09 | 7.84e-08 | 212 |
GO:0006303 | GO:0006303 | double-strand break repair via nonhomologous end joining | 16/1142 | 23/8135 | 4.96 | 1.92e-09 | 8.50e-08 | 23 |
GO:0045787 | GO:0045787 | positive regulation of cell cycle | 53/1142 | 166/8135 | 2.27 | 2.19e-09 | 9.59e-08 | 166 |
GO:0033044 | GO:0033044 | regulation of chromosome organization | 37/1142 | 97/8135 | 2.72 | 2.76e-09 | 1.19e-07 | 97 |
GO:0060964 | GO:0060964 | regulation of gene silencing by miRNA | 21/1142 | 38/8135 | 3.94 | 2.76e-09 | 1.19e-07 | 38 |
GO:1902750 | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 15/1142 | 21/8135 | 5.09 | 3.52e-09 | 1.50e-07 | 21 |
GO:0050000 | GO:0050000 | chromosome localization | 17/1142 | 27/8135 | 4.49 | 5.99e-09 | 2.50e-07 | 27 |
GO:0051303 | GO:0051303 | establishment of chromosome localization | 17/1142 | 27/8135 | 4.49 | 5.99e-09 | 2.50e-07 | 27 |
GO:0033046 | GO:0033046 | negative regulation of sister chromatid segregation | 14/1142 | 19/8135 | 5.25 | 6.26e-09 | 2.56e-07 | 19 |
GO:0051985 | GO:0051985 | negative regulation of chromosome segregation | 14/1142 | 19/8135 | 5.25 | 6.26e-09 | 2.56e-07 | 19 |
GO:0060147 | GO:0060147 | regulation of posttranscriptional gene silencing | 21/1142 | 40/8135 | 3.74 | 9.51e-09 | 3.81e-07 | 40 |
GO:0060966 | GO:0060966 | regulation of gene silencing by RNA | 21/1142 | 40/8135 | 3.74 | 9.51e-09 | 3.81e-07 | 40 |
GO:0000726 | GO:0000726 | non-recombinational repair | 16/1142 | 25/8135 | 4.56 | 1.21e-08 | 4.79e-07 | 25 |
GO:0000281 | GO:0000281 | mitotic cytokinesis | 17/1142 | 28/8135 | 4.32 | 1.33e-08 | 5.21e-07 | 28 |
GO:0006270 | GO:0006270 | DNA replication initiation | 12/1142 | 15/8135 | 5.70 | 1.68e-08 | 6.53e-07 | 15 |
GO:0090307 | GO:0090307 | mitotic spindle assembly | 14/1142 | 20/8135 | 4.99 | 1.82e-08 | 7.01e-07 | 20 |
GO:0006338 | GO:0006338 | chromatin remodeling | 26/1142 | 59/8135 | 3.14 | 1.94e-08 | 7.40e-07 | 59 |
GO:0061982 | GO:0061982 | meiosis I cell cycle process | 30/1142 | 75/8135 | 2.85 | 2.45e-08 | 9.27e-07 | 75 |
GO:0051225 | GO:0051225 | spindle assembly | 17/1142 | 29/8135 | 4.18 | 2.79e-08 | 1.05e-06 | 29 |
GO:0051052 | GO:0051052 | regulation of DNA metabolic process | 43/1142 | 131/8135 | 2.34 | 2.92e-08 | 1.09e-06 | 131 |
GO:0030261 | GO:0030261 | chromosome condensation | 13/1142 | 18/8135 | 5.14 | 3.33e-08 | 1.19e-06 | 18 |
GO:0033048 | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 13/1142 | 18/8135 | 5.14 | 3.33e-08 | 1.19e-06 | 18 |
GO:1905819 | GO:1905819 | negative regulation of chromosome separation | 13/1142 | 18/8135 | 5.14 | 3.33e-08 | 1.19e-06 | 18 |
GO:2000816 | GO:2000816 | negative regulation of mitotic sister chromatid separation | 13/1142 | 18/8135 | 5.14 | 3.33e-08 | 1.19e-06 | 18 |
GO:0000082 | GO:0000082 | G1/S transition of mitotic cell cycle | 32/1142 | 84/8135 | 2.71 | 3.38e-08 | 1.20e-06 | 84 |
GO:0045132 | GO:0045132 | meiotic chromosome segregation | 24/1142 | 53/8135 | 3.23 | 3.57e-08 | 1.26e-06 | 53 |
GO:0045839 | GO:0045839 | negative regulation of mitotic nuclear division | 15/1142 | 24/8135 | 4.45 | 5.60e-08 | 1.96e-06 | 24 |
GO:0007080 | GO:0007080 | mitotic metaphase plate congression | 11/1142 | 14/8135 | 5.60 | 9.68e-08 | 3.33e-06 | 14 |
GO:0008608 | GO:0008608 | attachment of spindle microtubules to kinetochore | 11/1142 | 14/8135 | 5.60 | 9.68e-08 | 3.33e-06 | 14 |
GO:0000018 | GO:0000018 | regulation of DNA recombination | 20/1142 | 41/8135 | 3.47 | 1.07e-07 | 3.65e-06 | 41 |
GO:0000077 | GO:0000077 | DNA damage checkpoint | 19/1142 | 38/8135 | 3.56 | 1.35e-07 | 4.57e-06 | 38 |
GO:0031145 | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 10/1142 | 12/8135 | 5.94 | 1.45e-07 | 4.85e-06 | 12 |
GO:0007127 | GO:0007127 | meiosis I | 28/1142 | 72/8135 | 2.77 | 1.46e-07 | 4.85e-06 | 72 |
GO:0035195 | GO:0035195 | gene silencing by miRNA | 22/1142 | 49/8135 | 3.20 | 1.60e-07 | 5.29e-06 | 49 |
GO:0007062 | GO:0007062 | sister chromatid cohesion | 12/1142 | 17/8135 | 5.03 | 1.74e-07 | 5.64e-06 | 17 |
GO:0010972 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 12/1142 | 17/8135 | 5.03 | 1.74e-07 | 5.64e-06 | 17 |
GO:0071459 | GO:0071459 | protein localization to chromosome, centromeric region | 9/1142 | 10/8135 | 6.41 | 1.80e-07 | 5.81e-06 | 10 |
GO:0007098 | GO:0007098 | centrosome cycle | 17/1142 | 32/8135 | 3.78 | 2.00e-07 | 6.34e-06 | 32 |
GO:0051290 | GO:0051290 | protein heterotetramerization | 17/1142 | 32/8135 | 3.78 | 2.00e-07 | 6.34e-06 | 32 |
GO:0045652 | GO:0045652 | regulation of megakaryocyte differentiation | 19/1142 | 39/8135 | 3.47 | 2.29e-07 | 7.19e-06 | 39 |
GO:0051784 | GO:0051784 | negative regulation of nuclear division | 16/1142 | 29/8135 | 3.93 | 2.30e-07 | 7.19e-06 | 29 |
GO:0032392 | GO:0032392 | DNA geometric change | 14/1142 | 23/8135 | 4.34 | 2.53e-07 | 7.85e-06 | 23 |
GO:0007094 | GO:0007094 | mitotic spindle assembly checkpoint | 11/1142 | 15/8135 | 5.22 | 3.17e-07 | 9.40e-06 | 15 |
GO:0031577 | GO:0031577 | spindle checkpoint | 11/1142 | 15/8135 | 5.22 | 3.17e-07 | 9.40e-06 | 15 |
GO:0045841 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 11/1142 | 15/8135 | 5.22 | 3.17e-07 | 9.40e-06 | 15 |
GO:0071173 | GO:0071173 | spindle assembly checkpoint | 11/1142 | 15/8135 | 5.22 | 3.17e-07 | 9.40e-06 | 15 |
GO:0071174 | GO:0071174 | mitotic spindle checkpoint | 11/1142 | 15/8135 | 5.22 | 3.17e-07 | 9.40e-06 | 15 |
GO:1902100 | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 11/1142 | 15/8135 | 5.22 | 3.17e-07 | 9.40e-06 | 15 |
GO:0044774 | GO:0044774 | mitotic DNA integrity checkpoint | 17/1142 | 33/8135 | 3.67 | 3.59e-07 | 1.06e-05 | 33 |
GO:0032465 | GO:0032465 | regulation of cytokinesis | 16/1142 | 31/8135 | 3.68 | 7.71e-07 | 2.26e-05 | 31 |
GO:0016441 | GO:0016441 | posttranscriptional gene silencing | 22/1142 | 53/8135 | 2.96 | 8.50e-07 | 2.45e-05 | 53 |
GO:0035194 | GO:0035194 | posttranscriptional gene silencing by RNA | 22/1142 | 53/8135 | 2.96 | 8.50e-07 | 2.45e-05 | 53 |
GO:0030219 | GO:0030219 | megakaryocyte differentiation | 20/1142 | 47/8135 | 3.03 | 1.67e-06 | 4.80e-05 | 47 |
GO:0000723 | GO:0000723 | telomere maintenance | 17/1142 | 36/8135 | 3.36 | 1.74e-06 | 4.95e-05 | 36 |
GO:0045910 | GO:0045910 | negative regulation of DNA recombination | 11/1142 | 17/8135 | 4.61 | 2.19e-06 | 6.18e-05 | 17 |
GO:2000779 | GO:2000779 | regulation of double-strand break repair | 13/1142 | 23/8135 | 4.03 | 2.24e-06 | 6.28e-05 | 23 |
GO:0032508 | GO:0032508 | DNA duplex unwinding | 12/1142 | 20/8135 | 4.27 | 2.35e-06 | 6.54e-05 | 20 |
GO:0031047 | GO:0031047 | gene silencing by RNA | 24/1142 | 64/8135 | 2.67 | 2.43e-06 | 6.74e-05 | 64 |
GO:0006282 | GO:0006282 | regulation of DNA repair | 17/1142 | 37/8135 | 3.27 | 2.80e-06 | 7.65e-05 | 37 |
GO:0031023 | GO:0031023 | microtubule organizing center organization | 17/1142 | 37/8135 | 3.27 | 2.80e-06 | 7.65e-05 | 37 |
GO:0031572 | GO:0031572 | G2 DNA damage checkpoint | 9/1142 | 12/8135 | 5.34 | 3.03e-06 | 8.18e-05 | 12 |
GO:0044818 | GO:0044818 | mitotic G2/M transition checkpoint | 9/1142 | 12/8135 | 5.34 | 3.03e-06 | 8.18e-05 | 12 |
GO:0046605 | GO:0046605 | regulation of centrosome cycle | 10/1142 | 15/8135 | 4.75 | 4.39e-06 | 1.18e-04 | 15 |
GO:0000079 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 18/1142 | 42/8135 | 3.05 | 4.90e-06 | 1.30e-04 | 42 |
GO:1901989 | GO:1901989 | positive regulation of cell cycle phase transition | 18/1142 | 42/8135 | 3.05 | 4.90e-06 | 1.30e-04 | 42 |
GO:0000226 | GO:0000226 | microtubule cytoskeleton organization | 56/1142 | 224/8135 | 1.78 | 7.01e-06 | 1.84e-04 | 224 |
GO:0072401 | GO:0072401 | signal transduction involved in DNA integrity checkpoint | 12/1142 | 22/8135 | 3.89 | 9.17e-06 | 2.38e-04 | 22 |
GO:0072422 | GO:0072422 | signal transduction involved in DNA damage checkpoint | 12/1142 | 22/8135 | 3.89 | 9.17e-06 | 2.38e-04 | 22 |
GO:1904029 | GO:1904029 | regulation of cyclin-dependent protein kinase activity | 18/1142 | 45/8135 | 2.85 | 1.57e-05 | 4.04e-04 | 45 |
GO:0036297 | GO:0036297 | interstrand cross-link repair | 8/1142 | 11/8135 | 5.18 | 1.64e-05 | 4.12e-04 | 11 |
GO:0045738 | GO:0045738 | negative regulation of DNA repair | 8/1142 | 11/8135 | 5.18 | 1.64e-05 | 4.12e-04 | 11 |
GO:0070316 | GO:0070316 | regulation of G0 to G1 transition | 8/1142 | 11/8135 | 5.18 | 1.64e-05 | 4.12e-04 | 11 |
GO:2000780 | GO:2000780 | negative regulation of double-strand break repair | 8/1142 | 11/8135 | 5.18 | 1.64e-05 | 4.12e-04 | 11 |
GO:0072395 | GO:0072395 | signal transduction involved in cell cycle checkpoint | 12/1142 | 23/8135 | 3.72 | 1.67e-05 | 4.18e-04 | 23 |
GO:0051607 | GO:0051607 | defense response to virus | 34/1142 | 118/8135 | 2.05 | 2.05e-05 | 5.10e-04 | 118 |
GO:0044786 | GO:0044786 | cell cycle DNA replication | 9/1142 | 14/8135 | 4.58 | 2.11e-05 | 5.22e-04 | 14 |
GO:0010569 | GO:0010569 | regulation of double-strand break repair via homologous recombination | 10/1142 | 17/8135 | 4.19 | 2.17e-05 | 5.33e-04 | 17 |
GO:0034622 | GO:0034622 | cellular protein-containing complex assembly | 81/1142 | 372/8135 | 1.55 | 2.22e-05 | 5.41e-04 | 372 |
GO:0098542 | GO:0098542 | defense response to other organism | 62/1142 | 268/8135 | 1.65 | 3.17e-05 | 7.68e-04 | 268 |
GO:0051053 | GO:0051053 | negative regulation of DNA metabolic process | 17/1142 | 43/8135 | 2.82 | 3.23e-05 | 7.78e-04 | 43 |
GO:0009314 | GO:0009314 | response to radiation | 47/1142 | 188/8135 | 1.78 | 3.79e-05 | 9.09e-04 | 188 |
GO:0007017 | GO:0007017 | microtubule-based process | 67/1142 | 298/8135 | 1.60 | 4.02e-05 | 9.59e-04 | 298 |
GO:0016233 | GO:0016233 | telomere capping | 10/1142 | 18/8135 | 3.96 | 4.27e-05 | 1.01e-03 | 18 |
GO:0000083 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 8/1142 | 12/8135 | 4.75 | 4.31e-05 | 1.01e-03 | 12 |
GO:0045023 | GO:0045023 | G0 to G1 transition | 8/1142 | 12/8135 | 4.75 | 4.31e-05 | 1.01e-03 | 12 |
GO:0051640 | GO:0051640 | organelle localization | 59/1142 | 254/8135 | 1.65 | 4.33e-05 | 1.01e-03 | 254 |
GO:0045931 | GO:0045931 | positive regulation of mitotic cell cycle | 22/1142 | 66/8135 | 2.37 | 5.41e-05 | 1.25e-03 | 66 |
GO:0044773 | GO:0044773 | mitotic DNA damage checkpoint | 13/1142 | 29/8135 | 3.19 | 5.84e-05 | 1.34e-03 | 29 |
GO:0070192 | GO:0070192 | chromosome organization involved in meiotic cell cycle | 15/1142 | 37/8135 | 2.89 | 6.65e-05 | 1.52e-03 | 37 |
GO:0007143 | GO:0007143 | female meiotic nuclear division | 9/1142 | 16/8135 | 4.01 | 9.26e-05 | 2.11e-03 | 16 |
GO:0045143 | GO:0045143 | homologous chromosome segregation | 15/1142 | 38/8135 | 2.81 | 9.58e-05 | 2.17e-03 | 38 |
GO:0031935 | GO:0031935 | regulation of chromatin silencing | 8/1142 | 13/8135 | 4.38 | 9.83e-05 | 2.18e-03 | 13 |
GO:0045653 | GO:0045653 | negative regulation of megakaryocyte differentiation | 8/1142 | 13/8135 | 4.38 | 9.83e-05 | 2.18e-03 | 13 |
GO:0051438 | GO:0051438 | regulation of ubiquitin-protein transferase activity | 8/1142 | 13/8135 | 4.38 | 9.83e-05 | 2.18e-03 | 13 |
GO:0051782 | GO:0051782 | negative regulation of cell division | 8/1142 | 13/8135 | 4.38 | 9.83e-05 | 2.18e-03 | 13 |
GO:0042770 | GO:0042770 | signal transduction in response to DNA damage | 16/1142 | 43/8135 | 2.65 | 1.29e-04 | 2.84e-03 | 43 |
GO:0010608 | GO:0010608 | posttranscriptional regulation of gene expression | 37/1142 | 144/8135 | 1.83 | 1.36e-04 | 2.96e-03 | 144 |
GO:1901992 | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 14/1142 | 35/8135 | 2.85 | 1.38e-04 | 3.00e-03 | 35 |
GO:0006063 | GO:0006063 | uronic acid metabolic process | 9/1142 | 17/8135 | 3.77 | 1.72e-04 | 3.68e-03 | 17 |
GO:0006890 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 9/1142 | 17/8135 | 3.77 | 1.72e-04 | 3.68e-03 | 17 |
GO:0019585 | GO:0019585 | glucuronate metabolic process | 9/1142 | 17/8135 | 3.77 | 1.72e-04 | 3.68e-03 | 17 |
GO:0007131 | GO:0007131 | reciprocal meiotic recombination | 12/1142 | 28/8135 | 3.05 | 1.91e-04 | 4.04e-03 | 28 |
GO:0035825 | GO:0035825 | homologous recombination | 12/1142 | 28/8135 | 3.05 | 1.91e-04 | 4.04e-03 | 28 |
GO:0051307 | GO:0051307 | meiotic chromosome separation | 8/1142 | 14/8135 | 4.07 | 2.01e-04 | 4.23e-03 | 14 |
GO:0051262 | GO:0051262 | protein tetramerization | 24/1142 | 81/8135 | 2.11 | 2.06e-04 | 4.31e-03 | 81 |
GO:0009812 | GO:0009812 | flavonoid metabolic process | 7/1142 | 11/8135 | 4.53 | 2.08e-04 | 4.32e-03 | 11 |
GO:0070647 | GO:0070647 | protein modification by small protein conjugation or removal | 56/1142 | 251/8135 | 1.59 | 2.11e-04 | 4.38e-03 | 251 |
GO:0010212 | GO:0010212 | response to ionizing radiation | 16/1142 | 45/8135 | 2.53 | 2.40e-04 | 4.92e-03 | 45 |
GO:0016567 | GO:0016567 | protein ubiquitination | 46/1142 | 197/8135 | 1.66 | 2.59e-04 | 5.29e-03 | 197 |
GO:0051302 | GO:0051302 | regulation of cell division | 25/1142 | 87/8135 | 2.05 | 2.60e-04 | 5.29e-03 | 87 |
GO:0007140 | GO:0007140 | male meiotic nuclear division | 13/1142 | 33/8135 | 2.81 | 2.86e-04 | 5.78e-03 | 33 |
GO:0031123 | GO:0031123 | RNA 3’-end processing | 9/1142 | 18/8135 | 3.56 | 3.02e-04 | 6.07e-03 | 18 |
GO:2001020 | GO:2001020 | regulation of response to DNA damage stimulus | 21/1142 | 69/8135 | 2.17 | 3.37e-04 | 6.75e-03 | 69 |
GO:0045815 | GO:0045815 | positive regulation of gene expression, epigenetic | 8/1142 | 15/8135 | 3.80 | 3.78e-04 | 7.49e-03 | 15 |
GO:0052695 | GO:0052695 | cellular glucuronidation | 8/1142 | 15/8135 | 3.80 | 3.78e-04 | 7.49e-03 | 15 |
GO:0051656 | GO:0051656 | establishment of organelle localization | 47/1142 | 206/8135 | 1.63 | 3.92e-04 | 7.74e-03 | 206 |
GO:0070507 | GO:0070507 | regulation of microtubule cytoskeleton organization | 20/1142 | 65/8135 | 2.19 | 3.95e-04 | 7.76e-03 | 65 |
GO:0002385 | GO:0002385 | mucosal immune response | 11/1142 | 26/8135 | 3.01 | 4.05e-04 | 7.88e-03 | 26 |
GO:0031936 | GO:0031936 | negative regulation of chromatin silencing | 7/1142 | 12/8135 | 4.16 | 4.38e-04 | 8.44e-03 | 12 |
GO:0033260 | GO:0033260 | nuclear DNA replication | 7/1142 | 12/8135 | 4.16 | 4.38e-04 | 8.44e-03 | 12 |
GO:0032446 | GO:0032446 | protein modification by small protein conjugation | 47/1142 | 207/8135 | 1.62 | 4.41e-04 | 8.45e-03 | 207 |
GO:0051054 | GO:0051054 | positive regulation of DNA metabolic process | 21/1142 | 71/8135 | 2.11 | 5.18e-04 | 9.88e-03 | 71 |
GO:0038111 | GO:0038111 | interleukin-7-mediated signaling pathway | 10/1142 | 23/8135 | 3.10 | 5.73e-04 | 1.09e-02 | 23 |
GO:0071158 | GO:0071158 | positive regulation of cell cycle arrest | 11/1142 | 27/8135 | 2.90 | 5.98e-04 | 1.13e-02 | 27 |
GO:0002504 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 15/1142 | 44/8135 | 2.43 | 6.25e-04 | 1.18e-02 | 44 |
GO:0002227 | GO:0002227 | innate immune response in mucosa | 8/1142 | 16/8135 | 3.56 | 6.63e-04 | 1.24e-02 | 16 |
GO:0022412 | GO:0022412 | cellular process involved in reproduction in multicellular organism | 44/1142 | 195/8135 | 1.61 | 7.61e-04 | 1.41e-02 | 195 |
GO:1902806 | GO:1902806 | regulation of cell cycle G1/S phase transition | 17/1142 | 54/8135 | 2.24 | 7.91e-04 | 1.46e-02 | 54 |
GO:0016073 | GO:0016073 | snRNA metabolic process | 7/1142 | 13/8135 | 3.84 | 8.34e-04 | 1.53e-02 | 13 |
GO:0051298 | GO:0051298 | centrosome duplication | 7/1142 | 13/8135 | 3.84 | 8.34e-04 | 1.53e-02 | 13 |
GO:0098760 | GO:0098760 | response to interleukin-7 | 10/1142 | 24/8135 | 2.97 | 8.60e-04 | 1.56e-02 | 24 |
GO:0098761 | GO:0098761 | cellular response to interleukin-7 | 10/1142 | 24/8135 | 2.97 | 8.60e-04 | 1.56e-02 | 24 |
GO:0002251 | GO:0002251 | organ or tissue specific immune response | 11/1142 | 28/8135 | 2.80 | 8.61e-04 | 1.56e-02 | 28 |
GO:0000729 | GO:0000729 | DNA double-strand break processing | 6/1142 | 10/8135 | 4.27 | 9.56e-04 | 1.70e-02 | 10 |
GO:0006998 | GO:0006998 | nuclear envelope organization | 6/1142 | 10/8135 | 4.27 | 9.56e-04 | 1.70e-02 | 10 |
GO:0035458 | GO:0035458 | cellular response to interferon-beta | 6/1142 | 10/8135 | 4.27 | 9.56e-04 | 1.70e-02 | 10 |
GO:0045005 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity | 6/1142 | 10/8135 | 4.27 | 9.56e-04 | 1.70e-02 | 10 |
GO:0006977 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8/1142 | 17/8135 | 3.35 | 1.10e-03 | 1.91e-02 | 17 |
GO:0072413 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint | 8/1142 | 17/8135 | 3.35 | 1.10e-03 | 1.91e-02 | 17 |
GO:0072431 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint | 8/1142 | 17/8135 | 3.35 | 1.10e-03 | 1.91e-02 | 17 |
GO:1902400 | GO:1902400 | intracellular signal transduction involved in G1 DNA damage checkpoint | 8/1142 | 17/8135 | 3.35 | 1.10e-03 | 1.91e-02 | 17 |
GO:1902402 | GO:1902402 | signal transduction involved in mitotic DNA damage checkpoint | 8/1142 | 17/8135 | 3.35 | 1.10e-03 | 1.91e-02 | 17 |
GO:1902403 | GO:1902403 | signal transduction involved in mitotic DNA integrity checkpoint | 8/1142 | 17/8135 | 3.35 | 1.10e-03 | 1.91e-02 | 17 |
GO:0006275 | GO:0006275 | regulation of DNA replication | 12/1142 | 33/8135 | 2.59 | 1.13e-03 | 1.96e-02 | 33 |
GO:0018149 | GO:0018149 | peptide cross-linking | 14/1142 | 42/8135 | 2.37 | 1.21e-03 | 2.08e-02 | 42 |
GO:0043900 | GO:0043900 | regulation of multi-organism process | 42/1142 | 188/8135 | 1.59 | 1.22e-03 | 2.09e-02 | 188 |
GO:0044380 | GO:0044380 | protein localization to cytoskeleton | 7/1142 | 14/8135 | 3.56 | 1.47e-03 | 2.50e-02 | 14 |
GO:0009615 | GO:0009615 | response to virus | 37/1142 | 162/8135 | 1.63 | 1.54e-03 | 2.61e-02 | 162 |
GO:0002495 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 14/1142 | 43/8135 | 2.32 | 1.57e-03 | 2.65e-02 | 43 |
GO:0051291 | GO:0051291 | protein heterooligomerization | 20/1142 | 72/8135 | 1.98 | 1.65e-03 | 2.78e-02 | 72 |
GO:0016572 | GO:0016572 | histone phosphorylation | 8/1142 | 18/8135 | 3.17 | 1.74e-03 | 2.85e-02 | 18 |
GO:0031571 | GO:0031571 | mitotic G1 DNA damage checkpoint | 8/1142 | 18/8135 | 3.17 | 1.74e-03 | 2.85e-02 | 18 |
GO:0032467 | GO:0032467 | positive regulation of cytokinesis | 8/1142 | 18/8135 | 3.17 | 1.74e-03 | 2.85e-02 | 18 |
GO:0044783 | GO:0044783 | G1 DNA damage checkpoint | 8/1142 | 18/8135 | 3.17 | 1.74e-03 | 2.85e-02 | 18 |
GO:0044819 | GO:0044819 | mitotic G1/S transition checkpoint | 8/1142 | 18/8135 | 3.17 | 1.74e-03 | 2.85e-02 | 18 |
GO:1902751 | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 8/1142 | 18/8135 | 3.17 | 1.74e-03 | 2.85e-02 | 18 |
GO:2001021 | GO:2001021 | negative regulation of response to DNA damage stimulus | 10/1142 | 26/8135 | 2.74 | 1.79e-03 | 2.91e-02 | 26 |
GO:0016445 | GO:0016445 | somatic diversification of immunoglobulins | 9/1142 | 22/8135 | 2.91 | 1.82e-03 | 2.95e-02 | 22 |
GO:0000022 | GO:0000022 | mitotic spindle elongation | 6/1142 | 11/8135 | 3.89 | 1.85e-03 | 2.98e-02 | 11 |
GO:0051231 | GO:0051231 | spindle elongation | 6/1142 | 11/8135 | 3.89 | 1.85e-03 | 2.98e-02 | 11 |
GO:0016569 | GO:0016569 | covalent chromatin modification | 29/1142 | 120/8135 | 1.72 | 1.95e-03 | 3.12e-02 | 120 |
GO:0016032 | GO:0016032 | viral process | 45/1142 | 211/8135 | 1.52 | 2.25e-03 | 3.58e-02 | 211 |
GO:0010639 | GO:0010639 | negative regulation of organelle organization | 33/1142 | 143/8135 | 1.64 | 2.25e-03 | 3.58e-02 | 143 |
GO:0007129 | GO:0007129 | synapsis | 11/1142 | 31/8135 | 2.53 | 2.27e-03 | 3.58e-02 | 31 |
GO:0002478 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 16/1142 | 54/8135 | 2.11 | 2.28e-03 | 3.58e-02 | 54 |
GO:0019886 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 13/1142 | 40/8135 | 2.32 | 2.33e-03 | 3.65e-02 | 40 |
GO:0030148 | GO:0030148 | sphingolipid biosynthetic process | 17/1142 | 59/8135 | 2.05 | 2.34e-03 | 3.66e-02 | 59 |
GO:0070268 | GO:0070268 | cornification | 24/1142 | 95/8135 | 1.80 | 2.48e-03 | 3.86e-02 | 95 |
GO:0045840 | GO:0045840 | positive regulation of mitotic nuclear division | 9/1142 | 23/8135 | 2.79 | 2.63e-03 | 4.07e-02 | 23 |
GO:0030330 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 12/1142 | 36/8135 | 2.37 | 2.67e-03 | 4.13e-02 | 36 |
GO:0071156 | GO:0071156 | regulation of cell cycle arrest | 13/1142 | 41/8135 | 2.26 | 2.98e-03 | 4.56e-02 | 41 |
GO:0072698 | GO:0072698 | protein localization to microtubule cytoskeleton | 6/1142 | 12/8135 | 3.56 | 3.27e-03 | 4.98e-02 | 12 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0044782 | GO:0044782 | cilium organization | 59/743 | 132/8135 | 4.89 | 1.70e-27 | 6.42e-24 | 132 |
GO:0060271 | GO:0060271 | cilium assembly | 55/743 | 123/8135 | 4.90 | 1.05e-25 | 1.99e-22 | 123 |
GO:0001578 | GO:0001578 | microtubule bundle formation | 36/743 | 62/8135 | 6.36 | 3.64e-22 | 3.44e-19 | 62 |
GO:0003341 | GO:0003341 | cilium movement | 31/743 | 46/8135 | 7.38 | 4.55e-22 | 3.44e-19 | 46 |
GO:0035082 | GO:0035082 | axoneme assembly | 31/743 | 46/8135 | 7.38 | 4.55e-22 | 3.44e-19 | 46 |
GO:0007017 | GO:0007017 | microtubule-based process | 78/743 | 298/8135 | 2.87 | 1.48e-18 | 9.30e-16 | 298 |
GO:0120031 | GO:0120031 | plasma membrane bounded cell projection assembly | 63/743 | 222/8135 | 3.11 | 5.09e-17 | 2.74e-14 | 222 |
GO:0030031 | GO:0030031 | cell projection assembly | 64/743 | 231/8135 | 3.03 | 1.06e-16 | 4.98e-14 | 231 |
GO:0007018 | GO:0007018 | microtubule-based movement | 39/743 | 119/8135 | 3.59 | 3.63e-13 | 1.52e-10 | 119 |
GO:0070286 | GO:0070286 | axonemal dynein complex assembly | 17/743 | 25/8135 | 7.45 | 9.67e-13 | 3.65e-10 | 25 |
GO:0070925 | GO:0070925 | organelle assembly | 64/743 | 279/8135 | 2.51 | 1.67e-12 | 5.72e-10 | 279 |
GO:0000226 | GO:0000226 | microtubule cytoskeleton organization | 55/743 | 224/8135 | 2.69 | 3.80e-12 | 1.19e-09 | 224 |
GO:0044458 | GO:0044458 | motile cilium assembly | 11/743 | 12/8135 | 10.00 | 3.80e-11 | 1.10e-08 | 12 |
GO:0034622 | GO:0034622 | cellular protein-containing complex assembly | 71/743 | 372/8135 | 2.09 | 8.44e-10 | 2.28e-07 | 372 |
GO:0003351 | GO:0003351 | epithelial cilium movement | 12/743 | 17/8135 | 7.73 | 1.25e-09 | 3.14e-07 | 17 |
GO:0006334 | GO:0006334 | nucleosome assembly | 26/743 | 77/8135 | 3.70 | 1.58e-09 | 3.72e-07 | 77 |
GO:0031497 | GO:0031497 | chromatin assembly | 26/743 | 85/8135 | 3.35 | 1.68e-08 | 3.73e-06 | 85 |
GO:0065004 | GO:0065004 | protein-DNA complex assembly | 28/743 | 98/8135 | 3.13 | 2.52e-08 | 5.28e-06 | 98 |
GO:0034728 | GO:0034728 | nucleosome organization | 26/743 | 87/8135 | 3.27 | 2.88e-08 | 5.71e-06 | 87 |
GO:0006333 | GO:0006333 | chromatin assembly or disassembly | 26/743 | 90/8135 | 3.16 | 6.22e-08 | 1.17e-05 | 90 |
GO:0060968 | GO:0060968 | regulation of gene silencing | 19/743 | 53/8135 | 3.93 | 8.54e-08 | 1.53e-05 | 53 |
GO:0006342 | GO:0006342 | chromatin silencing | 17/743 | 44/8135 | 4.23 | 1.15e-07 | 1.98e-05 | 44 |
GO:0006323 | GO:0006323 | DNA packaging | 27/743 | 100/8135 | 2.96 | 1.63e-07 | 2.67e-05 | 100 |
GO:0036158 | GO:0036158 | outer dynein arm assembly | 9/743 | 13/8135 | 7.58 | 2.16e-07 | 3.25e-05 | 13 |
GO:0036159 | GO:0036159 | inner dynein arm assembly | 9/743 | 13/8135 | 7.58 | 2.16e-07 | 3.25e-05 | 13 |
GO:0071824 | GO:0071824 | protein-DNA complex subunit organization | 28/743 | 109/8135 | 2.81 | 3.00e-07 | 4.36e-05 | 109 |
GO:0000183 | GO:0000183 | chromatin silencing at rDNA | 12/743 | 25/8135 | 5.26 | 5.25e-07 | 7.34e-05 | 25 |
GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 17/743 | 49/8135 | 3.80 | 7.05e-07 | 9.51e-05 | 49 |
GO:0001539 | GO:0001539 | cilium or flagellum-dependent cell motility | 11/743 | 23/8135 | 5.24 | 1.66e-06 | 2.09e-04 | 23 |
GO:0060285 | GO:0060285 | cilium-dependent cell motility | 11/743 | 23/8135 | 5.24 | 1.66e-06 | 2.09e-04 | 23 |
GO:0007368 | GO:0007368 | determination of left/right symmetry | 20/743 | 69/8135 | 3.17 | 1.96e-06 | 2.39e-04 | 69 |
GO:0016079 | GO:0016079 | synaptic vesicle exocytosis | 22/743 | 81/8135 | 2.97 | 2.04e-06 | 2.41e-04 | 81 |
GO:0017156 | GO:0017156 | calcium ion regulated exocytosis | 25/743 | 100/8135 | 2.74 | 2.22e-06 | 2.54e-04 | 100 |
GO:0031629 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane | 9/743 | 16/8135 | 6.16 | 2.68e-06 | 2.97e-04 | 16 |
GO:0071103 | GO:0071103 | DNA conformation change | 28/743 | 121/8135 | 2.53 | 2.91e-06 | 3.13e-04 | 121 |
GO:0060964 | GO:0060964 | regulation of gene silencing by miRNA | 14/743 | 38/8135 | 4.03 | 3.00e-06 | 3.14e-04 | 38 |
GO:0099500 | GO:0099500 | vesicle fusion to plasma membrane | 9/743 | 17/8135 | 5.80 | 5.23e-06 | 5.33e-04 | 17 |
GO:0060147 | GO:0060147 | regulation of posttranscriptional gene silencing | 14/743 | 40/8135 | 3.83 | 6.05e-06 | 5.72e-04 | 40 |
GO:0060966 | GO:0060966 | regulation of gene silencing by RNA | 14/743 | 40/8135 | 3.83 | 6.05e-06 | 5.72e-04 | 40 |
GO:0030317 | GO:0030317 | flagellated sperm motility | 18/743 | 62/8135 | 3.18 | 6.22e-06 | 5.72e-04 | 62 |
GO:0097722 | GO:0097722 | sperm motility | 18/743 | 62/8135 | 3.18 | 6.22e-06 | 5.72e-04 | 62 |
GO:0009855 | GO:0009855 | determination of bilateral symmetry | 20/743 | 75/8135 | 2.92 | 8.04e-06 | 7.22e-04 | 75 |
GO:0009799 | GO:0009799 | specification of symmetry | 20/743 | 76/8135 | 2.88 | 9.99e-06 | 8.77e-04 | 76 |
GO:0006335 | GO:0006335 | DNA replication-dependent nucleosome assembly | 10/743 | 23/8135 | 4.76 | 1.44e-05 | 1.21e-03 | 23 |
GO:0034723 | GO:0034723 | DNA replication-dependent nucleosome organization | 10/743 | 23/8135 | 4.76 | 1.44e-05 | 1.21e-03 | 23 |
GO:0017158 | GO:0017158 | regulation of calcium ion-dependent exocytosis | 19/743 | 72/8135 | 2.89 | 1.59e-05 | 1.30e-03 | 72 |
GO:0035195 | GO:0035195 | gene silencing by miRNA | 15/743 | 49/8135 | 3.35 | 1.82e-05 | 1.46e-03 | 49 |
GO:0006325 | GO:0006325 | chromatin organization | 45/743 | 261/8135 | 1.89 | 1.93e-05 | 1.52e-03 | 261 |
GO:0048489 | GO:0048489 | synaptic vesicle transport | 22/743 | 93/8135 | 2.59 | 2.31e-05 | 1.74e-03 | 93 |
GO:0097480 | GO:0097480 | establishment of synaptic vesicle localization | 22/743 | 93/8135 | 2.59 | 2.31e-05 | 1.74e-03 | 93 |
GO:0045652 | GO:0045652 | regulation of megakaryocyte differentiation | 13/743 | 39/8135 | 3.65 | 2.38e-05 | 1.76e-03 | 39 |
GO:0007269 | GO:0007269 | neurotransmitter secretion | 25/743 | 114/8135 | 2.40 | 2.64e-05 | 1.88e-03 | 114 |
GO:0099643 | GO:0099643 | signal release from synapse | 25/743 | 114/8135 | 2.40 | 2.64e-05 | 1.88e-03 | 114 |
GO:0045956 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 9/743 | 20/8135 | 4.93 | 2.81e-05 | 1.96e-03 | 20 |
GO:0097479 | GO:0097479 | synaptic vesicle localization | 23/743 | 102/8135 | 2.47 | 3.45e-05 | 2.37e-03 | 102 |
GO:0016441 | GO:0016441 | posttranscriptional gene silencing | 15/743 | 53/8135 | 3.10 | 5.11e-05 | 3.38e-03 | 53 |
GO:0035194 | GO:0035194 | posttranscriptional gene silencing by RNA | 15/743 | 53/8135 | 3.10 | 5.11e-05 | 3.38e-03 | 53 |
GO:0001956 | GO:0001956 | positive regulation of neurotransmitter secretion | 8/743 | 17/8135 | 5.15 | 5.37e-05 | 3.49e-03 | 17 |
GO:0016458 | GO:0016458 | gene silencing | 20/743 | 87/8135 | 2.52 | 8.29e-05 | 5.16e-03 | 87 |
GO:0031630 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 6/743 | 10/8135 | 6.57 | 8.67e-05 | 5.16e-03 | 10 |
GO:0051650 | GO:0051650 | establishment of vesicle localization | 25/743 | 122/8135 | 2.24 | 8.67e-05 | 5.16e-03 | 122 |
GO:0099504 | GO:0099504 | synaptic vesicle cycle | 25/743 | 122/8135 | 2.24 | 8.67e-05 | 5.16e-03 | 122 |
GO:0006904 | GO:0006904 | vesicle docking involved in exocytosis | 8/743 | 18/8135 | 4.87 | 8.89e-05 | 5.16e-03 | 18 |
GO:0016233 | GO:0016233 | telomere capping | 8/743 | 18/8135 | 4.87 | 8.89e-05 | 5.16e-03 | 18 |
GO:0031338 | GO:0031338 | regulation of vesicle fusion | 8/743 | 18/8135 | 4.87 | 8.89e-05 | 5.16e-03 | 18 |
GO:0051648 | GO:0051648 | vesicle localization | 26/743 | 134/8135 | 2.12 | 1.62e-04 | 9.29e-03 | 134 |
GO:0048172 | GO:0048172 | regulation of short-term neuronal synaptic plasticity | 6/743 | 11/8135 | 5.97 | 1.76e-04 | 9.91e-03 | 11 |
GO:0040029 | GO:0040029 | regulation of gene expression, epigenetic | 20/743 | 92/8135 | 2.38 | 1.88e-04 | 1.04e-02 | 92 |
GO:0098693 | GO:0098693 | regulation of synaptic vesicle cycle | 17/743 | 72/8135 | 2.59 | 1.98e-04 | 1.08e-02 | 72 |
GO:0140029 | GO:0140029 | exocytic process | 12/743 | 41/8135 | 3.20 | 2.02e-04 | 1.08e-02 | 41 |
GO:2000300 | GO:2000300 | regulation of synaptic vesicle exocytosis | 14/743 | 53/8135 | 2.89 | 2.04e-04 | 1.08e-02 | 53 |
GO:0030219 | GO:0030219 | megakaryocyte differentiation | 13/743 | 47/8135 | 3.03 | 2.08e-04 | 1.09e-02 | 47 |
GO:0099003 | GO:0099003 | vesicle-mediated transport in synapse | 23/743 | 115/8135 | 2.19 | 2.40e-04 | 1.24e-02 | 115 |
GO:0051290 | GO:0051290 | protein heterotetramerization | 10/743 | 32/8135 | 3.42 | 3.81e-04 | 1.94e-02 | 32 |
GO:1902803 | GO:1902803 | regulation of synaptic vesicle transport | 14/743 | 57/8135 | 2.69 | 4.63e-04 | 2.33e-02 | 57 |
GO:0031047 | GO:0031047 | gene silencing by RNA | 15/743 | 64/8135 | 2.57 | 5.04e-04 | 2.50e-02 | 64 |
GO:0045653 | GO:0045653 | negative regulation of megakaryocyte differentiation | 6/743 | 13/8135 | 5.05 | 5.57e-04 | 2.73e-02 | 13 |
GO:0046928 | GO:0046928 | regulation of neurotransmitter secretion | 16/743 | 72/8135 | 2.43 | 6.25e-04 | 3.02e-02 | 72 |
GO:0032200 | GO:0032200 | telomere organization | 12/743 | 46/8135 | 2.86 | 6.50e-04 | 3.10e-02 | 46 |
GO:0051590 | GO:0051590 | positive regulation of neurotransmitter transport | 9/743 | 29/8135 | 3.40 | 7.89e-04 | 3.72e-02 | 29 |
GO:0006836 | GO:0006836 | neurotransmitter transport | 31/743 | 188/8135 | 1.81 | 8.22e-04 | 3.78e-02 | 188 |
GO:0006906 | GO:0006906 | vesicle fusion | 10/743 | 35/8135 | 3.13 | 8.42e-04 | 3.78e-02 | 35 |
GO:0090174 | GO:0090174 | organelle membrane fusion | 10/743 | 35/8135 | 3.13 | 8.42e-04 | 3.78e-02 | 35 |
GO:1903307 | GO:1903307 | positive regulation of regulated secretory pathway | 10/743 | 35/8135 | 3.13 | 8.42e-04 | 3.78e-02 | 35 |
GO:0009132 | GO:0009132 | nucleoside diphosphate metabolic process | 13/743 | 54/8135 | 2.64 | 8.98e-04 | 3.99e-02 | 54 |
GO:0048278 | GO:0048278 | vesicle docking | 8/743 | 24/8135 | 3.65 | 9.10e-04 | 3.99e-02 | 24 |
GO:0048284 | GO:0048284 | organelle fusion | 11/743 | 42/8135 | 2.87 | 1.05e-03 | 4.54e-02 | 42 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0043588 | GO:0043588 | skin development | 86/1640 | 241/8135 | 1.77 | 9.36e-09 | 4.23e-05 | 241 |
GO:0070268 | GO:0070268 | cornification | 42/1640 | 95/8135 | 2.19 | 8.20e-08 | 1.85e-04 | 95 |
GO:0008544 | GO:0008544 | epidermis development | 91/1640 | 273/8135 | 1.65 | 1.44e-07 | 2.17e-04 | 273 |
GO:0030216 | GO:0030216 | keratinocyte differentiation | 58/1640 | 162/8135 | 1.78 | 2.18e-06 | 2.46e-03 | 162 |
GO:0031424 | GO:0031424 | keratinization | 45/1640 | 123/8135 | 1.81 | 1.57e-05 | 1.36e-02 | 123 |
GO:0009913 | GO:0009913 | epidermal cell differentiation | 64/1640 | 195/8135 | 1.63 | 1.80e-05 | 1.36e-02 | 195 |
GO:0030111 | GO:0030111 | regulation of Wnt signaling pathway | 55/1640 | 163/8135 | 1.67 | 2.89e-05 | 1.86e-02 | 163 |
GO:0071470 | GO:0071470 | cellular response to osmotic stress | 11/1640 | 16/8135 | 3.41 | 3.45e-05 | 1.95e-02 | 16 |
GO:0060828 | GO:0060828 | regulation of canonical Wnt signaling pathway | 43/1640 | 122/8135 | 1.75 | 6.71e-05 | 3.03e-02 | 122 |
GO:0016055 | GO:0016055 | Wnt signaling pathway | 72/1640 | 238/8135 | 1.50 | 1.14e-04 | 4.31e-02 | 238 |
GO:0198738 | GO:0198738 | cell-cell signaling by wnt | 72/1640 | 238/8135 | 1.50 | 1.14e-04 | 4.31e-02 | 238 |
GO:0051216 | GO:0051216 | cartilage development | 49/1640 | 148/8135 | 1.64 | 1.32e-04 | 4.59e-02 | 148 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0003341 | GO:0003341 | cilium movement | 37/3011 | 46/8135 | 2.17 | 1.92e-09 | 8.95e-06 | 46 |
GO:0044782 | GO:0044782 | cilium organization | 81/3011 | 132/8135 | 1.66 | 9.26e-09 | 1.94e-05 | 132 |
GO:0035082 | GO:0035082 | axoneme assembly | 36/3011 | 46/8135 | 2.11 | 1.25e-08 | 1.94e-05 | 46 |
GO:0060271 | GO:0060271 | cilium assembly | 75/3011 | 123/8135 | 1.65 | 4.81e-08 | 5.61e-05 | 123 |
GO:0070286 | GO:0070286 | axonemal dynein complex assembly | 22/3011 | 25/8135 | 2.38 | 1.90e-07 | 1.77e-04 | 25 |
GO:0001578 | GO:0001578 | microtubule bundle formation | 39/3011 | 62/8135 | 1.70 | 2.93e-05 | 1.37e-02 | 62 |
GO:0036158 | GO:0036158 | outer dynein arm assembly | 12/3011 | 13/8135 | 2.49 | 5.59e-05 | 2.00e-02 | 13 |
ID | Description | GeneRatio | BgRatio | FoldChange | pvalue | qvalue | GS_size | |
---|---|---|---|---|---|---|---|---|
GO:0000278 | GO:0000278 | mitotic cell cycle | 191/2566 | 326/8135 | 1.86 | 8.38e-25 | 3.70e-21 | 326 |
GO:1903047 | GO:1903047 | mitotic cell cycle process | 164/2566 | 267/8135 | 1.95 | 1.66e-24 | 3.70e-21 | 267 |
GO:0022402 | GO:0022402 | cell cycle process | 239/2566 | 470/8135 | 1.61 | 2.53e-19 | 3.76e-16 | 470 |
GO:0051276 | GO:0051276 | chromosome organization | 195/2566 | 385/8135 | 1.61 | 1.13e-15 | 1.13e-12 | 385 |
GO:0044772 | GO:0044772 | mitotic cell cycle phase transition | 101/2566 | 164/8135 | 1.95 | 1.27e-15 | 1.13e-12 | 164 |
GO:0000070 | GO:0000070 | mitotic sister chromatid segregation | 46/2566 | 56/8135 | 2.60 | 6.33e-15 | 4.70e-12 | 56 |
GO:0044770 | GO:0044770 | cell cycle phase transition | 105/2566 | 177/8135 | 1.88 | 1.30e-14 | 8.28e-12 | 177 |
GO:0140014 | GO:0140014 | mitotic nuclear division | 72/2566 | 107/8135 | 2.13 | 2.36e-14 | 1.32e-11 | 107 |
GO:0000819 | GO:0000819 | sister chromatid segregation | 52/2566 | 68/8135 | 2.42 | 2.67e-14 | 1.32e-11 | 68 |
GO:0007059 | GO:0007059 | chromosome segregation | 76/2566 | 118/8135 | 2.04 | 1.54e-13 | 6.87e-11 | 118 |
GO:0051726 | GO:0051726 | regulation of cell cycle | 197/2566 | 412/8135 | 1.52 | 1.13e-12 | 4.58e-10 | 412 |
GO:0051301 | GO:0051301 | cell division | 119/2566 | 219/8135 | 1.72 | 1.26e-12 | 4.69e-10 | 219 |
GO:0000280 | GO:0000280 | nuclear division | 107/2566 | 192/8135 | 1.77 | 2.11e-12 | 7.24e-10 | 192 |
GO:0007346 | GO:0007346 | regulation of mitotic cell cycle | 112/2566 | 207/8135 | 1.72 | 8.49e-12 | 2.70e-09 | 207 |
GO:0071103 | GO:0071103 | DNA conformation change | 74/2566 | 121/8135 | 1.94 | 1.40e-11 | 4.03e-09 | 121 |
GO:0048285 | GO:0048285 | organelle fission | 111/2566 | 206/8135 | 1.71 | 1.49e-11 | 4.03e-09 | 206 |
GO:0098813 | GO:0098813 | nuclear chromosome segregation | 67/2566 | 106/8135 | 2.00 | 1.54e-11 | 4.03e-09 | 106 |
GO:0010564 | GO:0010564 | regulation of cell cycle process | 125/2566 | 243/8135 | 1.63 | 5.01e-11 | 1.24e-08 | 243 |
GO:1902850 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 36/2566 | 47/8135 | 2.43 | 2.51e-10 | 5.88e-08 | 47 |
GO:0006259 | GO:0006259 | DNA metabolic process | 145/2566 | 301/8135 | 1.53 | 6.55e-10 | 1.46e-07 | 301 |
GO:0006260 | GO:0006260 | DNA replication | 50/2566 | 77/8135 | 2.06 | 1.52e-09 | 3.22e-07 | 77 |
GO:0007052 | GO:0007052 | mitotic spindle organization | 30/2566 | 39/8135 | 2.44 | 6.84e-09 | 1.39e-06 | 39 |
GO:1901990 | GO:1901990 | regulation of mitotic cell cycle phase transition | 65/2566 | 113/8135 | 1.82 | 8.57e-09 | 1.66e-06 | 113 |
GO:0007051 | GO:0007051 | spindle organization | 36/2566 | 51/8135 | 2.24 | 1.08e-08 | 2.01e-06 | 51 |
GO:0006261 | GO:0006261 | DNA-dependent DNA replication | 31/2566 | 42/8135 | 2.34 | 2.10e-08 | 3.74e-06 | 42 |
GO:1901987 | GO:1901987 | regulation of cell cycle phase transition | 69/2566 | 125/8135 | 1.75 | 3.04e-08 | 5.21e-06 | 125 |
GO:0051983 | GO:0051983 | regulation of chromosome segregation | 27/2566 | 35/8135 | 2.45 | 3.59e-08 | 5.71e-06 | 35 |
GO:0000075 | GO:0000075 | cell cycle checkpoint | 43/2566 | 67/8135 | 2.03 | 3.59e-08 | 5.71e-06 | 67 |
GO:0032392 | GO:0032392 | DNA geometric change | 20/2566 | 23/8135 | 2.76 | 5.52e-08 | 8.49e-06 | 23 |
GO:0007088 | GO:0007088 | regulation of mitotic nuclear division | 48/2566 | 79/8135 | 1.93 | 7.38e-08 | 1.10e-05 | 79 |
GO:0045787 | GO:0045787 | positive regulation of cell cycle | 85/2566 | 166/8135 | 1.62 | 8.39e-08 | 1.20e-05 | 166 |
GO:0032508 | GO:0032508 | DNA duplex unwinding | 18/2566 | 20/8135 | 2.85 | 8.61e-08 | 1.20e-05 | 20 |
GO:0071824 | GO:0071824 | protein-DNA complex subunit organization | 61/2566 | 109/8135 | 1.77 | 9.81e-08 | 1.32e-05 | 109 |
GO:0000082 | GO:0000082 | G1/S transition of mitotic cell cycle | 50/2566 | 84/8135 | 1.89 | 1.01e-07 | 1.32e-05 | 84 |
GO:0006323 | GO:0006323 | DNA packaging | 57/2566 | 100/8135 | 1.81 | 1.09e-07 | 1.39e-05 | 100 |
GO:0044843 | GO:0044843 | cell cycle G1/S phase transition | 53/2566 | 91/8135 | 1.85 | 1.15e-07 | 1.43e-05 | 91 |
GO:0045786 | GO:0045786 | negative regulation of cell cycle | 103/2566 | 212/8135 | 1.54 | 1.20e-07 | 1.45e-05 | 212 |
GO:0065004 | GO:0065004 | protein-DNA complex assembly | 56/2566 | 98/8135 | 1.81 | 1.25e-07 | 1.47e-05 | 98 |
GO:0044839 | GO:0044839 | cell cycle G2/M phase transition | 45/2566 | 74/8135 | 1.93 | 1.82e-07 | 2.08e-05 | 74 |
GO:0010965 | GO:0010965 | regulation of mitotic sister chromatid separation | 20/2566 | 24/8135 | 2.64 | 2.33e-07 | 2.39e-05 | 24 |
GO:0033047 | GO:0033047 | regulation of mitotic sister chromatid segregation | 20/2566 | 24/8135 | 2.64 | 2.33e-07 | 2.39e-05 | 24 |
GO:0051306 | GO:0051306 | mitotic sister chromatid separation | 20/2566 | 24/8135 | 2.64 | 2.33e-07 | 2.39e-05 | 24 |
GO:0006281 | GO:0006281 | DNA repair | 69/2566 | 130/8135 | 1.68 | 2.37e-07 | 2.39e-05 | 130 |
GO:0034502 | GO:0034502 | protein localization to chromosome | 17/2566 | 19/8135 | 2.84 | 2.47e-07 | 2.39e-05 | 19 |
GO:0051310 | GO:0051310 | metaphase plate congression | 17/2566 | 19/8135 | 2.84 | 2.47e-07 | 2.39e-05 | 19 |
GO:0006302 | GO:0006302 | double-strand break repair | 47/2566 | 79/8135 | 1.89 | 2.49e-07 | 2.39e-05 | 79 |
GO:0000086 | GO:0000086 | G2/M transition of mitotic cell cycle | 42/2566 | 68/8135 | 1.96 | 2.52e-07 | 2.39e-05 | 68 |
GO:0010948 | GO:0010948 | negative regulation of cell cycle process | 54/2566 | 95/8135 | 1.80 | 2.66e-07 | 2.47e-05 | 95 |
GO:0051783 | GO:0051783 | regulation of nuclear division | 54/2566 | 96/8135 | 1.78 | 4.24e-07 | 3.85e-05 | 96 |
GO:0051304 | GO:0051304 | chromosome separation | 26/2566 | 36/8135 | 2.29 | 6.08e-07 | 5.42e-05 | 36 |
GO:0051321 | GO:0051321 | meiotic cell cycle | 73/2566 | 143/8135 | 1.62 | 7.95e-07 | 6.95e-05 | 143 |
GO:1905818 | GO:1905818 | regulation of chromosome separation | 20/2566 | 25/8135 | 2.54 | 8.17e-07 | 7.00e-05 | 25 |
GO:1902749 | GO:1902749 | regulation of cell cycle G2/M phase transition | 34/2566 | 53/8135 | 2.03 | 9.92e-07 | 8.09e-05 | 53 |
GO:0034508 | GO:0034508 | centromere complex assembly | 21/2566 | 27/8135 | 2.47 | 9.97e-07 | 8.09e-05 | 27 |
GO:0006270 | GO:0006270 | DNA replication initiation | 14/2566 | 15/8135 | 2.96 | 9.98e-07 | 8.09e-05 | 15 |
GO:0051784 | GO:0051784 | negative regulation of nuclear division | 22/2566 | 29/8135 | 2.41 | 1.15e-06 | 9.16e-05 | 29 |
GO:0010389 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 31/2566 | 47/8135 | 2.09 | 1.23e-06 | 9.58e-05 | 47 |
GO:0031497 | GO:0031497 | chromatin assembly | 48/2566 | 85/8135 | 1.79 | 1.58e-06 | 1.22e-04 | 85 |
GO:0090068 | GO:0090068 | positive regulation of cell cycle process | 61/2566 | 116/8135 | 1.67 | 1.78e-06 | 1.34e-04 | 116 |
GO:0006333 | GO:0006333 | chromatin assembly or disassembly | 50/2566 | 90/8135 | 1.76 | 1.86e-06 | 1.38e-04 | 90 |
GO:0032200 | GO:0032200 | telomere organization | 30/2566 | 46/8135 | 2.07 | 2.60e-06 | 1.90e-04 | 46 |
GO:0006342 | GO:0006342 | chromatin silencing | 29/2566 | 44/8135 | 2.09 | 2.78e-06 | 1.95e-04 | 44 |
GO:0006334 | GO:0006334 | nucleosome assembly | 44/2566 | 77/8135 | 1.81 | 2.79e-06 | 1.95e-04 | 77 |
GO:0033045 | GO:0033045 | regulation of sister chromatid segregation | 21/2566 | 28/8135 | 2.38 | 2.80e-06 | 1.95e-04 | 28 |
GO:0007080 | GO:0007080 | mitotic metaphase plate congression | 13/2566 | 14/8135 | 2.94 | 2.97e-06 | 2.04e-04 | 14 |
GO:0033046 | GO:0033046 | negative regulation of sister chromatid segregation | 16/2566 | 19/8135 | 2.67 | 3.15e-06 | 2.10e-04 | 19 |
GO:0051985 | GO:0051985 | negative regulation of chromosome segregation | 16/2566 | 19/8135 | 2.67 | 3.15e-06 | 2.10e-04 | 19 |
GO:0034728 | GO:0034728 | nucleosome organization | 48/2566 | 87/8135 | 1.75 | 3.88e-06 | 2.51e-04 | 87 |
GO:0007091 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 17/2566 | 21/8135 | 2.57 | 4.29e-06 | 2.73e-04 | 21 |
GO:0045814 | GO:0045814 | negative regulation of gene expression, epigenetic | 31/2566 | 49/8135 | 2.01 | 4.60e-06 | 2.89e-04 | 49 |
GO:1903046 | GO:1903046 | meiotic cell cycle process | 58/2566 | 112/8135 | 1.64 | 5.97e-06 | 3.70e-04 | 112 |
GO:0031055 | GO:0031055 | chromatin remodeling at centromere | 19/2566 | 25/8135 | 2.41 | 6.13e-06 | 3.74e-04 | 25 |
GO:0033048 | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 15/2566 | 18/8135 | 2.64 | 8.50e-06 | 4.98e-04 | 18 |
GO:1905819 | GO:1905819 | negative regulation of chromosome separation | 15/2566 | 18/8135 | 2.64 | 8.50e-06 | 4.98e-04 | 18 |
GO:2000816 | GO:2000816 | negative regulation of mitotic sister chromatid separation | 15/2566 | 18/8135 | 2.64 | 8.50e-06 | 4.98e-04 | 18 |
GO:0071459 | GO:0071459 | protein localization to chromosome, centromeric region | 10/2566 | 10/8135 | 3.17 | 9.63e-06 | 5.58e-04 | 10 |
GO:0030071 | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 16/2566 | 20/8135 | 2.54 | 1.11e-05 | 6.36e-04 | 20 |
GO:0040029 | GO:0040029 | regulation of gene expression, epigenetic | 49/2566 | 92/8135 | 1.69 | 1.15e-05 | 6.49e-04 | 92 |
GO:0000910 | GO:0000910 | cytokinesis | 33/2566 | 55/8135 | 1.90 | 1.19e-05 | 6.55e-04 | 55 |
GO:0007093 | GO:0007093 | mitotic cell cycle checkpoint | 33/2566 | 55/8135 | 1.90 | 1.19e-05 | 6.55e-04 | 55 |
GO:0044784 | GO:0044784 | metaphase/anaphase transition of cell cycle | 17/2566 | 22/8135 | 2.45 | 1.33e-05 | 7.24e-04 | 22 |
GO:0140013 | GO:0140013 | meiotic nuclear division | 55/2566 | 107/8135 | 1.63 | 1.37e-05 | 7.28e-04 | 107 |
GO:0006336 | GO:0006336 | DNA replication-independent nucleosome assembly | 18/2566 | 24/8135 | 2.38 | 1.50e-05 | 7.66e-04 | 24 |
GO:0034724 | GO:0034724 | DNA replication-independent nucleosome organization | 18/2566 | 24/8135 | 2.38 | 1.50e-05 | 7.66e-04 | 24 |
GO:0045839 | GO:0045839 | negative regulation of mitotic nuclear division | 18/2566 | 24/8135 | 2.38 | 1.50e-05 | 7.66e-04 | 24 |
GO:0061640 | GO:0061640 | cytoskeleton-dependent cytokinesis | 23/2566 | 34/8135 | 2.14 | 1.59e-05 | 8.07e-04 | 34 |
GO:0000281 | GO:0000281 | mitotic cytokinesis | 20/2566 | 28/8135 | 2.26 | 1.66e-05 | 8.31e-04 | 28 |
GO:0031570 | GO:0031570 | DNA integrity checkpoint | 28/2566 | 45/8135 | 1.97 | 2.10e-05 | 1.03e-03 | 45 |
GO:2001251 | GO:2001251 | negative regulation of chromosome organization | 28/2566 | 45/8135 | 1.97 | 2.10e-05 | 1.03e-03 | 45 |
GO:0045930 | GO:0045930 | negative regulation of mitotic cell cycle | 52/2566 | 101/8135 | 1.63 | 2.21e-05 | 1.07e-03 | 101 |
GO:0007062 | GO:0007062 | sister chromatid cohesion | 14/2566 | 17/8135 | 2.61 | 2.27e-05 | 1.09e-03 | 17 |
GO:0000083 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 11/2566 | 12/8135 | 2.91 | 2.59e-05 | 1.19e-03 | 12 |
GO:0031145 | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 11/2566 | 12/8135 | 2.91 | 2.59e-05 | 1.19e-03 | 12 |
GO:0006310 | GO:0006310 | DNA recombination | 53/2566 | 104/8135 | 1.62 | 2.68e-05 | 1.22e-03 | 104 |
GO:1902099 | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 16/2566 | 21/8135 | 2.42 | 3.30e-05 | 1.49e-03 | 21 |
GO:0034080 | GO:0034080 | CENP-A containing nucleosome assembly | 17/2566 | 23/8135 | 2.34 | 3.60e-05 | 1.59e-03 | 23 |
GO:0061641 | GO:0061641 | CENP-A containing chromatin organization | 17/2566 | 23/8135 | 2.34 | 3.60e-05 | 1.59e-03 | 23 |
GO:0043486 | GO:0043486 | histone exchange | 19/2566 | 27/8135 | 2.23 | 3.81e-05 | 1.66e-03 | 27 |
GO:0000724 | GO:0000724 | double-strand break repair via homologous recombination | 27/2566 | 44/8135 | 1.95 | 4.22e-05 | 1.81e-03 | 44 |
GO:0000725 | GO:0000725 | recombinational repair | 27/2566 | 44/8135 | 1.95 | 4.22e-05 | 1.81e-03 | 44 |
GO:0008608 | GO:0008608 | attachment of spindle microtubules to kinetochore | 12/2566 | 14/8135 | 2.72 | 4.37e-05 | 1.84e-03 | 14 |
GO:0044786 | GO:0044786 | cell cycle DNA replication | 12/2566 | 14/8135 | 2.72 | 4.37e-05 | 1.84e-03 | 14 |
GO:0000723 | GO:0000723 | telomere maintenance | 23/2566 | 36/8135 | 2.03 | 6.35e-05 | 2.64e-03 | 36 |
GO:0016458 | GO:0016458 | gene silencing | 45/2566 | 87/8135 | 1.64 | 6.70e-05 | 2.77e-03 | 87 |
GO:0033044 | GO:0033044 | regulation of chromosome organization | 49/2566 | 97/8135 | 1.60 | 7.13e-05 | 2.91e-03 | 97 |
GO:0007098 | GO:0007098 | centrosome cycle | 21/2566 | 32/8135 | 2.08 | 7.45e-05 | 3.02e-03 | 32 |
GO:0090307 | GO:0090307 | mitotic spindle assembly | 15/2566 | 20/8135 | 2.38 | 8.07e-05 | 3.24e-03 | 20 |
GO:0045931 | GO:0045931 | positive regulation of mitotic cell cycle | 36/2566 | 66/8135 | 1.73 | 8.54e-05 | 3.37e-03 | 66 |
GO:1901988 | GO:1901988 | negative regulation of cell cycle phase transition | 36/2566 | 66/8135 | 1.73 | 8.54e-05 | 3.37e-03 | 66 |
GO:0006338 | GO:0006338 | chromatin remodeling | 33/2566 | 59/8135 | 1.77 | 8.67e-05 | 3.39e-03 | 59 |
GO:1901992 | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 22/2566 | 35/8135 | 1.99 | 1.31e-04 | 5.07e-03 | 35 |
GO:0060968 | GO:0060968 | regulation of gene silencing | 30/2566 | 53/8135 | 1.79 | 1.35e-04 | 5.14e-03 | 53 |
GO:1901991 | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 33/2566 | 60/8135 | 1.74 | 1.35e-04 | 5.14e-03 | 60 |
GO:0007094 | GO:0007094 | mitotic spindle assembly checkpoint | 12/2566 | 15/8135 | 2.54 | 1.56e-04 | 5.63e-03 | 15 |
GO:0031577 | GO:0031577 | spindle checkpoint | 12/2566 | 15/8135 | 2.54 | 1.56e-04 | 5.63e-03 | 15 |
GO:0045841 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 12/2566 | 15/8135 | 2.54 | 1.56e-04 | 5.63e-03 | 15 |
GO:0071173 | GO:0071173 | spindle assembly checkpoint | 12/2566 | 15/8135 | 2.54 | 1.56e-04 | 5.63e-03 | 15 |
GO:0071174 | GO:0071174 | mitotic spindle checkpoint | 12/2566 | 15/8135 | 2.54 | 1.56e-04 | 5.63e-03 | 15 |
GO:1902100 | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 12/2566 | 15/8135 | 2.54 | 1.56e-04 | 5.63e-03 | 15 |
GO:1901989 | GO:1901989 | positive regulation of cell cycle phase transition | 25/2566 | 42/8135 | 1.89 | 1.63e-04 | 5.87e-03 | 42 |
GO:0043044 | GO:0043044 | ATP-dependent chromatin remodeling | 19/2566 | 29/8135 | 2.08 | 1.71e-04 | 6.04e-03 | 29 |
GO:0051225 | GO:0051225 | spindle assembly | 19/2566 | 29/8135 | 2.08 | 1.71e-04 | 6.04e-03 | 29 |
GO:0050000 | GO:0050000 | chromosome localization | 18/2566 | 27/8135 | 2.11 | 1.83e-04 | 6.36e-03 | 27 |
GO:0051303 | GO:0051303 | establishment of chromosome localization | 18/2566 | 27/8135 | 2.11 | 1.83e-04 | 6.36e-03 | 27 |
GO:0000183 | GO:0000183 | chromatin silencing at rDNA | 17/2566 | 25/8135 | 2.16 | 1.92e-04 | 6.65e-03 | 25 |
GO:0033260 | GO:0033260 | nuclear DNA replication | 10/2566 | 12/8135 | 2.64 | 3.25e-04 | 1.08e-02 | 12 |
GO:0070507 | GO:0070507 | regulation of microtubule cytoskeleton organization | 34/2566 | 65/8135 | 1.66 | 3.86e-04 | 1.27e-02 | 65 |
GO:0051054 | GO:0051054 | positive regulation of DNA metabolic process | 36/2566 | 71/8135 | 1.61 | 5.74e-04 | 1.87e-02 | 71 |
GO:0006335 | GO:0006335 | DNA replication-dependent nucleosome assembly | 15/2566 | 23/8135 | 2.07 | 9.08e-04 | 2.87e-02 | 23 |
GO:0006882 | GO:0006882 | cellular zinc ion homeostasis | 15/2566 | 23/8135 | 2.07 | 9.08e-04 | 2.87e-02 | 23 |
GO:0034723 | GO:0034723 | DNA replication-dependent nucleosome organization | 15/2566 | 23/8135 | 2.07 | 9.08e-04 | 2.87e-02 | 23 |
GO:0061982 | GO:0061982 | meiosis I cell cycle process | 37/2566 | 75/8135 | 1.56 | 9.44e-04 | 2.96e-02 | 75 |
GO:0051782 | GO:0051782 | negative regulation of cell division | 10/2566 | 13/8135 | 2.44 | 1.01e-03 | 3.08e-02 | 13 |
GO:0016441 | GO:0016441 | posttranscriptional gene silencing | 28/2566 | 53/8135 | 1.67 | 1.01e-03 | 3.08e-02 | 53 |
GO:0035194 | GO:0035194 | posttranscriptional gene silencing by RNA | 28/2566 | 53/8135 | 1.67 | 1.01e-03 | 3.08e-02 | 53 |
GO:0045132 | GO:0045132 | meiotic chromosome segregation | 28/2566 | 53/8135 | 1.67 | 1.01e-03 | 3.08e-02 | 53 |
GO:0061351 | GO:0061351 | neural precursor cell proliferation | 42/2566 | 88/8135 | 1.51 | 1.04e-03 | 3.16e-02 | 88 |
GO:0006890 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 12/2566 | 17/8135 | 2.24 | 1.07e-03 | 3.23e-02 | 17 |
GO:0031023 | GO:0031023 | microtubule organizing center organization | 21/2566 | 37/8135 | 1.80 | 1.29e-03 | 3.83e-02 | 37 |
GO:0035195 | GO:0035195 | gene silencing by miRNA | 26/2566 | 49/8135 | 1.68 | 1.39e-03 | 4.10e-02 | 49 |
GO:0006275 | GO:0006275 | regulation of DNA replication | 19/2566 | 33/8135 | 1.83 | 1.73e-03 | 4.94e-02 | 33 |
GO:0044774 | GO:0044774 | mitotic DNA integrity checkpoint | 19/2566 | 33/8135 | 1.83 | 1.73e-03 | 4.94e-02 | 33 |
GO:0060147 | GO:0060147 | regulation of posttranscriptional gene silencing | 22/2566 | 40/8135 | 1.74 | 1.74e-03 | 4.94e-02 | 40 |
GO:0060966 | GO:0060966 | regulation of gene silencing by RNA | 22/2566 | 40/8135 | 1.74 | 1.74e-03 | 4.94e-02 | 40 |
Mutation_status | TP53_LOF_up | TP53_LOF_down | TP53_mis_up | TP53_mis_down | CDH1_LOF_up |
Signif_GO_terms | 143 | 6 | 142 | 7 | 7 |
Mutation_status | CDH1_LOF_down | GATA3_LOF_up | GATA3_LOF_down | PIK3CA_mis_up | PIK3CA_mis_down |
Signif_GO_terms | 263 | 87 | 12 | 7 | 144 |
In contrast to the guided version, here we provide no guidance (\(G = \vec{0}\)) to our sparse factor analysis model to serve as a comparison.
We matched the factors obtained from GFSA with those from FLASH, and conducted pairwise comparisons for both factors and gene loadings.
In the following heatmaps, factors are labeled by the KO condition(s) that they have an association p-value < 1e-4 with.